descriptor_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	section_name	section_description	path	root_field	parent_path	parent_name	parent_description	preferred_term	term_id	term_label	description	raw_json	postcomp_located_in	postcomp_located_in_ids	postcomp_modifier	postcomp_therapeutic_agent	postcomp_therapeutic_agent_ids	qualifier_clinical_course	qualifier_clinical_course_ids	qualifier_clinical_course_predicate_ids	qualifier_has_participant	qualifier_has_participant_ids	qualifier_has_participant_predicate_ids	qualifier_immunologic_factor	qualifier_immunologic_factor_ids	qualifier_immunologic_factor_predicate_ids	qualifier_monoclonal_antibody_predicate_ids	qualifier_route_of_administration	qualifier_route_of_administration_ids	qualifier_route_of_administration_predicate_ids	qualifier_surgical_procedure	qualifier_surgical_procedure_ids	qualifier_surgical_procedure_predicate_ids	qualifier_therapeutic_agent	qualifier_therapeutic_agent_ids	qualifier_therapeutic_agent_predicate_ids	qualifier_therapeutic_procedure	qualifier_therapeutic_procedure_ids	qualifier_therapeutic_procedure_predicate_ids
1	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"	cell_types[0]	cell_types	cell_types			neural crest cell	CL:0011012	neural crest cell		"{""preferred_term"": ""neural crest cell"", ""term"": {""id"": ""CL:0011012"", ""label"": ""neural crest cell""}}"																											
2	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"	cell_types[1]	cell_types	cell_types			pharyngeal arch mesenchyme cell	CL:0000134	mesenchymal stem cell		"{""preferred_term"": ""pharyngeal arch mesenchyme cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}"																											
3	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"	locations[0]	locations	locations			pharyngeal arch	UBERON:0002539	pharyngeal arch		"{""preferred_term"": ""pharyngeal arch"", ""term"": {""id"": ""UBERON:0002539"", ""label"": ""pharyngeal arch""}}"																											
4	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"	locations[1]	locations	locations			pharyngeal pouch 3	UBERON:0007124	pharyngeal pouch 3		"{""preferred_term"": ""pharyngeal pouch 3"", ""term"": {""id"": ""UBERON:0007124"", ""label"": ""pharyngeal pouch 3""}}"																											
5	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"	biological_processes[0]	biological_processes	biological_processes			pharyngeal system development	GO:0060037	pharyngeal system development		"{""preferred_term"": ""pharyngeal system development"", ""term"": {""id"": ""GO:0060037"", ""label"": ""pharyngeal system development""}}"																											
6	4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	Cardiac neural crest migration defect	"Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.
"	cell_types[0]	cell_types	cell_types			migratory cardiac neural crest cell	CL:2000073	migratory cardiac neural crest cell		"{""preferred_term"": ""migratory cardiac neural crest cell"", ""term"": {""id"": ""CL:2000073"", ""label"": ""migratory cardiac neural crest cell""}}"																											
7	4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	Cardiac neural crest migration defect	"Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.
"	locations[0]	locations	locations			cardiac outflow tract	UBERON:0004145	outflow tract		"{""preferred_term"": ""cardiac outflow tract"", ""term"": {""id"": ""UBERON:0004145"", ""label"": ""outflow tract""}}"																											
8	4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	Cardiac neural crest migration defect	"Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.
"	biological_processes[0]	biological_processes	biological_processes			cardiac neural crest cell migration involved in outflow tract morphogenesis	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis		"{""preferred_term"": ""cardiac neural crest cell migration involved in outflow tract morphogenesis"", ""term"": {""id"": ""GO:0003253"", ""label"": ""cardiac neural crest cell migration involved in outflow tract morphogenesis""}}"																											
9	4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	Cardiac neural crest migration defect	"Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.
"	biological_processes[1]	biological_processes	biological_processes			outflow tract morphogenesis	GO:0003151	outflow tract morphogenesis		"{""preferred_term"": ""outflow tract morphogenesis"", ""term"": {""id"": ""GO:0003151"", ""label"": ""outflow tract morphogenesis""}}"																											
10	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"	cell_types[0]	cell_types	cell_types			cortical thymic epithelial cell	CL:0002364	cortical thymic epithelial cell		"{""preferred_term"": ""cortical thymic epithelial cell"", ""term"": {""id"": ""CL:0002364"", ""label"": ""cortical thymic epithelial cell""}}"																											
11	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"	cell_types[1]	cell_types	cell_types			medullary thymic epithelial cell	CL:0002365	medullary thymic epithelial cell		"{""preferred_term"": ""medullary thymic epithelial cell"", ""term"": {""id"": ""CL:0002365"", ""label"": ""medullary thymic epithelial cell""}}"																											
12	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"	cell_types[2]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
13	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"	locations[0]	locations	locations			thymus	UBERON:0002370	thymus		"{""preferred_term"": ""thymus"", ""term"": {""id"": ""UBERON:0002370"", ""label"": ""thymus""}}"																											
14	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"	biological_processes[0]	biological_processes	biological_processes			neural crest cell differentiation involved in thymus development	GO:1902637	neural crest cell differentiation involved in thymus development		"{""preferred_term"": ""neural crest cell differentiation involved in thymus development"", ""term"": {""id"": ""GO:1902637"", ""label"": ""neural crest cell differentiation involved in thymus development""}}"																											
15	6	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	3	Parathyroid hypoplasia and hypocalcemia	"The parathyroid glands derive from the third and fourth pharyngeal pouches. Defective pouch development causes parathyroid hypoplasia, leading to hypoparathyroidism and hypocalcemia. Neonatal hypocalcemia may present with seizures and is often the presenting feature.
"	locations[0]	locations	locations			parathyroid gland	UBERON:0001132	parathyroid gland		"{""preferred_term"": ""parathyroid gland"", ""term"": {""id"": ""UBERON:0001132"", ""label"": ""parathyroid gland""}}"																											
16	6	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	3	Parathyroid hypoplasia and hypocalcemia	"The parathyroid glands derive from the third and fourth pharyngeal pouches. Defective pouch development causes parathyroid hypoplasia, leading to hypoparathyroidism and hypocalcemia. Neonatal hypocalcemia may present with seizures and is often the presenting feature.
"	biological_processes[0]	biological_processes	biological_processes			neural crest cell differentiation involved in parathyroid gland development	GO:1902638	neural crest cell differentiation involved in parathyroid gland development		"{""preferred_term"": ""neural crest cell differentiation involved in parathyroid gland development"", ""term"": {""id"": ""GO:1902638"", ""label"": ""neural crest cell differentiation involved in parathyroid gland development""}}"																											
31	27	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	0	ALK Gene Rearrangement	ALK rearrangements result from chromosomal inversions or translocations that fuse the ALK kinase domain to an N-terminal partner gene (usually EML4). The partner provides a dimerization domain, causing constitutive ALK kinase activation independent of ligand.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
32	27	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	0	ALK Gene Rearrangement	ALK rearrangements result from chromosomal inversions or translocations that fuse the ALK kinase domain to an N-terminal partner gene (usually EML4). The partner provides a dimerization domain, causing constitutive ALK kinase activation independent of ligand.	biological_processes[0]	biological_processes	biological_processes			protein kinase activity	GO:0004672	protein kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}"			INCREASED																								
33	28	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ALK Signaling	The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
34	28	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ALK Signaling	The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
35	28	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ALK Signaling	The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration.	biological_processes[2]	biological_processes	biological_processes			JAK-STAT cascade	GO:0007259	JAK-STAT cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"			INCREASED																								
36	29	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	ALK-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ALK signaling for survival. ALK inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
37	30	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	3	ALK TKI Resistance	Resistance to ALK TKIs develops through ALK-dependent mechanisms (secondary mutations like G1202R, compound mutations) or ALK-independent bypass pathways (MET, EGFR, KRAS). Later-generation TKIs (lorlatinib) overcome most single ALK mutations.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
48	45	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	0	PML-RARA Fusion Oncogene Formation	The t(15;17)(q24;q21) translocation fuses the PML gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17. The resulting fusion protein retains the DNA-binding and ligand-binding domains of RARA but gains aberrant properties from PML, including enhanced corepressor recruitment and altered subnuclear localization.	cell_types[0]	cell_types	cell_types			promyelocyte	CL:0000836	promyelocyte		"{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}"																											
49	45	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	0	PML-RARA Fusion Oncogene Formation	The t(15;17)(q24;q21) translocation fuses the PML gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17. The resulting fusion protein retains the DNA-binding and ligand-binding domains of RARA but gains aberrant properties from PML, including enhanced corepressor recruitment and altered subnuclear localization.	biological_processes[0]	biological_processes	biological_processes			myeloid cell differentiation	GO:0030099	myeloid cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}"			DECREASED																								
50	46	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	1	Transcriptional Repression of Differentiation Genes	PML-RARA binds retinoic acid response elements but recruits corepressor complexes (NCoR, SMRT, HDACs) at physiological retinoic acid concentrations. This silences RARA target genes required for granulocyte differentiation, causing a differentiation block at the promyelocyte stage. Pharmacological doses of ATRA overcome this block.	cell_types[0]	cell_types	cell_types			promyelocyte	CL:0000836	promyelocyte		"{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}"																											
51	46	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	1	Transcriptional Repression of Differentiation Genes	PML-RARA binds retinoic acid response elements but recruits corepressor complexes (NCoR, SMRT, HDACs) at physiological retinoic acid concentrations. This silences RARA target genes required for granulocyte differentiation, causing a differentiation block at the promyelocyte stage. Pharmacological doses of ATRA overcome this block.	biological_processes[0]	biological_processes	biological_processes			granulocyte differentiation	GO:0030851	granulocyte differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""granulocyte differentiation"", ""term"": {""id"": ""GO:0030851"", ""label"": ""granulocyte differentiation""}}"			DECREASED																								
52	47	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	2	PML Nuclear Body Disruption	Wild-type PML organizes nuclear bodies that regulate multiple cellular processes including apoptosis and senescence. PML-RARA disrupts PML nuclear bodies into a microspeckled pattern, impairing PML tumor suppressor functions. Arsenic trioxide restores PML nuclear bodies and induces PML-RARA degradation.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
53	48	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	3	Impaired Tumor Suppression	Disruption of PML nuclear bodies impairs p53-mediated senescence and apoptosis pathways. This contributes to the survival and accumulation of leukemic promyelocytes.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
54	49	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	4	Promyelocyte Accumulation	The differentiation block at the promyelocyte stage leads to accumulation of abnormal promyelocytes in bone marrow and blood. These cells contain abundant azurophilic granules and release procoagulant factors.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
55	49	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	4	Promyelocyte Accumulation	The differentiation block at the promyelocyte stage leads to accumulation of abnormal promyelocytes in bone marrow and blood. These cells contain abundant azurophilic granules and release procoagulant factors.	cell_types[0]	cell_types	cell_types			promyelocyte	CL:0000836	promyelocyte		"{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}"																											
56	50	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	5	Coagulopathy	APL promyelocytes release tissue factor and cancer procoagulant from azurophilic granules, triggering disseminated intravascular coagulation. Annexin II expression promotes plasmin generation causing hyperfibrinolysis. This combination causes severe, often fatal bleeding before and during early treatment.	biological_processes[0]	biological_processes	biological_processes			blood coagulation	GO:0007596	blood coagulation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"			ABNORMAL																								
69	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	TTR Tetramer Destabilization	Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.	biological_processes[0]	biological_processes	biological_processes			protein tetramerization	GO:0051289	protein homotetramerization		"{""preferred_term"": ""protein tetramerization"", ""term"": {""id"": ""GO:0051289"", ""label"": ""protein homotetramerization""}}"																											
70	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	TTR Tetramer Destabilization	Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.	biological_processes[1]	biological_processes	biological_processes			protein folding	GO:0006457	protein folding		"{""preferred_term"": ""protein folding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}"																											
71	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	TTR Tetramer Destabilization	Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.	locations[0]	locations	locations			extracellular space	GO:0005615	extracellular space		"{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular space""}}"																											
72	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	TTR Tetramer Destabilization	Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.	locations[1]	locations	locations			blood plasma	UBERON:0001969	blood plasma		"{""preferred_term"": ""blood plasma"", ""term"": {""id"": ""UBERON:0001969"", ""label"": ""blood plasma""}}"																											
73	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.	biological_processes[0]	biological_processes	biological_processes			amyloid fibril formation	GO:0043241	amyloid fibril formation		"{""preferred_term"": ""amyloid fibril formation"", ""term"": {""id"": ""GO:0043241"", ""label"": ""amyloid fibril formation""}}"																											
74	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.	biological_processes[1]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
75	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.	locations[0]	locations	locations			extracellular space	GO:0005615	extracellular space		"{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular space""}}"																											
76	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.	locations[1]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
77	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.	locations[2]	locations	locations			peripheral nervous system	UBERON:0000010	peripheral nervous system		"{""preferred_term"": ""peripheral nervous system"", ""term"": {""id"": ""UBERON:0000010"", ""label"": ""peripheral nervous system""}}"																											
78	75	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	2	Oxidative Stress and Mitochondrial Dysfunction	TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury.	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
79	75	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	2	Oxidative Stress and Mitochondrial Dysfunction	TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury.	biological_processes[1]	biological_processes	biological_processes			mitochondrion organization	GO:0007005	mitochondrion organization		"{""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}"																											
80	75	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	2	Oxidative Stress and Mitochondrial Dysfunction	TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury.	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
81	75	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	2	Oxidative Stress and Mitochondrial Dysfunction	TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury.	locations[0]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
82	76	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	3	Calcium Homeostasis Disruption	Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis.	biological_processes[0]	biological_processes	biological_processes			calcium ion homeostasis	GO:0055074	calcium ion homeostasis		"{""preferred_term"": ""calcium ion homeostasis"", ""term"": {""id"": ""GO:0055074"", ""label"": ""calcium ion homeostasis""}}"																											
83	76	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	3	Calcium Homeostasis Disruption	Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis.	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
84	76	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	3	Calcium Homeostasis Disruption	Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis.	locations[0]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
85	77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.	biological_processes[0]	biological_processes	biological_processes			axonogenesis	GO:0007409	axonogenesis		"{""preferred_term"": ""axonogenesis"", ""term"": {""id"": ""GO:0007409"", ""label"": ""axonogenesis""}}"																											
86	77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.	biological_processes[1]	biological_processes	biological_processes			myelination	GO:0042552	myelination		"{""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
87	77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.	cell_types[0]	cell_types	cell_types			peripheral neuron	CL:0000107	autonomic neuron		"{""preferred_term"": ""peripheral neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}"																											
88	77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.	cell_types[1]	cell_types	cell_types			Schwann cell	CL:0002573	Schwann cell		"{""preferred_term"": ""Schwann cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}"																											
89	77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.	locations[0]	locations	locations			peripheral nervous system	UBERON:0000010	peripheral nervous system		"{""preferred_term"": ""peripheral nervous system"", ""term"": {""id"": ""UBERON:0000010"", ""label"": ""peripheral nervous system""}}"																											
108	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
109	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"	cell_types[1]	cell_types	cell_types			Growth Plate Chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
110	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
111	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"	biological_processes[1]	biological_processes	biological_processes			Cartilage Development	GO:0051216	cartilage development		"{""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}"																											
112	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"	biological_processes[2]	biological_processes	biological_processes			Endochondral Bone Development	GO:0060351	cartilage development involved in endochondral bone morphogenesis		"{""preferred_term"": ""Endochondral Bone Development"", ""term"": {""id"": ""GO:0060351"", ""label"": ""cartilage development involved in endochondral bone morphogenesis""}}"																											
113	104	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	1	Extracellular Matrix Deficiency	"Defective type II collagen secretion results in severely abnormal cartilage extracellular matrix. The cartilage lacks normal fibrillar architecture and fails to provide the template for endochondral ossification.
"	biological_processes[0]	biological_processes	biological_processes			ECM Organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""ECM Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
123	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	gene	gene	$	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	FGFR3	hgnc:3690	FGFR3	Fibroblast growth factor receptor 3, a transmembrane tyrosine kinase receptor that negatively regulates endochondral bone growth.	"{""description"": ""Fibroblast growth factor receptor 3, a transmembrane tyrosine kinase receptor that negatively regulates endochondral bone growth."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"			INCREASED																								
124	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	cell_types[0]	cell_types	cell_types			Growth plate chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
125	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	cell_types[1]	cell_types	cell_types			Hypertrophic chondrocyte	CL:0000743	hypertrophic chondrocyte		"{""preferred_term"": ""Hypertrophic chondrocyte"", ""term"": {""id"": ""CL:0000743"", ""label"": ""hypertrophic chondrocyte""}}"																											
126	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	biological_processes[0]	biological_processes	biological_processes			FGFR signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
127	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	biological_processes[1]	biological_processes	biological_processes			Endochondral ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
128	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"	biological_processes[2]	biological_processes	biological_processes			Chondrocyte differentiation	GO:0002062	chondrocyte differentiation		"{""preferred_term"": ""Chondrocyte differentiation"", ""term"": {""id"": ""GO:0002062"", ""label"": ""chondrocyte differentiation""}}"																											
129	118	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	1	Impaired growth plate cartilage development	"In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).
"	cell_types[0]	cell_types	cell_types			Columnar chondrocyte	CL:0000744	columnar chondrocyte		"{""preferred_term"": ""Columnar chondrocyte"", ""term"": {""id"": ""CL:0000744"", ""label"": ""columnar chondrocyte""}}"																											
130	118	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	1	Impaired growth plate cartilage development	"In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).
"	biological_processes[0]	biological_processes	biological_processes			Growth plate chondrocyte differentiation	GO:0003418	growth plate cartilage chondrocyte differentiation		"{""preferred_term"": ""Growth plate chondrocyte differentiation"", ""term"": {""id"": ""GO:0003418"", ""label"": ""growth plate cartilage chondrocyte differentiation""}}"																											
131	118	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	1	Impaired growth plate cartilage development	"In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).
"	biological_processes[1]	biological_processes	biological_processes			Bone development	GO:0060348	bone development		"{""preferred_term"": ""Bone development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}"																											
144	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	cell_types[0]	cell_types	cell_types			Retinal Ganglion Cell	CL:0000740	retinal ganglion cell		"{""preferred_term"": ""Retinal Ganglion Cell"", ""term"": {""id"": ""CL:0000740"", ""label"": ""retinal ganglion cell""}}"																											
145	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	locations[0]	locations	locations			Visual Cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""Visual Cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
146	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	locations[1]	locations	locations			Trigeminal Ganglion	UBERON:0001675	trigeminal ganglion		"{""preferred_term"": ""Trigeminal Ganglion"", ""term"": {""id"": ""UBERON:0001675"", ""label"": ""trigeminal ganglion""}}"																											
147	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	locations[2]	locations	locations			Trigeminal Nerve	UBERON:0001645	trigeminal nerve		"{""preferred_term"": ""Trigeminal Nerve"", ""term"": {""id"": ""UBERON:0001645"", ""label"": ""trigeminal nerve""}}"																											
148	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	locations[3]	locations	locations			Retina	UBERON:0000966	retina		"{""preferred_term"": ""Retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}"																											
149	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	biological_processes[0]	biological_processes	biological_processes			Visual Perception	GO:0007601	visual perception		"{""preferred_term"": ""Visual Perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}"																											
150	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.	biological_processes[1]	biological_processes	biological_processes			Sensory Perception of Pain	GO:0019233	sensory perception of pain		"{""preferred_term"": ""Sensory Perception of Pain"", ""term"": {""id"": ""GO:0019233"", ""label"": ""sensory perception of pain""}}"																											
151	140	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	1	Parasympathetic Generalization	Light-evoked activation in parasympathetic pathways spreads to nasal secretomotor pathways, causing nasal prickle preceding the sneeze.	cell_types[0]	cell_types	cell_types			Autonomic Neuron	CL:0000107	autonomic neuron		"{""preferred_term"": ""Autonomic Neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}"																											
152	140	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	1	Parasympathetic Generalization	Light-evoked activation in parasympathetic pathways spreads to nasal secretomotor pathways, causing nasal prickle preceding the sneeze.	locations[0]	locations	locations			Nasal Cavity	UBERON:0001707	nasal cavity		"{""preferred_term"": ""Nasal Cavity"", ""term"": {""id"": ""UBERON:0001707"", ""label"": ""nasal cavity""}}"																											
153	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	Central Cortical Processing	Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex.	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
154	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	Central Cortical Processing	Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex.	locations[0]	locations	locations			Cerebral Cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""Cerebral Cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
155	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	Central Cortical Processing	Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex.	locations[1]	locations	locations			Insula	UBERON:0002022	insula of Rolando		"{""preferred_term"": ""Insula"", ""term"": {""id"": ""UBERON:0002022"", ""label"": ""insula of Rolando""}}"																											
156	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	Central Cortical Processing	Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex.	biological_processes[0]	biological_processes	biological_processes			Sensory Processing	GO:0050890	cognition		"{""preferred_term"": ""Sensory Processing"", ""term"": {""id"": ""GO:0050890"", ""label"": ""cognition""}}"																											
157	142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	Brainstem Sneeze Circuit	The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern.	cell_types[0]	cell_types	cell_types			Sensory Neuron	CL:0000101	sensory neuron		"{""preferred_term"": ""Sensory Neuron"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}"																											
158	142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	Brainstem Sneeze Circuit	The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern.	locations[0]	locations	locations			Medulla Oblongata	UBERON:0001896	medulla oblongata		"{""preferred_term"": ""Medulla Oblongata"", ""term"": {""id"": ""UBERON:0001896"", ""label"": ""medulla oblongata""}}"																											
159	142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	Brainstem Sneeze Circuit	The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern.	locations[1]	locations	locations			Trigeminal Nucleus	UBERON:0002925	trigeminal nucleus		"{""preferred_term"": ""Trigeminal Nucleus"", ""term"": {""id"": ""UBERON:0002925"", ""label"": ""trigeminal nucleus""}}"																											
160	142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	Brainstem Sneeze Circuit	The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern.	biological_processes[0]	biological_processes	biological_processes			Respiratory Reflex	GO:0002087	regulation of respiratory gaseous exchange by neurological system process		"{""preferred_term"": ""Respiratory Reflex"", ""term"": {""id"": ""GO:0002087"", ""label"": ""regulation of respiratory gaseous exchange by neurological system process""}}"																											
175	170	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	0	Follicular keratinization	"Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.
"	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
176	170	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	0	Follicular keratinization	"Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.
"	locations[0]	locations	locations			pilosebaceous unit	UBERON:0011932	pilosebaceous unit		"{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}"																											
177	171	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	1	Microcomedone formation	"Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.
"	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
178	171	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	1	Microcomedone formation	"Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.
"	locations[0]	locations	locations			pilosebaceous unit	UBERON:0011932	pilosebaceous unit		"{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}"																											
179	172	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	2	Sebum overproduction	"Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.
"	cell_types[0]	cell_types	cell_types			sebocyte	CL:0000317	sebocyte		"{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}"																											
180	172	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	2	Sebum overproduction	"Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.
"	biological_processes[0]	biological_processes	biological_processes			lipid metabolism	GO:0006629	lipid metabolic process		"{""preferred_term"": ""lipid metabolism"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}"																											
181	173	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	3	Sebum compositional change	"Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.
"	cell_types[0]	cell_types	cell_types			sebocyte	CL:0000317	sebocyte		"{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}"																											
182	173	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	3	Sebum compositional change	"Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.
"	biological_processes[0]	biological_processes	biological_processes			lipid metabolism	GO:0006629	lipid metabolic process		"{""preferred_term"": ""lipid metabolism"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}"																											
183	174	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	4	C. acnes follicular colonization	"Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.
"	cell_types[0]	cell_types	cell_types			sebocyte	CL:0000317	sebocyte		"{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}"																											
184	174	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	4	C. acnes follicular colonization	"Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.
"	locations[0]	locations	locations			pilosebaceous unit	UBERON:0011932	pilosebaceous unit		"{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}"																											
185	175	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	5	Inflammasome activation	"Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.
"	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
186	175	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	5	Inflammasome activation	"Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
187	176	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	6	Cytokine-driven inflammation	"Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
188	176	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	6	Cytokine-driven inflammation	"Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
270	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	cell_types[0]	cell_types	cell_types			CD4 T-lymphocyte	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4 T-lymphocyte"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
271	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	biological_processes[0]	biological_processes	biological_processes			reverse transcription	GO:0001171	reverse transcription		"{""preferred_term"": ""reverse transcription"", ""term"": {""id"": ""GO:0001171"", ""label"": ""reverse transcription""}}"																											
272	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	biological_processes[1]	biological_processes	biological_processes			DNA integration	GO:0015074	DNA integration		"{""preferred_term"": ""DNA integration"", ""term"": {""id"": ""GO:0015074"", ""label"": ""DNA integration""}}"																											
273	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	biological_processes[2]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
274	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	genes[0]	genes	genes			CD4	hgnc:1678	CD4		"{""preferred_term"": ""CD4"", ""term"": {""id"": ""hgnc:1678"", ""label"": ""CD4""}}"																											
275	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	genes[1]	genes	genes			CCR5	hgnc:1606	CCR5		"{""preferred_term"": ""CCR5"", ""term"": {""id"": ""hgnc:1606"", ""label"": ""CCR5""}}"																											
276	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	genes[2]	genes	genes			CXCR4	hgnc:2561	CXCR4		"{""preferred_term"": ""CXCR4"", ""term"": {""id"": ""hgnc:2561"", ""label"": ""CXCR4""}}"																											
277	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
278	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.	locations[1]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
279	219	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	1	Immune System Collapse	Progressive loss of CD4 T-cells leads to severe immunodeficiency.	cell_types[0]	cell_types	cell_types			CD4 T-lymphocyte	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4 T-lymphocyte"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
280	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	Opportunistic Infections	Impaired immunity allows opportunistic pathogens to cause infections.	biological_processes[0]	biological_processes	biological_processes			pyroptotic inflammatory response	GO:0070269	pyroptotic inflammatory response		"{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}"																											
281	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	CNS Reservoir and Neuroinflammation	HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.	cell_types[0]	cell_types	cell_types			microglia	CL:0000129	microglial cell		"{""preferred_term"": ""microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
282	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	CNS Reservoir and Neuroinflammation	HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
283	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	CNS Reservoir and Neuroinflammation	HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.	genes[0]	genes	genes			SAMHD1	hgnc:15925	SAMHD1		"{""preferred_term"": ""SAMHD1"", ""term"": {""id"": ""hgnc:15925"", ""label"": ""SAMHD1""}}"																											
284	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	CNS Reservoir and Neuroinflammation	HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
285	222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).	genes[0]	genes	genes			APOBEC3G	hgnc:17357	APOBEC3G		"{""preferred_term"": ""APOBEC3G"", ""term"": {""id"": ""hgnc:17357"", ""label"": ""APOBEC3G""}}"																											
286	222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).	genes[1]	genes	genes			TRIM5	hgnc:16276	TRIM5		"{""preferred_term"": ""TRIM5"", ""term"": {""id"": ""hgnc:16276"", ""label"": ""TRIM5""}}"																											
287	222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).	genes[2]	genes	genes			BST2	hgnc:1119	BST2		"{""preferred_term"": ""BST2"", ""term"": {""id"": ""hgnc:1119"", ""label"": ""BST2""}}"																											
288	222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).	genes[3]	genes	genes			SERINC5	hgnc:18825	SERINC5		"{""preferred_term"": ""SERINC5"", ""term"": {""id"": ""hgnc:18825"", ""label"": ""SERINC5""}}"																											
289	222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).	biological_processes[0]	biological_processes	biological_processes			defense response to virus	GO:0051607	defense response to virus		"{""preferred_term"": ""defense response to virus"", ""term"": {""id"": ""GO:0051607"", ""label"": ""defense response to virus""}}"																											
290	223	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	5	AIDS-related Cancers	Weakened immune surveillance increases risk of certain cancers.	biological_processes[0]	biological_processes	biological_processes			immune response to tumor cell	GO:0002418	immune response to tumor cell		"{""modifier"": ""DECREASED"", ""preferred_term"": ""immune response to tumor cell"", ""term"": {""id"": ""GO:0002418"", ""label"": ""immune response to tumor cell""}}"			DECREASED																								
301	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta cytotoxic T cell	CL:0000794	CD8-positive, alpha-beta cytotoxic T cell		"{""preferred_term"": ""CD8-positive, alpha-beta cytotoxic T cell"", ""term"": {""id"": ""CL:0000794"", ""label"": ""CD8-positive, alpha-beta cytotoxic T cell""}}"																											
302	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	cell_types[1]	cell_types	cell_types			T-helper 1 cell	CL:0000545	T-helper 1 cell		"{""preferred_term"": ""T-helper 1 cell"", ""term"": {""id"": ""CL:0000545"", ""label"": ""T-helper 1 cell""}}"																											
303	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	cell_types[2]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
304	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	biological_processes[0]	biological_processes	biological_processes			adaptive immune response	GO:0002250	adaptive immune response		"{""preferred_term"": ""adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
305	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	biological_processes[1]	biological_processes	biological_processes			T cell mediated cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
306	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	biological_processes[2]	biological_processes	biological_processes			type 1 immune response	GO:0042093	type 1 immune response		"{""preferred_term"": ""type 1 immune response"", ""term"": {""id"": ""GO:0042093"", ""label"": ""type 1 immune response""}}"																											
307	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	biological_processes[3]	biological_processes	biological_processes			antigen processing and presentation of peptide antigen via MHC class II	GO:0002495	antigen processing and presentation of peptide antigen via MHC class II		"{""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class II"", ""term"": {""id"": ""GO:0002495"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class II""}}"																											
308	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	locations[0]	locations	locations			adrenal cortex	UBERON:0001235	adrenal cortex		"{""preferred_term"": ""adrenal cortex"", ""term"": {""id"": ""UBERON:0001235"", ""label"": ""adrenal cortex""}}"																											
309	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	locations[1]	locations	locations			zona glomerulosa of adrenal gland	UBERON:0002104	zona glomerulosa of adrenal gland		"{""preferred_term"": ""zona glomerulosa of adrenal gland"", ""term"": {""id"": ""UBERON:0002104"", ""label"": ""zona glomerulosa of adrenal gland""}}"																											
310	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.	locations[2]	locations	locations			zona fasciculata of adrenal gland	UBERON:0002105	zona fasciculata of adrenal gland		"{""preferred_term"": ""zona fasciculata of adrenal gland"", ""term"": {""id"": ""UBERON:0002105"", ""label"": ""zona fasciculata of adrenal gland""}}"																											
311	255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	Reduced Cortisol Production	Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency.	biological_processes[0]	biological_processes	biological_processes			glucocorticoid biosynthetic process	GO:0006704	glucocorticoid biosynthetic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""glucocorticoid biosynthetic process"", ""term"": {""id"": ""GO:0006704"", ""label"": ""glucocorticoid biosynthetic process""}}"			DECREASED																								
312	255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	Reduced Cortisol Production	Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency.	biological_processes[1]	biological_processes	biological_processes			gluconeogenesis	GO:0006094	gluconeogenesis		"{""modifier"": ""DECREASED"", ""preferred_term"": ""gluconeogenesis"", ""term"": {""id"": ""GO:0006094"", ""label"": ""gluconeogenesis""}}"			DECREASED																								
313	255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	Reduced Cortisol Production	Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency.	biological_processes[2]	biological_processes	biological_processes			response to stress	GO:0006950	response to stress		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to stress"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}"			ABNORMAL																								
314	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	Reduced Aldosterone Production	Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.	biological_processes[0]	biological_processes	biological_processes			mineralocorticoid biosynthetic process	GO:0006705	mineralocorticoid biosynthetic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""mineralocorticoid biosynthetic process"", ""term"": {""id"": ""GO:0006705"", ""label"": ""mineralocorticoid biosynthetic process""}}"			DECREASED																								
315	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	Reduced Aldosterone Production	Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.	biological_processes[1]	biological_processes	biological_processes			sodium ion transport	GO:0006814	sodium ion transport		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""sodium ion transport"", ""term"": {""id"": ""GO:0006814"", ""label"": ""sodium ion transport""}}"			ABNORMAL																								
316	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	Reduced Aldosterone Production	Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.	biological_processes[2]	biological_processes	biological_processes			potassium ion transport	GO:0006813	potassium ion transport		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""potassium ion transport"", ""term"": {""id"": ""GO:0006813"", ""label"": ""potassium ion transport""}}"			ABNORMAL																								
317	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	Reduced Aldosterone Production	Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.	locations[0]	locations	locations			zona glomerulosa of adrenal gland	UBERON:0002104	zona glomerulosa of adrenal gland		"{""preferred_term"": ""zona glomerulosa of adrenal gland"", ""term"": {""id"": ""UBERON:0002104"", ""label"": ""zona glomerulosa of adrenal gland""}}"																											
318	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[0]	genes	genes			HLA-DRB1				"{""preferred_term"": ""HLA-DRB1""}"																											
319	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[1]	genes	genes			HLA-DQA1				"{""preferred_term"": ""HLA-DQA1""}"																											
320	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[2]	genes	genes			HLA-DQB1				"{""preferred_term"": ""HLA-DQB1""}"																											
321	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[3]	genes	genes			CTLA4	hgnc:2505	CTLA4		"{""preferred_term"": ""CTLA4"", ""term"": {""id"": ""hgnc:2505"", ""label"": ""CTLA4""}}"																											
322	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[4]	genes	genes			PTPN22	hgnc:9652	PTPN22		"{""preferred_term"": ""PTPN22"", ""term"": {""id"": ""hgnc:9652"", ""label"": ""PTPN22""}}"																											
323	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[5]	genes	genes			BACH2	hgnc:936	BACH2		"{""preferred_term"": ""BACH2"", ""term"": {""id"": ""hgnc:936"", ""label"": ""BACH2""}}"																											
324	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[6]	genes	genes			CLEC16A	hgnc:26922	CLEC16A		"{""preferred_term"": ""CLEC16A"", ""term"": {""id"": ""hgnc:26922"", ""label"": ""CLEC16A""}}"																											
325	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[7]	genes	genes			NLRP1	hgnc:22861	NLRP1		"{""preferred_term"": ""NLRP1"", ""term"": {""id"": ""hgnc:22861"", ""label"": ""NLRP1""}}"																											
326	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[8]	genes	genes			CIITA	hgnc:1752	CIITA		"{""preferred_term"": ""CIITA"", ""term"": {""id"": ""hgnc:1752"", ""label"": ""CIITA""}}"																											
327	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	genes[9]	genes	genes			STAT4	hgnc:11365	STAT4		"{""preferred_term"": ""STAT4"", ""term"": {""id"": ""hgnc:11365"", ""label"": ""STAT4""}}"																											
328	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	biological_processes[0]	biological_processes	biological_processes			negative regulation of T cell receptor signaling pathway	GO:0050860	negative regulation of T cell receptor signaling pathway		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""negative regulation of T cell receptor signaling pathway"", ""term"": {""id"": ""GO:0050860"", ""label"": ""negative regulation of T cell receptor signaling pathway""}}"			ABNORMAL																								
329	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	biological_processes[1]	biological_processes	biological_processes			antigen processing and presentation	GO:0019882	antigen processing and presentation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"			ABNORMAL																								
330	257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.	biological_processes[2]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"			INCREASED																								
349	290	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	0	HTLV-1 Infection and Tax Oncoprotein Expression	HTLV-1 preferentially infects CD4+ T cells and integrates into the host genome. The viral Tax protein is the primary driver of transformation, functioning as a transcriptional activator that hijacks multiple cellular pathways. Tax activates NF-kappaB, CREB/ATF, and AP-1 transcription factors, driving T-cell proliferation and survival.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
350	290	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	0	HTLV-1 Infection and Tax Oncoprotein Expression	HTLV-1 preferentially infects CD4+ T cells and integrates into the host genome. The viral Tax protein is the primary driver of transformation, functioning as a transcriptional activator that hijacks multiple cellular pathways. Tax activates NF-kappaB, CREB/ATF, and AP-1 transcription factors, driving T-cell proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			viral transcription	GO:0019083	viral transcription		"{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}"																											
351	291	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	1	Tax-Mediated NF-kappaB Activation	Tax activates both canonical and non-canonical NF-kappaB pathways through direct interaction with IKK complex and NIK. Constitutive NF-kappaB activation drives expression of anti-apoptotic genes (BCL-XL, cIAP, survivin), cytokines (IL-2, IL-15), and cell cycle regulators, promoting T-cell survival and proliferation.	biological_processes[0]	biological_processes	biological_processes			positive regulation of NF-kappaB transcription factor activity	GO:0051092	positive regulation of NF-kappaB transcription factor activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of NF-kappaB transcription factor activity"", ""term"": {""id"": ""GO:0051092"", ""label"": ""positive regulation of NF-kappaB transcription factor activity""}}"			INCREASED																								
352	292	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	2	Genomic Instability and Accumulation of Mutations	Tax impairs multiple DNA repair pathways including nucleotide excision repair, base excision repair, and double-strand break repair. This leads to accumulation of somatic mutations over the decades-long latency period. Tax also causes aneuploidy through centrosome amplification and mitotic checkpoint dysfunction.	biological_processes[0]	biological_processes	biological_processes			DNA damage response	GO:0006974	DNA damage response		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}"			DECREASED																								
353	293	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	3	Apoptosis Resistance	Multiple mechanisms contribute to apoptosis resistance: NF-kappaB-mediated upregulation of BCL-XL and cIAP, Tax-mediated p53 inhibition, and HBZ-mediated enhancement of regulatory T-cell survival. This allows accumulation of cells with genomic abnormalities.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
354	294	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	4	Uncontrolled T-Cell Proliferation	Combined effects of constitutive NF-kappaB activation, accumulated mutations, and apoptosis resistance result in clonal expansion of HTLV-1-infected T cells. ATLL cells acquire a CD4+CD25+FOXP3+ regulatory T-cell phenotype with immunosuppressive properties.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
355	294	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	4	Uncontrolled T-Cell Proliferation	Combined effects of constitutive NF-kappaB activation, accumulated mutations, and apoptosis resistance result in clonal expansion of HTLV-1-infected T cells. ATLL cells acquire a CD4+CD25+FOXP3+ regulatory T-cell phenotype with immunosuppressive properties.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
370	315	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	0	Aflatoxin B1 Metabolic Activation	AFB1 is absorbed from the gut and transported to the liver where it undergoes cytochrome P450-mediated oxidation (primarily CYP3A4 and CYP1A2) to form AFB1-8,9-epoxide, a highly reactive electrophile. This epoxide binds covalently to DNA, forming pro-mutagenic adducts primarily at guanine residues.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
371	315	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	0	Aflatoxin B1 Metabolic Activation	AFB1 is absorbed from the gut and transported to the liver where it undergoes cytochrome P450-mediated oxidation (primarily CYP3A4 and CYP1A2) to form AFB1-8,9-epoxide, a highly reactive electrophile. This epoxide binds covalently to DNA, forming pro-mutagenic adducts primarily at guanine residues.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
372	316	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	1	TP53 R249S Hotspot Mutation	The aflatoxin-DNA adduct forms preferentially at the third position of codon 249 in TP53, causing a G>T transversion that results in arginine-to-serine substitution (R249S). This mutation is found in approximately 50% of HCCs in high-aflatoxin regions but is rare in low-exposure areas. The R249S mutation impairs p53 DNA binding and transcriptional activity, eliminating its tumor suppressor function.	biological_processes[0]	biological_processes	biological_processes			DNA damage response	GO:0006974	DNA damage response		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}"			DECREASED																								
373	317	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	2	HBV-Aflatoxin Synergistic Interaction	HBV and aflatoxin interact synergistically through multiple mechanisms: HBV-induced chronic inflammation increases hepatocyte proliferation, allowing fixation of aflatoxin-induced mutations; HBx protein inhibits DNA repair; and viral integration may disrupt tumor suppressor genes. The multiplicative interaction results in approximately 60-fold increased HCC risk compared to unexposed individuals.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
374	318	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	3	Loss of Cell Cycle Checkpoint Control	TP53 R249S mutation combined with HBx-mediated p53 inhibition and Rb pathway inactivation results in loss of cell cycle checkpoint control. Cells with DNA damage continue to proliferate, accumulating additional mutations.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
375	319	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	4	Apoptosis Resistance	Loss of functional p53 impairs the intrinsic apoptotic pathway in response to DNA damage. Combined with HBV-associated survival signals, this allows accumulation of cells with oncogenic mutations.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
376	320	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	5	Uncontrolled Hepatocyte Proliferation	The combination of impaired checkpoints, apoptosis resistance, chronic inflammation, and hepatocyte regeneration drives clonal expansion of transformed cells, eventually leading to HCC development.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
377	320	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	5	Uncontrolled Hepatocyte Proliferation	The combination of impaired checkpoints, apoptosis resistance, chronic inflammation, and hepatocyte regeneration drives clonal expansion of transformed cells, eventually leading to HCC development.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
390	346	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	0	Drusen Accumulation	"Lipid and protein deposits accumulate between retinal pigment epithelium and Bruch's membrane. Drusen indicate RPE dysfunction and are early hallmark of AMD.
"	cell_types[0]	cell_types	cell_types			Retinal Pigment Epithelial Cell	CL:0002586	retinal pigment epithelial cell		"{""preferred_term"": ""Retinal Pigment Epithelial Cell"", ""term"": {""id"": ""CL:0002586"", ""label"": ""retinal pigment epithelial cell""}}"																											
391	347	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	1	RPE Dysfunction and Loss	"Oxidative stress, lipofuscin accumulation, and inflammation damage RPE cells. RPE loss leads to photoreceptor death and geographic atrophy in dry AMD.
"	biological_processes[0]	biological_processes	biological_processes			Oxidative Stress Response	GO:0006979	response to oxidative stress		"{""preferred_term"": ""Oxidative Stress Response"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
392	348	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	2	Complement Dysregulation	"Excessive complement activation in the macula contributes to chronic inflammation and tissue damage. CFH variants are major genetic risk factor.
"	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
393	349	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	3	Choroidal Neovascularization	"In wet AMD, VEGF-driven abnormal blood vessel growth from choroid invades through Bruch's membrane. These fragile vessels leak and bleed, causing rapid vision loss.
"	biological_processes[0]	biological_processes	biological_processes			Angiogenesis	GO:0001525	angiogenesis		"{""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"																											
403	366	14	Ainhum	Ainhum.yaml	pathophysiology	0	Constricting groove forms around proximal toe	A groove or fissure of constricting tissue develops around a toe, most often the fifth toe.	locations[0]	locations	locations			pedal digit 5	UBERON:0003635	pedal digit 5		"{""preferred_term"": ""pedal digit 5"", ""term"": {""id"": ""UBERON:0003635"", ""label"": ""pedal digit 5""}}"																											
415	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	V5/MT motion-processing cortex dysfunction	The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
416	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	V5/MT motion-processing cortex dysfunction	The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration.	locations[0]	locations	locations			visual cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
417	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	V5/MT motion-processing cortex dysfunction	The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration.	locations[1]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
418	387	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	1	Left V5/MT susceptibility to acute interference	In right-handed individuals, left V5/MT appears particularly susceptible to acute interference during experimental disruption, implicating hemispheric vulnerability in motion perception.	locations[0]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
419	388	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	2	Right-hemispheric V5/MT predominance in clinical cases	Clinical cases more often involve right-hemispheric V5/MT afflictions, suggesting dominance of the right V5/MT in motion perception.	locations[0]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
420	389	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	3	Severity depends on surviving motion network components and stimulus speed	The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
421	389	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	3	Severity depends on surviving motion network components and stimulus speed	The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects.	locations[0]	locations	locations			visual cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
422	389	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	3	Severity depends on surviving motion network components and stimulus speed	The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects.	locations[1]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
423	390	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	4	Structural neurological damage to motion network	Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
424	390	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	4	Structural neurological damage to motion network	Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions.	locations[0]	locations	locations			visual cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
425	390	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	4	Structural neurological damage to motion network	Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions.	locations[1]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
426	391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	Paroxysmal or intoxication-related cortical dysfunction	A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
427	391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	Paroxysmal or intoxication-related cortical dysfunction	A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy.	locations[0]	locations	locations			visual cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
428	391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	Paroxysmal or intoxication-related cortical dysfunction	A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy.	locations[1]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
429	392	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	6	Epileptic hyperexcitability of MT/V5 cortex	Paroxysmal hyperexcitability in right temporal and parietal cortices, including MT/V5, can trigger akinetopsia episodes.	locations[0]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
430	393	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	7	Induced disruption from TMS or medications	Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
431	393	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	7	Induced disruption from TMS or medications	Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits.	locations[0]	locations	locations			visual cortex	UBERON:0000411	visual cortex		"{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
432	393	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	7	Induced disruption from TMS or medications	Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits.	locations[1]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
433	394	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	8	Bilateral V5/MT lesions	Bilateral injury to V5/MT within the secondary visual cortex disrupts motion-processing circuitry.	locations[0]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
434	395	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	9	Global akinetopsia with chronic course	Global motion blindness with chronicity most often occurs when V5/MT is affected bilaterally.	locations[0]	locations	locations			secondary visual cortex	UBERON:0022232	secondary visual cortex		"{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}"																											
443	402	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	0	Alcohol metabolism and cellular stress	Alcohol metabolism and cellular stress cause hepatocyte and immune cell injury with cytokine and chemokine production.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
444	402	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	0	Alcohol metabolism and cellular stress	Alcohol metabolism and cellular stress cause hepatocyte and immune cell injury with cytokine and chemokine production.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
445	403	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	1	Gut-liver axis and endotoxin translocation	Ethanol damages the intestinal barrier, releasing endotoxins that contribute to ALD pathogenesis.	biological_processes[0]	biological_processes	biological_processes			response to lipopolysaccharide	GO:0032496	response to lipopolysaccharide		"{""preferred_term"": ""response to lipopolysaccharide"", ""term"": {""id"": ""GO:0032496"", ""label"": ""response to lipopolysaccharide""}}"																											
448	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	cell_types[0]	cell_types	cell_types			Neurons	CL:0000540	neuron		"{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
449	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	cell_types[1]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
450	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	cell_types[2]	cell_types	cell_types			Astrocytes	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocytes"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
451	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	biological_processes[0]	biological_processes	biological_processes			Protein misfolding	GO:0006457	protein folding		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Protein misfolding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}"			ABNORMAL																								
452	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	biological_processes[1]	biological_processes	biological_processes			Aggregation	GO:0034205	amyloid-beta formation		"{""preferred_term"": ""Aggregation"", ""term"": {""id"": ""GO:0034205"", ""label"": ""amyloid-beta formation""}}"																											
453	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	biological_processes[2]	biological_processes	biological_processes			Neuroinflammation	GO:0150076	neuroinflammatory response		"{""preferred_term"": ""Neuroinflammation"", ""term"": {""id"": ""GO:0150076"", ""label"": ""neuroinflammatory response""}}"																											
454	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	locations[0]	locations	locations			Cerebral Cortex				"{""preferred_term"": ""Cerebral Cortex""}"																											
455	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	locations[1]	locations	locations			Hippocampus				"{""preferred_term"": ""Hippocampus""}"																											
456	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	locations[2]	locations	locations			Subcortical Regions				"{""preferred_term"": ""Subcortical Regions""}"																											
457	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	chemical_entities[0]	chemical_entities	chemical_entities			Amyloid-beta peptides (A40, A42)				"{""preferred_term"": ""Amyloid-beta peptides (A40, A42)""}"																											
458	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	genes[0]	genes	genes			APP	hgnc:620	APP		"{""preferred_term"": ""APP"", ""term"": {""id"": ""hgnc:620"", ""label"": ""APP""}}"																											
459	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	genes[1]	genes	genes			PSEN1	hgnc:9508	PSEN1		"{""preferred_term"": ""PSEN1"", ""term"": {""id"": ""hgnc:9508"", ""label"": ""PSEN1""}}"																											
460	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	genes[2]	genes	genes			PSEN2	hgnc:9509	PSEN2		"{""preferred_term"": ""PSEN2"", ""term"": {""id"": ""hgnc:9509"", ""label"": ""PSEN2""}}"																											
461	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.	pathways[0]	pathways	pathways			Amyloid precursor protein processing	GO:0042982	amyloid precursor protein metabolic process		"{""preferred_term"": ""Amyloid precursor protein processing"", ""term"": {""id"": ""GO:0042982"", ""label"": ""amyloid precursor protein metabolic process""}}"																											
462	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	cell_types[0]	cell_types	cell_types			Neurons	CL:0000540	neuron		"{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
463	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	biological_processes[0]	biological_processes	biological_processes			Protein hyperphosphorylation	GO:0006468	protein phosphorylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Protein hyperphosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}"			INCREASED																								
464	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	biological_processes[1]	biological_processes	biological_processes			Microtubule destabilization	GO:0007019	microtubule depolymerization		"{""preferred_term"": ""Microtubule destabilization"", ""term"": {""id"": ""GO:0007019"", ""label"": ""microtubule depolymerization""}}"																											
465	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	locations[0]	locations	locations			Entorhinal Cortex				"{""preferred_term"": ""Entorhinal Cortex""}"																											
466	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	locations[1]	locations	locations			Hippocampus				"{""preferred_term"": ""Hippocampus""}"																											
467	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	locations[2]	locations	locations			Neocortex				"{""preferred_term"": ""Neocortex""}"																											
468	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	chemical_entities[0]	chemical_entities	chemical_entities			Tau protein				"{""preferred_term"": ""Tau protein""}"																											
469	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	genes[0]	genes	genes			MAPT	hgnc:6893	MAPT		"{""preferred_term"": ""MAPT"", ""term"": {""id"": ""hgnc:6893"", ""label"": ""MAPT""}}"																											
470	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.	pathways[0]	pathways	pathways			Tau phosphorylation cascade	GO:0006468	protein phosphorylation		"{""preferred_term"": ""Tau phosphorylation cascade"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}"																											
471	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	cell_types[0]	cell_types	cell_types			Neurons	CL:0000540	neuron		"{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
472	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	biological_processes[0]	biological_processes	biological_processes			Neurotransmitter release	GO:0007269	neurotransmitter secretion		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Neurotransmitter release"", ""term"": {""id"": ""GO:0007269"", ""label"": ""neurotransmitter secretion""}}"			DECREASED																								
473	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	biological_processes[1]	biological_processes	biological_processes			Synaptic plasticity	GO:0048167	regulation of synaptic plasticity		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Synaptic plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"			DECREASED																								
474	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	locations[0]	locations	locations			Synapses				"{""preferred_term"": ""Synapses""}"																											
475	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	locations[1]	locations	locations			Neuronal dendrites				"{""preferred_term"": ""Neuronal dendrites""}"																											
476	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	chemical_entities[0]	chemical_entities	chemical_entities			Acetylcholine	CHEBI:15355	acetylcholine		"{""preferred_term"": ""Acetylcholine"", ""term"": {""id"": ""CHEBI:15355"", ""label"": ""acetylcholine""}}"																											
477	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	chemical_entities[1]	chemical_entities	chemical_entities			Glutamate	CHEBI:14321	glutamate(1-)		"{""preferred_term"": ""Glutamate"", ""term"": {""id"": ""CHEBI:14321"", ""label"": ""glutamate(1-)""}}"																											
478	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	chemical_entities[2]	chemical_entities	chemical_entities			GABA	CHEBI:16865	gamma-aminobutyric acid		"{""preferred_term"": ""GABA"", ""term"": {""id"": ""CHEBI:16865"", ""label"": ""gamma-aminobutyric acid""}}"																											
479	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	pathways[0]	pathways	pathways			Synaptic vesicle recycling	GO:0099504	synaptic vesicle cycle		"{""preferred_term"": ""Synaptic vesicle recycling"", ""term"": {""id"": ""GO:0099504"", ""label"": ""synaptic vesicle cycle""}}"																											
480	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.	pathways[1]	pathways	pathways			Neurotransmitter receptor signaling	GO:0050804	modulation of chemical synaptic transmission		"{""preferred_term"": ""Neurotransmitter receptor signaling"", ""term"": {""id"": ""GO:0050804"", ""label"": ""modulation of chemical synaptic transmission""}}"																											
481	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	cell_types[0]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
482	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	cell_types[1]	cell_types	cell_types			Astrocytes	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocytes"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
483	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	biological_processes[0]	biological_processes	biological_processes			Immune activation	GO:0002253	activation of immune response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Immune activation"", ""term"": {""id"": ""GO:0002253"", ""label"": ""activation of immune response""}}"			INCREASED																								
484	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	biological_processes[1]	biological_processes	biological_processes			Cytokine production	GO:0001816	cytokine production		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"			INCREASED																								
485	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	biological_processes[2]	biological_processes	biological_processes			Phagocytosis	GO:0006909	phagocytosis		"{""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}"																											
486	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	chemical_entities[0]	chemical_entities	chemical_entities			Cytokines				"{""preferred_term"": ""Cytokines""}"																											
487	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	chemical_entities[1]	chemical_entities	chemical_entities			Chemokines				"{""preferred_term"": ""Chemokines""}"																											
488	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	chemical_entities[2]	chemical_entities	chemical_entities			Complement proteins				"{""preferred_term"": ""Complement proteins""}"																											
489	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	pathways[0]	pathways	pathways			NF-B signaling	GO:0007249	canonical NF-kappaB signal transduction		"{""preferred_term"": ""NF-B signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""canonical NF-kappaB signal transduction""}}"																											
490	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.	pathways[1]	pathways	pathways			NLRP3 inflammasome activation	GO:0044546	NLRP3 inflammasome complex assembly		"{""preferred_term"": ""NLRP3 inflammasome activation"", ""term"": {""id"": ""GO:0044546"", ""label"": ""NLRP3 inflammasome complex assembly""}}"																											
491	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	biological_processes[0]	biological_processes	biological_processes			Free radical production	GO:1903409	reactive oxygen species biosynthetic process		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Free radical production"", ""term"": {""id"": ""GO:1903409"", ""label"": ""reactive oxygen species biosynthetic process""}}"			INCREASED																								
492	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	biological_processes[1]	biological_processes	biological_processes			Antioxidant defense	GO:0006979	response to oxidative stress		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Antioxidant defense"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"			DECREASED																								
493	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	cellular_components[0]	cellular_components	cellular_components			Mitochondria	GO:0005739	mitochondrion		"{""preferred_term"": ""Mitochondria"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}"																											
494	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	cellular_components[1]	cellular_components	cellular_components			Cell membranes	GO:0005886	plasma membrane		"{""preferred_term"": ""Cell membranes"", ""term"": {""id"": ""GO:0005886"", ""label"": ""plasma membrane""}}"																											
495	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	chemical_entities[0]	chemical_entities	chemical_entities			Reactive oxygen species (ROS)	CHEBI:26523	reactive oxygen species		"{""preferred_term"": ""Reactive oxygen species (ROS)"", ""term"": {""id"": ""CHEBI:26523"", ""label"": ""reactive oxygen species""}}"																											
496	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	chemical_entities[1]	chemical_entities	chemical_entities			Reactive nitrogen species (RNS)	CHEBI:62764	reactive nitrogen species		"{""preferred_term"": ""Reactive nitrogen species (RNS)"", ""term"": {""id"": ""CHEBI:62764"", ""label"": ""reactive nitrogen species""}}"																											
497	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	pathways[0]	pathways	pathways			Mitochondrial electron transport chain	GO:0022904	respiratory electron transport chain		"{""preferred_term"": ""Mitochondrial electron transport chain"", ""term"": {""id"": ""GO:0022904"", ""label"": ""respiratory electron transport chain""}}"																											
498	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.	pathways[1]	pathways	pathways			NADPH oxidase activation				"{""preferred_term"": ""NADPH oxidase activation""}"																											
499	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	cell_types[0]	cell_types	cell_types			Endothelial cells	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial cells"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
500	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	cell_types[1]	cell_types	cell_types			Pericytes	CL:0000669	pericyte		"{""preferred_term"": ""Pericytes"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}"																											
501	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	biological_processes[0]	biological_processes	biological_processes			Blood-brain barrier regulation	GO:1905603	regulation of blood-brain barrier permeability		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""Blood-brain barrier regulation"", ""term"": {""id"": ""GO:1905603"", ""label"": ""regulation of blood-brain barrier permeability""}}"			DYSREGULATED																								
502	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	biological_processes[1]	biological_processes	biological_processes			Cerebral blood flow	GO:0120275	cerebral blood circulation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Cerebral blood flow"", ""term"": {""id"": ""GO:0120275"", ""label"": ""cerebral blood circulation""}}"			DECREASED																								
503	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	locations[0]	locations	locations			Cerebral blood vessels				"{""preferred_term"": ""Cerebral blood vessels""}"																											
504	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	locations[1]	locations	locations			Blood-brain barrier				"{""preferred_term"": ""Blood-brain barrier""}"																											
505	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	pathways[0]	pathways	pathways			Neurovascular coupling				"{""preferred_term"": ""Neurovascular coupling""}"																											
506	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	pathways[1]	pathways	pathways			Perivascular drainage				"{""preferred_term"": ""Perivascular drainage""}"																											
507	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.	genes[0]	genes	genes			LRP1	hgnc:6692	LRP1		"{""preferred_term"": ""LRP1"", ""term"": {""id"": ""hgnc:6692"", ""label"": ""LRP1""}}"																											
508	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	cell_types[0]	cell_types	cell_types			Neurons	CL:0000540	neuron		"{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
509	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	biological_processes[0]	biological_processes	biological_processes			Autophagy	GO:0006914	autophagy		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"			DECREASED																								
510	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	biological_processes[1]	biological_processes	biological_processes			Lysosomal degradation	GO:0007041	lysosomal transport		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Lysosomal degradation"", ""term"": {""id"": ""GO:0007041"", ""label"": ""lysosomal transport""}}"			DECREASED																								
511	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	biological_processes[2]	biological_processes	biological_processes			Protein catabolic process	GO:0030163	protein catabolic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Protein catabolic process"", ""term"": {""id"": ""GO:0030163"", ""label"": ""protein catabolic process""}}"			DECREASED																								
512	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	locations[0]	locations	locations			Hippocampus				"{""preferred_term"": ""Hippocampus""}"																											
513	426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.	locations[1]	locations	locations			Cerebral Cortex				"{""preferred_term"": ""Cerebral Cortex""}"																											
524	446	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	0	Loss of Hair Follicle Immune Privilege	Hair follicles normally maintain immune privilege through low MHC class I expression and local immunosuppressive factors. Collapse of immune privilege exposes hair follicle antigens to immune surveillance.	biological_processes[0]	biological_processes	biological_processes			Immune Response	GO:0006955	immune response		"{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
525	447	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	1	CD8+ T Cell-Mediated Attack	NKG2D-expressing CD8+ T cells infiltrate the hair bulb and attack hair follicle cells. IFN-gamma produced by these cells induces MHC class I upregulation and further T cell recruitment.	cell_types[0]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
526	447	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	1	CD8+ T Cell-Mediated Attack	NKG2D-expressing CD8+ T cells infiltrate the hair bulb and attack hair follicle cells. IFN-gamma produced by these cells induces MHC class I upregulation and further T cell recruitment.	biological_processes[0]	biological_processes	biological_processes			T Cell Cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
527	448	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	2	JAK-STAT Signaling Activation	IFN-gamma signaling through JAK1/2-STAT1 pathway drives disease pathogenesis. This pathway is a key therapeutic target, with JAK inhibitors showing efficacy in alopecia areata.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT Signaling	GO:0007259	receptor signaling pathway via JAK-STAT		"{""preferred_term"": ""JAK-STAT Signaling"", ""term"": {""id"": ""GO:0007259"", ""label"": ""receptor signaling pathway via JAK-STAT""}}"																											
528	449	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	3	Chemokine-Mediated Immune Cell Recruitment	CXCL12 and other chemokines recruit and activate CD8+ T cells to the hair follicle. IFN-gamma induces CXCL12 production from dermal fibroblasts, amplifying immune cell infiltration and contributing to disease progression.	biological_processes[0]	biological_processes	biological_processes			Immune Response	GO:0006955	immune response		"{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
535	460	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	0	Protease-Antiprotease Imbalance in Lung	"Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
536	460	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	0	Protease-Antiprotease Imbalance in Lung	"Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.
"	biological_processes[0]	biological_processes	biological_processes			neutrophil degranulation	GO:0043312	neutrophil degranulation		"{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}"																											
537	461	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	1	Hepatic Protein Aggregation	"The Z variant of AAT (E342K, PiZZ genotype) causes misfolding of AAT protein in hepatocytes. Misfolded AAT accumulates in the endoplasmic reticulum, forming polymers that cannot be secreted, leading to hepatocyte injury and liver disease.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
538	461	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	1	Hepatic Protein Aggregation	"The Z variant of AAT (E342K, PiZZ genotype) causes misfolding of AAT protein in hepatocytes. Misfolded AAT accumulates in the endoplasmic reticulum, forming polymers that cannot be secreted, leading to hepatocyte injury and liver disease.
"	biological_processes[0]	biological_processes	biological_processes			response to endoplasmic reticulum stress	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""response to endoplasmic reticulum stress"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
539	462	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	2	Neutrophil Recruitment to Lung Parenchyma	"Inflammatory signals recruit neutrophils to the lung tissue, particularly in response to cigarette smoke, respiratory infections, or other inflammatory stimuli.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
540	462	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	2	Neutrophil Recruitment to Lung Parenchyma	"Inflammatory signals recruit neutrophils to the lung tissue, particularly in response to cigarette smoke, respiratory infections, or other inflammatory stimuli.
"	biological_processes[0]	biological_processes	biological_processes			leukocyte migration	GO:0050900	leukocyte migration		"{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}"																											
541	463	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	3	Neutrophil Elastase Release	"Activated neutrophils release elastase and other proteases that, in the absence of sufficient alpha-1 antitrypsin inhibition, remain enzymatically active and degrade structural proteins.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
542	463	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	3	Neutrophil Elastase Release	"Activated neutrophils release elastase and other proteases that, in the absence of sufficient alpha-1 antitrypsin inhibition, remain enzymatically active and degrade structural proteins.
"	biological_processes[0]	biological_processes	biological_processes			proteolysis	GO:0006508	proteolysis		"{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}"																											
543	464	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	4	Alveolar Tissue Destruction	"Progressive degradation of alveolar walls and elastin fibers leads to loss of structural integrity, air trapping, and emphysema development.
"	biological_processes[0]	biological_processes	biological_processes			extracellular matrix disassembly	GO:0022617	extracellular matrix disassembly		"{""preferred_term"": ""extracellular matrix disassembly"", ""term"": {""id"": ""GO:0022617"", ""label"": ""extracellular matrix disassembly""}}"																											
556	486	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	0	PAX-FOXO1 Fusion Oncogene	The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation.	cell_types[0]	cell_types	cell_types			skeletal muscle myoblast	CL:0000515	skeletal muscle myoblast		"{""preferred_term"": ""skeletal muscle myoblast"", ""term"": {""id"": ""CL:0000515"", ""label"": ""skeletal muscle myoblast""}}"																											
557	486	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	0	PAX-FOXO1 Fusion Oncogene	The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			ABNORMAL																								
558	486	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	0	PAX-FOXO1 Fusion Oncogene	The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation.	locations[0]	locations	locations			zone of skin	UBERON:0000014	zone of skin		"{""preferred_term"": ""zone of skin"", ""term"": {""id"": ""UBERON:0000014"", ""label"": ""zone of skin""}}"																											
559	487	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	1	Blocked Myogenic Differentiation	PAX-FOXO1 fusion protein blocks the normal myogenic differentiation program by interfering with MYOD1 and myogenin function. Tumor cells express early myogenic markers (desmin, myogenin) but fail to complete differentiation into mature skeletal muscle, remaining in a proliferative progenitor state.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
560	488	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	2	Aberrant Cell Proliferation	PAX-FOXO1 activates genes promoting cell cycle progression and survival, including MYCN, which is commonly amplified in ARMS. The fusion protein also suppresses apoptosis through multiple mechanisms, contributing to tumor aggressiveness.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
571	500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	Amyloid-Beta Plaque Formation	"Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
572	500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	Amyloid-Beta Plaque Formation	"Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.
"	cell_types[1]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
573	500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	Amyloid-Beta Plaque Formation	"Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.
"	biological_processes[0]	biological_processes	biological_processes			amyloid precursor protein catabolic process	GO:0042987	amyloid precursor protein catabolic process		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""amyloid precursor protein catabolic process"", ""term"": {""id"": ""GO:0042987"", ""label"": ""amyloid precursor protein catabolic process""}}"			ABNORMAL																								
574	501	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	"Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation by various kinases reduces its affinity for microtubules, leading to accumulation of free tau that aggregates into paired helical filaments and NFTs. This causes mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
575	502	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	"Oligomeric forms of A and tau are toxic to synapses, interfering with molecular pathways required for synaptic plasticity and memory. This synaptic dysfunction precedes neuronal death and correlates with cognitive impairment severity.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
576	503	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	3	Neuroinflammation	"Chronic activation of microglia and astrocytes in response to A plaques and tau tangles. While initially attempting to clear pathological proteins, sustained inflammation produces pro-inflammatory cytokines and reactive oxygen species that damage neurons and exacerbate neurodegeneration.
"	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
577	504	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	4	Neuronal Death	"Progressive loss of neurons, particularly in the hippocampus and cortex, leading to brain atrophy. Neuronal death results from accumulated damage from A toxicity, tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
591	531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	Motor Neuron Degeneration	"Progressive death of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord leads to denervation of skeletal muscles. The loss of upper motor neurons causes spasticity and hyperreflexia, while lower motor neuron loss results in muscle weakness, atrophy, and fasciculations.
"	cell_types[0]	cell_types	cell_types			motor neuron	CL:0000100	motor neuron		"{""preferred_term"": ""motor neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}"																											
592	531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	Motor Neuron Degeneration	"Progressive death of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord leads to denervation of skeletal muscles. The loss of upper motor neurons causes spasticity and hyperreflexia, while lower motor neuron loss results in muscle weakness, atrophy, and fasciculations.
"	locations[0]	locations	locations			primary motor cortex	UBERON:0001384	primary motor cortex		"{""preferred_term"": ""primary motor cortex"", ""term"": {""id"": ""UBERON:0001384"", ""label"": ""primary motor cortex""}}"																											
593	532	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	1	TDP-43 Proteinopathy	"Cytoplasmic aggregation of TDP-43 (TAR DNA-binding protein 43) is found in approximately 97% of ALS cases. TDP-43 normally functions in RNA processing but becomes mislocalized from the nucleus to cytoplasmic inclusions, leading to both loss of nuclear function and toxic gain of function. This impairs RNA splicing including STMN2.
"	genes[0]	genes	genes			TARDBP	hgnc:11571	TARDBP		"{""preferred_term"": ""TARDBP"", ""term"": {""id"": ""hgnc:11571"", ""label"": ""TARDBP""}}"																											
594	532	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	1	TDP-43 Proteinopathy	"Cytoplasmic aggregation of TDP-43 (TAR DNA-binding protein 43) is found in approximately 97% of ALS cases. TDP-43 normally functions in RNA processing but becomes mislocalized from the nucleus to cytoplasmic inclusions, leading to both loss of nuclear function and toxic gain of function. This impairs RNA splicing including STMN2.
"	biological_processes[0]	biological_processes	biological_processes			RNA splicing	GO:0000375	RNA splicing, via transesterification reactions		"{""preferred_term"": ""RNA splicing"", ""term"": {""id"": ""GO:0000375"", ""label"": ""RNA splicing, via transesterification reactions""}}"																											
595	533	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	2	C9orf72 Repeat Expansion Toxicity	"Hexanucleotide (GGGGCC) repeat expansion in C9orf72 is the most common genetic cause of ALS, accounting for 40% of familial and 5-10% of sporadic cases. The expansion leads to RNA foci formation, dipeptide repeat protein aggregation, and haploinsufficiency.
"	genes[0]	genes	genes			C9orf72	hgnc:28337	C9orf72		"{""preferred_term"": ""C9orf72"", ""term"": {""id"": ""hgnc:28337"", ""label"": ""C9orf72""}}"																											
596	534	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	3	Glutamate Excitotoxicity	"Impaired glutamate clearance by astrocytes leads to excessive glutamate accumulation in the synaptic cleft, causing prolonged activation of glutamate receptors on motor neurons. This results in calcium overload and subsequent neuronal death.
"	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
597	534	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	3	Glutamate Excitotoxicity	"Impaired glutamate clearance by astrocytes leads to excessive glutamate accumulation in the synaptic cleft, causing prolonged activation of glutamate receptors on motor neurons. This results in calcium overload and subsequent neuronal death.
"	biological_processes[0]	biological_processes	biological_processes			neurotransmitter transport	GO:0006836	neurotransmitter transport		"{""preferred_term"": ""neurotransmitter transport"", ""term"": {""id"": ""GO:0006836"", ""label"": ""neurotransmitter transport""}}"																											
598	535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	Oxidative Stress	"Motor neurons are particularly vulnerable to oxidative damage due to high metabolic demands. Mutations in SOD1, which encodes superoxide dismutase 1, lead to misfolded protein aggregation and increased oxidative stress contributing to neuronal death.
"	genes[0]	genes	genes			SOD1	hgnc:11179	SOD1		"{""preferred_term"": ""SOD1"", ""term"": {""id"": ""hgnc:11179"", ""label"": ""SOD1""}}"																											
599	535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	Oxidative Stress	"Motor neurons are particularly vulnerable to oxidative damage due to high metabolic demands. Mutations in SOD1, which encodes superoxide dismutase 1, lead to misfolded protein aggregation and increased oxidative stress contributing to neuronal death.
"	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
600	536	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	5	Neuroinflammation	"Activated microglia and astrocytes contribute to motor neuron death through the release of pro-inflammatory cytokines, reactive oxygen species, and other neurotoxic factors. This non-cell-autonomous mechanism amplifies neurodegeneration.
"	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
601	536	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	5	Neuroinflammation	"Activated microglia and astrocytes contribute to motor neuron death through the release of pro-inflammatory cytokines, reactive oxygen species, and other neurotoxic factors. This non-cell-autonomous mechanism amplifies neurodegeneration.
"	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
602	537	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	6	Microglial TREM2 Signaling	"TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.
"	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
603	537	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	6	Microglial TREM2 Signaling	"TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.
"	genes[0]	genes	genes			TREM2	hgnc:17761	TREM2		"{""preferred_term"": ""TREM2"", ""term"": {""id"": ""hgnc:17761"", ""label"": ""TREM2""}}"																											
604	537	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	6	Microglial TREM2 Signaling	"TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.
"	biological_processes[0]	biological_processes	biological_processes			microglial cell activation	GO:0001774	microglial cell activation		"{""preferred_term"": ""microglial cell activation"", ""term"": {""id"": ""GO:0001774"", ""label"": ""microglial cell activation""}}"																											
605	538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	Axonal Transport Dysfunction	"Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.
"	genes[0]	genes	genes			KIF5A	hgnc:8938	KIF5A		"{""preferred_term"": ""KIF5A"", ""term"": {""id"": ""hgnc:8938"", ""label"": ""KIF5A""}}"																											
606	538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	Axonal Transport Dysfunction	"Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.
"	genes[1]	genes	genes			DCTN1	hgnc:2701	DCTN1		"{""preferred_term"": ""DCTN1"", ""term"": {""id"": ""hgnc:2701"", ""label"": ""DCTN1""}}"																											
607	538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	Axonal Transport Dysfunction	"Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.
"	genes[2]	genes	genes			PFN1	hgnc:8880	PFN1		"{""preferred_term"": ""PFN1"", ""term"": {""id"": ""hgnc:8880"", ""label"": ""PFN1""}}"																											
608	538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	Axonal Transport Dysfunction	"Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.
"	biological_processes[0]	biological_processes	biological_processes			anterograde axonal transport	GO:0008089	anterograde axonal transport		"{""preferred_term"": ""anterograde axonal transport"", ""term"": {""id"": ""GO:0008089"", ""label"": ""anterograde axonal transport""}}"																											
609	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"	genes[0]	genes	genes			TBK1	hgnc:11584	TBK1		"{""preferred_term"": ""TBK1"", ""term"": {""id"": ""hgnc:11584"", ""label"": ""TBK1""}}"																											
610	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"	genes[1]	genes	genes			OPTN	hgnc:17101	OPTN		"{""preferred_term"": ""OPTN"", ""term"": {""id"": ""hgnc:17101"", ""label"": ""OPTN""}}"																											
611	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"	genes[2]	genes	genes			VCP	hgnc:12666	VCP		"{""preferred_term"": ""VCP"", ""term"": {""id"": ""hgnc:12666"", ""label"": ""VCP""}}"																											
612	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"	genes[3]	genes	genes			SQSTM1	hgnc:11240	SQSTM1		"{""preferred_term"": ""SQSTM1"", ""term"": {""id"": ""hgnc:11240"", ""label"": ""SQSTM1""}}"																											
613	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"	biological_processes[0]	biological_processes	biological_processes			autophagy	GO:0006914	autophagy		"{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
614	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	Genetic Drivers and Therapeutic Translation	"Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.
"	genes[0]	genes	genes			C9orf72	hgnc:28337	C9orf72		"{""preferred_term"": ""C9orf72"", ""term"": {""id"": ""hgnc:28337"", ""label"": ""C9orf72""}}"																											
615	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	Genetic Drivers and Therapeutic Translation	"Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.
"	genes[1]	genes	genes			SOD1	hgnc:11179	SOD1		"{""preferred_term"": ""SOD1"", ""term"": {""id"": ""hgnc:11179"", ""label"": ""SOD1""}}"																											
616	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	Genetic Drivers and Therapeutic Translation	"Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.
"	genes[2]	genes	genes			TARDBP	hgnc:11571	TARDBP		"{""preferred_term"": ""TARDBP"", ""term"": {""id"": ""hgnc:11571"", ""label"": ""TARDBP""}}"																											
617	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	Genetic Drivers and Therapeutic Translation	"Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.
"	genes[3]	genes	genes			FUS	hgnc:4016	FUS		"{""preferred_term"": ""FUS"", ""term"": {""id"": ""hgnc:4016"", ""label"": ""FUS""}}"																											
634	562	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	0	HLA-B27-Associated Immune Activation	HLA-B27 misfolding in the endoplasmic reticulum triggers the unfolded protein response and IL-23 production. Aberrant antigen presentation may also activate autoreactive T cells against joint antigens.	biological_processes[0]	biological_processes	biological_processes			Antigen Presentation	GO:0019882	antigen processing and presentation		"{""preferred_term"": ""Antigen Presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"																											
635	563	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	1	IL-23/IL-17 Axis Activation	IL-23-driven expansion of Th17 cells and innate lymphoid cells produces IL-17, driving inflammation at entheses and in the spine. This pathway is a key therapeutic target.	cell_types[0]	cell_types	cell_types			T Helper Cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
636	563	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	1	IL-23/IL-17 Axis Activation	IL-23-driven expansion of Th17 cells and innate lymphoid cells produces IL-17, driving inflammation at entheses and in the spine. This pathway is a key therapeutic target.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
637	564	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	2	Enthesitis and New Bone Formation	Inflammation at entheses (tendon/ligament insertions) leads to erosion followed by aberrant bone formation. Syndesmophytes and ankylosis result from dysregulated osteoblast activity driven by Wnt and BMP signaling.	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
638	564	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	2	Enthesitis and New Bone Formation	Inflammation at entheses (tendon/ligament insertions) leads to erosion followed by aberrant bone formation. Syndesmophytes and ankylosis result from dysregulated osteoblast activity driven by Wnt and BMP signaling.	biological_processes[0]	biological_processes	biological_processes			Bone Formation	GO:0001503	ossification		"{""preferred_term"": ""Bone Formation"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}"																											
645	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	Antibody Production	The immune system produces antiphospholipid antibodies that target proteins associated with phospholipids in cell membranes.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
646	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	Antibody Production	The immune system produces antiphospholipid antibodies that target proteins associated with phospholipids in cell membranes.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
647	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	Organ Damage	Clots in vital organs can impair function and cause significant damage.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
648	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	Organ Damage	Clots in vital organs can impair function and cause significant damage.	locations[1]	locations	locations			kidneys	UBERON:0002113	kidney		"{""preferred_term"": ""kidneys"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
649	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	Organ Damage	Clots in vital organs can impair function and cause significant damage.	locations[2]	locations	locations			lungs	UBERON:0002048	lung		"{""preferred_term"": ""lungs"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
658	606	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
659	606	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
660	606	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
661	607	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	1	Premature Suture Fusion	"Enhanced FGFR2 signaling in cranial suture mesenchyme promotes premature osteogenic differentiation and fusion of the coronal sutures, restricting skull growth perpendicular to the fused sutures and causing characteristic turricephaly (tower skull).
"	biological_processes[0]	biological_processes	biological_processes			Osteoblast Differentiation	GO:0001649	osteoblast differentiation		"{""preferred_term"": ""Osteoblast Differentiation"", ""term"": {""id"": ""GO:0001649"", ""label"": ""osteoblast differentiation""}}"																											
662	608	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	2	ERK1/2 and PKC Pathway Dysregulation	"The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.
"	cell_types[0]	cell_types	cell_types			Mesenchymal stem cell	CL:0000134	mesenchymal stem cell		"{""preferred_term"": ""Mesenchymal stem cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}"																											
663	608	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	2	ERK1/2 and PKC Pathway Dysregulation	"The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.
"	biological_processes[0]	biological_processes	biological_processes			ERK1/2 Cascade	GO:0070371	ERK1 and ERK2 cascade		"{""preferred_term"": ""ERK1/2 Cascade"", ""term"": {""id"": ""GO:0070371"", ""label"": ""ERK1 and ERK2 cascade""}}"																											
664	608	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	2	ERK1/2 and PKC Pathway Dysregulation	"The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.
"	biological_processes[1]	biological_processes	biological_processes			Protein Kinase C Signaling	GO:0070528	protein kinase C signaling		"{""preferred_term"": ""Protein Kinase C Signaling"", ""term"": {""id"": ""GO:0070528"", ""label"": ""protein kinase C signaling""}}"																											
676	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	cell_types[0]	cell_types	cell_types			granulosa cell	CL:0000501	granulosa cell	Ovarian site of aromatase expression for estrogen synthesis	"{""description"": ""Ovarian site of aromatase expression for estrogen synthesis"", ""preferred_term"": ""granulosa cell"", ""term"": {""id"": ""CL:0000501"", ""label"": ""granulosa cell""}}"																											
677	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	cell_types[1]	cell_types	cell_types			trophoblast cell	CL:0000351	trophoblast cell	Placental aromatase site; loss causes maternal and fetal virilization	"{""description"": ""Placental aromatase site; loss causes maternal and fetal virilization"", ""preferred_term"": ""trophoblast cell"", ""term"": {""id"": ""CL:0000351"", ""label"": ""trophoblast cell""}}"																											
678	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	cell_types[2]	cell_types	cell_types			Leydig cell	CL:0000178	Leydig cell	Testicular androgen source; peripheral aromatization affects systemic hormone balance	"{""description"": ""Testicular androgen source; peripheral aromatization affects systemic hormone balance"", ""preferred_term"": ""Leydig cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}"																											
679	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	cell_types[3]	cell_types	cell_types			adipocyte	CL:0000136	adipocyte	Peripheral aromatase expression site contributing to local estrogen production	"{""description"": ""Peripheral aromatase expression site contributing to local estrogen production"", ""preferred_term"": ""adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}"																											
680	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	biological_processes[0]	biological_processes	biological_processes			estrogen biosynthetic process	GO:0006703	estrogen biosynthetic process	Aromatase-catalyzed estrogen synthesis is directly impaired	"{""description"": ""Aromatase-catalyzed estrogen synthesis is directly impaired"", ""preferred_term"": ""estrogen biosynthetic process"", ""term"": {""id"": ""GO:0006703"", ""label"": ""estrogen biosynthetic process""}}"																											
681	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	biological_processes[1]	biological_processes	biological_processes			steroid biosynthetic process	GO:0006694	steroid biosynthetic process	Overall steroidogenesis altered with accumulation of androgens	"{""description"": ""Overall steroidogenesis altered with accumulation of androgens"", ""preferred_term"": ""steroid biosynthetic process"", ""term"": {""id"": ""GO:0006694"", ""label"": ""steroid biosynthetic process""}}"																											
682	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	biological_processes[2]	biological_processes	biological_processes			androgen metabolic process	GO:0008209	androgen metabolic process	Androgen metabolism shifts toward accumulation of C19 steroids	"{""description"": ""Androgen metabolism shifts toward accumulation of C19 steroids"", ""preferred_term"": ""androgen metabolic process"", ""term"": {""id"": ""GO:0008209"", ""label"": ""androgen metabolic process""}}"																											
683	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	locations[0]	locations	locations			ovary	UBERON:0000992	ovary	Site of granulosa aromatase; ovarian development and fertility impacted	"{""description"": ""Site of granulosa aromatase; ovarian development and fertility impacted"", ""preferred_term"": ""ovary"", ""term"": {""id"": ""UBERON:0000992"", ""label"": ""ovary""}}"																											
684	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	locations[1]	locations	locations			placenta	UBERON:0001987	placenta	Crucial for fetal estrogen production; maternal virilization if deficient	"{""description"": ""Crucial for fetal estrogen production; maternal virilization if deficient"", ""preferred_term"": ""placenta"", ""term"": {""id"": ""UBERON:0001987"", ""label"": ""placenta""}}"																											
685	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	locations[2]	locations	locations			testis	UBERON:0000473	testis	Androgen source; 46,XY genital phenotype often milder than 46,XX	"{""description"": ""Androgen source; 46,XY genital phenotype often milder than 46,XX"", ""preferred_term"": ""testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}"																											
686	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.	locations[3]	locations	locations			bone tissue	UBERON:0002481	bone tissue	Affected by estrogen deficiency causing delayed epiphyseal closure and osteopenia	"{""description"": ""Affected by estrogen deficiency causing delayed epiphyseal closure and osteopenia"", ""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}"																											
687	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	cell_types[0]	cell_types	cell_types			osteoblast	CL:0000062	osteoblast	Bone-forming cell; estrogen deficiency increases bone resorption risk	"{""description"": ""Bone-forming cell; estrogen deficiency increases bone resorption risk"", ""preferred_term"": ""osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
688	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	cell_types[1]	cell_types	cell_types			osteoclast	CL:0000092	osteoclast	Bone-resorbing cell; activity increases when estrogen is low	"{""description"": ""Bone-resorbing cell; activity increases when estrogen is low"", ""preferred_term"": ""osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}"																											
689	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	biological_processes[0]	biological_processes	biological_processes			estrogen receptor signaling pathway	GO:0030520	estrogen receptor signaling pathway	Downstream estrogen signaling reduced affecting multiple tissues	"{""description"": ""Downstream estrogen signaling reduced affecting multiple tissues"", ""preferred_term"": ""estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""estrogen receptor signaling pathway""}}"																											
690	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	biological_processes[1]	biological_processes	biological_processes			regulation of gonadotropin secretion	GO:0032274	regulation of gonadotropin secretion	HPG feedback disrupted causing hypergonadotropic hypogonadism	"{""description"": ""HPG feedback disrupted causing hypergonadotropic hypogonadism"", ""preferred_term"": ""regulation of gonadotropin secretion"", ""term"": {""id"": ""GO:0032274"", ""label"": ""regulation of gonadotropin secretion""}}"																											
691	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	biological_processes[2]	biological_processes	biological_processes			bone remodeling	GO:0046849	bone remodeling	Imbalanced osteoblast/osteoclast activity leading to bone loss	"{""description"": ""Imbalanced osteoblast/osteoclast activity leading to bone loss"", ""preferred_term"": ""bone remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}"																											
692	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	biological_processes[3]	biological_processes	biological_processes			endochondral ossification	GO:0001958	endochondral ossification	Delayed epiphyseal closure due to low estrogen levels	"{""description"": ""Delayed epiphyseal closure due to low estrogen levels"", ""preferred_term"": ""endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
693	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	locations[0]	locations	locations			uterus	UBERON:0000995	uterus	Estrogen-dependent organ; hypoplasia and poor endometrial development possible	"{""description"": ""Estrogen-dependent organ; hypoplasia and poor endometrial development possible"", ""preferred_term"": ""uterus"", ""term"": {""id"": ""UBERON:0000995"", ""label"": ""uterus""}}"																											
694	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	locations[1]	locations	locations			bone tissue	UBERON:0002481	bone tissue	Chronic hypoestrogenism results in low bone mass and fracture risk	"{""description"": ""Chronic hypoestrogenism results in low bone mass and fracture risk"", ""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}"																											
695	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	locations[2]	locations	locations			adipose tissue	UBERON:0001013	adipose tissue	Peripheral aromatase loss alters metabolic regulation and lipid profiles	"{""description"": ""Peripheral aromatase loss alters metabolic regulation and lipid profiles"", ""preferred_term"": ""adipose tissue"", ""term"": {""id"": ""UBERON:0001013"", ""label"": ""adipose tissue""}}"																											
696	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.	locations[3]	locations	locations			brain	UBERON:0000955	brain	Central estrogen actions on behavior and HPG axis signaling disrupted	"{""description"": ""Central estrogen actions on behavior and HPG axis signaling disrupted"", ""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
711	652	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	0	Arsenic Uptake and Metabolism	Inorganic arsenic is absorbed from the gut or lungs and undergoes hepatic methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). The metabolic pathway produces monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The trivalent intermediate MMA(III) is highly reactive and toxic. Genetic polymorphisms in AS3MT affect methylation efficiency and cancer risk.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
712	652	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	0	Arsenic Uptake and Metabolism	Inorganic arsenic is absorbed from the gut or lungs and undergoes hepatic methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). The metabolic pathway produces monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The trivalent intermediate MMA(III) is highly reactive and toxic. Genetic polymorphisms in AS3MT affect methylation efficiency and cancer risk.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
713	653	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	1	Oxidative Stress and DNA Damage	Arsenic generates reactive oxygen species (ROS) through multiple mechanisms including mitochondrial dysfunction and NADPH oxidase activation. ROS cause oxidative DNA damage including 8-oxoguanine formation, DNA strand breaks, and chromosomal aberrations. Unlike classic genotoxins, arsenic does not form direct DNA adducts but induces damage through indirect mechanisms.	biological_processes[0]	biological_processes	biological_processes			DNA damage response	GO:0006974	DNA damage response		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}"			ABNORMAL																								
714	654	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	2	Epigenetic Dysregulation	Arsenic causes global DNA hypomethylation while inducing promoter-specific hypermethylation of tumor suppressor genes. This occurs partly through competition for methyl groups (arsenic methylation depletes SAM) and altered DNMT activity. Histone modifications and miRNA expression are also affected, contributing to aberrant gene expression patterns.	biological_processes[0]	biological_processes	biological_processes			DNA methylation	GO:0006306	DNA methylation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}"			ABNORMAL																								
715	655	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	3	Impaired DNA Repair	Arsenic inhibits multiple DNA repair pathways including nucleotide excision repair, base excision repair, and mismatch repair. It inhibits zinc finger proteins involved in repair by displacing zinc. PARP-1, XPA, and other repair factors are direct targets. This repair deficiency synergizes with oxidative damage to promote mutagenesis.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
716	656	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	4	Tumor Suppressor Gene Silencing	Arsenic-induced promoter hypermethylation silences tumor suppressor genes including p16INK4A, RASSF1A, and p53. This epigenetic silencing contributes to cell cycle dysregulation and resistance to apoptosis without requiring genetic mutation.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
717	657	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	5	Genomic Instability	The combination of oxidative DNA damage, impaired repair, and aberrant mitotic spindle function leads to genomic instability, aneuploidy, and chromosomal aberrations. Arsenic disrupts spindle assembly by targeting tubulin and centrosome function.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			ABNORMAL																								
718	658	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Combined effects of epigenetic silencing, genomic instability, and constitutive growth signaling drive proliferation of transformed cells in target organs. The skin, lung, and bladder are particularly susceptible due to their exposure to arsenic and its metabolites.	cell_types[0]	cell_types	cell_types			epithelial cell	CL:0000066	epithelial cell		"{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
719	658	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Combined effects of epigenetic silencing, genomic instability, and constitutive growth signaling drive proliferation of transformed cells in target organs. The skin, lung, and bladder are particularly susceptible due to their exposure to arsenic and its metabolites.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
758	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[0]	cell_types	cell_types			Mast Cell	CL:0000097	mast cell		"{""preferred_term"": ""Mast Cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}"																											
759	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[1]	cell_types	cell_types			Eosinophil	CL:0000771	eosinophil		"{""preferred_term"": ""Eosinophil"", ""term"": {""id"": ""CL:0000771"", ""label"": ""eosinophil""}}"																											
760	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[2]	cell_types	cell_types			T-Lymphocyte	CL:0000084	T cell		"{""preferred_term"": ""T-Lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
761	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[3]	cell_types	cell_types			Bronchial Epithelial Cell	CL:0002328	bronchial epithelial cell		"{""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}"																											
762	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[4]	cell_types	cell_types			Basophil	CL:0000767	basophil		"{""preferred_term"": ""Basophil"", ""term"": {""id"": ""CL:0000767"", ""label"": ""basophil""}}"																											
763	695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.	cell_types[5]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
764	696	28	Asthma	Asthma.yaml	pathophysiology	1	Bronchoconstriction	During an asthma attack, smooth muscles around the airways tighten and narrow the airway.	cell_types[0]	cell_types	cell_types			Smooth Muscle Cells	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cells"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
765	697	28	Asthma	Asthma.yaml	pathophysiology	2	Mucus Overproduction	Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing.	cell_types[0]	cell_types	cell_types			Goblet Cell	CL:0000160	goblet cell		"{""preferred_term"": ""Goblet Cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}"																											
766	697	28	Asthma	Asthma.yaml	pathophysiology	2	Mucus Overproduction	Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing.	cell_types[1]	cell_types	cell_types			Bronchial Epithelial Cell	CL:0002328	bronchial epithelial cell		"{""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}"																											
767	697	28	Asthma	Asthma.yaml	pathophysiology	2	Mucus Overproduction	Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing.	cell_types[2]	cell_types	cell_types			Mucosal Epithelial Cell	CL:0002202	epithelial cell of tracheobronchial tree		"{""preferred_term"": ""Mucosal Epithelial Cell"", ""term"": {""id"": ""CL:0002202"", ""label"": ""epithelial cell of tracheobronchial tree""}}"																											
768	698	28	Asthma	Asthma.yaml	pathophysiology	3	Airway Remodeling	Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
769	698	28	Asthma	Asthma.yaml	pathophysiology	3	Airway Remodeling	Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function.	cell_types[1]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
770	698	28	Asthma	Asthma.yaml	pathophysiology	3	Airway Remodeling	Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function.	cell_types[2]	cell_types	cell_types			Bronchial Epithelial Cell	CL:0002328	bronchial epithelial cell		"{""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}"																											
786	731	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	0	Atrial Electrical Remodeling	"Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.
"	cell_types[0]	cell_types	cell_types			Atrial Cardiomyocyte	CL:0002129	regular atrial cardiac myocyte		"{""preferred_term"": ""Atrial Cardiomyocyte"", ""term"": {""id"": ""CL:0002129"", ""label"": ""regular atrial cardiac myocyte""}}"																											
787	731	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	0	Atrial Electrical Remodeling	"Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.
"	biological_processes[0]	biological_processes	biological_processes			Cardiac Conduction	GO:0086001	cardiac muscle cell action potential		"{""preferred_term"": ""Cardiac Conduction"", ""term"": {""id"": ""GO:0086001"", ""label"": ""cardiac muscle cell action potential""}}"																											
788	732	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	1	Atrial Structural Remodeling	"Atrial fibrosis and dilation create substrate for AF maintenance. Fibrosis disrupts normal conduction and creates reentrant circuits.
"	cell_types[0]	cell_types	cell_types			Cardiac Fibroblast	CL:0002548	fibroblast of cardiac tissue		"{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}"																											
799	751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	Fungal Gut Fermentation	"Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.
"	cell_types[0]	cell_types	cell_types			Enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""Enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
800	751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	Fungal Gut Fermentation	"Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.
"	biological_processes[0]	biological_processes	biological_processes			Fermentation	GO:0006113	fermentation		"{""preferred_term"": ""Fermentation"", ""term"": {""id"": ""GO:0006113"", ""label"": ""fermentation""}}"																											
801	751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	Fungal Gut Fermentation	"Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.
"	biological_processes[1]	biological_processes	biological_processes			Ethanol Metabolic Process	GO:0006067	ethanol metabolic process		"{""preferred_term"": ""Ethanol Metabolic Process"", ""term"": {""id"": ""GO:0006067"", ""label"": ""ethanol metabolic process""}}"																											
802	752	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	1	Bacterial Fermentation by Klebsiella	"High-alcohol-producing Klebsiella pneumoniae and related species can generate endogenous ethanol through the 2,3-butanediol fermentation pathway. These bacteria possess multiple copies of alcohol dehydrogenase genes enabling excessive ethanol production even under aerobic conditions.
"	cell_types[0]	cell_types	cell_types			Enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""Enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
803	752	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	1	Bacterial Fermentation by Klebsiella	"High-alcohol-producing Klebsiella pneumoniae and related species can generate endogenous ethanol through the 2,3-butanediol fermentation pathway. These bacteria possess multiple copies of alcohol dehydrogenase genes enabling excessive ethanol production even under aerobic conditions.
"	biological_processes[0]	biological_processes	biological_processes			Fermentation	GO:0006113	fermentation		"{""preferred_term"": ""Fermentation"", ""term"": {""id"": ""GO:0006113"", ""label"": ""fermentation""}}"																											
804	753	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	2	Impaired Hepatic Ethanol Clearance	"The liver normally clears endogenous ethanol through first-pass metabolism via alcohol dehydrogenase. When ethanol production exceeds hepatic clearance capacity or hepatic function is compromised, ethanol enters systemic circulation causing intoxication symptoms.
"	cell_types[0]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
805	753	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	2	Impaired Hepatic Ethanol Clearance	"The liver normally clears endogenous ethanol through first-pass metabolism via alcohol dehydrogenase. When ethanol production exceeds hepatic clearance capacity or hepatic function is compromised, ethanol enters systemic circulation causing intoxication symptoms.
"	biological_processes[0]	biological_processes	biological_processes			Ethanol Metabolic Process	GO:0006067	ethanol metabolic process		"{""preferred_term"": ""Ethanol Metabolic Process"", ""term"": {""id"": ""GO:0006067"", ""label"": ""ethanol metabolic process""}}"																											
817	771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	Warm Autoantibody-Mediated Hemolysis	IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
818	771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	Warm Autoantibody-Mediated Hemolysis	IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane.	cell_types[1]	cell_types	cell_types			Red Blood Cell	CL:0000232	erythrocyte		"{""preferred_term"": ""Red Blood Cell"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
819	771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	Warm Autoantibody-Mediated Hemolysis	IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane.	biological_processes[0]	biological_processes	biological_processes			Phagocytosis	GO:0006909	phagocytosis		"{""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}"																											
820	772	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	1	Cold Agglutinin-Mediated Hemolysis	IgM autoantibodies bind RBCs at low temperatures and activate complement. C3b-coated cells undergo extravascular hemolysis in the liver, or MAC formation causes intravascular hemolysis.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
821	773	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	2	B Cell Dysregulation	Loss of B cell tolerance allows production of anti-RBC autoantibodies. In secondary AIHA, underlying conditions (lymphoma, CLL, SLE) drive autoantibody production.	cell_types[0]	cell_types	cell_types			B Cell	CL:0000236	B cell		"{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
822	773	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	2	B Cell Dysregulation	Loss of B cell tolerance allows production of anti-RBC autoantibodies. In secondary AIHA, underlying conditions (lymphoma, CLL, SLE) drive autoantibody production.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
827	790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	T Cell-Mediated Hepatocyte Destruction	Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
828	790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	T Cell-Mediated Hepatocyte Destruction	Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules.	cell_types[1]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
829	790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	T Cell-Mediated Hepatocyte Destruction	Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules.	cell_types[2]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
830	790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	T Cell-Mediated Hepatocyte Destruction	Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules.	biological_processes[0]	biological_processes	biological_processes			T Cell Cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
831	791	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	1	Autoantibody Production	Characteristic autoantibodies include ANA, SMA (anti-actin), anti-LKM1 (anti-CYP2D6), and anti-SLA. While useful for diagnosis, their direct pathogenic role is uncertain.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
832	792	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	2	Regulatory T Cell Deficiency	Impaired function and reduced numbers of regulatory T cells (Tregs) fail to suppress autoreactive T cells, allowing ongoing liver damage.	cell_types[0]	cell_types	cell_types			Regulatory T Cell	CL:0000815	regulatory T cell		"{""preferred_term"": ""Regulatory T Cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}"																											
833	792	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	2	Regulatory T Cell Deficiency	Impaired function and reduced numbers of regulatory T cells (Tregs) fail to suppress autoreactive T cells, allowing ongoing liver damage.	biological_processes[0]	biological_processes	biological_processes			Immune Regulation	GO:0002682	regulation of immune system process		"{""preferred_term"": ""Immune Regulation"", ""term"": {""id"": ""GO:0002682"", ""label"": ""regulation of immune system process""}}"																											
838	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	cell_types[0]	cell_types	cell_types			migratory neural crest cell	CL:0000333	migratory neural crest cell		"{""preferred_term"": ""migratory neural crest cell"", ""term"": {""id"": ""CL:0000333"", ""label"": ""migratory neural crest cell""}}"																											
839	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	biological_processes[0]	biological_processes	biological_processes			neural crest cell migration	GO:0001755	neural crest cell migration		"{""preferred_term"": ""neural crest cell migration"", ""term"": {""id"": ""GO:0001755"", ""label"": ""neural crest cell migration""}}"																											
840	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	biological_processes[1]	biological_processes	biological_processes			eye morphogenesis	GO:0048592	eye morphogenesis		"{""preferred_term"": ""eye morphogenesis"", ""term"": {""id"": ""GO:0048592"", ""label"": ""eye morphogenesis""}}"																											
841	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	biological_processes[2]	biological_processes	biological_processes			canonical Wnt signaling pathway	GO:0060070	canonical Wnt signaling pathway		"{""preferred_term"": ""canonical Wnt signaling pathway"", ""term"": {""id"": ""GO:0060070"", ""label"": ""canonical Wnt signaling pathway""}}"																											
842	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	locations[0]	locations	locations			trabecular meshwork	UBERON:0001810	trabecular meshwork		"{""preferred_term"": ""trabecular meshwork"", ""term"": {""id"": ""UBERON:0001810"", ""label"": ""trabecular meshwork""}}"																											
843	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	locations[1]	locations	locations			corneal endothelium	UBERON:0001772	corneal endothelium		"{""preferred_term"": ""corneal endothelium"", ""term"": {""id"": ""UBERON:0001772"", ""label"": ""corneal endothelium""}}"																											
844	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.	locations[2]	locations	locations			iris stroma	UBERON:0011821	iris stroma		"{""preferred_term"": ""iris stroma"", ""term"": {""id"": ""UBERON:0011821"", ""label"": ""iris stroma""}}"																											
845	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	Dysregulated Transcription Factor Activity	Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis.	biological_processes[0]	biological_processes	biological_processes			regulation of transcription by RNA polymerase II	GO:0006357	regulation of transcription by RNA polymerase II		"{""preferred_term"": ""regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0006357"", ""label"": ""regulation of transcription by RNA polymerase II""}}"																											
846	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	Dysregulated Transcription Factor Activity	Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis.	biological_processes[1]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
858	835	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation.	cell_types[0]	cell_types	cell_types			thyroid follicular cell	CL:0002258	thyroid follicular cell		"{""preferred_term"": ""thyroid follicular cell"", ""term"": {""id"": ""CL:0002258"", ""label"": ""thyroid follicular cell""}}"																											
859	835	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
860	835	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation.	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
861	836	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	1	MEK-ERK Pathway Hyperactivation	Mutant BRAF constitutively phosphorylates and activates MEK1/2, leading to sustained ERK1/2 activation. This drives uncontrolled proliferation and is the rationale for combined BRAF/MEK inhibition therapy.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
862	837	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	2	Thyroid Dedifferentiation	BRAF V600E-driven MAPK activation suppresses expression of thyroid differentiation genes including NIS (sodium-iodide symporter), leading to radioiodine refractoriness. This loss of differentiation is associated with more aggressive disease behavior.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
874	853	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The V600E mutation substitutes glutamic acid for valine at position 600 in the activation segment of BRAF kinase. This mimics phosphorylation-induced activation, locking BRAF in an active conformation. The mutant kinase signals constitutively through MEK and ERK without upstream RAS activation.	cell_types[0]	cell_types	cell_types			colon epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
875	853	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The V600E mutation substitutes glutamic acid for valine at position 600 in the activation segment of BRAF kinase. This mimics phosphorylation-induced activation, locking BRAF in an active conformation. The mutant kinase signals constitutively through MEK and ERK without upstream RAS activation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
876	854	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	1	Uncontrolled MAPK Pathway Signaling	Constitutive BRAF V600E activation leads to continuous phosphorylation of MEK1/2, which phosphorylates ERK1/2. Activated ERK translocates to the nucleus and drives expression of genes promoting cell proliferation, survival, and invasion. This signaling is independent of growth factor receptor activation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
877	854	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	1	Uncontrolled MAPK Pathway Signaling	Constitutive BRAF V600E activation leads to continuous phosphorylation of MEK1/2, which phosphorylates ERK1/2. Activated ERK translocates to the nucleus and drives expression of genes promoting cell proliferation, survival, and invasion. This signaling is independent of growth factor receptor activation.	biological_processes[1]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
878	855	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	2	Enhanced Cell Proliferation	Sustained ERK signaling promotes entry into the cell cycle by inducing cyclin D1 and other proliferative genes while suppressing cell cycle inhibitors. This drives continuous tumor cell division independent of external growth signals.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
879	856	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	3	EGFR Feedback Reactivation	Unlike melanoma, colorectal cancer cells have high EGFR expression. When BRAF is inhibited, relief of ERK-mediated negative feedback leads to rapid EGFR reactivation, which signals through RAS and CRAF to restore MAPK pathway activity. This explains why BRAF inhibitor monotherapy fails in colorectal cancer but works in melanoma.	biological_processes[0]	biological_processes	biological_processes			ERBB signaling pathway	GO:0038127	ERBB signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB signaling pathway"", ""term"": {""id"": ""GO:0038127"", ""label"": ""ERBB signaling pathway""}}"			INCREASED																								
890	871	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	0	BRAF V600E Oncogenic Mutation	The BRAF V600E mutation substitutes glutamic acid for valine at codon 600 in the activation segment. This mimics phosphorylation, causing constitutive kinase activation. V600E signals as a monomer independent of upstream RAS, unlike wild-type BRAF which requires RAS-mediated dimerization.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
891	871	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	0	BRAF V600E Oncogenic Mutation	The BRAF V600E mutation substitutes glutamic acid for valine at codon 600 in the activation segment. This mimics phosphorylation, causing constitutive kinase activation. V600E signals as a monomer independent of upstream RAS, unlike wild-type BRAF which requires RAS-mediated dimerization.	biological_processes[0]	biological_processes	biological_processes			protein kinase activity	GO:0004672	protein kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}"			INCREASED																								
892	872	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive MAPK Pathway Activation	BRAF V600E constitutively phosphorylates and activates MEK1/2, which in turn phosphorylates and activates ERK1/2. This leads to uncontrolled proliferation and survival signaling. The lack of dependence on upstream RAS makes the tumor exquisitely sensitive to BRAF inhibition.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
893	873	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Survival	Constitutive ERK signaling drives expression of cyclin D1 and other cell cycle genes, promoting uncontrolled proliferation. ERK also inhibits pro-apoptotic proteins through phosphorylation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
894	874	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	3	BRAF/MEK Inhibitor Resistance	Resistance to BRAF/MEK inhibition can develop through MAPK pathway reactivation (BRAF amplification, MEK mutations, NRAS mutations), bypass pathway activation (PI3K-AKT), or histologic transformation. Combination BRAF+MEK inhibition delays resistance compared to BRAF inhibitor monotherapy.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
905	887	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	0	BRAF V600 Oncogenic Mutation	BRAF V600 mutations, predominantly V600E and V600K, result in substitution of the valine residue in the activation loop of the BRAF kinase. This removes an autoinhibitory mechanism, causing constitutive kinase activity independent of upstream RAS signaling. The mutant BRAF signals as a monomer, unlike wild-type BRAF which requires dimerization for activation.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
906	887	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	0	BRAF V600 Oncogenic Mutation	BRAF V600 mutations, predominantly V600E and V600K, result in substitution of the valine residue in the activation loop of the BRAF kinase. This removes an autoinhibitory mechanism, causing constitutive kinase activity independent of upstream RAS signaling. The mutant BRAF signals as a monomer, unlike wild-type BRAF which requires dimerization for activation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
907	888	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	1	Constitutive MAPK Pathway Activation	Mutant BRAF continuously phosphorylates and activates MEK1/2, which in turn activates ERK1/2. This constitutive MAPK signaling drives expression of genes promoting cell cycle progression, survival, and proliferation. The pathway operates independently of growth factor stimulation.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
908	888	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	1	Constitutive MAPK Pathway Activation	Mutant BRAF continuously phosphorylates and activates MEK1/2, which in turn activates ERK1/2. This constitutive MAPK signaling drives expression of genes promoting cell cycle progression, survival, and proliferation. The pathway operates independently of growth factor stimulation.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
909	889	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
910	889	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
911	889	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
912	890	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	3	Apoptosis Resistance	BRAF V600 signaling promotes melanoma cell survival through multiple anti-apoptotic mechanisms, including upregulation of BCL2 family members and suppression of pro-apoptotic BIM. This contributes to tumor persistence and therapy resistance.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
920	903	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	0	Homologous Recombination Repair Deficiency	Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways.	cell_types[0]	cell_types	cell_types			prostate gland cell	CL:0002231	epithelial cell of prostate		"{""preferred_term"": ""prostate gland cell"", ""term"": {""id"": ""CL:0002231"", ""label"": ""epithelial cell of prostate""}}"																											
921	903	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	0	Homologous Recombination Repair Deficiency	Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways.	biological_processes[0]	biological_processes	biological_processes			double-strand break repair via homologous recombination	GO:0000724	double-strand break repair via homologous recombination		"{""modifier"": ""DECREASED"", ""preferred_term"": ""double-strand break repair via homologous recombination"", ""term"": {""id"": ""GO:0000724"", ""label"": ""double-strand break repair via homologous recombination""}}"			DECREASED																								
922	903	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	0	Homologous Recombination Repair Deficiency	Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways.	locations[0]	locations	locations			prostate gland	UBERON:0002367	prostate gland		"{""preferred_term"": ""prostate gland"", ""term"": {""id"": ""UBERON:0002367"", ""label"": ""prostate gland""}}"																											
923	904	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	1	Genomic Instability	HRR deficiency leads to genomic instability characterized by chromosomal rearrangements, copy number alterations, and mutational signatures typical of BRCA deficiency. This drives aggressive tumor behavior but also creates therapeutic vulnerabilities.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
924	905	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	2	Synthetic Lethality with PARP Inhibition	PARP enzymes are essential for single-strand break repair. In HRR-deficient cells, PARP inhibition causes accumulation of double-strand breaks that cannot be repaired, leading to synthetic lethality and selective tumor cell death.	biological_processes[0]	biological_processes	biological_processes			single-strand break repair	GO:0000012	single-strand break repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""single-strand break repair"", ""term"": {""id"": ""GO:0000012"", ""label"": ""single-strand break repair""}}"			DECREASED																								
941	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.	locations[0]	locations	locations			blood-brain barrier	UBERON:0000120	blood-brain barrier		"{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}"																											
942	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.	locations[1]	locations	locations			meninges	UBERON:0002360	meninges		"{""preferred_term"": ""meninges"", ""term"": {""id"": ""UBERON:0002360"", ""label"": ""meninges""}}"																											
943	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.	locations[2]	locations	locations			cerebrospinal fluid	UBERON:0001359	cerebrospinal fluid		"{""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}"																											
944	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.	cell_types[0]	cell_types	cell_types			brain microvascular endothelial cell	CL:2000044	brain microvascular endothelial cell		"{""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}"																											
945	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.	cell_types[1]	cell_types	cell_types			choroid plexus epithelial cell	CL:0000706	choroid plexus epithelial cell		"{""preferred_term"": ""choroid plexus epithelial cell"", ""term"": {""id"": ""CL:0000706"", ""label"": ""choroid plexus epithelial cell""}}"																											
946	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	locations[0]	locations	locations			subarachnoid space	UBERON:0001496	subarachnoid space		"{""preferred_term"": ""subarachnoid space"", ""term"": {""id"": ""UBERON:0001496"", ""label"": ""subarachnoid space""}}"																											
947	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
948	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
949	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	cell_types[2]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
950	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	chemical_entities[0]	chemical_entities	chemical_entities			Cytokines	CHEBI:59527	cytokine		"{""preferred_term"": ""Cytokines"", ""term"": {""id"": ""CHEBI:59527"", ""label"": ""cytokine""}}"																											
951	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	chemical_entities[1]	chemical_entities	chemical_entities			Chemokines	CHEBI:80222	chemokine		"{""preferred_term"": ""Chemokines"", ""term"": {""id"": ""CHEBI:80222"", ""label"": ""chemokine""}}"																											
952	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
953	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.	biological_processes[1]	biological_processes	biological_processes			innate immune response	GO:0045087	innate immune response		"{""preferred_term"": ""innate immune response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}"																											
954	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	Increased Intracranial Pressure	Inflammation and accumulation of purulent exudate lead to increased intracranial pressure.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
955	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	Increased Intracranial Pressure	Inflammation and accumulation of purulent exudate lead to increased intracranial pressure.	locations[1]	locations	locations			cerebrospinal fluid	UBERON:0001359	cerebrospinal fluid		"{""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}"																											
956	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	genes[0]	genes	genes			TLR2	hgnc:11849	TLR2		"{""preferred_term"": ""TLR2"", ""term"": {""id"": ""hgnc:11849"", ""label"": ""TLR2""}}"																											
957	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	genes[1]	genes	genes			TLR4	hgnc:11850	TLR4		"{""preferred_term"": ""TLR4"", ""term"": {""id"": ""hgnc:11850"", ""label"": ""TLR4""}}"																											
958	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	locations[0]	locations	locations			blood-brain barrier	UBERON:0000120	blood-brain barrier		"{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}"																											
959	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	locations[1]	locations	locations			meninges	UBERON:0002360	meninges		"{""preferred_term"": ""meninges"", ""term"": {""id"": ""UBERON:0002360"", ""label"": ""meninges""}}"																											
960	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
961	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
962	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	cell_types[2]	cell_types	cell_types			brain microvascular endothelial cell	CL:2000044	brain microvascular endothelial cell		"{""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}"																											
963	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	biological_processes[0]	biological_processes	biological_processes			toll-like receptor signaling pathway	GO:0002224	toll-like receptor signaling pathway		"{""preferred_term"": ""toll-like receptor signaling pathway"", ""term"": {""id"": ""GO:0002224"", ""label"": ""toll-like receptor signaling pathway""}}"																											
964	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.	biological_processes[1]	biological_processes	biological_processes			I-kappaB kinase/NF-kappaB signaling	GO:0007249	I-kappaB kinase/NF-kappaB signaling		"{""preferred_term"": ""I-kappaB kinase/NF-kappaB signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""I-kappaB kinase/NF-kappaB signaling""}}"																											
965	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	genes[0]	genes	genes			NLRP3	hgnc:16400	NLRP3		"{""preferred_term"": ""NLRP3"", ""term"": {""id"": ""hgnc:16400"", ""label"": ""NLRP3""}}"																											
966	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	genes[1]	genes	genes			CASP1	hgnc:1499	CASP1		"{""preferred_term"": ""CASP1"", ""term"": {""id"": ""hgnc:1499"", ""label"": ""CASP1""}}"																											
967	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
968	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	locations[1]	locations	locations			cerebrospinal fluid	UBERON:0001359	cerebrospinal fluid		"{""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}"																											
969	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
970	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
971	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	biological_processes[0]	biological_processes	biological_processes			inflammasome complex assembly	GO:0061702	inflammasome complex assembly		"{""preferred_term"": ""inflammasome complex assembly"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex assembly""}}"																											
972	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.	biological_processes[1]	biological_processes	biological_processes			pyroptosis	GO:0070269	pyroptosis		"{""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}"																											
973	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	genes[0]	genes	genes			IL22	hgnc:5982	IL22		"{""preferred_term"": ""IL22"", ""term"": {""id"": ""hgnc:5982"", ""label"": ""IL22""}}"																											
974	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	genes[1]	genes	genes			STAT3	hgnc:11364	STAT3		"{""preferred_term"": ""STAT3"", ""term"": {""id"": ""hgnc:11364"", ""label"": ""STAT3""}}"																											
975	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	genes[2]	genes	genes			VEGFA	hgnc:12680	VEGFA		"{""preferred_term"": ""VEGFA"", ""term"": {""id"": ""hgnc:12680"", ""label"": ""VEGFA""}}"																											
976	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	genes[3]	genes	genes			EGR1	hgnc:3238	EGR1		"{""preferred_term"": ""EGR1"", ""term"": {""id"": ""hgnc:3238"", ""label"": ""EGR1""}}"																											
977	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	genes[4]	genes	genes			MMP9	hgnc:7176	MMP9		"{""preferred_term"": ""MMP9"", ""term"": {""id"": ""hgnc:7176"", ""label"": ""MMP9""}}"																											
978	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	locations[0]	locations	locations			blood-brain barrier	UBERON:0000120	blood-brain barrier		"{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}"																											
979	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	cell_types[0]	cell_types	cell_types			brain microvascular endothelial cell	CL:2000044	brain microvascular endothelial cell		"{""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}"																											
980	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT cascade	GO:0007259	JAK-STAT cascade		"{""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"																											
981	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	biological_processes[1]	biological_processes	biological_processes			VEGF-activated receptor activity	GO:0005021	vascular endothelial growth factor-activated receptor activity		"{""preferred_term"": ""VEGF-activated receptor activity"", ""term"": {""id"": ""GO:0005021"", ""label"": ""vascular endothelial growth factor-activated receptor activity""}}"																											
982	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	biological_processes[2]	biological_processes	biological_processes			tight junction organization	GO:0120193	tight junction organization		"{""preferred_term"": ""tight junction organization"", ""term"": {""id"": ""GO:0120193"", ""label"": ""tight junction organization""}}"																											
983	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.	biological_processes[3]	biological_processes	biological_processes			extracellular matrix disassembly	GO:0022617	extracellular matrix disassembly		"{""preferred_term"": ""extracellular matrix disassembly"", ""term"": {""id"": ""GO:0022617"", ""label"": ""extracellular matrix disassembly""}}"																											
1019	976	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the function of primary cilia due to mutations in BBS genes lead to a wide range of symptoms.	cellular_components[0]	cellular_components	cellular_components			Primary Cilium	GO:0005929	cilium		"{""preferred_term"": ""Primary Cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
1020	977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.	cellular_components[0]	cellular_components	cellular_components			BBSome	GO:0034464	BBSome		"{""preferred_term"": ""BBSome"", ""term"": {""id"": ""GO:0034464"", ""label"": ""BBSome""}}"																											
1021	977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.	cellular_components[1]	cellular_components	cellular_components			Ciliary Transition Zone	GO:0035869	ciliary transition zone		"{""preferred_term"": ""Ciliary Transition Zone"", ""term"": {""id"": ""GO:0035869"", ""label"": ""ciliary transition zone""}}"																											
1022	977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.	biological_processes[0]	biological_processes	biological_processes			Intraflagellar Transport	GO:0042073	intraflagellar transport		"{""preferred_term"": ""Intraflagellar Transport"", ""term"": {""id"": ""GO:0042073"", ""label"": ""intraflagellar transport""}}"																											
1023	977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.	biological_processes[1]	biological_processes	biological_processes			Protein Localization to Cilium	GO:0061512	protein localization to cilium		"{""preferred_term"": ""Protein Localization to Cilium"", ""term"": {""id"": ""GO:0061512"", ""label"": ""protein localization to cilium""}}"																											
1024	977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.	locations[0]	locations	locations			Photoreceptor Connecting Cilium	GO:0042622	photoreceptor inner segment		"{""preferred_term"": ""Photoreceptor Connecting Cilium"", ""term"": {""id"": ""GO:0042622"", ""label"": ""photoreceptor inner segment""}}"																											
1025	978	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	2	Hypothalamic Leptin Resistance	Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity.	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1026	978	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	2	Hypothalamic Leptin Resistance	Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity.	locations[0]	locations	locations			Hypothalamus	UBERON:0001898	hypothalamus		"{""preferred_term"": ""Hypothalamus"", ""term"": {""id"": ""UBERON:0001898"", ""label"": ""hypothalamus""}}"																											
1027	978	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	2	Hypothalamic Leptin Resistance	Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity.	biological_processes[0]	biological_processes	biological_processes			Regulation of Appetite	GO:0032098	regulation of appetite		"{""preferred_term"": ""Regulation of Appetite"", ""term"": {""id"": ""GO:0032098"", ""label"": ""regulation of appetite""}}"																											
1028	978	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	2	Hypothalamic Leptin Resistance	Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity.	biological_processes[1]	biological_processes	biological_processes			Leptin Receptor Signaling	GO:0038110	interleukin-35-mediated signaling pathway		"{""preferred_term"": ""Leptin Receptor Signaling"", ""term"": {""id"": ""GO:0038110"", ""label"": ""interleukin-35-mediated signaling pathway""}}"																											
1029	979	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	3	Renal Ciliary Dysfunction	Renal tubular epithelial cells depend on primary cilia for proper solute handling and signaling. BBSome-mediated ciliary dysfunction disrupts these processes, leading to concentrating and diluting defects, progressive renal cysts, dysplasia, and chronic kidney disease.	cell_types[0]	cell_types	cell_types			Renal Tubular Epithelial Cell	CL:0002306	epithelial cell of proximal tubule		"{""preferred_term"": ""Renal Tubular Epithelial Cell"", ""term"": {""id"": ""CL:0002306"", ""label"": ""epithelial cell of proximal tubule""}}"																											
1030	979	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	3	Renal Ciliary Dysfunction	Renal tubular epithelial cells depend on primary cilia for proper solute handling and signaling. BBSome-mediated ciliary dysfunction disrupts these processes, leading to concentrating and diluting defects, progressive renal cysts, dysplasia, and chronic kidney disease.	locations[0]	locations	locations			Kidney	UBERON:0002113	kidney		"{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
1047	1011	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	0	PTCH1 Loss of Function	PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome.	cell_types[0]	cell_types	cell_types			basal cell of epidermis	CL:0002187	basal cell of epidermis		"{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}"																											
1048	1011	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	0	PTCH1 Loss of Function	PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
1049	1011	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	0	PTCH1 Loss of Function	PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
1050	1012	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	1	SMO Activating Mutations	Smoothened (SMO) is a G-protein coupled receptor-like protein that transduces Hedgehog signal. Activating mutations in SMO, though less common than PTCH1 loss, render SMO constitutively active regardless of PTCH1 status. Some SMO mutations confer resistance to vismodegib.	cell_types[0]	cell_types	cell_types			basal cell of epidermis	CL:0002187	basal cell of epidermis		"{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}"																											
1051	1012	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	1	SMO Activating Mutations	Smoothened (SMO) is a G-protein coupled receptor-like protein that transduces Hedgehog signal. Activating mutations in SMO, though less common than PTCH1 loss, render SMO constitutively active regardless of PTCH1 status. Some SMO mutations confer resistance to vismodegib.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
1052	1013	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	2	Constitutive Hedgehog Pathway Activation	Loss of PTCH1 or activating SMO mutations result in constitutive activation of the Hedgehog signaling cascade. Active SMO translocates to the primary cilium and promotes activation of GLI transcription factors (GLI1, GLI2), which drive expression of target genes promoting proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
1053	1014	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	3	GLI Transcription Factor Activation	Active Hedgehog signaling promotes GLI transcription factor processing and nuclear translocation. GLI1 and GLI2 activate transcription of target genes including PTCH1, GLI1 (positive feedback), cyclin D1, MYC, and BCL2, promoting proliferation and survival of basal cells.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1054	1015	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	4	Uncontrolled Basal Cell Proliferation	Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology.	cell_types[0]	cell_types	cell_types			basal cell of epidermis	CL:0002187	basal cell of epidermis		"{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}"																											
1055	1015	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	4	Uncontrolled Basal Cell Proliferation	Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
1056	1015	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	4	Uncontrolled Basal Cell Proliferation	Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1066	1029	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	0	HLA-B51-Associated Immune Dysregulation	Strong association with HLA-B51. Aberrant peptide presentation and cross-reactivity with microbial antigens may trigger autoinflammatory responses. ERAP1 variants affect peptide processing for HLA-B51.	biological_processes[0]	biological_processes	biological_processes			Antigen Presentation	GO:0019882	antigen processing and presentation		"{""preferred_term"": ""Antigen Presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"																											
1067	1030	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	1	Neutrophil Hyperactivation	Neutrophils show enhanced chemotaxis, phagocytosis, and oxidative burst. Pathergy response (exaggerated skin reaction to minor trauma) reflects neutrophil hyperreactivity. NETs may contribute to vascular damage.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
1068	1030	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	1	Neutrophil Hyperactivation	Neutrophils show enhanced chemotaxis, phagocytosis, and oxidative burst. Pathergy response (exaggerated skin reaction to minor trauma) reflects neutrophil hyperreactivity. NETs may contribute to vascular damage.	biological_processes[0]	biological_processes	biological_processes			Neutrophil Activation	GO:0042119	neutrophil activation		"{""preferred_term"": ""Neutrophil Activation"", ""term"": {""id"": ""GO:0042119"", ""label"": ""neutrophil activation""}}"																											
1069	1031	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	2	Th1/Th17 Cytokine Imbalance	Elevated IL-17, IFN-gamma, and TNF-alpha drive tissue inflammation. IL-23/IL-17 axis is particularly important and represents a therapeutic target.	cell_types[0]	cell_types	cell_types			T Helper Cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
1070	1031	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	2	Th1/Th17 Cytokine Imbalance	Elevated IL-17, IFN-gamma, and TNF-alpha drive tissue inflammation. IL-23/IL-17 axis is particularly important and represents a therapeutic target.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1079	1056	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	0	Prostatic Stromal and Epithelial Proliferation	"Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.
"	cell_types[0]	cell_types	cell_types			Prostatic Epithelial Cell	CL:0002231	epithelial cell of prostate		"{""preferred_term"": ""Prostatic Epithelial Cell"", ""term"": {""id"": ""CL:0002231"", ""label"": ""epithelial cell of prostate""}}"																											
1080	1056	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	0	Prostatic Stromal and Epithelial Proliferation	"Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.
"	biological_processes[0]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell population proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"																											
1081	1058	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	2	Detrusor Dysfunction	"Chronic obstruction leads to detrusor muscle hypertrophy and later decompensation. Results in overactive bladder symptoms and incomplete emptying.
"	cell_types[0]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
1082	1059	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	3	Androgen-Dependent Growth	"DHT converted from testosterone by 5-alpha reductase drives prostatic growth. 5-alpha reductase inhibitors shrink prostate.
"	biological_processes[0]	biological_processes	biological_processes			Androgen Response	GO:0030521	androgen receptor signaling pathway		"{""preferred_term"": ""Androgen Response"", ""term"": {""id"": ""GO:0030521"", ""label"": ""androgen receptor signaling pathway""}}"																											
1083	1060	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	4	Hypoxia-Induced Epithelial-Mesenchymal Transition	"Hypoxic basal epithelial cells (BE5) drive nodular formation through upregulation of FOS and activation of EMT signaling, particularly in glandular nodules of the transition zone.
"	biological_processes[0]	biological_processes	biological_processes			Epithelial to Mesenchymal Transition	GO:0001837	epithelial to mesenchymal transition		"{""preferred_term"": ""Epithelial to Mesenchymal Transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}"																											
1084	1061	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	5	TGF-beta/ROCK1 Mediated Stromal Hyperplasia	"Aberrant activation of TGF-beta/ROCK1 pathway recruits mesenchymal stem cells that differentiate into fibroblasts and myofibroblasts, driving stromal hyperplasia and fibrosis.
"	biological_processes[0]	biological_processes	biological_processes			TGF-beta Signaling	GO:0007179	transforming growth factor beta receptor signaling pathway		"{""preferred_term"": ""TGF-beta Signaling"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}"																											
1085	1062	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	6	ROCK-Mediated Fibrosis and Beta-Catenin Signaling	"ROCK1/2 activation promotes fibrosis, EMT, and cell proliferation by stabilizing beta-catenin and activating downstream targets including C-MYC, Snail, and Survivin. ROCK inhibition reverses these processes.
"	biological_processes[0]	biological_processes	biological_processes			Wnt Signaling Pathway	GO:0016055	Wnt signaling pathway		"{""preferred_term"": ""Wnt Signaling Pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"																											
1086	1063	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	7	Oxidative Stress and Epithelial Plasticity	"Low-androgen signaling epithelial populations show increased vulnerability to oxidative stress due to reduced antioxidant defenses. Mitochondrial ROS drives cell proliferation and stemness in BPH.
"	biological_processes[0]	biological_processes	biological_processes			Response to Oxidative Stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
1087	1064	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	8	Inflammation and IL-6 Signaling	"Periodontal pathogens and inflammatory stimuli upregulate IL-6, IL-6R, and gp130, activating the Akt pathway to promote epithelial and stromal proliferation while inhibiting apoptosis.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1094	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1095	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	cell_types[1]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
1096	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	cell_types[2]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1097	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	biological_processes[0]	biological_processes	biological_processes			Glycoprotein catabolism	GO:0006516	glycoprotein catabolic process		"{""preferred_term"": ""Glycoprotein catabolism"", ""term"": {""id"": ""GO:0006516"", ""label"": ""glycoprotein catabolic process""}}"																											
1098	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	locations[0]	locations	locations			Lysosome	GO:0005764	lysosome		"{""preferred_term"": ""Lysosome"", ""term"": {""id"": ""GO:0005764"", ""label"": ""lysosome""}}"																											
1099	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"	locations[1]	locations	locations			Brain	UBERON:0000955	brain		"{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
1105	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	Monoamine Dysregulation	"Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
1106	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	Monoamine Dysregulation	"Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.
"	cell_types[1]	cell_types	cell_types			Serotonergic Neuron	CL:0000850	serotonergic neuron		"{""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}"																											
1107	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	Monoamine Dysregulation	"Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.
"	cell_types[2]	cell_types	cell_types			Noradrenergic Neuron	CL:0008025	noradrenergic neuron		"{""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}"																											
1108	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	Monoamine Dysregulation	"Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.
"	biological_processes[0]	biological_processes	biological_processes			Neurotransmitter Signaling	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Neurotransmitter Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
1109	1104	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	1	Mitochondrial Dysfunction	"Impaired cellular energy metabolism and oxidative stress affect neuronal function. Mitochondrial abnormalities linked to mood dysregulation.
"	biological_processes[0]	biological_processes	biological_processes			Mitochondrial Function	GO:0007005	mitochondrion organization		"{""preferred_term"": ""Mitochondrial Function"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}"																											
1110	1105	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	2	Circadian Rhythm Disruption	"Disrupted sleep-wake cycles and circadian gene expression contribute to mood instability. Sleep deprivation can trigger mania.
"	biological_processes[0]	biological_processes	biological_processes			Circadian Rhythm	GO:0007623	circadian rhythm		"{""preferred_term"": ""Circadian Rhythm"", ""term"": {""id"": ""GO:0007623"", ""label"": ""circadian rhythm""}}"																											
1111	1106	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	3	Neuroplasticity Alterations	"Reduced BDNF and altered synaptic plasticity in mood circuits. Lithium and other mood stabilizers enhance neuroplasticity.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1112	1106	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	3	Neuroplasticity Alterations	"Reduced BDNF and altered synaptic plasticity in mood circuits. Lithium and other mood stabilizers enhance neuroplasticity.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Plasticity	GO:0048167	regulation of synaptic plasticity		"{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"																											
1113	1107	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	4	Neuroinflammation	"Elevated inflammatory markers during mood episodes. Microglial activation and cytokine abnormalities contribute to pathophysiology.
"	cell_types[0]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
1114	1107	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	4	Neuroinflammation	"Elevated inflammatory markers during mood episodes. Microglial activation and cytokine abnormalities contribute to pathophysiology.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1141	1145	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	0	Exposure to Avian Proteins	Repeated inhalation of avian proteins from bird droppings, feathers, or serum triggers bird-related hypersensitivity pneumonitis.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1142	1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	Expansion of Resident Monocytes and Interstitial Macrophages	Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
1143	1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	Expansion of Resident Monocytes and Interstitial Macrophages	Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1144	1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	Expansion of Resident Monocytes and Interstitial Macrophages	Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung.	cell_types[2]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
1145	1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	Expansion of Resident Monocytes and Interstitial Macrophages	Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1146	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
1147	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1148	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.	cell_types[2]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
1149	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.	cell_types[3]	cell_types	cell_types			alveolar macrophage	CL:0000583	alveolar macrophage		"{""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}"																											
1150	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1151	1148	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	3	Th1/Th2 to Th2/Th17 Cytokine Shift	Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
1152	1148	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	3	Th1/Th2 to Th2/Th17 Cytokine Shift	Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response.	biological_processes[0]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
1153	1148	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	3	Th1/Th2 to Th2/Th17 Cytokine Shift	Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1154	1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	Bird Antigen-Driven Humoral Response	Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1155	1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	Bird Antigen-Driven Humoral Response	Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"																											
1156	1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	Bird Antigen-Driven Humoral Response	Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis.	biological_processes[1]	biological_processes	biological_processes			antigen processing and presentation	GO:0019882	antigen processing and presentation		"{""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"																											
1157	1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	Bird Antigen-Driven Humoral Response	Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1158	1150	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	5	Species-Specific Bird Antigen Panels	Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species.	triggers[0]	triggers	triggers			pigeon	NCBITaxon:8932	Columba livia		"{""preferred_term"": ""pigeon"", ""term"": {""id"": ""NCBITaxon:8932"", ""label"": ""Columba livia""}}"																											
1159	1150	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	5	Species-Specific Bird Antigen Panels	Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species.	triggers[1]	triggers	triggers			parrot	NCBITaxon:9223	Psittaciformes		"{""preferred_term"": ""parrot"", ""term"": {""id"": ""NCBITaxon:9223"", ""label"": ""Psittaciformes""}}"																											
1160	1150	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	5	Species-Specific Bird Antigen Panels	Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species.	triggers[2]	triggers	triggers			budgerigar	NCBITaxon:13146	Melopsittacus undulatus		"{""preferred_term"": ""budgerigar"", ""term"": {""id"": ""NCBITaxon:13146"", ""label"": ""Melopsittacus undulatus""}}"																											
1161	1151	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	6	Classical Monocyte Enrichment	Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
1162	1151	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	6	Classical Monocyte Enrichment	Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states.	biological_processes[0]	biological_processes	biological_processes			chemokine-mediated signaling pathway	GO:0070098	chemokine-mediated signaling pathway		"{""preferred_term"": ""chemokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0070098"", ""label"": ""chemokine-mediated signaling pathway""}}"																											
1163	1151	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	6	Classical Monocyte Enrichment	Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1164	1152	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	7	Monocyte-to-SPP1hi Macrophage Differentiation	Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
1165	1152	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	7	Monocyte-to-SPP1hi Macrophage Differentiation	Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1166	1152	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	7	Monocyte-to-SPP1hi Macrophage Differentiation	Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1167	1153	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	8	Cytotoxic T Cell Program with Profibrotic Signaling	Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
1168	1153	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	8	Cytotoxic T Cell Program with Profibrotic Signaling	Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways.	biological_processes[0]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
1169	1153	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	8	Cytotoxic T Cell Program with Profibrotic Signaling	Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1170	1154	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	9	MMP14-High Macrophage Profibrotic Activity	MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling.	cell_types[0]	cell_types	cell_types			alveolar macrophage	CL:0000583	alveolar macrophage		"{""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}"																											
1171	1154	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	9	MMP14-High Macrophage Profibrotic Activity	MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1172	1154	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	9	MMP14-High Macrophage Profibrotic Activity	MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling.	locations[0]	locations	locations			alveolus of lung	UBERON:0002299	alveolus of lung		"{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}"																											
1173	1155	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	10	TLR2 and NF-B Regulation of MMP14 and Exosome Secretion	TLR2 and NF-B signaling regulate MMP14 expression and macrophage exosome secretion in antigen-stimulated hypersensitivity pneumonitis models.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1197	1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.	cell_types[0]	cell_types	cell_types			airway epithelial cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
1198	1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.	cell_types[1]	cell_types	cell_types			ciliated epithelial cell	CL:0000067	ciliated epithelial cell		"{""preferred_term"": ""ciliated epithelial cell"", ""term"": {""id"": ""CL:0000067"", ""label"": ""ciliated epithelial cell""}}"																											
1199	1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.	biological_processes[0]	biological_processes	biological_processes			mucociliary clearance	GO:0003351	epithelial cilium movement involved in extracellular fluid movement		"{""preferred_term"": ""mucociliary clearance"", ""term"": {""id"": ""GO:0003351"", ""label"": ""epithelial cilium movement involved in extracellular fluid movement""}}"																											
1200	1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.	biological_processes[1]	biological_processes	biological_processes			cilium movement	GO:0003341	cilium movement		"{""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}"																											
1201	1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1202	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
1203	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	biological_processes[0]	biological_processes	biological_processes			neutrophil degranulation	GO:0043312	neutrophil degranulation		"{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}"																											
1204	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	biological_processes[1]	biological_processes	biological_processes			neutrophil extracellular trap formation	GO:0036148	NETosis		"{""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0036148"", ""label"": ""NETosis""}}"																											
1205	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	biological_processes[2]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1206	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1207	1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.	locations[1]	locations	locations			extracellular space	GO:0005615	extracellular region		"{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular region""}}"																											
1208	1195	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	4	Protease-Antiprotease Imbalance	Excess neutrophil serine proteases (NE, PR3, CatG) overwhelm antiproteases (SLPI, A1AT), degrading structural proteins and perpetuating tissue damage.	biological_processes[0]	biological_processes	biological_processes			proteolysis	GO:0006508	proteolysis		"{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}"																											
1209	1195	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	4	Protease-Antiprotease Imbalance	Excess neutrophil serine proteases (NE, PR3, CatG) overwhelm antiproteases (SLPI, A1AT), degrading structural proteins and perpetuating tissue damage.	locations[0]	locations	locations			extracellular space	GO:0005615	extracellular region		"{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular region""}}"																											
1210	1196	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	5	Goblet Cell Hyperplasia and Mucus Hypersecretion	Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance.	cell_types[0]	cell_types	cell_types			goblet cell	CL:0000160	goblet cell		"{""preferred_term"": ""goblet cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}"																											
1211	1196	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	5	Goblet Cell Hyperplasia and Mucus Hypersecretion	Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance.	biological_processes[0]	biological_processes	biological_processes			mucus secretion	GO:0070254	mucus secretion		"{""preferred_term"": ""mucus secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}"																											
1212	1196	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	5	Goblet Cell Hyperplasia and Mucus Hypersecretion	Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1213	1197	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	6	Inflammasome Activation and IL-1beta Signaling	NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment.	biological_processes[0]	biological_processes	biological_processes			NLRP3 inflammasome complex assembly	GO:0072559	NLRP3 inflammasome complex assembly		"{""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}"																											
1214	1197	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	6	Inflammasome Activation and IL-1beta Signaling	NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment.	biological_processes[1]	biological_processes	biological_processes			interleukin-1 beta production	GO:0032611	interleukin-1 beta production		"{""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
1215	1197	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	6	Inflammasome Activation and IL-1beta Signaling	NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment.	cell_types[0]	cell_types	cell_types			airway epithelial cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
1216	1197	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	6	Inflammasome Activation and IL-1beta Signaling	NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1217	1198	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	7	Microbiome Dysbiosis	Reduced microbial diversity with Proteobacteria dominance, particularly Pseudomonas aeruginosa and Haemophilus influenzae, drives chronic infection, exacerbations, and disease progression.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1218	1198	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	7	Microbiome Dysbiosis	Reduced microbial diversity with Proteobacteria dominance, particularly Pseudomonas aeruginosa and Haemophilus influenzae, drives chronic infection, exacerbations, and disease progression.	locations[1]	locations	locations			respiratory tract mucus	UBERON:0016403	respiratory tract mucus		"{""preferred_term"": ""respiratory tract mucus"", ""term"": {""id"": ""UBERON:0016403"", ""label"": ""respiratory tract mucus""}}"																											
1234	1226	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	0	MYC Translocation and Oncogene Activation	The hallmark of Burkitt lymphoma is translocation of the MYC oncogene on chromosome 8 to an immunoglobulin locus, most commonly t(8;14)(q24;q32) involving the IGH locus, or less commonly t(2;8) or t(8;22) involving light chain loci. This places MYC under control of immunoglobulin enhancers, resulting in constitutive MYC overexpression.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1235	1226	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	0	MYC Translocation and Oncogene Activation	The hallmark of Burkitt lymphoma is translocation of the MYC oncogene on chromosome 8 to an immunoglobulin locus, most commonly t(8;14)(q24;q32) involving the IGH locus, or less commonly t(2;8) or t(8;22) involving light chain loci. This places MYC under control of immunoglobulin enhancers, resulting in constitutive MYC overexpression.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			INCREASED																								
1236	1227	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	1	Uncontrolled B-Cell Proliferation	MYC is a master transcriptional regulator of cell growth and proliferation. Constitutive MYC expression drives continuous cell cycle progression, resulting in one of the fastest doubling times of any human tumor (approximately 24 hours). The proliferation fraction approaches 100% (Ki-67 staining).	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1237	1227	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	1	Uncontrolled B-Cell Proliferation	MYC is a master transcriptional regulator of cell growth and proliferation. Constitutive MYC expression drives continuous cell cycle progression, resulting in one of the fastest doubling times of any human tumor (approximately 24 hours). The proliferation fraction approaches 100% (Ki-67 staining).	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1238	1228	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	2	Apoptosis Resistance	While MYC normally sensitizes cells to apoptosis, Burkitt lymphoma cells acquire mutations or alterations that counteract MYC-induced apoptosis. TP53 mutations occur in approximately 30% of cases. EBV-encoded EBNA1 and EBERs provide additional survival signals in EBV-positive cases.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
1239	1229	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	3	High-Grade Malignancy with Rapid Tumor Growth	The combination of constitutive MYC-driven proliferation and apoptosis resistance results in rapidly growing tumors. The high proliferation rate paradoxically makes the tumor highly sensitive to chemotherapy, contributing to excellent cure rates with intensive treatment.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1255	1246	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	0	PIGL Gene Mutations	Mutations in PIGL gene disrupt glycosylphosphatidylinositol (GPI) anchor biosynthesis. PIGL encodes a de-N-acetylase required for GPI anchor formation, essential for anchoring various cell surface proteins including receptors, enzymes, and adhesion molecules.	biological_processes[0]	biological_processes	biological_processes			glycosylphosphatidylinositol biosynthetic process	GO:0006506	GPI anchor biosynthetic process		"{""preferred_term"": ""glycosylphosphatidylinositol biosynthetic process"", ""term"": {""id"": ""GO:0006506"", ""label"": ""GPI anchor biosynthetic process""}}"																											
1256	1247	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	1	GPI Anchor Deficiency	Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome.	biological_processes[0]	biological_processes	biological_processes			cell adhesion	GO:0007155	cell adhesion		"{""preferred_term"": ""cell adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}"																											
1257	1247	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	1	GPI Anchor Deficiency	Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome.	biological_processes[1]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"																											
1258	1247	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	1	GPI Anchor Deficiency	Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome.	biological_processes[2]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
1275	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"	cell_types[0]	cell_types	cell_types			neural progenitor cell	CL:0011020	neural progenitor cell		"{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}"																											
1276	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"	cell_types[1]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1277	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"	biological_processes[0]	biological_processes	biological_processes			chromatin organization	GO:0006325	chromatin organization		"{""preferred_term"": ""chromatin organization"", ""term"": {""id"": ""GO:0006325"", ""label"": ""chromatin organization""}}"																											
1278	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"	biological_processes[1]	biological_processes	biological_processes			regulation of gene expression	GO:0010468	regulation of gene expression		"{""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"																											
1279	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
1280	1268	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	1	Chromatin Architecture Disruption	"Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.
"	biological_processes[0]	biological_processes	biological_processes			chromosome organization	GO:0051276	chromosome organization		"{""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}"																											
1281	1268	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	1	Chromatin Architecture Disruption	"Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.
"	biological_processes[1]	biological_processes	biological_processes			regulation of chromatin organization	GO:1902275	regulation of chromatin organization		"{""preferred_term"": ""regulation of chromatin organization"", ""term"": {""id"": ""GO:1902275"", ""label"": ""regulation of chromatin organization""}}"																											
1282	1268	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	1	Chromatin Architecture Disruption	"Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.
"	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
1283	1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	Neurodevelopmental Gene Dysregulation	"CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.
"	cell_types[0]	cell_types	cell_types			neural progenitor cell	CL:0011020	neural progenitor cell		"{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}"																											
1284	1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	Neurodevelopmental Gene Dysregulation	"CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.
"	cell_types[1]	cell_types	cell_types			cerebral cortex neuron	CL:0010012	cerebral cortex neuron		"{""preferred_term"": ""cerebral cortex neuron"", ""term"": {""id"": ""CL:0010012"", ""label"": ""cerebral cortex neuron""}}"																											
1285	1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	Neurodevelopmental Gene Dysregulation	"CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.
"	biological_processes[0]	biological_processes	biological_processes			regulation of gene expression	GO:0010468	regulation of gene expression		"{""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"																											
1286	1270	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	3	Abnormal Neural Progenitor Cell Development	"CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.
"	cell_types[0]	cell_types	cell_types			neural progenitor cell	CL:0011020	neural progenitor cell		"{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}"																											
1287	1270	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	3	Abnormal Neural Progenitor Cell Development	"CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.
"	cell_types[1]	cell_types	cell_types			cerebral cortex GABAergic interneuron	CL:0010011	cerebral cortex GABAergic interneuron		"{""preferred_term"": ""cerebral cortex GABAergic interneuron"", ""term"": {""id"": ""CL:0010011"", ""label"": ""cerebral cortex GABAergic interneuron""}}"																											
1288	1270	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	3	Abnormal Neural Progenitor Cell Development	"CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.
"	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
1303	1298	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	0	Fetal Akinesia	Reduced fetal movement during development leads to connective tissue accumulation and shortening around joints, resulting in fixed flexion deformities at birth. This is the fundamental pathomechanism across arthrogryposis types.	cell_types[0]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
1304	1299	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	1	Sarcomere Dysfunction	Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures.	cell_types[0]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
1305	1299	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	1	Sarcomere Dysfunction	Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures.	biological_processes[0]	biological_processes	biological_processes			sarcomere organization	GO:0045214	sarcomere organization		"{""preferred_term"": ""sarcomere organization"", ""term"": {""id"": ""GO:0045214"", ""label"": ""sarcomere organization""}}"																											
1306	1299	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	1	Sarcomere Dysfunction	Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures.	biological_processes[1]	biological_processes	biological_processes			muscle contraction	GO:0006936	muscle contraction		"{""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}"																											
1307	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	gene	gene	$	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	PRG4	hgnc:9364	PRG4	Encodes lubricin, a secreted mucinous glycoprotein that provides boundary lubrication and anti-adhesive properties at joint surfaces.	"{""description"": ""Encodes lubricin, a secreted mucinous glycoprotein that provides boundary lubrication and anti-adhesive properties at joint surfaces."", ""preferred_term"": ""PRG4"", ""term"": {""id"": ""hgnc:9364"", ""label"": ""PRG4""}}"																											
1308	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	cell_types[0]	cell_types	cell_types			type B synovial cell	CL:0002301	type B synovial cell		"{""preferred_term"": ""type B synovial cell"", ""term"": {""id"": ""CL:0002301"", ""label"": ""type B synovial cell""}}"																											
1309	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	cell_types[1]	cell_types	cell_types			chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
1310	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	locations[0]	locations	locations			synovial membrane of joint	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane of joint"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
1311	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1312	1301	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	3	Flexor Tendon Abnormalities	Abnormalities or shortening in the flexor tendons can contribute to the inability to fully extend one or more fingers.	locations[0]	locations	locations			tendon	UBERON:0000043	tendon		"{""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}"																											
1313	1302	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	4	Joint Contracture	Permanent soft tissue shortening around joints, leading to fixed flexion deformity. Results from fibroconnective remodeling of volar plate and tendon sheaths.	locations[0]	locations	locations			interphalangeal joint of manual digit	UBERON:0007721	interphalangeal joint of manual digit		"{""preferred_term"": ""interphalangeal joint of manual digit"", ""term"": {""id"": ""UBERON:0007721"", ""label"": ""interphalangeal joint of manual digit""}}"																											
1323	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1324	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"	cell_types[1]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
1325	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"	biological_processes[0]	biological_processes	biological_processes			MAPK Cascade	GO:0000165	MAPK cascade		"{""preferred_term"": ""MAPK Cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
1326	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"	biological_processes[1]	biological_processes	biological_processes			ERK1/2 Cascade	GO:0070371	ERK1 and ERK2 cascade		"{""preferred_term"": ""ERK1/2 Cascade"", ""term"": {""id"": ""GO:0070371"", ""label"": ""ERK1 and ERK2 cascade""}}"																											
1327	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"	biological_processes[2]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell population proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"																											
1342	1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	Gluten-Triggered Immune Response	"Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.
"	cell_types[0]	cell_types	cell_types			T Helper Cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
1343	1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	Gluten-Triggered Immune Response	"Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.
"	biological_processes[0]	biological_processes	biological_processes			Antigen Processing	GO:0019882	antigen processing and presentation		"{""preferred_term"": ""Antigen Processing"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"																											
1344	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	Intestinal Epithelial Damage	"Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.
"	cell_types[0]	cell_types	cell_types			Intestinal Epithelial Cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""Intestinal Epithelial Cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1345	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	Intestinal Epithelial Damage	"Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.
"	biological_processes[0]	biological_processes	biological_processes			Apoptosis	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
1346	1347	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	2	Autoantibody Production	"B cells produce antibodies against tTG (anti-tTG IgA) and deamidated gliadin peptides (anti-DGP). These serve as diagnostic markers and may contribute to pathology.
"	cell_types[0]	cell_types	cell_types			Plasma Cell	CL:0000786	plasma cell		"{""preferred_term"": ""Plasma Cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}"																											
1357	1371	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	0	E6 Oncoprotein-Mediated p53 Degradation	The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells.	cell_types[0]	cell_types	cell_types			epithelial cell of cervix	CL:0002535	epithelial cell of cervix		"{""preferred_term"": ""epithelial cell of cervix"", ""term"": {""id"": ""CL:0002535"", ""label"": ""epithelial cell of cervix""}}"																											
1358	1371	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	0	E6 Oncoprotein-Mediated p53 Degradation	The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells.	biological_processes[0]	biological_processes	biological_processes			proteasome-mediated ubiquitin-dependent protein catabolic process	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process		"{""modifier"": ""INCREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}"			INCREASED																								
1359	1371	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	0	E6 Oncoprotein-Mediated p53 Degradation	The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
1360	1371	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	0	E6 Oncoprotein-Mediated p53 Degradation	The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells.	locations[0]	locations	locations			uterine cervix	UBERON:0000002	uterine cervix		"{""preferred_term"": ""uterine cervix"", ""term"": {""id"": ""UBERON:0000002"", ""label"": ""uterine cervix""}}"																											
1361	1372	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	1	E7 Oncoprotein-Mediated pRB Inactivation	The HPV E7 oncoprotein binds to and inactivates the retinoblastoma protein (pRB), releasing E2F transcription factors to drive uncontrolled cell cycle progression. E7 also targets pRB family members p107 and p130, and destabilizes pRB through proteasomal degradation.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			ABNORMAL																								
1362	1372	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	1	E7 Oncoprotein-Mediated pRB Inactivation	The HPV E7 oncoprotein binds to and inactivates the retinoblastoma protein (pRB), releasing E2F transcription factors to drive uncontrolled cell cycle progression. E7 also targets pRB family members p107 and p130, and destabilizes pRB through proteasomal degradation.	biological_processes[1]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
1363	1373	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	2	HPV Genome Integration	Integration of HPV DNA into the host genome disrupts the viral E2 gene, which normally represses E6/E7 expression. This results in constitutive overexpression of E6 and E7 oncoproteins, a critical step in malignant progression from CIN3 to invasive carcinoma.	biological_processes[0]	biological_processes	biological_processes			viral DNA integration into host DNA	GO:0044826	viral DNA integration into host DNA		"{""preferred_term"": ""viral DNA integration into host DNA"", ""term"": {""id"": ""GO:0044826"", ""label"": ""viral DNA integration into host DNA""}}"																											
1364	1374	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	3	Cervical Intraepithelial Neoplasia Progression	HPV infection induces a spectrum of preinvasive lesions graded as CIN1, CIN2, and CIN3 (carcinoma in situ). Low-grade lesions (CIN1) often regress, while high-grade lesions (CIN2/3) have significant risk of progression to invasive carcinoma over 10-20 years if untreated.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1385	1423	61	Cholera	Cholera.yaml	pathophysiology	0	Cholera Toxin Binding and Uptake	Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1386	1423	61	Cholera	Cholera.yaml	pathophysiology	0	Cholera Toxin Binding and Uptake	Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1387	1423	61	Cholera	Cholera.yaml	pathophysiology	0	Cholera Toxin Binding and Uptake	Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.	biological_processes[0]	biological_processes	biological_processes			endocytosis	GO:0006897	endocytosis		"{""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}"																											
1388	1423	61	Cholera	Cholera.yaml	pathophysiology	0	Cholera Toxin Binding and Uptake	Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.	biological_processes[1]	biological_processes	biological_processes			retrograde vesicle-mediated transport	GO:0006890	retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum		"{""preferred_term"": ""retrograde vesicle-mediated transport"", ""term"": {""id"": ""GO:0006890"", ""label"": ""retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum""}}"																											
1389	1424	61	Cholera	Cholera.yaml	pathophysiology	1	ERAD-mediated CTA1 Translocation	The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1390	1424	61	Cholera	Cholera.yaml	pathophysiology	1	ERAD-mediated CTA1 Translocation	The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1391	1424	61	Cholera	Cholera.yaml	pathophysiology	1	ERAD-mediated CTA1 Translocation	The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.	biological_processes[0]	biological_processes	biological_processes			ERAD pathway	GO:0030433	ubiquitin-dependent ERAD pathway		"{""preferred_term"": ""ERAD pathway"", ""term"": {""id"": ""GO:0030433"", ""label"": ""ubiquitin-dependent ERAD pathway""}}"																											
1392	1425	61	Cholera	Cholera.yaml	pathophysiology	2	Gs ADP-Ribosylation	Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1393	1425	61	Cholera	Cholera.yaml	pathophysiology	2	Gs ADP-Ribosylation	Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1394	1425	61	Cholera	Cholera.yaml	pathophysiology	2	Gs ADP-Ribosylation	Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.	biological_processes[0]	biological_processes	biological_processes			adenylate cyclase-activating G protein-coupled receptor signaling pathway	GO:0007189	adenylate cyclase-activating G protein-coupled receptor signaling pathway		"{""preferred_term"": ""adenylate cyclase-activating G protein-coupled receptor signaling pathway"", ""term"": {""id"": ""GO:0007189"", ""label"": ""adenylate cyclase-activating G protein-coupled receptor signaling pathway""}}"																											
1395	1426	61	Cholera	Cholera.yaml	pathophysiology	3	Cholera Toxin	Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1396	1426	61	Cholera	Cholera.yaml	pathophysiology	3	Cholera Toxin	Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1397	1427	61	Cholera	Cholera.yaml	pathophysiology	4	Increased cAMP	Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1398	1427	61	Cholera	Cholera.yaml	pathophysiology	4	Increased cAMP	Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1399	1427	61	Cholera	Cholera.yaml	pathophysiology	4	Increased cAMP	Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.	biological_processes[0]	biological_processes	biological_processes			cAMP-mediated signaling	GO:0019933	cAMP-mediated signaling		"{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}"																											
1400	1427	61	Cholera	Cholera.yaml	pathophysiology	4	Increased cAMP	Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.	biological_processes[1]	biological_processes	biological_processes			chloride transmembrane transport	GO:1902476	chloride transmembrane transport		"{""preferred_term"": ""chloride transmembrane transport"", ""term"": {""id"": ""GO:1902476"", ""label"": ""chloride transmembrane transport""}}"																											
1401	1428	61	Cholera	Cholera.yaml	pathophysiology	5	Profuse Watery Diarrhea	Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1402	1429	61	Cholera	Cholera.yaml	pathophysiology	6	Colonization and Biofilm Formation	V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1403	1429	61	Cholera	Cholera.yaml	pathophysiology	6	Colonization and Biofilm Formation	V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1404	1429	61	Cholera	Cholera.yaml	pathophysiology	6	Colonization and Biofilm Formation	V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.	biological_processes[0]	biological_processes	biological_processes			biofilm formation	GO:0042710	biofilm formation		"{""preferred_term"": ""biofilm formation"", ""term"": {""id"": ""GO:0042710"", ""label"": ""biofilm formation""}}"																											
1405	1429	61	Cholera	Cholera.yaml	pathophysiology	6	Colonization and Biofilm Formation	V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.	biological_processes[1]	biological_processes	biological_processes			bacterial adhesion to host	GO:0044406	adhesion of symbiont to host		"{""preferred_term"": ""bacterial adhesion to host"", ""term"": {""id"": ""GO:0044406"", ""label"": ""adhesion of symbiont to host""}}"																											
1406	1430	61	Cholera	Cholera.yaml	pathophysiology	7	Accessory Toxins and Virulence Factors	V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1407	1430	61	Cholera	Cholera.yaml	pathophysiology	7	Accessory Toxins and Virulence Factors	V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1408	1430	61	Cholera	Cholera.yaml	pathophysiology	7	Accessory Toxins and Virulence Factors	V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.	biological_processes[0]	biological_processes	biological_processes			disruption of cells of other organism	GO:0044364	disruption of cells of other organism		"{""preferred_term"": ""disruption of cells of other organism"", ""term"": {""id"": ""GO:0044364"", ""label"": ""disruption of cells of other organism""}}"																											
1409	1430	61	Cholera	Cholera.yaml	pathophysiology	7	Accessory Toxins and Virulence Factors	V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.	biological_processes[1]	biological_processes	biological_processes			tight junction organization	GO:0120193	tight junction organization		"{""preferred_term"": ""tight junction organization"", ""term"": {""id"": ""GO:0120193"", ""label"": ""tight junction organization""}}"																											
1410	1431	61	Cholera	Cholera.yaml	pathophysiology	8	Host Metabolic Reprogramming	Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
1411	1431	61	Cholera	Cholera.yaml	pathophysiology	8	Host Metabolic Reprogramming	Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
1412	1431	61	Cholera	Cholera.yaml	pathophysiology	8	Host Metabolic Reprogramming	Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.	biological_processes[0]	biological_processes	biological_processes			regulation of lipid metabolic process	GO:0019216	regulation of lipid metabolic process		"{""preferred_term"": ""regulation of lipid metabolic process"", ""term"": {""id"": ""GO:0019216"", ""label"": ""regulation of lipid metabolic process""}}"																											
1435	1473	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	0	T Cell-Mediated Demyelination	CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
1436	1473	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	0	T Cell-Mediated Demyelination	CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells.	cell_types[1]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
1437	1473	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	0	T Cell-Mediated Demyelination	CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells.	biological_processes[0]	biological_processes	biological_processes			Adaptive Immune Response	GO:0002250	adaptive immune response		"{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
1438	1474	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	1	Antibody and Complement-Mediated Damage	Autoantibodies against myelin proteins and nodal/paranodal antigens (neurofascin, contactin-1) contribute to demyelination. Complement deposition amplifies nerve damage.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
1439	1474	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	1	Antibody and Complement-Mediated Damage	Autoantibodies against myelin proteins and nodal/paranodal antigens (neurofascin, contactin-1) contribute to demyelination. Complement deposition amplifies nerve damage.	biological_processes[1]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
1440	1475	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	2	Macrophage-Mediated Myelin Stripping	Activated macrophages invade nerve fibers and actively strip myelin from axons, causing segmental demyelination visible on nerve biopsy.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1441	1475	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	2	Macrophage-Mediated Myelin Stripping	Activated macrophages invade nerve fibers and actively strip myelin from axons, causing segmental demyelination visible on nerve biopsy.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1446	1499	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	0	Nephron Loss	"Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.
"	cell_types[0]	cell_types	cell_types			Podocyte	CL:0000653	podocyte		"{""preferred_term"": ""Podocyte"", ""term"": {""id"": ""CL:0000653"", ""label"": ""podocyte""}}"																											
1447	1499	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	0	Nephron Loss	"Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.
"	cell_types[1]	cell_types	cell_types			Tubular Epithelial Cell	CL:0002306	epithelial cell of proximal tubule		"{""preferred_term"": ""Tubular Epithelial Cell"", ""term"": {""id"": ""CL:0002306"", ""label"": ""epithelial cell of proximal tubule""}}"																											
1448	1500	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	1	Glomerulosclerosis	"Scarring and hardening of glomeruli impairs filtration function. Driven by hemodynamic stress, inflammation, and metabolic factors.
"	biological_processes[0]	biological_processes	biological_processes			Fibrosis	GO:0048251	elastic fiber assembly		"{""preferred_term"": ""Fibrosis"", ""term"": {""id"": ""GO:0048251"", ""label"": ""elastic fiber assembly""}}"																											
1449	1501	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	2	Tubulointerstitial Fibrosis	"Fibrotic replacement of tubular structures by collagen-producing myofibroblasts. The final common pathway of CKD progression.
"	cell_types[0]	cell_types	cell_types			Myofibroblast	CL:0000186	myofibroblast cell		"{""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}"																											
1450	1502	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	3	RAAS Activation	"Inappropriately activated renin-angiotensin-aldosterone system promotes glomerular hypertension, fibrosis, and sodium retention.
"	biological_processes[0]	biological_processes	biological_processes			RAAS Signaling	GO:0002018	renin-angiotensin regulation of aldosterone production		"{""preferred_term"": ""RAAS Signaling"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}"																											
1459	1528	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	0	B-cell Receptor Signaling Dysregulation	CLL cells exhibit constitutive B-cell receptor (BCR) signaling, either through autonomous signaling or antigen-driven activation. This chronic BCR stimulation activates downstream kinases including BTK, PI3K, and SYK, driving proliferation and survival. BCR signaling intensity correlates with clinical aggressiveness.	cell_types[0]	cell_types	cell_types			mature B cell	CL:0000785	mature B cell		"{""preferred_term"": ""mature B cell"", ""term"": {""id"": ""CL:0000785"", ""label"": ""mature B cell""}}"																											
1460	1528	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	0	B-cell Receptor Signaling Dysregulation	CLL cells exhibit constitutive B-cell receptor (BCR) signaling, either through autonomous signaling or antigen-driven activation. This chronic BCR stimulation activates downstream kinases including BTK, PI3K, and SYK, driving proliferation and survival. BCR signaling intensity correlates with clinical aggressiveness.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"			INCREASED																								
1461	1529	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	1	BTK Pathway Activation	Bruton tyrosine kinase (BTK) is essential for BCR signaling and CLL cell survival. BTK activation promotes NF-kB signaling, cell adhesion, and tissue homing. BTK inhibitors disrupt these signals, mobilizing CLL cells from protective tissue microenvironments and inducing apoptosis.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
1462	1530	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	2	Microenvironmental Survival Signals	CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
1463	1530	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	2	Microenvironmental Survival Signals	CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important.	locations[1]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
1464	1530	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	2	Microenvironmental Survival Signals	CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1465	1531	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	3	NF-kB Activation and Survival	NF-kB transcription factors are constitutively activated in CLL and promote expression of anti-apoptotic genes including BCL2, MCL1, and XIAP. This contributes to the apoptosis resistance characteristic of CLL cells.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
1466	1532	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	4	CLL Cell Accumulation	The combination of defective apoptosis, microenvironmental support, and low-level proliferation leads to progressive accumulation of clonal B cells. CLL is primarily a disease of accumulation rather than rapid proliferation.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1486	1550	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene Formation	The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms.	cell_types[0]	cell_types	cell_types			hematopoietic stem cell	CL:0000037	hematopoietic stem cell		"{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}"																											
1487	1550	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene Formation	The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms.	biological_processes[0]	biological_processes	biological_processes			protein phosphorylation	GO:0006468	protein phosphorylation		"{""preferred_term"": ""protein phosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}"																											
1488	1550	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene Formation	The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms.	gene_products[0]	gene_products	gene_products			BCR-ABL1 fusion protein	NCIT:C16325	BCR/ABL1 Fusion Protein		"{""preferred_term"": ""BCR-ABL1 fusion protein"", ""term"": {""id"": ""NCIT:C16325"", ""label"": ""BCR/ABL1 Fusion Protein""}}"																											
1489	1551	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	1	Constitutive Tyrosine Kinase Activation	The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival.	cell_types[0]	cell_types	cell_types			myeloid cell	CL:0000763	myeloid cell		"{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}"																											
1490	1551	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	1	Constitutive Tyrosine Kinase Activation	The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
1491	1551	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	1	Constitutive Tyrosine Kinase Activation	The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival.	biological_processes[1]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
1492	1552	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	2	Uncontrolled Myeloid Proliferation	BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
1493	1552	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	2	Uncontrolled Myeloid Proliferation	BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment.	cell_types[0]	cell_types	cell_types			granulocyte	CL:0000094	granulocyte		"{""preferred_term"": ""granulocyte"", ""term"": {""id"": ""CL:0000094"", ""label"": ""granulocyte""}}"																											
1494	1552	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	2	Uncontrolled Myeloid Proliferation	BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment.	cell_types[1]	cell_types	cell_types			myeloid progenitor cell	CL:0000049	common myeloid progenitor		"{""preferred_term"": ""myeloid progenitor cell"", ""term"": {""id"": ""CL:0000049"", ""label"": ""common myeloid progenitor""}}"																											
1495	1552	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	2	Uncontrolled Myeloid Proliferation	BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment.	biological_processes[0]	biological_processes	biological_processes			myeloid cell homeostasis	GO:0002262	myeloid cell homeostasis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""myeloid cell homeostasis"", ""term"": {""id"": ""GO:0002262"", ""label"": ""myeloid cell homeostasis""}}"			ABNORMAL																								
1496	1553	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	3	Apoptosis Resistance	BCR-ABL1 activates anti-apoptotic pathways, particularly through PI3K-AKT signaling and upregulation of BCL2 family members. This confers resistance to programmed cell death, allowing accumulation of leukemic cells.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
1497	1554	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	4	Genomic Instability and Disease Progression	BCR-ABL1 induces genomic instability through reactive oxygen species generation and impaired DNA repair. This promotes acquisition of additional mutations and chromosomal abnormalities, driving progression from chronic phase to blast crisis.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
1517	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.	cell_types[0]	cell_types	cell_types			Epithelial Cell	CL:0000066	epithelial cell		"{""preferred_term"": ""Epithelial Cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
1518	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1519	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.	biological_processes[1]	biological_processes	biological_processes			airway remodeling			Structural changes in airway architecture	"{""description"": ""Structural changes in airway architecture"", ""preferred_term"": ""airway remodeling""}"																											
1520	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1521	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.	locations[1]	locations	locations			small airway			Terminal and respiratory bronchioles	"{""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}"																											
1522	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
1523	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1524	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	cell_types[2]	cell_types	cell_types			T-lymphocyte	CL:0000084	T cell		"{""preferred_term"": ""T-lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
1525	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1526	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	biological_processes[1]	biological_processes	biological_processes			neutrophil degranulation	GO:0043312	neutrophil degranulation		"{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}"																											
1527	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1528	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.	locations[1]	locations	locations			alveolus of lung	UBERON:0002299	alveolus of lung		"{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}"																											
1529	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.	cell_types[0]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
1530	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1531	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.	biological_processes[1]	biological_processes	biological_processes			fibrosis			Excessive deposition of connective tissue	"{""description"": ""Excessive deposition of connective tissue"", ""preferred_term"": ""fibrosis""}"																											
1532	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1533	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.	locations[1]	locations	locations			small airway			Terminal and respiratory bronchioles	"{""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}"																											
1534	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.	cell_types[0]	cell_types	cell_types			Alveolar Macrophage	CL:0000583	alveolar macrophage		"{""preferred_term"": ""Alveolar Macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}"																											
1535	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.	biological_processes[0]	biological_processes	biological_processes			proteolysis	GO:0006508	proteolysis		"{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}"																											
1536	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.	biological_processes[1]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1537	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.	locations[0]	locations	locations			alveolus of lung	UBERON:0002299	alveolus of lung		"{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}"																											
1538	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.	locations[1]	locations	locations			lung parenchyma	UBERON:0008946	lung parenchyma		"{""preferred_term"": ""lung parenchyma"", ""term"": {""id"": ""UBERON:0008946"", ""label"": ""lung parenchyma""}}"																											
1539	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	cell_types[0]	cell_types	cell_types			airway epithelial cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
1540	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	cell_types[1]	cell_types	cell_types			Alveolar Macrophage	CL:0000583	alveolar macrophage		"{""preferred_term"": ""Alveolar Macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}"																											
1541	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
1542	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	biological_processes[1]	biological_processes	biological_processes			mitochondrion organization	GO:0007005	mitochondrion organization		"{""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}"																											
1543	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	biological_processes[2]	biological_processes	biological_processes			mitophagy	GO:0000422	mitophagy		"{""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000422"", ""label"": ""mitophagy""}}"																											
1544	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1545	1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.	locations[1]	locations	locations			alveolus of lung	UBERON:0002299	alveolus of lung		"{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}"																											
1546	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	cell_types[0]	cell_types	cell_types			goblet cell	CL:0000160	goblet cell		"{""preferred_term"": ""goblet cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}"																											
1547	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	cell_types[1]	cell_types	cell_types			club cell	CL:0000158	club cell		"{""preferred_term"": ""club cell"", ""term"": {""id"": ""CL:0000158"", ""label"": ""club cell""}}"																											
1548	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	biological_processes[0]	biological_processes	biological_processes			mucus secretion	GO:0070254	mucus secretion		"{""preferred_term"": ""mucus secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}"																											
1549	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	biological_processes[1]	biological_processes	biological_processes			cilium movement	GO:0003341	cilium movement		"{""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}"																											
1550	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1551	1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.	locations[1]	locations	locations			small airway			Terminal and respiratory bronchioles	"{""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}"																											
1552	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1553	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	cell_types[1]	cell_types	cell_types			airway epithelial cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
1554	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	biological_processes[0]	biological_processes	biological_processes			NLRP3 inflammasome complex assembly	GO:0072559	NLRP3 inflammasome complex assembly		"{""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}"																											
1555	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1556	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	locations[0]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
1557	1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.	locations[1]	locations	locations			alveolus of lung	UBERON:0002299	alveolus of lung		"{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}"																											
1558	1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.	cell_types[0]	cell_types	cell_types			airway epithelial cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
1559	1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.	cell_types[1]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1560	1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.	biological_processes[0]	biological_processes	biological_processes			cellular senescence	GO:0090398	cellular senescence		"{""preferred_term"": ""cellular senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}"																											
1561	1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1562	1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.	locations[0]	locations	locations			lung	UBERON:0002048	lung		"{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
1584	1628	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	0	Recurrent Acinar Cell Injury	"Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.
"	cell_types[0]	cell_types	cell_types			Pancreatic Acinar Cell	CL:0002064	pancreatic acinar cell		"{""preferred_term"": ""Pancreatic Acinar Cell"", ""term"": {""id"": ""CL:0002064"", ""label"": ""pancreatic acinar cell""}}"																											
1585	1628	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	0	Recurrent Acinar Cell Injury	"Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1586	1629	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	1	Pancreatic Fibrosis	"Activated pancreatic stellate cells produce excessive collagen, leading to progressive fibrosis. Fibrosis replaces functional parenchyma and causes ductal strictures.
"	cell_types[0]	cell_types	cell_types			Pancreatic Stellate Cell	CL:0002410	pancreatic stellate cell		"{""preferred_term"": ""Pancreatic Stellate Cell"", ""term"": {""id"": ""CL:0002410"", ""label"": ""pancreatic stellate cell""}}"																											
1587	1629	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	1	Pancreatic Fibrosis	"Activated pancreatic stellate cells produce excessive collagen, leading to progressive fibrosis. Fibrosis replaces functional parenchyma and causes ductal strictures.
"	biological_processes[0]	biological_processes	biological_processes			Extracellular Matrix Organization				"{""preferred_term"": ""Extracellular Matrix Organization""}"																											
1588	1630	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	2	Exocrine Insufficiency	"Loss of acinar cell mass leads to insufficient digestive enzyme production. Steatorrhea and malabsorption occur when >90% of exocrine function is lost.
"	biological_processes[0]	biological_processes	biological_processes			Digestive System Process				"{""preferred_term"": ""Digestive System Process""}"																											
1589	1631	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	3	Endocrine Insufficiency	"Progressive loss of islet cells leads to diabetes mellitus (type 3c). Often occurs later in disease course.
"	cell_types[0]	cell_types	cell_types			Pancreatic Beta Cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
1596	1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	VHL Tumor Suppressor Inactivation	Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes.	cell_types[0]	cell_types	cell_types			kidney epithelial cell	CL:0002518	kidney epithelial cell		"{""preferred_term"": ""kidney epithelial cell"", ""term"": {""id"": ""CL:0002518"", ""label"": ""kidney epithelial cell""}}"																											
1597	1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	VHL Tumor Suppressor Inactivation	Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes.	biological_processes[0]	biological_processes	biological_processes			cellular response to hypoxia	GO:0071456	cellular response to hypoxia		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cellular response to hypoxia"", ""term"": {""id"": ""GO:0071456"", ""label"": ""cellular response to hypoxia""}}"			INCREASED																								
1598	1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	VHL Tumor Suppressor Inactivation	Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes.	biological_processes[1]	biological_processes	biological_processes			proteasome-mediated ubiquitin-dependent protein catabolic process	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}"			DECREASED																								
1599	1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	VHL Tumor Suppressor Inactivation	Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes.	locations[0]	locations	locations			kidney	UBERON:0002113	kidney		"{""preferred_term"": ""kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
1600	1653	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	1	HIF-2 Stabilization	Without VHL-mediated degradation, HIF-2 protein accumulates in the cytoplasm and translocates to the nucleus where it dimerizes with HIF-1 (ARNT) to form an active transcription factor. HIF-2 is the critical HIF isoform in ccRCC.	biological_processes[0]	biological_processes	biological_processes			protein stabilization	GO:0050821	protein stabilization		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein stabilization"", ""term"": {""id"": ""GO:0050821"", ""label"": ""protein stabilization""}}"			INCREASED																								
1601	1654	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	2	VEGF-Driven Angiogenesis	HIF-2 transcriptionally activates VEGF (vascular endothelial growth factor), driving tumor neovascularization. The resulting hypervascular phenotype is characteristic of ccRCC and the basis for VEGFR-targeted therapy.	biological_processes[0]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
1602	1654	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	2	VEGF-Driven Angiogenesis	HIF-2 transcriptionally activates VEGF (vascular endothelial growth factor), driving tumor neovascularization. The resulting hypervascular phenotype is characteristic of ccRCC and the basis for VEGFR-targeted therapy.	biological_processes[1]	biological_processes	biological_processes			vascular endothelial growth factor receptor signaling pathway	GO:0048010	vascular endothelial growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""vascular endothelial growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0048010"", ""label"": ""vascular endothelial growth factor receptor signaling pathway""}}"			INCREASED																								
1603	1655	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	3	Growth Factor Pathway Activation	HIF-2 activates transcription of growth-promoting genes including TGF- (which activates EGFR signaling) and cyclin D1 (which promotes cell cycle progression). This drives tumor cell proliferation independent of angiogenesis.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1604	1656	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	4	Epigenetic Dysregulation	Secondary mutations in chromatin remodeling genes (PBRM1 in 40%, BAP1 in 15%, SETD2 in 15%) contribute to ccRCC progression. BAP1 mutations are associated with higher grade tumors and worse prognosis compared to PBRM1 mutations. These mutations cooperate with VHL loss to drive tumor evolution.	biological_processes[0]	biological_processes	biological_processes			chromatin remodeling	GO:0006338	chromatin remodeling		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}"			ABNORMAL																								
1619	1672	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	0	EWSR1-ATF1 Fusion Oncogene	The t(12;22)(q13;q12) translocation fuses the EWSR1 gene on chromosome 22 with ATF1 on chromosome 12 in approximately 90% of cases. The fusion protein functions as an aberrant transcription factor that constitutively activates MITF (microphthalmia-associated transcription factor), driving melanocytic differentiation and survival programs.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			ABNORMAL																								
1620	1672	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	0	EWSR1-ATF1 Fusion Oncogene	The t(12;22)(q13;q12) translocation fuses the EWSR1 gene on chromosome 22 with ATF1 on chromosome 12 in approximately 90% of cases. The fusion protein functions as an aberrant transcription factor that constitutively activates MITF (microphthalmia-associated transcription factor), driving melanocytic differentiation and survival programs.	locations[0]	locations	locations			tendon	UBERON:0000043	tendon		"{""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}"																											
1621	1673	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	1	MITF Activation	EWSR1-ATF1 directly activates transcription of MITF, the master transcription factor of melanocyte lineage. MITF in turn activates genes involved in melanogenesis, cell survival, and proliferation. This explains the melanocytic phenotype despite soft tissue origin.	biological_processes[0]	biological_processes	biological_processes			regulation of gene expression	GO:0010468	regulation of gene expression		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"			ABNORMAL																								
1622	1674	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	2	Melanocytic Differentiation	Downstream of MITF activation, CCS cells express melanocytic markers including S100, HMB45, Melan-A, and tyrosinase. Melanin pigment may be present. However, unlike melanoma, CCS lacks UV-induced mutations and BRAF/NRAS alterations typical of cutaneous melanoma.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			ABNORMAL																								
1638	1690	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	0	Antibiotic-Induced Microbial Depletion	"Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin, cephalosporins) cause indiscriminate killing of gut commensals, dramatically reducing microbial diversity and biomass. This creates ecological opportunity for C. difficile colonization.
"	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
1639	1694	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	4	Toxin Production (TcdA/TcdB)	"C. difficile secretes two large clostridial glucosylating toxins: TcdA (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42) by monoglucosylation of a critical threonine residue, disrupting the actin cytoskeleton.
"	biological_processes[0]	biological_processes	biological_processes			Pathogenesis	GO:0009405	pathogenesis		"{""preferred_term"": ""Pathogenesis"", ""term"": {""id"": ""GO:0009405"", ""label"": ""pathogenesis""}}"																											
1640	1695	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	5	Epithelial Cell Death and Barrier Disruption	"Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton condensation, loss of cell-cell junctions, and epithelial cell rounding followed by death. This creates gaps in the epithelial barrier, exposing the lamina propria to luminal contents.
"	cell_types[0]	cell_types	cell_types			Colonic Epithelial Cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
1641	1696	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	6	Neutrophil Recruitment and Inflammation	"TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic ""volcano lesions"" and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.
"	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
1642	1696	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	6	Neutrophil Recruitment and Inflammation	"TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic ""volcano lesions"" and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
1643	1697	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	7	Pseudomembranous Colitis	"Characteristic raised yellow-white plaques on colonic mucosa composed of fibrin, mucus, neutrophils, and cellular debris overlying areas of epithelial necrosis. Represents severe C. difficile infection with high morbidity. Fluid secretion and diarrhea result from barrier loss and inflammation.
"	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
1668	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	cell_types[0]	cell_types	cell_types			intraepithelial lymphocyte	CL:0002496	intraepithelial lymphocyte		"{""preferred_term"": ""intraepithelial lymphocyte"", ""term"": {""id"": ""CL:0002496"", ""label"": ""intraepithelial lymphocyte""}}"																											
1669	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	cell_types[1]	cell_types	cell_types			plasma cell	CL:0000786	plasma cell		"{""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}"																											
1670	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	cell_types[2]	cell_types	cell_types			eosinophil	CL:0000041	mature eosinophil		"{""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000041"", ""label"": ""mature eosinophil""}}"																											
1671	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	biological_processes[0]	biological_processes	biological_processes			T cell mediated immune response	GO:0002292	T cell differentiation involved in immune response		"{""preferred_term"": ""T cell mediated immune response"", ""term"": {""id"": ""GO:0002292"", ""label"": ""T cell differentiation involved in immune response""}}"																											
1672	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	biological_processes[1]	biological_processes	biological_processes			response to cytokine	GO:0034097	response to cytokine		"{""preferred_term"": ""response to cytokine"", ""term"": {""id"": ""GO:0034097"", ""label"": ""response to cytokine""}}"																											
1673	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	locations[0]	locations	locations			small intestinal mucosa	UBERON:0001273	small intestine		"{""preferred_term"": ""small intestinal mucosa"", ""term"": {""id"": ""UBERON:0001273"", ""label"": ""small intestine""}}"																											
1674	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"	locations[1]	locations	locations			lamina propria	UBERON:0001982	lamina propria		"{""preferred_term"": ""lamina propria"", ""term"": {""id"": ""UBERON:0001982"", ""label"": ""lamina propria""}}"																											
1675	1723	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	1	Epithelial barrier dysfunction and tight junction disruption	"Immune-mediated epithelial damage impairs the intestinal epithelial barrier through disruption of tight junction proteins, particularly zonula occludens-1 (ZO-1/TJP1). Loss of barrier function allows increased paracellular transport and bacterial antigen exposure, perpetuating the inflammatory cycle. Crypt epithelial apoptosis and reduced junctional integrity compromise the epithelial seal, contributing to persistent diarrhea and protein-losing enteropathy.
"	biological_processes[0]	biological_processes	biological_processes			cell junction organization	GO:0034330	cell junction organization		"{""preferred_term"": ""cell junction organization"", ""term"": {""id"": ""GO:0034330"", ""label"": ""cell junction organization""}}"																											
1676	1723	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	1	Epithelial barrier dysfunction and tight junction disruption	"Immune-mediated epithelial damage impairs the intestinal epithelial barrier through disruption of tight junction proteins, particularly zonula occludens-1 (ZO-1/TJP1). Loss of barrier function allows increased paracellular transport and bacterial antigen exposure, perpetuating the inflammatory cycle. Crypt epithelial apoptosis and reduced junctional integrity compromise the epithelial seal, contributing to persistent diarrhea and protein-losing enteropathy.
"	biological_processes[1]	biological_processes	biological_processes			epithelial cell differentiation	GO:0030855	epithelial cell differentiation		"{""preferred_term"": ""epithelial cell differentiation"", ""term"": {""id"": ""GO:0030855"", ""label"": ""epithelial cell differentiation""}}"																											
1677	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"	cell_types[0]	cell_types	cell_types			myofibroblast	CL:0000186	myofibroblast cell		"{""preferred_term"": ""myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}"																											
1678	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"	cell_types[1]	cell_types	cell_types			capillary endothelial cell	CL:0002144	capillary endothelial cell		"{""preferred_term"": ""capillary endothelial cell"", ""term"": {""id"": ""CL:0002144"", ""label"": ""capillary endothelial cell""}}"																											
1679	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"	biological_processes[0]	biological_processes	biological_processes			positive regulation of collagen biosynthetic process	GO:0032965	positive regulation of collagen biosynthetic process		"{""preferred_term"": ""positive regulation of collagen biosynthetic process"", ""term"": {""id"": ""GO:0032965"", ""label"": ""positive regulation of collagen biosynthetic process""}}"																											
1680	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"	biological_processes[1]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1681	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"	locations[0]	locations	locations			subepithelial lamina propria	UBERON:0001982	lamina propria		"{""preferred_term"": ""subepithelial lamina propria"", ""term"": {""id"": ""UBERON:0001982"", ""label"": ""lamina propria""}}"																											
1715	1753	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	0	CBF Transcription Factor Complex Disruption	The core binding factor complex consists of RUNX1 (alpha subunit) and CBFB (beta subunit). RUNX1 binds DNA while CBFB stabilizes this binding. Both t(8;21) and inv(16) produce fusion proteins that dominantly inhibit normal CBF function, disrupting transcription of genes essential for myeloid differentiation.	cell_types[0]	cell_types	cell_types			myeloid progenitor cell	CL:0000049	common myeloid progenitor		"{""preferred_term"": ""myeloid progenitor cell"", ""term"": {""id"": ""CL:0000049"", ""label"": ""common myeloid progenitor""}}"																											
1716	1753	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	0	CBF Transcription Factor Complex Disruption	The core binding factor complex consists of RUNX1 (alpha subunit) and CBFB (beta subunit). RUNX1 binds DNA while CBFB stabilizes this binding. Both t(8;21) and inv(16) produce fusion proteins that dominantly inhibit normal CBF function, disrupting transcription of genes essential for myeloid differentiation.	biological_processes[0]	biological_processes	biological_processes			myeloid cell differentiation	GO:0030099	myeloid cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}"			DECREASED																								
1717	1754	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	1	Differentiation Block at Myeloid Stage	CBF fusion proteins recruit corepressor complexes including HDACs and NCoR, converting CBF from a transcriptional activator to a repressor. This silences differentiation genes while partially preserving some myeloid identity, resulting in blasts with partial maturation features.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
1718	1754	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	1	Differentiation Block at Myeloid Stage	CBF fusion proteins recruit corepressor complexes including HDACs and NCoR, converting CBF from a transcriptional activator to a repressor. This silences differentiation genes while partially preserving some myeloid identity, resulting in blasts with partial maturation features.	biological_processes[0]	biological_processes	biological_processes			granulocyte differentiation	GO:0030851	granulocyte differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""granulocyte differentiation"", ""term"": {""id"": ""GO:0030851"", ""label"": ""granulocyte differentiation""}}"			DECREASED																								
1719	1755	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	2	Self-Renewal Maintenance	CBF fusion proteins maintain expression of self-renewal genes while blocking differentiation. Additional mutations, particularly in receptor tyrosine kinases (KIT, FLT3), provide proliferative signals that cooperate with CBF fusions to cause overt leukemia.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1720	1756	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	3	Leukemic Blast Accumulation	The combination of differentiation block, maintained self-renewal, and cooperating mutations leads to accumulation of immature myeloid blasts in the bone marrow, causing bone marrow failure and circulating leukemia.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
1721	1756	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	3	Leukemic Blast Accumulation	The combination of differentiation block, maintained self-renewal, and cooperating mutations leads to accumulation of immature myeloid blasts in the bone marrow, causing bone marrow failure and circulating leukemia.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
1732	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	Atherosclerotic Plaque Formation	"Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.
"	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1733	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	Atherosclerotic Plaque Formation	"Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.
"	cell_types[1]	cell_types	cell_types			Foam Cell	CL:0000891	foam cell		"{""preferred_term"": ""Foam Cell"", ""term"": {""id"": ""CL:0000891"", ""label"": ""foam cell""}}"																											
1734	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	Atherosclerotic Plaque Formation	"Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.
"	cell_types[2]	cell_types	cell_types			Vascular Smooth Muscle Cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""Vascular Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
1735	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	Atherosclerotic Plaque Formation	"Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.
"	biological_processes[0]	biological_processes	biological_processes			Lipid Accumulation	GO:0034383	low-density lipoprotein particle clearance		"{""preferred_term"": ""Lipid Accumulation"", ""term"": {""id"": ""GO:0034383"", ""label"": ""low-density lipoprotein particle clearance""}}"																											
1736	1780	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Damage to the endothelial lining promotes lipid deposition, platelet adhesion, and inflammatory cell recruitment. Reduced nitric oxide production impairs vasodilation.
"	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
1737	1780	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Damage to the endothelial lining promotes lipid deposition, platelet adhesion, and inflammatory cell recruitment. Reduced nitric oxide production impairs vasodilation.
"	biological_processes[0]	biological_processes	biological_processes			Nitric Oxide Production	GO:0006809	nitric oxide biosynthetic process		"{""preferred_term"": ""Nitric Oxide Production"", ""term"": {""id"": ""GO:0006809"", ""label"": ""nitric oxide biosynthetic process""}}"																											
1738	1781	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	2	Plaque Rupture and Thrombosis	"Unstable plaques with thin fibrous caps are prone to rupture, exposing thrombogenic material and triggering acute coronary events (myocardial infarction).
"	cell_types[0]	cell_types	cell_types			Platelet	CL:0000233	platelet		"{""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}"																											
1739	1781	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	2	Plaque Rupture and Thrombosis	"Unstable plaques with thin fibrous caps are prone to rupture, exposing thrombogenic material and triggering acute coronary events (myocardial infarction).
"	biological_processes[0]	biological_processes	biological_processes			Thrombosis	GO:0007596	blood coagulation		"{""preferred_term"": ""Thrombosis"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
1743	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1744	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"	cell_types[1]	cell_types	cell_types			Atrial Cardiomyocyte	CL:0002129	regular atrial cardiac myocyte		"{""preferred_term"": ""Atrial Cardiomyocyte"", ""term"": {""id"": ""CL:0002129"", ""label"": ""regular atrial cardiac myocyte""}}"																											
1745	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"	biological_processes[0]	biological_processes	biological_processes			RAS Signaling	GO:0007265	Ras protein signal transduction		"{""preferred_term"": ""RAS Signaling"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}"																											
1746	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"	biological_processes[1]	biological_processes	biological_processes			MAPK Cascade	GO:0000165	MAPK cascade		"{""preferred_term"": ""MAPK Cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
1747	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"	biological_processes[2]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell population proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"																											
1748	1794	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	1	Tumor Predisposition	"The same activating HRAS mutations that cause Costello syndrome are found as somatic mutations in various cancers. Germline activation creates a predisposition to embryonal tumors, particularly rhabdomyosarcoma.
"	biological_processes[0]	biological_processes	biological_processes			Cell Cycle Regulation	GO:0051726	regulation of cell cycle		"{""preferred_term"": ""Cell Cycle Regulation"", ""term"": {""id"": ""GO:0051726"", ""label"": ""regulation of cell cycle""}}"																											
1765	1827	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	2	Paneth Cell Autophagy Impairment	Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion.	cell_types[0]	cell_types	cell_types			Paneth cell	CL:0000510	paneth cell		"{""preferred_term"": ""Paneth cell"", ""term"": {""id"": ""CL:0000510"", ""label"": ""paneth cell""}}"																											
1766	1827	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	2	Paneth Cell Autophagy Impairment	Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion.	biological_processes[0]	biological_processes	biological_processes			Autophagy	GO:0006914	autophagy		"{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
1767	1827	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	2	Paneth Cell Autophagy Impairment	Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion.	locations[0]	locations	locations			Terminal ileum	UBERON:0001211	ileum		"{""preferred_term"": ""Terminal ileum"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}"																											
1768	1828	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	3	Antimicrobial Defense Deficiency	Reduced secretion of antimicrobial peptides (defensins, lysozyme) allows increased bacterial translocation across the intestinal epithelium.	biological_processes[0]	biological_processes	biological_processes			Antimicrobial humoral response	GO:0019730	antimicrobial humoral response		"{""preferred_term"": ""Antimicrobial humoral response"", ""term"": {""id"": ""GO:0019730"", ""label"": ""antimicrobial humoral response""}}"																											
1769	1828	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	3	Antimicrobial Defense Deficiency	Reduced secretion of antimicrobial peptides (defensins, lysozyme) allows increased bacterial translocation across the intestinal epithelium.	locations[0]	locations	locations			Terminal ileum	UBERON:0001211	ileum		"{""preferred_term"": ""Terminal ileum"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}"																											
1770	1829	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	4	Macrophage Autophagy Dysfunction	Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1771	1829	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	4	Macrophage Autophagy Dysfunction	Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release.	biological_processes[0]	biological_processes	biological_processes			Autophagy	GO:0006914	autophagy		"{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
1772	1829	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	4	Macrophage Autophagy Dysfunction	Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release.	locations[0]	locations	locations			Intestinal lamina propria	UBERON:0011878	lamina propria of small intestine		"{""preferred_term"": ""Intestinal lamina propria"", ""term"": {""id"": ""UBERON:0011878"", ""label"": ""lamina propria of small intestine""}}"																											
1773	1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.	cell_types[0]	cell_types	cell_types			Th17 cell	CL:0000899	T-helper 17 cell		"{""preferred_term"": ""Th17 cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}"																											
1774	1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.	cell_types[1]	cell_types	cell_types			Dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""Dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
1775	1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.	biological_processes[0]	biological_processes	biological_processes			Th17 cell differentiation	GO:0072538	T-helper 17 type immune response		"{""preferred_term"": ""Th17 cell differentiation"", ""term"": {""id"": ""GO:0072538"", ""label"": ""T-helper 17 type immune response""}}"																											
1776	1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.	biological_processes[1]	biological_processes	biological_processes			IL-23 signaling				"{""preferred_term"": ""IL-23 signaling""}"																											
1777	1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.	locations[0]	locations	locations			Intestinal mucosa	UBERON:0001211	ileum		"{""preferred_term"": ""Intestinal mucosa"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}"																											
1778	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1779	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	cell_types[1]	cell_types	cell_types			Myofibroblast	CL:0000186	myofibroblast cell		"{""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}"																											
1780	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	biological_processes[0]	biological_processes	biological_processes			Extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
1781	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	biological_processes[1]	biological_processes	biological_processes			Tissue remodeling	GO:0048771	tissue remodeling		"{""preferred_term"": ""Tissue remodeling"", ""term"": {""id"": ""GO:0048771"", ""label"": ""tissue remodeling""}}"																											
1782	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	locations[0]	locations	locations			Intestinal wall	UBERON:0001262	wall of intestine		"{""preferred_term"": ""Intestinal wall"", ""term"": {""id"": ""UBERON:0001262"", ""label"": ""wall of intestine""}}"																											
1783	1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.	locations[1]	locations	locations			Mesenteric adipose tissue	UBERON:0003427	mesenteric fat pad		"{""preferred_term"": ""Mesenteric adipose tissue"", ""term"": {""id"": ""UBERON:0003427"", ""label"": ""mesenteric fat pad""}}"																											
1784	1832	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	7	TL1A-Mediated T Cell Activation	Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
1785	1832	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	7	TL1A-Mediated T Cell Activation	Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage.	biological_processes[0]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
1786	1832	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	7	TL1A-Mediated T Cell Activation	Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage.	locations[0]	locations	locations			Rectal mucosa	UBERON:0003346	rectal mucosa		"{""preferred_term"": ""Rectal mucosa"", ""term"": {""id"": ""UBERON:0003346"", ""label"": ""rectal mucosa""}}"																											
1787	1833	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	8	Myeloid Cell Recruitment to Perianal Tissue	Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1788	1833	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	8	Myeloid Cell Recruitment to Perianal Tissue	Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation.	biological_processes[0]	biological_processes	biological_processes			Leukocyte migration	GO:0050900	leukocyte migration		"{""preferred_term"": ""Leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}"																											
1789	1833	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	8	Myeloid Cell Recruitment to Perianal Tissue	Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation.	locations[0]	locations	locations			Perianal region	UBERON:0012336	perianal space		"{""preferred_term"": ""Perianal region"", ""term"": {""id"": ""UBERON:0012336"", ""label"": ""perianal space""}}"																											
1790	1834	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	9	Myeloid-Stromal Cell Crosstalk	Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
1791	1834	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	9	Myeloid-Stromal Cell Crosstalk	Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation.	cell_types[1]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
1792	1834	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	9	Myeloid-Stromal Cell Crosstalk	Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation.	biological_processes[0]	biological_processes	biological_processes			Type II interferon signaling	GO:0060337	type I interferon signaling pathway		"{""preferred_term"": ""Type II interferon signaling"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}"																											
1793	1834	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	9	Myeloid-Stromal Cell Crosstalk	Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation.	locations[0]	locations	locations			Perianal region	UBERON:0012336	perianal space		"{""preferred_term"": ""Perianal region"", ""term"": {""id"": ""UBERON:0012336"", ""label"": ""perianal space""}}"																											
1821	1869	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	0	Hamartomatous polyp formation in the gastrointestinal tract	"Cronkhite-Canada syndrome is characterized by widespread hamartomatous polyps involving the entire gastrointestinal tract, most commonly the stomach, small intestine, and colon. The polyps are composed of abundant lamina propria inflammatory infiltrate with cystic glands. Pathological examination shows gland/crypt changes including cystic dilatation filled with protein fluid or mucus, gland withering and branching, and lamina propria edema.
"	biological_processes[0]	biological_processes	biological_processes			Epithelial cell proliferation	GO:0050673	epithelial cell proliferation		"{""preferred_term"": ""Epithelial cell proliferation"", ""term"": {""id"": ""GO:0050673"", ""label"": ""epithelial cell proliferation""}}"																											
1822	1869	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	0	Hamartomatous polyp formation in the gastrointestinal tract	"Cronkhite-Canada syndrome is characterized by widespread hamartomatous polyps involving the entire gastrointestinal tract, most commonly the stomach, small intestine, and colon. The polyps are composed of abundant lamina propria inflammatory infiltrate with cystic glands. Pathological examination shows gland/crypt changes including cystic dilatation filled with protein fluid or mucus, gland withering and branching, and lamina propria edema.
"	biological_processes[1]	biological_processes	biological_processes			Epithelial cell morphogenesis	GO:0003382	epithelial cell morphogenesis		"{""preferred_term"": ""Epithelial cell morphogenesis"", ""term"": {""id"": ""GO:0003382"", ""label"": ""epithelial cell morphogenesis""}}"																											
1823	1870	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	1	Autoimmune and IgG4-mediated inflammation	"Evidence supports an autoimmune/inflammatory pathophysiology with IgG4-positive plasma cell infiltration in polyps, frequent autoantibodies including antinuclear antibody positivity, and association with other autoimmune diseases. CCS often responds to immunosuppressive therapy, further supporting immune-mediated pathogenesis.
"	biological_processes[0]	biological_processes	biological_processes			Plasma cell differentiation	GO:0002317	plasma cell differentiation		"{""preferred_term"": ""Plasma cell differentiation"", ""term"": {""id"": ""GO:0002317"", ""label"": ""plasma cell differentiation""}}"																											
1824	1870	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	1	Autoimmune and IgG4-mediated inflammation	"Evidence supports an autoimmune/inflammatory pathophysiology with IgG4-positive plasma cell infiltration in polyps, frequent autoantibodies including antinuclear antibody positivity, and association with other autoimmune diseases. CCS often responds to immunosuppressive therapy, further supporting immune-mediated pathogenesis.
"	biological_processes[1]	biological_processes	biological_processes			Cytokine production	GO:0001816	cytokine production		"{""preferred_term"": ""Cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"																											
1825	1871	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	2	Epithelial barrier dysfunction and protein-losing enteropathy	"Mucosal inflammation and structural changes result in epithelial barrier dysfunction with protein loss into the gastrointestinal lumen. This leads to hypoalbuminemia, edema, malabsorption, and nutritional deficiencies that contribute to systemic manifestations including cutaneous findings.
"	biological_processes[0]	biological_processes	biological_processes			Tight junction	GO:0070160	tight junction		"{""preferred_term"": ""Tight junction"", ""term"": {""id"": ""GO:0070160"", ""label"": ""tight junction""}}"																											
1826	1872	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	3	Helicobacter pylori infection and dysbiosis	"Helicobacter pylori infection has been reported in approximately 50% of CCS cases, and symptom improvement following H. pylori eradication has been documented in some patients. Broader dysbiosis may contribute to mucosal inflammation and disease pathogenesis.
"	biological_processes[0]	biological_processes	biological_processes			Defense response to bacterium	GO:0042742	defense response to bacterium		"{""preferred_term"": ""Defense response to bacterium"", ""term"": {""id"": ""GO:0042742"", ""label"": ""defense response to bacterium""}}"																											
1836	1884	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
1837	1884	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
1838	1884	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
1847	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
1848	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"	cell_types[1]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
1849	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
1850	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
1851	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"	biological_processes[2]	biological_processes	biological_processes			Epidermal Cell Differentiation	GO:0009913	epidermal cell differentiation		"{""preferred_term"": ""Epidermal Cell Differentiation"", ""term"": {""id"": ""GO:0009913"", ""label"": ""epidermal cell differentiation""}}"																											
1859	1904	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	0	Chronic Cortisol Excess	"Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.
"	biological_processes[0]	biological_processes	biological_processes			glucocorticoid secretion	GO:0035933	glucocorticoid secretion		"{""preferred_term"": ""glucocorticoid secretion"", ""term"": {""id"": ""GO:0035933"", ""label"": ""glucocorticoid secretion""}}"																											
1860	1904	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	0	Chronic Cortisol Excess	"Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.
"	cell_types[0]	cell_types	cell_types			glucocorticoid secreting cell	CL:0000460	glucocorticoid secreting cell		"{""preferred_term"": ""glucocorticoid secreting cell"", ""term"": {""id"": ""CL:0000460"", ""label"": ""glucocorticoid secreting cell""}}"																											
1861	1905	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	1	Hypothalamic-Pituitary-Adrenal Axis Dysregulation	"In endogenous Cushing's, the normal negative feedback regulation of cortisol on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH secretion from pituitary or ectopic sources, while ACTH-independent forms involve autonomous adrenal cortisol production bypassing normal regulation.
"	cell_types[0]	cell_types	cell_types			corticotroph	CL:0002309	corticotroph		"{""preferred_term"": ""corticotroph"", ""term"": {""id"": ""CL:0002309"", ""label"": ""corticotroph""}}"																											
1862	1906	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	2	Metabolic Consequences of Hypercortisolism	"Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis, protein catabolism in muscle and skin, redistribution of adipose tissue to central deposits, and altered lipid metabolism, leading to the characteristic phenotypic features of the syndrome.
"	biological_processes[0]	biological_processes	biological_processes			response to glucocorticoid	GO:0051384	response to glucocorticoid		"{""preferred_term"": ""response to glucocorticoid"", ""term"": {""id"": ""GO:0051384"", ""label"": ""response to glucocorticoid""}}"																											
1878	1934	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	0	CFTR Dysfunction	"Mutations in CFTR gene cause defective chloride channel function. Impaired chloride and bicarbonate transport leads to thick, dehydrated secretions in airways, pancreas, and other organs.
"	biological_processes[0]	biological_processes	biological_processes			Chloride Transport	GO:0006821	chloride transport		"{""preferred_term"": ""Chloride Transport"", ""term"": {""id"": ""GO:0006821"", ""label"": ""chloride transport""}}"																											
1879	1935	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	1	Airway Mucus Obstruction	"Defective CFTR leads to depleted airway surface liquid and thick mucus. Impaired mucociliary clearance causes chronic bacterial infection, inflammation, and progressive bronchiectasis.
"	cell_types[0]	cell_types	cell_types			Airway Epithelial Cell	CL:0002328	bronchial epithelial cell		"{""preferred_term"": ""Airway Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}"																											
1880	1935	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	1	Airway Mucus Obstruction	"Defective CFTR leads to depleted airway surface liquid and thick mucus. Impaired mucociliary clearance causes chronic bacterial infection, inflammation, and progressive bronchiectasis.
"	biological_processes[0]	biological_processes	biological_processes			Mucus Secretion	GO:0070254	mucus secretion		"{""preferred_term"": ""Mucus Secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}"																											
1881	1936	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	2	Pancreatic Insufficiency	"Thick secretions obstruct pancreatic ducts, causing autodigestion, fibrosis, and exocrine pancreatic insufficiency. Malabsorption of fats and fat-soluble vitamins results.
"	cell_types[0]	cell_types	cell_types			Pancreatic Acinar Cell	CL:0002064	pancreatic acinar cell		"{""preferred_term"": ""Pancreatic Acinar Cell"", ""term"": {""id"": ""CL:0002064"", ""label"": ""pancreatic acinar cell""}}"																											
1890	1954	84	Danon disease	Danon_disease.yaml	pathophysiology	0	LAMP2 protein deficiency	"Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.
"	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
1891	1954	84	Danon disease	Danon_disease.yaml	pathophysiology	0	LAMP2 protein deficiency	"Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.
"	cell_types[1]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
1892	1954	84	Danon disease	Danon_disease.yaml	pathophysiology	0	LAMP2 protein deficiency	"Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.
"	biological_processes[0]	biological_processes	biological_processes			lysosome organization	GO:0007040	lysosome organization		"{""preferred_term"": ""lysosome organization"", ""term"": {""id"": ""GO:0007040"", ""label"": ""lysosome organization""}}"																											
1893	1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	Impaired autophagosome-lysosome fusion	"LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.
"	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
1894	1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	Impaired autophagosome-lysosome fusion	"LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.
"	cell_types[1]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
1895	1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	Impaired autophagosome-lysosome fusion	"LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.
"	biological_processes[0]	biological_processes	biological_processes			macroautophagy	GO:0016236	macroautophagy		"{""preferred_term"": ""macroautophagy"", ""term"": {""id"": ""GO:0016236"", ""label"": ""macroautophagy""}}"																											
1896	1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	Impaired autophagosome-lysosome fusion	"LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.
"	biological_processes[1]	biological_processes	biological_processes			autophagosome maturation	GO:0097352	autophagosome maturation		"{""preferred_term"": ""autophagosome maturation"", ""term"": {""id"": ""GO:0097352"", ""label"": ""autophagosome maturation""}}"																											
1897	1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	Autophagic vacuole accumulation	"Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.
"	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
1898	1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	Autophagic vacuole accumulation	"Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.
"	cell_types[1]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
1899	1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	Autophagic vacuole accumulation	"Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.
"	biological_processes[0]	biological_processes	biological_processes			macroautophagy	GO:0016236	macroautophagy		"{""preferred_term"": ""macroautophagy"", ""term"": {""id"": ""GO:0016236"", ""label"": ""macroautophagy""}}"																											
1900	1957	84	Danon disease	Danon_disease.yaml	pathophysiology	3	Impaired mitophagy	"Defective autophagosome-lysosome fusion specifically impairs the mitophagy pathway, preventing clearance of damaged and depolarized mitochondria from cardiomyocytes.
"	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
1901	1957	84	Danon disease	Danon_disease.yaml	pathophysiology	3	Impaired mitophagy	"Defective autophagosome-lysosome fusion specifically impairs the mitophagy pathway, preventing clearance of damaged and depolarized mitochondria from cardiomyocytes.
"	biological_processes[0]	biological_processes	biological_processes			mitophagy	GO:0000423	mitophagy		"{""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000423"", ""label"": ""mitophagy""}}"																											
1902	1958	84	Danon disease	Danon_disease.yaml	pathophysiology	4	Mitochondrial dysfunction and oxidative stress	"Accumulation of damaged and depolarized mitochondria results in reduced mitochondrial respiration, increased reactive oxygen species production, and oxidative stress, contributing to cardiomyocyte injury and arrhythmogenesis.
"	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
1903	1958	84	Danon disease	Danon_disease.yaml	pathophysiology	4	Mitochondrial dysfunction and oxidative stress	"Accumulation of damaged and depolarized mitochondria results in reduced mitochondrial respiration, increased reactive oxygen species production, and oxidative stress, contributing to cardiomyocyte injury and arrhythmogenesis.
"	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
1911	1969	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	0	Alpha-Synuclein Aggregation and Lewy Body Formation	"DLB is characterized morphologically by widespread cortical and subcortical alpha-synuclein aggregation forming Lewy bodies and Lewy neurites. The alpha-synuclein pathology leads to neuronal dysfunction and is central to the disease pathogenesis. The distribution and severity of Lewy body pathology correlates with cognitive impairment and clinical features.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1912	1970	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	1	Autophagy-Lysosome Dysfunction	"Impaired autophagy and lysosomal functions are central to DLB pathogenesis. Neurons are particularly vulnerable to autophagy-lysosomal defects due to their postmitotic nature and polarized morphologies. Mutations in genes regulating autophagy and lysosomal functions, particularly GBA, contribute to impaired clearance of alpha-synuclein aggregates and damaged organelles. This dysfunction creates a vicious cycle where accumulating protein aggregates further impair the autophagic-lysosomal system.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1913	1971	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	2	Neuronal Death	"Progressive loss of neurons due to alpha-synuclein pathology and associated proteinopathies, leading to brain atrophy particularly in cortical and limbic regions. The neurodegeneration underlies the progressive cognitive decline and other clinical features of DLB.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
1924	1990	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	0	COL1A1-PDGFB Fusion Oncogene	The t(17;22)(q22;q13) translocation or supernumerary ring chromosomes containing material from chromosomes 17 and 22 fuse the COL1A1 gene to PDGFB. This places PDGFB under control of the highly active COL1A1 promoter, resulting in constitutive expression of a functional PDGF-BB growth factor.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			ABNORMAL																								
1925	1990	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	0	COL1A1-PDGFB Fusion Oncogene	The t(17;22)(q22;q13) translocation or supernumerary ring chromosomes containing material from chromosomes 17 and 22 fuse the COL1A1 gene to PDGFB. This places PDGFB under control of the highly active COL1A1 promoter, resulting in constitutive expression of a functional PDGF-BB growth factor.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
1926	1991	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	1	Autocrine PDGFR Signaling	Tumor cells secrete mature PDGF-BB which binds to PDGFR-beta on the same or neighboring tumor cells, creating an autocrine/paracrine growth loop. PDGFR-beta activation drives proliferation through the MAPK and PI3K pathways. This signaling can be blocked by imatinib.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1927	1992	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	2	Sustained Proliferation	Constitutive PDGFR-beta signaling drives sustained proliferation of dermal fibroblasts. The infiltrative growth pattern with finger-like projections into subcutaneous fat explains the high local recurrence rate after incomplete excision.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
1935	2004	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	0	Complement-Mediated Microangiopathy	Membrane attack complex (MAC) deposition on endomysial capillaries leads to capillary damage, ischemia, and perifascicular atrophy characteristic of dermatomyositis. This distinguishes it from polymyositis.	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
1936	2004	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	0	Complement-Mediated Microangiopathy	Membrane attack complex (MAC) deposition on endomysial capillaries leads to capillary damage, ischemia, and perifascicular atrophy characteristic of dermatomyositis. This distinguishes it from polymyositis.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
1937	2005	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	1	Type I Interferon Pathway Activation	Strong type I interferon signature in muscle and skin. Plasmacytoid dendritic cells accumulate in affected tissues and produce IFN-alpha, driving inflammation and MxA protein expression.	cell_types[0]	cell_types	cell_types			Plasmacytoid Dendritic Cell	CL:0000784	plasmacytoid dendritic cell		"{""preferred_term"": ""Plasmacytoid Dendritic Cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}"																											
1938	2005	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	1	Type I Interferon Pathway Activation	Strong type I interferon signature in muscle and skin. Plasmacytoid dendritic cells accumulate in affected tissues and produce IFN-alpha, driving inflammation and MxA protein expression.	biological_processes[0]	biological_processes	biological_processes			Type I Interferon Response	GO:0034340	response to type I interferon		"{""preferred_term"": ""Type I Interferon Response"", ""term"": {""id"": ""GO:0034340"", ""label"": ""response to type I interferon""}}"																											
1939	2006	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	2	Myositis-Specific Autoantibodies	Distinct autoantibodies define clinical phenotypes: anti-Mi-2 (classic dermatomyositis), anti-MDA5 (amyopathic with ILD), anti-TIF1-gamma (cancer-associated), and anti-NXP2 (calcinosis).	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
1940	2007	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	3	CD4+ T Cell and B Cell Infiltration	Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
1941	2007	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	3	CD4+ T Cell and B Cell Infiltration	Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue.	cell_types[1]	cell_types	cell_types			B Cell	CL:0000236	B cell		"{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1942	2007	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	3	CD4+ T Cell and B Cell Infiltration	Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue.	biological_processes[0]	biological_processes	biological_processes			Adaptive Immune Response	GO:0002250	adaptive immune response		"{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
1948	2023	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	0	EWSR1-WT1 Fusion Oncogene	The t(11;22)(p13;q12) translocation fuses EWSR1 on chromosome 22 with WT1 on chromosome 11. The resulting fusion protein contains the potent transcriptional activation domain of EWSR1 fused to the zinc finger DNA-binding domain of WT1. This chimeric transcription factor activates aberrant gene expression programs including PDGFA.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			ABNORMAL																								
1949	2023	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	0	EWSR1-WT1 Fusion Oncogene	The t(11;22)(p13;q12) translocation fuses EWSR1 on chromosome 22 with WT1 on chromosome 11. The resulting fusion protein contains the potent transcriptional activation domain of EWSR1 fused to the zinc finger DNA-binding domain of WT1. This chimeric transcription factor activates aberrant gene expression programs including PDGFA.	locations[0]	locations	locations			peritoneum	UBERON:0002358	peritoneum		"{""preferred_term"": ""peritoneum"", ""term"": {""id"": ""UBERON:0002358"", ""label"": ""peritoneum""}}"																											
1950	2024	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	1	PDGFA Activation	EWSR1-WT1 directly activates transcription of PDGFA, creating an autocrine growth loop that stimulates tumor cell proliferation and may contribute to the characteristic desmoplastic stromal reaction.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1951	2025	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	2	Multiphenotypic Differentiation	DSRCT displays a unique multiphenotypic immunophenotype with co-expression of epithelial (cytokeratin, EMA), mesenchymal (vimentin, desmin), and neural (NSE) markers. This reflects the aberrant differentiation program driven by EWSR1-WT1.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			ABNORMAL																								
1977	2062	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	0	Germinal Center B-cell Origin	DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior.	cell_types[0]	cell_types	cell_types			centrocyte	CL:0009111	centrocyte		"{""preferred_term"": ""centrocyte"", ""term"": {""id"": ""CL:0009111"", ""label"": ""centrocyte""}}"																											
1978	2062	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	0	Germinal Center B-cell Origin	DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior.	cell_types[1]	cell_types	cell_types			centroblast	CL:0009112	centroblast		"{""preferred_term"": ""centroblast"", ""term"": {""id"": ""CL:0009112"", ""label"": ""centroblast""}}"																											
1979	2062	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	0	Germinal Center B-cell Origin	DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
1980	2063	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	1	BCL2 Overexpression and Apoptosis Resistance	BCL2 translocation t(14;18) occurs in approximately 30% of GCB-DLBCL, placing BCL2 under immunoglobulin enhancer control. Resulting BCL2 overexpression blocks the mitochondrial apoptosis pathway, allowing survival of cells that would normally die in the germinal center.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
1981	2064	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	2	MYC-Driven Proliferation	MYC rearrangements occur in 10-15% of DLBCL, most commonly with IGH but also with non-immunoglobulin partners. MYC overexpression drives cellular proliferation and metabolism. When combined with BCL2 rearrangement (double-hit lymphoma), creates highly aggressive disease.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
1982	2065	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	3	NF-kB Constitutive Activation	ABC-DLBCL shows constitutive NF-kB activation through various mechanisms including BCR signaling mutations (CD79A/B), CARD11 mutations, MYD88 L265P mutation, or A20 deletion. NF-kB promotes survival and contributes to the aggressive behavior of ABC subtype.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
1983	2065	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	3	NF-kB Constitutive Activation	ABC-DLBCL shows constitutive NF-kB activation through various mechanisms including BCR signaling mutations (CD79A/B), CARD11 mutations, MYD88 L265P mutation, or A20 deletion. NF-kB promotes survival and contributes to the aggressive behavior of ABC subtype.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
1984	2066	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	4	Lymphoma Cell Accumulation	The combination of blocked apoptosis, enhanced proliferation, and constitutive survival signaling leads to aggressive expansion of large B-cell lymphoma involving lymph nodes and extranodal sites.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
1985	2066	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	4	Lymphoma Cell Accumulation	The combination of blocked apoptosis, enhanced proliferation, and constitutive survival signaling leads to aggressive expansion of large B-cell lymphoma involving lymph nodes and extranodal sites.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
2003	2093	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	1	Interferon Hyperactivation	Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
2004	2093	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	1	Interferon Hyperactivation	Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation.	biological_processes[0]	biological_processes	biological_processes			type I interferon-mediated signaling pathway	GO:0060337	type I interferon-mediated signaling pathway		"{""preferred_term"": ""type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon-mediated signaling pathway""}}"																											
2005	2093	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	1	Interferon Hyperactivation	Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation.	biological_processes[1]	biological_processes	biological_processes			cell surface receptor signaling pathway via JAK-STAT	GO:0007259	cell surface receptor signaling pathway via JAK-STAT		"{""preferred_term"": ""cell surface receptor signaling pathway via JAK-STAT"", ""term"": {""id"": ""GO:0007259"", ""label"": ""cell surface receptor signaling pathway via JAK-STAT""}}"																											
2006	2093	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	1	Interferon Hyperactivation	Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation.	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
2007	2094	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	2	Neurodevelopmental Alterations	Impaired neurogenesis with progenitor cell-cycle defects and shift from neuron to astrocyte differentiation, leading to reduced neuronal output and circuit dysfunction. Astrocytes show increased numbers and reactive states due to lineage shift from neurogenesis to astrogliogenesis.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
2008	2094	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	2	Neurodevelopmental Alterations	Impaired neurogenesis with progenitor cell-cycle defects and shift from neuron to astrocyte differentiation, leading to reduced neuronal output and circuit dysfunction. Astrocytes show increased numbers and reactive states due to lineage shift from neurogenesis to astrogliogenesis.	locations[0]	locations	locations			Ammon's horn	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
2024	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.	cell_types[0]	cell_types	cell_types			inhibitory interneuron	CL:0000498	inhibitory interneuron		"{""preferred_term"": ""inhibitory interneuron"", ""term"": {""id"": ""CL:0000498"", ""label"": ""inhibitory interneuron""}}"																											
2025	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.	biological_processes[0]	biological_processes	biological_processes			voltage-gated sodium channel activity	GO:0005248	voltage-gated sodium channel activity		"{""preferred_term"": ""voltage-gated sodium channel activity"", ""term"": {""id"": ""GO:0005248"", ""label"": ""voltage-gated sodium channel activity""}}"																											
2026	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.	biological_processes[1]	biological_processes	biological_processes			neuronal action potential	GO:0019228	neuronal action potential		"{""preferred_term"": ""neuronal action potential"", ""term"": {""id"": ""GO:0019228"", ""label"": ""neuronal action potential""}}"																											
2027	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
2028	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.	locations[1]	locations	locations			Ammon's horn	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
2029	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.	cell_types[0]	cell_types	cell_types			inhibitory interneuron	CL:0000498	inhibitory interneuron		"{""preferred_term"": ""inhibitory interneuron"", ""term"": {""id"": ""CL:0000498"", ""label"": ""inhibitory interneuron""}}"																											
2030	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.	biological_processes[0]	biological_processes	biological_processes			synaptic transmission, GABAergic	GO:0051932	synaptic transmission, GABAergic		"{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}"																											
2031	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
2032	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.	locations[1]	locations	locations			Ammon's horn	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
2033	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.	locations[2]	locations	locations			dorsal plus ventral thalamus	UBERON:0001897	dorsal plus ventral thalamus		"{""preferred_term"": ""dorsal plus ventral thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}"																											
2034	2127	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	2	Astrocyte Dysregulation	Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
2035	2127	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	2	Astrocyte Dysregulation	Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility.	locations[0]	locations	locations			cerebral cortex	UBERON:0000956	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}"																											
2036	2127	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	2	Astrocyte Dysregulation	Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility.	locations[1]	locations	locations			Ammon's horn	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
2055	2153	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	0	Dystrophin Deficiency	"Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.
"	cell_types[0]	cell_types	cell_types			Skeletal Muscle Fiber	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Fiber"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
2056	2153	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	0	Dystrophin Deficiency	"Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.
"	biological_processes[0]	biological_processes	biological_processes			Muscle Contraction	GO:0006936	muscle contraction		"{""preferred_term"": ""Muscle Contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}"																											
2057	2154	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	1	Progressive Muscle Degeneration	"Without dystrophin, muscle fibers are susceptible to contraction-induced damage. Repeated cycles of degeneration and regeneration exhaust satellite cell pools, leading to fibrosis and fatty replacement of muscle tissue.
"	cell_types[0]	cell_types	cell_types			Skeletal Muscle Fiber	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Fiber"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
2058	2154	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	1	Progressive Muscle Degeneration	"Without dystrophin, muscle fibers are susceptible to contraction-induced damage. Repeated cycles of degeneration and regeneration exhaust satellite cell pools, leading to fibrosis and fatty replacement of muscle tissue.
"	biological_processes[0]	biological_processes	biological_processes			Muscle Degeneration	GO:0061061	muscle structure development		"{""preferred_term"": ""Muscle Degeneration"", ""term"": {""id"": ""GO:0061061"", ""label"": ""muscle structure development""}}"																											
2067	2173	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	0	EBV Latent Infection of Gastric Epithelium	EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways.	cell_types[0]	cell_types	cell_types			epithelial cell	CL:0000066	epithelial cell		"{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
2068	2173	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	0	EBV Latent Infection of Gastric Epithelium	EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways.	locations[0]	locations	locations			stomach	UBERON:0000945	stomach		"{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}"																											
2069	2173	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	0	EBV Latent Infection of Gastric Epithelium	EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways.	biological_processes[0]	biological_processes	biological_processes			viral transcription	GO:0019083	viral transcription		"{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}"																											
2070	2174	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	1	Epigenetic Reprogramming and CIMP-High Phenotype	EBV-associated gastric cancer displays the most extreme CpG island methylator phenotype (CIMP) of any cancer type. EBV-encoded proteins, particularly LMP2A, induce aberrant DNA methylation leading to silencing of tumor suppressor genes including CDKN2A (p16), CDH1 (E-cadherin), and MLH1. This epigenetic reprogramming is a hallmark feature distinguishing EBV-positive from EBV-negative gastric cancers.	biological_processes[0]	biological_processes	biological_processes			DNA methylation	GO:0006306	DNA methylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}"			INCREASED																								
2071	2175	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	PIK3CA mutations occur in approximately 80% of EBV-positive gastric cancers, the highest frequency of any gastric cancer subtype. Combined with LMP2A signaling which activates PI3K through mimicry of B-cell receptor signaling, this leads to constitutive AKT activation promoting cell survival and proliferation.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
2072	2176	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	3	Tumor Suppressor Gene Silencing	Promoter hypermethylation silences multiple tumor suppressor genes. CDKN2A (p16INK4A) silencing removes G1/S checkpoint control. CDH1 (E-cadherin) silencing promotes epithelial-mesenchymal transition. Unlike other gastric cancer subtypes, TP53 mutations are rare in EBV-positive tumors.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
2073	2177	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	4	Uncontrolled Cell Proliferation	Combined effects of PI3K-AKT activation, tumor suppressor silencing, and viral oncogene expression drive uncontrolled proliferation of infected gastric epithelial cells, leading to tumor formation.	cell_types[0]	cell_types	cell_types			epithelial cell	CL:0000066	epithelial cell		"{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
2074	2177	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	4	Uncontrolled Cell Proliferation	Combined effects of PI3K-AKT activation, tumor suppressor silencing, and viral oncogene expression drive uncontrolled proliferation of infected gastric epithelial cells, leading to tumor formation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2085	2194	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	0	EGFR Oncogenic Mutations	Activating EGFR mutations occur in the tyrosine kinase domain and cause constitutive receptor activation independent of ligand binding. Mutations alter the ATP-binding pocket, favoring the active kinase conformation and enhancing sensitivity to ATP-competitive TKIs.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
2086	2194	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	0	EGFR Oncogenic Mutations	Activating EGFR mutations occur in the tyrosine kinase domain and cause constitutive receptor activation independent of ligand binding. Mutations alter the ATP-binding pocket, favoring the active kinase conformation and enhancing sensitivity to ATP-competitive TKIs.	biological_processes[0]	biological_processes	biological_processes			epidermal growth factor receptor signaling pathway	GO:0007173	epidermal growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}"			INCREASED																								
2087	2195	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive EGFR Signaling	Mutant EGFR is constitutively phosphorylated, activating downstream signaling cascades including RAS-RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The tumor becomes dependent on (addicted to) EGFR signaling for survival.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2088	2195	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive EGFR Signaling	Mutant EGFR is constitutively phosphorylated, activating downstream signaling cascades including RAS-RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The tumor becomes dependent on (addicted to) EGFR signaling for survival.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
2089	2196	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	EGFR-mutant tumors exhibit oncogene addiction, with survival critically dependent on continued EGFR signaling. EGFR inhibition leads to rapid tumor regression through induction of apoptosis and cell cycle arrest. This creates the therapeutic window for TKI therapy.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2090	2197	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	3	TKI Resistance Mechanisms	Resistance to EGFR TKIs develops through multiple mechanisms: secondary EGFR mutations (T790M, C797S), bypass pathway activation (MET amplification, HER2 amplification), and histologic transformation (small cell or squamous). Understanding resistance guides sequential therapy selection.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
2101	2215	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	0	Estrogen Receptor Activation	ER+ breast cancer is driven by estrogen-dependent activation of the estrogen receptor alpha (ER), a nuclear hormone receptor that functions as a ligand-activated transcription factor. Estrogen binding induces receptor dimerization, DNA binding, and transcriptional activation of target genes.	cell_types[0]	cell_types	cell_types			luminal epithelial cell of mammary gland	CL:0002326	luminal epithelial cell of mammary gland		"{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}"																											
2102	2215	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	0	Estrogen Receptor Activation	ER+ breast cancer is driven by estrogen-dependent activation of the estrogen receptor alpha (ER), a nuclear hormone receptor that functions as a ligand-activated transcription factor. Estrogen binding induces receptor dimerization, DNA binding, and transcriptional activation of target genes.	biological_processes[0]	biological_processes	biological_processes			intracellular estrogen receptor signaling pathway	GO:0030520	intracellular estrogen receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""intracellular estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}"			INCREASED																								
2103	2216	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	1	Estrogen-Driven Transcription	Activated ER binds estrogen response elements (EREs) in target gene promoters, recruiting coactivators and driving transcription of genes promoting cell cycle progression (CCND1), survival (BCL2), and growth factor signaling (IGF1R, EGFR). This creates estrogen-dependent tumor growth.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			INCREASED																								
2104	2217	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	2	Cell Cycle Progression	ER signaling drives expression of cyclin D1 (CCND1), which complexes with CDK4/6 to phosphorylate Rb and promote G1-S transition. This creates the therapeutic rationale for CDK4/6 inhibitors in ER+ breast cancer.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""INCREASED"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			INCREASED																								
2105	2217	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	2	Cell Cycle Progression	ER signaling drives expression of cyclin D1 (CCND1), which complexes with CDK4/6 to phosphorylate Rb and promote G1-S transition. This creates the therapeutic rationale for CDK4/6 inhibitors in ER+ breast cancer.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2120	2242	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	0	Viral Entry via Endocytosis	Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
2121	2242	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	0	Viral Entry via Endocytosis	Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2122	2242	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	0	Viral Entry via Endocytosis	Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.	cell_types[2]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
2123	2242	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	0	Viral Entry via Endocytosis	Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.	biological_processes[0]	biological_processes	biological_processes			symbiont entry into host cell	GO:0046718	symbiont entry into host cell		"{""preferred_term"": ""symbiont entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""symbiont entry into host cell""}}"																											
2124	2243	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	1	Immune Evasion and Viral Replication	Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
2125	2243	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	1	Immune Evasion and Viral Replication	Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2126	2243	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	1	Immune Evasion and Viral Replication	Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells.	cell_types[2]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
2127	2244	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	2	Endothelial Dysfunction and Vascular Leak	Ebola virus glycoprotein (GP) and secreted GP (sGP) contribute to endothelial cell activation and barrier disruption. This leads to increased vascular permeability, fluid extravasation, and hypovolemic shock. Endothelial dysfunction is a central feature of Ebola hemorrhagic fever.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
2128	2244	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	2	Endothelial Dysfunction and Vascular Leak	Ebola virus glycoprotein (GP) and secreted GP (sGP) contribute to endothelial cell activation and barrier disruption. This leads to increased vascular permeability, fluid extravasation, and hypovolemic shock. Endothelial dysfunction is a central feature of Ebola hemorrhagic fever.	locations[0]	locations	locations			blood vessel	UBERON:0001981	blood vessel		"{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}"																											
2129	2245	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	3	Coagulopathy and Disseminated Intravascular Coagulation	Ebola infection triggers systemic inflammatory response with cytokine release, endothelial activation, and tissue factor pathway activation. This leads to thromboinflammation, platelet activation, consumptive coagulopathy, and disseminated intravascular coagulation (DIC), resulting in hemorrhagic manifestations.	biological_processes[0]	biological_processes	biological_processes			blood coagulation	GO:0007596	blood coagulation		"{""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
2130	2245	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	3	Coagulopathy and Disseminated Intravascular Coagulation	Ebola infection triggers systemic inflammatory response with cytokine release, endothelial activation, and tissue factor pathway activation. This leads to thromboinflammation, platelet activation, consumptive coagulopathy, and disseminated intravascular coagulation (DIC), resulting in hemorrhagic manifestations.	locations[0]	locations	locations			blood vessel	UBERON:0001981	blood vessel		"{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}"																											
2131	2246	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	4	Multiorgan Involvement	Ebola virus infects multiple organs including liver, spleen, lymph nodes, and kidneys. Hepatic dysfunction with elevated liver enzymes (AST > ALT pattern) and splenic involvement contribute to multiorgan failure in severe cases.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
2132	2246	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	4	Multiorgan Involvement	Ebola virus infects multiple organs including liver, spleen, lymph nodes, and kidneys. Hepatic dysfunction with elevated liver enzymes (AST > ALT pattern) and splenic involvement contribute to multiorgan failure in severe cases.	locations[1]	locations	locations			spleen	UBERON:0002106	spleen		"{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}"																											
2155	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	Collagen Abnormalities	Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly.	biological_processes[0]	biological_processes	biological_processes			collagen fibril organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
2156	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	Collagen Abnormalities	Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly.	biological_processes[1]	biological_processes	biological_processes			collagen biosynthetic process	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
2157	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
2158	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.	cell_types[0]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
2159	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.	cell_types[1]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
2160	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.	locations[0]	locations	locations			dermis	UBERON:0002067	dermis		"{""preferred_term"": ""dermis"", ""term"": {""id"": ""UBERON:0002067"", ""label"": ""dermis""}}"																											
2161	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.	locations[1]	locations	locations			blood vessel	UBERON:0001981	blood vessel		"{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}"																											
2162	2293	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	3	Integrin-Mediated Mechanotransduction Dysregulation	Defective collagen matrix leads to altered integrin signaling, particularly upregulation of integrin v3, contributing to persistent inflammation and impaired wound healing in classical EDS.	biological_processes[0]	biological_processes	biological_processes			integrin-mediated signaling pathway	GO:0007229	integrin-mediated signaling pathway		"{""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}"																											
2163	2293	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	3	Integrin-Mediated Mechanotransduction Dysregulation	Defective collagen matrix leads to altered integrin signaling, particularly upregulation of integrin v3, contributing to persistent inflammation and impaired wound healing in classical EDS.	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2164	2294	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	4	Autophagy and Proteostasis Dysfunction	Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control.	biological_processes[0]	biological_processes	biological_processes			autophagy	GO:0006914	autophagy		"{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
2165	2294	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	4	Autophagy and Proteostasis Dysfunction	Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control.	biological_processes[1]	biological_processes	biological_processes			protein folding	GO:0006457	protein folding		"{""preferred_term"": ""protein folding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}"																											
2166	2294	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	4	Autophagy and Proteostasis Dysfunction	Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control.	cellular_components[0]	cellular_components	cellular_components			lysosome	GO:0005764	lysosome		"{""preferred_term"": ""lysosome"", ""term"": {""id"": ""GO:0005764"", ""label"": ""lysosome""}}"																											
2167	2294	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	4	Autophagy and Proteostasis Dysfunction	Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control.	cellular_components[1]	cellular_components	cellular_components			autophagosome	GO:0005776	autophagosome		"{""preferred_term"": ""autophagosome"", ""term"": {""id"": ""GO:0005776"", ""label"": ""autophagosome""}}"																											
2168	2295	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	5	Complement-Mediated ECM Degradation	Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS.	biological_processes[0]	biological_processes	biological_processes			complement activation, classical pathway	GO:0006958	complement activation, classical pathway		"{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}"																											
2169	2295	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	5	Complement-Mediated ECM Degradation	Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS.	biological_processes[1]	biological_processes	biological_processes			proteolysis	GO:0006508	proteolysis		"{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}"																											
2170	2295	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	5	Complement-Mediated ECM Degradation	Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS.	locations[0]	locations	locations			periodontium	UBERON:0002405	periodontium		"{""preferred_term"": ""periodontium"", ""term"": {""id"": ""UBERON:0002405"", ""label"": ""periodontium""}}"																											
2185	2319	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	0	Collagen Type V Abnormalities	Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly.	biological_processes[0]	biological_processes	biological_processes			collagen fibril organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
2186	2319	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	0	Collagen Type V Abnormalities	Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly.	biological_processes[1]	biological_processes	biological_processes			collagen biosynthetic process	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
2187	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen type V leads to weakened connective tissues throughout the body.	cell_types[0]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
2188	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen type V leads to weakened connective tissues throughout the body.	cell_types[1]	cell_types	cell_types			dermal fibroblast	CL:0002620	skin fibroblast		"{""preferred_term"": ""dermal fibroblast"", ""term"": {""id"": ""CL:0002620"", ""label"": ""skin fibroblast""}}"																											
2189	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen type V leads to weakened connective tissues throughout the body.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
2190	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen type V leads to weakened connective tissues throughout the body.	cellular_components[0]	cellular_components	cellular_components			extracellular matrix	GO:0031012	extracellular matrix		"{""preferred_term"": ""extracellular matrix"", ""term"": {""id"": ""GO:0031012"", ""label"": ""extracellular matrix""}}"																											
2191	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
2192	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
2193	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	locations[1]	locations	locations			tendon	UBERON:0000043	tendon		"{""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}"																											
2194	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	locations[2]	locations	locations			corneal stroma	UBERON:0001772	corneal stroma		"{""preferred_term"": ""corneal stroma"", ""term"": {""id"": ""UBERON:0001772"", ""label"": ""corneal stroma""}}"																											
2195	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	biological_processes[0]	biological_processes	biological_processes			wound healing	GO:0042060	wound healing		"{""preferred_term"": ""wound healing"", ""term"": {""id"": ""GO:0042060"", ""label"": ""wound healing""}}"																											
2196	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	biological_processes[1]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"																											
2197	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	biological_processes[2]	biological_processes	biological_processes			integrin-mediated signaling pathway	GO:0007229	integrin-mediated signaling pathway		"{""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}"																											
2198	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.	cellular_components[0]	cellular_components	cellular_components			pericellular matrix	GO:0036046	pericellular matrix		"{""preferred_term"": ""pericellular matrix"", ""term"": {""id"": ""GO:0036046"", ""label"": ""pericellular matrix""}}"																											
2212	2348	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	0	Loss of Heterozygosity at 11p15	Loss of heterozygosity (LOH) at chromosome 11p15.5 is the hallmark genetic event in ERMS, occurring in approximately 80% of cases. This region contains the imprinted IGF2 gene, and LOH results in loss of the maternal allele with duplication of the paternal allele, leading to biallelic IGF2 expression and growth factor pathway activation.	cell_types[0]	cell_types	cell_types			skeletal muscle myoblast	CL:0000515	skeletal muscle myoblast		"{""preferred_term"": ""skeletal muscle myoblast"", ""term"": {""id"": ""CL:0000515"", ""label"": ""skeletal muscle myoblast""}}"																											
2213	2348	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	0	Loss of Heterozygosity at 11p15	Loss of heterozygosity (LOH) at chromosome 11p15.5 is the hallmark genetic event in ERMS, occurring in approximately 80% of cases. This region contains the imprinted IGF2 gene, and LOH results in loss of the maternal allele with duplication of the paternal allele, leading to biallelic IGF2 expression and growth factor pathway activation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2214	2349	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	1	IGF2 Overexpression	Loss of imprinting at 11p15 results in biallelic expression of IGF2, leading to autocrine and paracrine growth stimulation through IGF1R signaling. This promotes cell proliferation and survival in ERMS cells.	biological_processes[0]	biological_processes	biological_processes			regulation of cell population proliferation	GO:0042127	regulation of cell population proliferation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of cell population proliferation"", ""term"": {""id"": ""GO:0042127"", ""label"": ""regulation of cell population proliferation""}}"			ABNORMAL																								
2215	2350	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	2	RAS Pathway Activation	Activating mutations in RAS pathway genes (NRAS, KRAS, HRAS) occur in approximately 35% of ERMS cases. FGFR4 mutations occur in 7-10% of cases. These mutations drive proliferation through MAPK and PI3K pathway activation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2226	2368	104	Endometriosis	Endometriosis.yaml	pathophysiology	0	Ectopic Endometrial Tissue	"Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.
"	cell_types[0]	cell_types	cell_types			Endometrial Stromal Cell	CL:0002255	stromal cell of endometrium		"{""preferred_term"": ""Endometrial Stromal Cell"", ""term"": {""id"": ""CL:0002255"", ""label"": ""stromal cell of endometrium""}}"																											
2227	2368	104	Endometriosis	Endometriosis.yaml	pathophysiology	0	Ectopic Endometrial Tissue	"Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.
"	biological_processes[0]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell population proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"																											
2228	2370	104	Endometriosis	Endometriosis.yaml	pathophysiology	2	Chronic Inflammation	"Ectopic lesions trigger chronic pelvic inflammation with elevated cytokines and prostaglandins. Inflammatory milieu contributes to pain and adhesion formation.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2229	2371	104	Endometriosis	Endometriosis.yaml	pathophysiology	3	Estrogen Dependence	"Endometriotic lesions produce their own estrogen via aromatase and are highly estrogen-responsive. Progesterone resistance impairs normal tissue regression.
"	biological_processes[0]	biological_processes	biological_processes			Estrogen Response	GO:0043627	response to estrogen		"{""preferred_term"": ""Estrogen Response"", ""term"": {""id"": ""GO:0043627"", ""label"": ""response to estrogen""}}"																											
2230	2372	104	Endometriosis	Endometriosis.yaml	pathophysiology	4	Immune Dysfunction	"Immune system alterations enable ectopic endometrial cells to evade clearance. Includes increased peritoneal macrophages, reduced NK cell cytotoxicity, T cell dysfunction, and elevated inflammatory cytokines. Crosstalk between endometrial stromal cells and macrophages impairs NK cell function via IL-10 and TGF-beta secretion.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2231	2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	Hypoxia and Angiogenesis	"Ectopic lesions experience hypoxia which stabilizes HIF-1alpha, upregulating VEGF and promoting angiogenesis. Neovascularization supports lesion survival and growth. Ovarian endometriomas show particularly high expression of hypoxic and angiogenic factors.
"	biological_processes[0]	biological_processes	biological_processes			Response to Hypoxia	GO:0001666	response to hypoxia		"{""preferred_term"": ""Response to Hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"																											
2232	2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	Hypoxia and Angiogenesis	"Ectopic lesions experience hypoxia which stabilizes HIF-1alpha, upregulating VEGF and promoting angiogenesis. Neovascularization supports lesion survival and growth. Ovarian endometriomas show particularly high expression of hypoxic and angiogenic factors.
"	biological_processes[1]	biological_processes	biological_processes			Angiogenesis	GO:0001525	angiogenesis		"{""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"																											
2240	2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	Neuronal Hyperexcitability	"Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.
"	cell_types[0]	cell_types	cell_types			Pyramidal Neuron	CL:0000598	pyramidal neuron		"{""preferred_term"": ""Pyramidal Neuron"", ""term"": {""id"": ""CL:0000598"", ""label"": ""pyramidal neuron""}}"																											
2241	2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	Neuronal Hyperexcitability	"Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.
"	cell_types[1]	cell_types	cell_types			GABAergic Interneuron	CL:0000617	GABAergic neuron		"{""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0000617"", ""label"": ""GABAergic neuron""}}"																											
2242	2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	Neuronal Hyperexcitability	"Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Transmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Synaptic Transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
2243	2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	Blood-Brain Barrier Disruption	"Loss of tight junction proteins (claudin-5) in brain endothelial cells leads to blood-brain barrier breakdown, allowing albumin extravasation and disruption of ionic homeostasis.
"	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
2244	2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	Blood-Brain Barrier Disruption	"Loss of tight junction proteins (claudin-5) in brain endothelial cells leads to blood-brain barrier breakdown, allowing albumin extravasation and disruption of ionic homeostasis.
"	biological_processes[0]	biological_processes	biological_processes			Blood-Brain Barrier Maintenance	GO:0035633	maintenance of blood-brain barrier		"{""preferred_term"": ""Blood-Brain Barrier Maintenance"", ""term"": {""id"": ""GO:0035633"", ""label"": ""maintenance of blood-brain barrier""}}"																											
2245	2407	105	Epilepsy	Epilepsy.yaml	pathophysiology	2	Network Hyperexcitability	"Abnormal synchronization of neuronal networks that can recruit adjacent or distant brain regions, leading to seizure propagation.
"	biological_processes[0]	biological_processes	biological_processes			Neuronal Activity	GO:0019226	transmission of nerve impulse		"{""preferred_term"": ""Neuronal Activity"", ""term"": {""id"": ""GO:0019226"", ""label"": ""transmission of nerve impulse""}}"																											
2246	2408	105	Epilepsy	Epilepsy.yaml	pathophysiology	3	Neuroinflammation and Gliosis	"Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.
"	cell_types[0]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
2247	2408	105	Epilepsy	Epilepsy.yaml	pathophysiology	3	Neuroinflammation and Gliosis	"Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.
"	cell_types[1]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
2248	2408	105	Epilepsy	Epilepsy.yaml	pathophysiology	3	Neuroinflammation and Gliosis	"Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.
"	biological_processes[0]	biological_processes	biological_processes			Neuroinflammatory Response	GO:0150076	neuroinflammatory response		"{""preferred_term"": ""Neuroinflammatory Response"", ""term"": {""id"": ""GO:0150076"", ""label"": ""neuroinflammatory response""}}"																											
2249	2409	105	Epilepsy	Epilepsy.yaml	pathophysiology	4	Synaptic Reorganization	"Aberrant sprouting, formation of new synaptic connections, and altered synaptic plasticity that promote recurrent excitatory circuits and seizure susceptibility.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Plasticity	GO:0048167	regulation of synaptic plasticity		"{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"																											
2250	2410	105	Epilepsy	Epilepsy.yaml	pathophysiology	5	mTOR Pathway Hyperactivation	"Constitutive activation of the mechanistic target of rapamycin (mTOR) signaling pathway, driving abnormal neuronal growth and development of dysmorphic neurons in focal cortical malformations.
"	biological_processes[0]	biological_processes	biological_processes			mTOR Signaling	GO:0031929	TOR signaling		"{""preferred_term"": ""mTOR Signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}"																											
2257	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	Vascular Resistance	"Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.
"	cell_types[0]	cell_types	cell_types			Vascular Smooth Muscle Cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""Vascular Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
2258	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	Vascular Resistance	"Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.
"	cell_types[1]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
2259	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	Vascular Resistance	"Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.
"	biological_processes[0]	biological_processes	biological_processes			Blood Pressure Regulation	GO:0008217	regulation of blood pressure		"{""preferred_term"": ""Blood Pressure Regulation"", ""term"": {""id"": ""GO:0008217"", ""label"": ""regulation of blood pressure""}}"																											
2260	2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	Renin-Angiotensin-Aldosterone System Dysregulation	"Overactivation of the RAAS leads to sodium retention, vasoconstriction, and vascular remodeling, all contributing to elevated blood pressure.
"	cell_types[0]	cell_types	cell_types			Kidney Granular Cell	CL:0000648	kidney granular cell		"{""preferred_term"": ""Kidney Granular Cell"", ""term"": {""id"": ""CL:0000648"", ""label"": ""kidney granular cell""}}"																											
2261	2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	Renin-Angiotensin-Aldosterone System Dysregulation	"Overactivation of the RAAS leads to sodium retention, vasoconstriction, and vascular remodeling, all contributing to elevated blood pressure.
"	biological_processes[0]	biological_processes	biological_processes			RAAS Pathway	GO:0002018	renin-angiotensin regulation of aldosterone production		"{""preferred_term"": ""RAAS Pathway"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}"																											
2262	2433	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	2	Sympathetic Nervous System Overactivity	"Enhanced sympathetic tone increases heart rate, cardiac output, and peripheral vascular resistance through catecholamine release.
"	biological_processes[0]	biological_processes	biological_processes			Sympathetic Regulation	GO:0003082	positive regulation of systemic arterial blood pressure by norepinephrine-epinephrine		"{""preferred_term"": ""Sympathetic Regulation"", ""term"": {""id"": ""GO:0003082"", ""label"": ""positive regulation of systemic arterial blood pressure by norepinephrine-epinephrine""}}"																											
2263	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	Immune and Inflammatory Activation	"Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.
"	cell_types[0]	cell_types	cell_types			T Cell	CL:0000084	T cell		"{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
2264	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	Immune and Inflammatory Activation	"Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.
"	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2265	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	Immune and Inflammatory Activation	"Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.
"	cell_types[2]	cell_types	cell_types			Dendritic Cell	CL:0000451	dendritic cell		"{""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
2266	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	Immune and Inflammatory Activation	"Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2267	2435	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	4	Oxidative Stress	"Increased production of reactive oxygen species (ROS) by NADPH oxidases and decreased antioxidant defenses lead to oxidative stress. ROS impair nitric oxide bioavailability, promote endothelial dysfunction, and activate inflammatory pathways, all contributing to elevated blood pressure and kidney injury.
"	biological_processes[0]	biological_processes	biological_processes			ROS Metabolic Process	GO:0072593	reactive oxygen species metabolic process		"{""preferred_term"": ""ROS Metabolic Process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}"																											
2273	2452	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation.	cell_types[0]	cell_types	cell_types			megakaryocyte	CL:0000556	megakaryocyte		"{""preferred_term"": ""megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}"																											
2274	2452	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT signaling pathway	GO:0007259	JAK-STAT cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"			INCREASED																								
2275	2452	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
2276	2453	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	1	Enhanced Megakaryopoiesis	Constitutive JAK-STAT signaling drives increased megakaryocyte proliferation and maturation. Unlike myelofibrosis, megakaryocytes in ET are large and mature without significant atypia or clustering.	biological_processes[0]	biological_processes	biological_processes			megakaryocyte differentiation	GO:0030219	megakaryocyte differentiation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""megakaryocyte differentiation"", ""term"": {""id"": ""GO:0030219"", ""label"": ""megakaryocyte differentiation""}}"			INCREASED																								
2277	2454	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	2	Platelet Dysfunction and Thrombosis Risk	Despite elevated platelet counts, thrombosis risk is multifactorial and involves platelet activation, leukocyte-platelet interactions, and endothelial dysfunction. Paradoxically, extreme thrombocytosis (>1,000,000/uL) may cause acquired von Willebrand disease and bleeding.	biological_processes[0]	biological_processes	biological_processes			platelet activation	GO:0030168	platelet activation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""platelet activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}"			ABNORMAL																								
2291	2470	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	0	EWS-FLI1 Fusion Oncogene	The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma.	cell_types[0]	cell_types	cell_types			mesenchymal stem cell	CL:0000134	mesenchymal stem cell		"{""preferred_term"": ""mesenchymal stem cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}"																											
2292	2470	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	0	EWS-FLI1 Fusion Oncogene	The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma.	biological_processes[0]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			ABNORMAL																								
2293	2470	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	0	EWS-FLI1 Fusion Oncogene	The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma.	locations[0]	locations	locations			bone tissue	UBERON:0002481	bone tissue		"{""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}"																											
2294	2471	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	1	Aberrant Transcriptional Regulation	EWS-FLI1 binds to GGAA microsatellite repeats throughout the genome, creating de novo enhancers that activate oncogenic target genes including NKX2-2, NR0B1, and IGF1. This abnormal enhancer activity reprograms cell identity and drives the Ewing sarcoma phenotype.	biological_processes[0]	biological_processes	biological_processes			regulation of gene expression	GO:0010468	regulation of gene expression		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"			ABNORMAL																								
2295	2472	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	2	Blocked Differentiation	EWS-FLI1 represses genes required for mesenchymal differentiation, maintaining cells in a proliferative, undifferentiated state. The cell of origin remains debated but may be a neural crest-derived mesenchymal progenitor.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
2311	2489	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	0	FGFR2 Fusion and Constitutive Activation	FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways.	cell_types[0]	cell_types	cell_types			intrahepatic cholangiocyte	CL:0002538	intrahepatic cholangiocyte		"{""preferred_term"": ""intrahepatic cholangiocyte"", ""term"": {""id"": ""CL:0002538"", ""label"": ""intrahepatic cholangiocyte""}}"																											
2312	2489	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	0	FGFR2 Fusion and Constitutive Activation	FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways.	biological_processes[0]	biological_processes	biological_processes			fibroblast growth factor receptor signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"			INCREASED																								
2313	2489	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	0	FGFR2 Fusion and Constitutive Activation	FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways.	locations[0]	locations	locations			intrahepatic bile duct	UBERON:0003704	intrahepatic bile duct		"{""preferred_term"": ""intrahepatic bile duct"", ""term"": {""id"": ""UBERON:0003704"", ""label"": ""intrahepatic bile duct""}}"																											
2314	2490	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	1	MAPK Pathway Activation	FGFR2 activation leads to recruitment of adaptor proteins (FRS2, GRB2) that activate RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2315	2491	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	FGFR2 signaling activates PI3K through adaptor proteins, leading to AKT phosphorylation. This promotes cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to FGFR inhibitors.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
2316	2493	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	4	Enhanced Cell Proliferation	Combined activation of MAPK, PI3K-AKT, and PLCgamma pathways drives enhanced cell proliferation. FGFR2 fusion-positive tumors are dependent on FGFR2 signaling, making them vulnerable to FGFR inhibition.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2330	2511	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	0	FGFR3 Constitutive Activation	Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor.	cell_types[0]	cell_types	cell_types			epithelial cell of urethra	CL:1000296	epithelial cell of urethra		"{""preferred_term"": ""epithelial cell of urethra"", ""term"": {""id"": ""CL:1000296"", ""label"": ""epithelial cell of urethra""}}"																											
2331	2511	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	0	FGFR3 Constitutive Activation	Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor.	biological_processes[0]	biological_processes	biological_processes			fibroblast growth factor receptor signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"			INCREASED																								
2332	2511	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	0	FGFR3 Constitutive Activation	Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor.	locations[0]	locations	locations			urinary bladder	UBERON:0001255	urinary bladder		"{""preferred_term"": ""urinary bladder"", ""term"": {""id"": ""UBERON:0001255"", ""label"": ""urinary bladder""}}"																											
2333	2512	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	FGFR3 activation stimulates the RAS-RAF-MEK-ERK signaling cascade through adaptor proteins FRS2 and GRB2. This drives uncontrolled urothelial cell proliferation and is a major effector of FGFR-mediated transformation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2334	2513	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	FGFR3 activation recruits PI3K and activates the PI3K-AKT-mTOR signaling pathway, promoting urothelial cell survival and resistance to apoptosis.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
2360	2554	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	0	FLT3 Receptor Constitutive Activation	FLT3 is a class III receptor tyrosine kinase normally involved in hematopoietic progenitor cell survival and proliferation. FLT3-ITD mutations cause ligand-independent receptor dimerization and constitutive autophosphorylation. FLT3-TKD mutations stabilize the active kinase conformation. Both result in aberrant downstream signaling.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
2361	2554	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	0	FLT3 Receptor Constitutive Activation	FLT3 is a class III receptor tyrosine kinase normally involved in hematopoietic progenitor cell survival and proliferation. FLT3-ITD mutations cause ligand-independent receptor dimerization and constitutive autophosphorylation. FLT3-TKD mutations stabilize the active kinase conformation. Both result in aberrant downstream signaling.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
2362	2555	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	1	STAT5 Hyperactivation	FLT3-ITD mutations preferentially activate STAT5 signaling compared to wild-type FLT3 or TKD mutations. Phosphorylated STAT5 translocates to the nucleus and activates transcription of anti-apoptotic genes (BCL-XL, PIM1) and cell cycle regulators, promoting leukemic cell survival and proliferation.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
2363	2555	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	1	STAT5 Hyperactivation	FLT3-ITD mutations preferentially activate STAT5 signaling compared to wild-type FLT3 or TKD mutations. Phosphorylated STAT5 translocates to the nucleus and activates transcription of anti-apoptotic genes (BCL-XL, PIM1) and cell cycle regulators, promoting leukemic cell survival and proliferation.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
2364	2556	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	2	RAS-MAPK Pathway Activation	FLT3 signaling activates the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival. This pathway is critical for the proliferative advantage of FLT3-mutated leukemic cells.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2365	2557	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	3	Apoptosis Resistance	FLT3-ITD-mediated STAT5 activation upregulates anti-apoptotic proteins including BCL-XL, MCL-1, and PIM kinases. This confers resistance to apoptosis and contributes to the aggressive clinical behavior of FLT3-ITD AML.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
2366	2558	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	4	Uncontrolled Myeloblast Proliferation	The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
2367	2558	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	4	Uncontrolled Myeloblast Proliferation	The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
2368	2558	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	4	Uncontrolled Myeloblast Proliferation	The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis.	biological_processes[0]	biological_processes	biological_processes			myeloid cell differentiation	GO:0030099	myeloid cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}"			DECREASED																								
2386	2576	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	0	Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation	"GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.
"	biological_processes[0]	biological_processes	biological_processes			glycosphingolipid metabolic process	GO:0006681	glycosphingolipid metabolic process		"{""preferred_term"": ""glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006681"", ""label"": ""glycosphingolipid metabolic process""}}"																											
2387	2576	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	0	Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation	"GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.
"	biological_processes[1]	biological_processes	biological_processes			lysosomal catabolic process	GO:0090487	lysosomal catabolic process		"{""preferred_term"": ""lysosomal catabolic process"", ""term"": {""id"": ""GO:0090487"", ""label"": ""lysosomal catabolic process""}}"																											
2388	2576	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	0	Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation	"GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.
"	genes[0]	genes	genes			GLA	hgnc:4296	GLA		"{""preferred_term"": ""GLA"", ""term"": {""id"": ""hgnc:4296"", ""label"": ""GLA""}}"																											
2389	2577	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	1	Endoplasmic reticulum stress and unfolded protein response	"Misfolded -Gal A variants trigger endoplasmic reticulum stress and activate the unfolded protein response (UPR). Persistent UPR activation causes apoptosis and inflammatory signaling through NF-B and MAPK pathways, contributing to cell death and tissue injury.
"	biological_processes[0]	biological_processes	biological_processes			response to unfolded protein	GO:0006986	response to unfolded protein		"{""preferred_term"": ""response to unfolded protein"", ""term"": {""id"": ""GO:0006986"", ""label"": ""response to unfolded protein""}}"																											
2390	2577	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	1	Endoplasmic reticulum stress and unfolded protein response	"Misfolded -Gal A variants trigger endoplasmic reticulum stress and activate the unfolded protein response (UPR). Persistent UPR activation causes apoptosis and inflammatory signaling through NF-B and MAPK pathways, contributing to cell death and tissue injury.
"	biological_processes[1]	biological_processes	biological_processes			NF-kappaB signaling pathway	GO:0007249	NF-kappaB signaling pathway		"{""preferred_term"": ""NF-kappaB signaling pathway"", ""term"": {""id"": ""GO:0007249"", ""label"": ""NF-kappaB signaling pathway""}}"																											
2391	2578	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	2	Mitochondrial dysfunction and oxidative stress	"Gb3 and lyso-Gb3 accumulation impairs mitochondrial function with reduced ATP production, complex I/III impairment, and elevated reactive oxygen species (ROS) production. Oxidative damage correlates with cardiac hypertrophy and contributes to cell death and inflammation.
"	biological_processes[0]	biological_processes	biological_processes			reactive oxygen species metabolic process	GO:0072593	reactive oxygen species metabolic process		"{""preferred_term"": ""reactive oxygen species metabolic process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}"																											
2392	2578	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	2	Mitochondrial dysfunction and oxidative stress	"Gb3 and lyso-Gb3 accumulation impairs mitochondrial function with reduced ATP production, complex I/III impairment, and elevated reactive oxygen species (ROS) production. Oxidative damage correlates with cardiac hypertrophy and contributes to cell death and inflammation.
"	biological_processes[1]	biological_processes	biological_processes			regulation of mitochondrial membrane potential	GO:0051881	regulation of mitochondrial membrane potential		"{""preferred_term"": ""regulation of mitochondrial membrane potential"", ""term"": {""id"": ""GO:0051881"", ""label"": ""regulation of mitochondrial membrane potential""}}"																											
2393	2579	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	3	Autophagy impairment	"Lysosomal Gb3 accumulation impairs autophagic flux, leading to accumulation of damaged proteins and organelles. Persistent podocyte injury despite enzyme replacement therapy is mediated in part by -synuclein accumulation, implicating lysosomal toxicity as a disease driver beyond Gb3 storage.
"	biological_processes[0]	biological_processes	biological_processes			autophagy	GO:0006914	autophagy		"{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
2394	2579	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	3	Autophagy impairment	"Lysosomal Gb3 accumulation impairs autophagic flux, leading to accumulation of damaged proteins and organelles. Persistent podocyte injury despite enzyme replacement therapy is mediated in part by -synuclein accumulation, implicating lysosomal toxicity as a disease driver beyond Gb3 storage.
"	genes[0]	genes	genes			SNCA	hgnc:11138	SNCA		"{""preferred_term"": ""SNCA"", ""term"": {""id"": ""hgnc:11138"", ""label"": ""SNCA""}}"																											
2395	2580	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	4	Innate immune activation and inflammation	"Substrate accumulation activates NLRP3 inflammasome and NF-B-mediated inflammatory responses, leading to elevation of IL-1, IL-6, IL-18, and TNF-. Complement cascade is activated with elevated C3a and C5a, particularly in patients with anti-drug antibodies. These inflammatory mediators propagate endothelial dysfunction and tissue injury.
"	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
2396	2580	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	4	Innate immune activation and inflammation	"Substrate accumulation activates NLRP3 inflammasome and NF-B-mediated inflammatory responses, leading to elevation of IL-1, IL-6, IL-18, and TNF-. Complement cascade is activated with elevated C3a and C5a, particularly in patients with anti-drug antibodies. These inflammatory mediators propagate endothelial dysfunction and tissue injury.
"	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2397	2581	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	5	Endothelial dysfunction and vascular remodeling	"Gb3/lyso-Gb3 accumulation in endothelial cells leads to upregulation of adhesion molecules (VCAM1, ICAM1), eNOS uncoupling, and reduced nitric oxide availability. Vascular smooth muscle proliferation and remodeling occur, contributing to microvascular dysfunction and increased thrombotic risk.
"	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
2398	2581	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	5	Endothelial dysfunction and vascular remodeling	"Gb3/lyso-Gb3 accumulation in endothelial cells leads to upregulation of adhesion molecules (VCAM1, ICAM1), eNOS uncoupling, and reduced nitric oxide availability. Vascular smooth muscle proliferation and remodeling occur, contributing to microvascular dysfunction and increased thrombotic risk.
"	biological_processes[0]	biological_processes	biological_processes			leukocyte adhesion to endothelial cells	GO:0007107	leukocyte adhesion to endothelial cells		"{""preferred_term"": ""leukocyte adhesion to endothelial cells"", ""term"": {""id"": ""GO:0007107"", ""label"": ""leukocyte adhesion to endothelial cells""}}"																											
2399	2582	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	6	Fibrosis and extracellular matrix remodeling	"TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.
"	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
2400	2582	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	6	Fibrosis and extracellular matrix remodeling	"TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.
"	biological_processes[1]	biological_processes	biological_processes			transforming growth factor beta signaling pathway	GO:0007179	transforming growth factor beta signaling pathway		"{""preferred_term"": ""transforming growth factor beta signaling pathway"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta signaling pathway""}}"																											
2401	2582	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	6	Fibrosis and extracellular matrix remodeling	"TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.
"	genes[0]	genes	genes			TGFB1	hgnc:11766	TGFB1		"{""preferred_term"": ""TGFB1"", ""term"": {""id"": ""hgnc:11766"", ""label"": ""TGFB1""}}"																											
2417	2599	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	0	APC Tumor Suppressor Loss	Germline heterozygous APC mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates APC function, initiating adenoma formation. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
2418	2599	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	0	APC Tumor Suppressor Loss	Germline heterozygous APC mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates APC function, initiating adenoma formation. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
2419	2600	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	1	Wnt/-Catenin Pathway Activation	APC normally functions in the destruction complex (with Axin, GSK3, CK1) to phosphorylate -catenin, targeting it for ubiquitination and proteasomal degradation. Loss of APC allows -catenin to accumulate, translocate to the nucleus, and activate Wnt target genes driving proliferation.	biological_processes[0]	biological_processes	biological_processes			Wnt signaling pathway	GO:0016055	Wnt signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"			INCREASED																								
2420	2601	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	2	Uncontrolled Intestinal Epithelial Proliferation	Nuclear -catenin activates TCF/LEF transcription factors, driving expression of Wnt target genes including MYC, CCND1 (cyclin D1), and others that promote cell cycle progression. This results in uncontrolled proliferation of intestinal crypt cells, forming adenomatous polyps.	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
2421	2601	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	2	Uncontrolled Intestinal Epithelial Proliferation	Nuclear -catenin activates TCF/LEF transcription factors, driving expression of Wnt target genes including MYC, CCND1 (cyclin D1), and others that promote cell cycle progression. This results in uncontrolled proliferation of intestinal crypt cells, forming adenomatous polyps.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2422	2602	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	3	Adenoma Formation	Sustained Wnt pathway activation drives adenoma development. Adenomas are benign neoplasms but represent the first step in the adenoma-carcinoma sequence. In FAP, hundreds to thousands of adenomas develop, dramatically increasing the probability that one will progress to carcinoma.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
2423	2602	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	3	Adenoma Formation	Sustained Wnt pathway activation drives adenoma development. Adenomas are benign neoplasms but represent the first step in the adenoma-carcinoma sequence. In FAP, hundreds to thousands of adenomas develop, dramatically increasing the probability that one will progress to carcinoma.	locations[1]	locations	locations			rectum	UBERON:0001052	rectum		"{""preferred_term"": ""rectum"", ""term"": {""id"": ""UBERON:0001052"", ""label"": ""rectum""}}"																											
2424	2603	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	4	Colorectal Cancer Progression	Adenomas acquire additional mutations in KRAS, TP53, SMAD4, and other genes through the adenoma-carcinoma sequence. In FAP, the large number of adenomas makes it virtually certain that at least one will progress to invasive adenocarcinoma without intervention.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2436	2624	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	0	MEFV Gene Mutation	Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation.	gene	gene	$	MEFV Gene Mutation	Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation.	MEFV				"{""preferred_term"": ""MEFV""}"																											
2437	2625	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	1	RhoA-PKN Regulatory Pathway Dysregulation	Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
2438	2625	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	1	RhoA-PKN Regulatory Pathway Dysregulation	Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold.	cell_types[1]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2439	2625	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	1	RhoA-PKN Regulatory Pathway Dysregulation	Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold.	biological_processes[0]	biological_processes	biological_processes			interleukin-1 beta production	GO:0032611	interleukin-1 beta production		"{""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
2440	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
2441	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2442	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	cell_types[2]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2443	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	biological_processes[0]	biological_processes	biological_processes			pyroptotic inflammatory response	GO:0070269	pyroptotic inflammatory response		"{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}"																											
2444	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	biological_processes[1]	biological_processes	biological_processes			interleukin-1 beta production	GO:0032611	interleukin-1 beta production		"{""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
2445	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	locations[0]	locations	locations			peritoneum	UBERON:0002358	peritoneum		"{""preferred_term"": ""peritoneum"", ""term"": {""id"": ""UBERON:0002358"", ""label"": ""peritoneum""}}"																											
2446	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	locations[1]	locations	locations			pleura	UBERON:0000977	pleura		"{""preferred_term"": ""pleura"", ""term"": {""id"": ""UBERON:0000977"", ""label"": ""pleura""}}"																											
2447	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	locations[2]	locations	locations			synovial membrane of synovial joint	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane of synovial joint"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
2448	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	pathways[0]	pathways	pathways			IL-1	GO:0032611	interleukin-1 beta production		"{""preferred_term"": ""IL-1"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
2449	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.	pathways[1]	pathways	pathways			inflammasome				"{""preferred_term"": ""inflammasome""}"																											
2450	2627	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	3	Gasdermin D-Mediated Pyroptosis	Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation.	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2451	2627	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	3	Gasdermin D-Mediated Pyroptosis	Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2452	2627	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	3	Gasdermin D-Mediated Pyroptosis	Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation.	biological_processes[0]	biological_processes	biological_processes			pyroptotic inflammatory response	GO:0070269	pyroptotic inflammatory response		"{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}"																											
2556	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	Hematopoietic Stem Cell Attrition	Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling.	cell_types[0]	cell_types	cell_types			hematopoietic stem cell	CL:0000037	hematopoietic stem cell		"{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}"																											
2557	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	Hematopoietic Stem Cell Attrition	Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling.	biological_processes[0]	biological_processes	biological_processes			response to aldehyde	GO:0043437	response to aldehyde		"{""preferred_term"": ""response to aldehyde"", ""term"": {""id"": ""GO:0043437"", ""label"": ""response to aldehyde""}}"																											
2558	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	Hematopoietic Stem Cell Attrition	Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling.	biological_processes[1]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress		"{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
2559	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	Hematopoietic Stem Cell Attrition	Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
2560	2707	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	4	Translesion Synthesis Defect	Impaired ability to bypass DNA lesions during replication through translesion synthesis polymerases, requiring functional FANCD2-FANCI complex and PCNA monoubiquitination.	biological_processes[0]	biological_processes	biological_processes			translesion synthesis	GO:0019985	translesion synthesis		"{""preferred_term"": ""translesion synthesis"", ""term"": {""id"": ""GO:0019985"", ""label"": ""translesion synthesis""}}"																											
2561	2708	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	5	Homologous Recombination Impairment	Defective repair of DNA double-strand breaks following interstrand crosslink unhooking, due to mutations in FA genes involved in HR pathway including BRCA2, PALB2, and BRCA1.	biological_processes[0]	biological_processes	biological_processes			homologous recombination	GO:0035825	homologous recombination		"{""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}"																											
2562	2709	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	6	Aldehyde-Induced Genotoxicity	Endogenous aldehydes (acetaldehyde and formaldehyde) from normal metabolism generate DNA interstrand crosslinks and DNA-protein crosslinks; impaired detoxification by ALDH2 and ADH5 exacerbates DNA damage burden.	biological_processes[0]	biological_processes	biological_processes			response to aldehyde	GO:0043437	response to aldehyde		"{""preferred_term"": ""response to aldehyde"", ""term"": {""id"": ""GO:0043437"", ""label"": ""response to aldehyde""}}"																											
2563	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	protein_complexes[0]	protein_complexes	protein_complexes			FA nuclear complex	GO:0043240	Fanconi anaemia nuclear complex		"{""preferred_term"": ""FA nuclear complex"", ""term"": {""id"": ""GO:0043240"", ""label"": ""Fanconi anaemia nuclear complex""}}"																											
2564	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	biological_processes[0]	biological_processes	biological_processes			protein ubiquitination	GO:0016567	protein ubiquitination		"{""preferred_term"": ""protein ubiquitination"", ""term"": {""id"": ""GO:0016567"", ""label"": ""protein ubiquitination""}}"																											
2565	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	genes[0]	genes	genes			FANCA	hgnc:3582	FANCA		"{""preferred_term"": ""FANCA"", ""term"": {""id"": ""hgnc:3582"", ""label"": ""FANCA""}}"																											
2566	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	genes[1]	genes	genes			FANCB	hgnc:3583	FANCB		"{""preferred_term"": ""FANCB"", ""term"": {""id"": ""hgnc:3583"", ""label"": ""FANCB""}}"																											
2567	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	genes[2]	genes	genes			FANCC	hgnc:3584	FANCC		"{""preferred_term"": ""FANCC"", ""term"": {""id"": ""hgnc:3584"", ""label"": ""FANCC""}}"																											
2568	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.	genes[3]	genes	genes			FANCG	hgnc:3588	FANCG		"{""preferred_term"": ""FANCG"", ""term"": {""id"": ""hgnc:3588"", ""label"": ""FANCG""}}"																											
2569	2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	ID Complex Dysfunction	Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub.	genes[0]	genes	genes			FANCD2	hgnc:3585	FANCD2		"{""preferred_term"": ""FANCD2"", ""term"": {""id"": ""hgnc:3585"", ""label"": ""FANCD2""}}"																											
2570	2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	ID Complex Dysfunction	Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub.	genes[1]	genes	genes			FANCI	hgnc:25568	FANCI		"{""preferred_term"": ""FANCI"", ""term"": {""id"": ""hgnc:25568"", ""label"": ""FANCI""}}"																											
2571	2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	ID Complex Dysfunction	Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub.	biological_processes[0]	biological_processes	biological_processes			protein monoubiquitination	GO:0006513	protein monoubiquitination		"{""preferred_term"": ""protein monoubiquitination"", ""term"": {""id"": ""GO:0006513"", ""label"": ""protein monoubiquitination""}}"																											
2572	2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	ID Complex Dysfunction	Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub.	biological_processes[1]	biological_processes	biological_processes			interstrand cross-link repair	GO:0036297	interstrand cross-link repair		"{""preferred_term"": ""interstrand cross-link repair"", ""term"": {""id"": ""GO:0036297"", ""label"": ""interstrand cross-link repair""}}"																											
2573	2712	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	9	Downstream Effector Dysfunction	Mutations in downstream effector genes (BRCA2/FANCD1, PALB2/FANCN, BRCA1/FANCS, RAD51C/FANCO, XRCC2/FANCU) impair homologous recombination and translesion synthesis. These overlap with familial breast/ovarian cancer genes; biallelic mutations produce the most severe FA phenotypes with early-onset solid tumors and more congenital anomalies.	genes[0]	genes	genes			BRCA2	hgnc:1101	BRCA2		"{""preferred_term"": ""BRCA2"", ""term"": {""id"": ""hgnc:1101"", ""label"": ""BRCA2""}}"																											
2574	2712	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	9	Downstream Effector Dysfunction	Mutations in downstream effector genes (BRCA2/FANCD1, PALB2/FANCN, BRCA1/FANCS, RAD51C/FANCO, XRCC2/FANCU) impair homologous recombination and translesion synthesis. These overlap with familial breast/ovarian cancer genes; biallelic mutations produce the most severe FA phenotypes with early-onset solid tumors and more congenital anomalies.	genes[1]	genes	genes			BRCA1	hgnc:1100	BRCA1		"{""preferred_term"": ""BRCA1"", ""term"": {""id"": ""hgnc:1100"", ""label"": ""BRCA1""}}"																											
2575	2713	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	10	Inflammatory Bone Marrow Microenvironment	Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition.	cell_types[0]	cell_types	cell_types			hematopoietic stem cell	CL:0000037	hematopoietic stem cell		"{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}"																											
2576	2713	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	10	Inflammatory Bone Marrow Microenvironment	Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2577	2713	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	10	Inflammatory Bone Marrow Microenvironment	Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
2578	2714	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	11	Developmental Progenitor Apoptosis	Unrepaired DNA damage in rapidly dividing embryonic progenitor cells activates p53-dependent apoptosis during critical developmental windows. This mechanism underlies the congenital malformations of FA, explaining the midline predominance of anomalies and correlation between pathway position and congenital abnormality burden.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
2579	2714	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	11	Developmental Progenitor Apoptosis	Unrepaired DNA damage in rapidly dividing embryonic progenitor cells activates p53-dependent apoptosis during critical developmental windows. This mechanism underlies the congenital malformations of FA, explaining the midline predominance of anomalies and correlation between pathway position and congenital abnormality burden.	biological_processes[1]	biological_processes	biological_processes			embryo development	GO:0009790	embryo development		"{""preferred_term"": ""embryo development"", ""term"": {""id"": ""GO:0009790"", ""label"": ""embryo development""}}"																											
2580	2715	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	12	Clonal Evolution	Progressive accumulation of somatic mutations and chromosomal aberrations in genomically unstable hematopoietic cells drives clonal selection and malignant transformation. Characteristic cytogenetic changes include gain of 1q and 3q and loss of 7q. Clones with selective growth advantage expand, leading to MDS and AML.	cell_types[0]	cell_types	cell_types			hematopoietic stem cell	CL:0000037	hematopoietic stem cell		"{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}"																											
2581	2715	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	12	Clonal Evolution	Progressive accumulation of somatic mutations and chromosomal aberrations in genomically unstable hematopoietic cells drives clonal selection and malignant transformation. Characteristic cytogenetic changes include gain of 1q and 3q and loss of 7q. Clones with selective growth advantage expand, leading to MDS and AML.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
2582	2716	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	13	Epithelial Cancer Susceptibility	Impaired genome maintenance in epithelial tissues renders them vulnerable to accumulation of oncogenic mutations. Squamous epithelia of the head/neck, oral cavity, esophagus, and anogenital regions are particularly susceptible due to high proliferative turnover and exposure to environmental mutagens including HPV.	cell_types[0]	cell_types	cell_types			epithelial cell	CL:0000066	epithelial cell		"{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
2583	2718	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	15	Endocrine Gland Dysfunction	Widespread endocrine abnormalities affect approximately 73-80% of FA patients. Developmental pituitary/hypothalamic defects (68% have small pituitary on MRI), direct effects of genomic instability on endocrine cell function, and chronic illness contribute. Manifests as GH deficiency, hypothyroidism, glucose dysregulation, hypogonadism, dyslipidemia, and metabolic syndrome.	locations[0]	locations	locations			pituitary gland	UBERON:0000007	pituitary gland		"{""preferred_term"": ""pituitary gland"", ""term"": {""id"": ""UBERON:0000007"", ""label"": ""pituitary gland""}}"																											
2584	2720	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	17	CNS Developmental Anomalies	Midline brain structural defects from neural progenitor loss during early CNS development. Includes small pituitary (68%), posterior fossa abnormalities (30% including Chiari I malformation and Dandy-Walker variant), and corpus callosum structural variation (30%).	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
2585	2720	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	17	CNS Developmental Anomalies	Midline brain structural defects from neural progenitor loss during early CNS development. Includes small pituitary (68%), posterior fossa abnormalities (30% including Chiari I malformation and Dandy-Walker variant), and corpus callosum structural variation (30%).	locations[1]	locations	locations			pituitary gland	UBERON:0000007	pituitary gland		"{""preferred_term"": ""pituitary gland"", ""term"": {""id"": ""UBERON:0000007"", ""label"": ""pituitary gland""}}"																											
2707	2824	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	0	Constitutive BMP Signaling Activation	The ACVR1 R206H mutation creates a pH-sensitive switch in the receptor's activation domain, leading to ligand-independent activation of BMP signaling and inappropriate osteogenic differentiation of connective tissue progenitors.	biological_processes[0]	biological_processes	biological_processes			BMP signaling pathway	GO:0030509	BMP signaling pathway		"{""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}"																											
2708	2824	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	0	Constitutive BMP Signaling Activation	The ACVR1 R206H mutation creates a pH-sensitive switch in the receptor's activation domain, leading to ligand-independent activation of BMP signaling and inappropriate osteogenic differentiation of connective tissue progenitors.	biological_processes[1]	biological_processes	biological_processes			ossification	GO:0001503	ossification		"{""preferred_term"": ""ossification"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}"																											
2709	2825	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	1	Impaired FKBP1A Regulatory Binding	The R206H mutation reduces binding affinity for FKBP1A/FKBP12, a safeguard protein that normally prevents inappropriate BMP signaling, resulting in leaky activation of the pathway.	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
2710	2826	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	2	Activin A Neomorphic Signaling	The R206H mutation renders ACVR1 responsive to Activin A ligands, which normally antagonize BMP signaling. This neomorphic gain-of-function allows Activin A to aberrantly activate osteogenic signaling, driving heterotopic ossification. Anti-Activin A antibodies can block HO. Activin A is an obligate factor for the initiation of HO in FOP.	biological_processes[0]	biological_processes	biological_processes			BMP signaling pathway	GO:0030509	BMP signaling pathway		"{""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}"																											
2711	2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	Heterotopic Ossification	Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase.	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
2712	2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	Heterotopic Ossification	Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase.	cell_types[1]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
2713	2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	Heterotopic Ossification	Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase.	biological_processes[0]	biological_processes	biological_processes			Endochondral ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
2714	2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	Heterotopic Ossification	Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase.	biological_processes[1]	biological_processes	biological_processes			Cartilage development	GO:0051216	cartilage development		"{""preferred_term"": ""Cartilage development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}"																											
2715	2828	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	4	Inflammatory Triggering of Flare-ups	Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2716	2828	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	4	Inflammatory Triggering of Flare-ups	Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%.	cell_types[1]	cell_types	cell_types			Mast cell	CL:0000097	mast cell		"{""preferred_term"": ""Mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}"																											
2717	2828	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	4	Inflammatory Triggering of Flare-ups	Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2728	2856	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	0	Central Sensitization	"Augmented pain processing in the central nervous system leads to amplified pain perception. Increased excitatory neurotransmitters (glutamate, substance P) and decreased inhibitory modulation.
"	biological_processes[0]	biological_processes	biological_processes			Pain Processing	GO:0048265	response to pain		"{""preferred_term"": ""Pain Processing"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}"																											
2729	2857	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	1	Descending Pain Modulation Dysfunction	"Impaired descending inhibitory pathways that normally dampen pain signals. Reduced serotonin and norepinephrine in descending pathways contributes to pain amplification.
"	biological_processes[0]	biological_processes	biological_processes			Neurotransmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Neurotransmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
2730	2858	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	2	Neuroinflammation	"Glial cell activation and elevated inflammatory mediators in the CNS may contribute to central sensitization and symptom persistence.
"	cell_types[0]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
2731	2859	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	3	HPA Axis Dysregulation	"Blunted cortisol response to stress and altered diurnal cortisol rhythm may contribute to fatigue and pain sensitivity.
"	biological_processes[0]	biological_processes	biological_processes			Stress Response	GO:0006950	response to stress		"{""preferred_term"": ""Stress Response"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}"																											
2732	2860	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	4	Small Fiber Pathology	"Structural and functional abnormalities of thinly myelinated A and unmyelinated C-fibers affecting approximately 50% of patients. Reduced intraepidermal nerve fiber density (IENFD) with proximal predominant pattern contributes ongoing peripheral nociceptive input.
"	cell_types[0]	cell_types	cell_types			Peripheral Sensory Neurons	CL:0000101	sensory neuron		"{""preferred_term"": ""Peripheral Sensory Neurons"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}"																											
2733	2861	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	5	Genetic Susceptibility	"Multiple genetic variants affect neurotransmitter systems, pain processing, and sensory signaling. CNS-enriched heritability with neural gene prioritization establishes genetic predisposition to altered pain perception and modulation.
"	biological_processes[0]	biological_processes	biological_processes			Pain Perception	GO:0019233	sensory perception of pain		"{""preferred_term"": ""Pain Perception"", ""term"": {""id"": ""GO:0019233"", ""label"": ""sensory perception of pain""}}"																											
2761	2894	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	0	FMRP Deficiency	"Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2762	2894	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	0	FMRP Deficiency	"Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Plasticity	GO:0048167	regulation of synaptic plasticity		"{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"																											
2763	2895	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	1	Abnormal Synaptic Development	"FMRP normally suppresses translation of many synaptic proteins. Its absence leads to excessive protein synthesis at synapses, abnormal dendritic spine morphology (long, thin spines), and impaired synaptic maturation and pruning.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2764	2895	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	1	Abnormal Synaptic Development	"FMRP normally suppresses translation of many synaptic proteins. Its absence leads to excessive protein synthesis at synapses, abnormal dendritic spine morphology (long, thin spines), and impaired synaptic maturation and pruning.
"	biological_processes[0]	biological_processes	biological_processes			Synapse Organization	GO:0050808	synapse organization		"{""preferred_term"": ""Synapse Organization"", ""term"": {""id"": ""GO:0050808"", ""label"": ""synapse organization""}}"																											
2775	2912	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	0	TDP-43 Proteinopathy	"TAR DNA-binding protein of 43 kDa (TDP-43) is the main ubiquitinated protein in tau-negative frontotemporal lobar degeneration (FTLD-TDP), accounting for over 50% of FTD cases. TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major pathogenic steps. The abnormal accumulation leads to neuronal dysfunction and death.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2776	2913	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	1	Tau Proteinopathy	"FTLD-tau is characterized by accumulation of hyperphosphorylated tau protein, accounting for approximately 45% of FTD cases. This includes Pick's disease with characteristic Pick bodies. The tau pathology disrupts microtubule function and causes neuronal degeneration primarily in frontal and temporal regions.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2777	2914	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	2	Frontal and Temporal Lobe Atrophy	"Progressive neuronal loss and atrophy predominantly affecting the frontal and temporal lobes, with patterns varying by genetic subtype. MAPT mutations show temporal predominance, while GRN and C9orf72 mutations may show more variable patterns. This structural degeneration underlies the behavioral and language deficits.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2778	2915	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	3	Neuronal Death	"Progressive loss of neurons in frontal and temporal cortices due to protein aggregation toxicity, leading to brain atrophy and functional decline. The neurodegeneration progresses over years to decades, with biomarker changes detectable up to 30 years before symptom onset in genetic cases.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
2787	2954	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	0	CagA-Mediated Oncogenic Signaling	The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk.	cell_types[0]	cell_types	cell_types			epithelial cell of stomach	CL:0002178	epithelial cell of stomach		"{""preferred_term"": ""epithelial cell of stomach"", ""term"": {""id"": ""CL:0002178"", ""label"": ""epithelial cell of stomach""}}"																											
2788	2954	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	0	CagA-Mediated Oncogenic Signaling	The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2789	2954	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	0	CagA-Mediated Oncogenic Signaling	The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
2790	2954	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	0	CagA-Mediated Oncogenic Signaling	The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk.	locations[0]	locations	locations			stomach	UBERON:0000945	stomach		"{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}"																											
2791	2955	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	1	VacA-Induced Cellular Damage	VacA (vacuolating cytotoxin A) is a pore-forming toxin that induces vacuolation, mitochondrial dysfunction, and apoptosis in epithelial cells. It also suppresses T cell function, allowing bacterial persistence. Different VacA alleles (s1/s2, m1/m2) confer different cancer risk.	biological_processes[0]	biological_processes	biological_processes			cellular response to cytotoxic stimulus	GO:0034620	cellular response to oxidative stress		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cellular response to cytotoxic stimulus"", ""term"": {""id"": ""GO:0034620"", ""label"": ""cellular response to oxidative stress""}}"			INCREASED																								
2792	2956	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	2	Chronic Inflammation (Correa Cascade)	H. pylori induces chronic gastritis with infiltration of neutrophils, lymphocytes, and macrophages. Persistent inflammation generates reactive oxygen and nitrogen species that cause DNA damage. Over decades, this leads to atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately adenocarcinoma.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"			INCREASED																								
2793	2956	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	2	Chronic Inflammation (Correa Cascade)	H. pylori induces chronic gastritis with infiltration of neutrophils, lymphocytes, and macrophages. Persistent inflammation generates reactive oxygen and nitrogen species that cause DNA damage. Over decades, this leads to atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately adenocarcinoma.	biological_processes[1]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""modifier"": ""INCREASED"", ""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"			INCREASED																								
2794	2957	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	3	CDH1/E-cadherin Inactivation	Loss of E-cadherin function through somatic mutation, promoter methylation, or loss of heterozygosity occurs in diffuse-type gastric cancer and some intestinal-type tumors. E-cadherin loss disrupts cell-cell adhesion and activates Wnt/beta-catenin signaling, promoting invasion.	genes[0]	genes	genes			CDH1				"{""preferred_term"": ""CDH1""}"																											
2795	2957	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	3	CDH1/E-cadherin Inactivation	Loss of E-cadherin function through somatic mutation, promoter methylation, or loss of heterozygosity occurs in diffuse-type gastric cancer and some intestinal-type tumors. E-cadherin loss disrupts cell-cell adhesion and activates Wnt/beta-catenin signaling, promoting invasion.	biological_processes[0]	biological_processes	biological_processes			cell-cell adhesion	GO:0098609	cell-cell adhesion		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell-cell adhesion"", ""term"": {""id"": ""GO:0098609"", ""label"": ""cell-cell adhesion""}}"			DECREASED																								
2809	2981	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	0	Lower Esophageal Sphincter Dysfunction	"Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.
"	biological_processes[0]	biological_processes	biological_processes			Smooth Muscle Contraction	GO:0006939	smooth muscle contraction		"{""preferred_term"": ""Smooth Muscle Contraction"", ""term"": {""id"": ""GO:0006939"", ""label"": ""smooth muscle contraction""}}"																											
2810	2982	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	1	Esophageal Mucosal Injury	"Gastric acid and pepsin damage esophageal epithelium, causing inflammation and erosions. Bile reflux in some patients adds to mucosal damage.
"	cell_types[0]	cell_types	cell_types			Esophageal Epithelial Cell	CL:0002252	epithelial cell of esophagus		"{""preferred_term"": ""Esophageal Epithelial Cell"", ""term"": {""id"": ""CL:0002252"", ""label"": ""epithelial cell of esophagus""}}"																											
2811	2983	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	2	Impaired Esophageal Clearance	"Reduced salivary neutralization, impaired peristalsis, and delayed acid clearance prolong mucosal exposure to refluxate.
"	biological_processes[0]	biological_processes	biological_processes			Digestion	GO:0007586	digestion		"{""preferred_term"": ""Digestion"", ""term"": {""id"": ""GO:0007586"", ""label"": ""digestion""}}"																											
2819	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.	cell_types[0]	cell_types	cell_types			interstitial cell of Cajal	CL:0002088	interstitial cell of Cajal		"{""preferred_term"": ""interstitial cell of Cajal"", ""term"": {""id"": ""CL:0002088"", ""label"": ""interstitial cell of Cajal""}}"																											
2820	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			receptor signaling protein tyrosine kinase activity	GO:0004716	receptor signaling protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}"			INCREASED																								
2821	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.	biological_processes[1]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
2822	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.	gene_products[0]	gene_products	gene_products			KIT receptor	NCIT:C17328	Mast/Stem Cell Growth Factor Receptor Kit		"{""preferred_term"": ""KIT receptor"", ""term"": {""id"": ""NCIT:C17328"", ""label"": ""Mast/Stem Cell Growth Factor Receptor Kit""}}"																											
2823	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.	locations[0]	locations	locations			gastrointestinal tract	UBERON:0005409	alimentary part of gastrointestinal system		"{""preferred_term"": ""gastrointestinal tract"", ""term"": {""id"": ""UBERON:0005409"", ""label"": ""alimentary part of gastrointestinal system""}}"																											
2824	3007	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	1	PDGFRA Receptor Activation	PDGFRA mutations, particularly D842V in the activation loop, result in constitutive kinase activity. These mutations activate similar downstream pathways as KIT but show different drug sensitivity profiles.	biological_processes[0]	biological_processes	biological_processes			platelet-derived growth factor receptor signaling pathway	GO:0048008	platelet-derived growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""platelet-derived growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0048008"", ""label"": ""platelet-derived growth factor receptor signaling pathway""}}"			INCREASED																								
2825	3008	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	2	RAS-MAPK Pathway Activation	Constitutive KIT or PDGFRA activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting cell proliferation. This pathway represents a potential therapeutic target when primary resistance to KIT/PDGFRA inhibitors occurs.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2826	3009	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	3	PI3K-AKT Pathway Activation	Constitutive KIT or PDGFRA activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting cell survival and resistance to apoptosis. This pathway cooperates with MAPK signaling to drive tumorigenesis.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
2838	3026	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	0	Glucocerebrosidase Deficiency	"Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.
"	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2839	3026	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	0	Glucocerebrosidase Deficiency	"Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.
"	biological_processes[0]	biological_processes	biological_processes			Sphingolipid Catabolism	GO:0030148	sphingolipid biosynthetic process		"{""preferred_term"": ""Sphingolipid Catabolism"", ""term"": {""id"": ""GO:0030148"", ""label"": ""sphingolipid biosynthetic process""}}"																											
2840	3027	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	1	Gaucher Cell Formation	"Lipid-laden macrophages (Gaucher cells) accumulate in spleen, liver, bone marrow, and other organs. These cells have characteristic crinkled tissue paper appearance and cause organ dysfunction through infiltration and inflammatory cytokine release.
"	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2841	3027	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	1	Gaucher Cell Formation	"Lipid-laden macrophages (Gaucher cells) accumulate in spleen, liver, bone marrow, and other organs. These cells have characteristic crinkled tissue paper appearance and cause organ dysfunction through infiltration and inflammatory cytokine release.
"	biological_processes[0]	biological_processes	biological_processes			Macrophage Activation	GO:0042116	macrophage activation		"{""preferred_term"": ""Macrophage Activation"", ""term"": {""id"": ""GO:0042116"", ""label"": ""macrophage activation""}}"																											
2849	3049	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	0	Amygdala Hyperactivity	"Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.
"	cell_types[0]	cell_types	cell_types			Amygdala Pyramidal Neuron	CL:4023110	amygdala pyramidal neuron		"{""preferred_term"": ""Amygdala Pyramidal Neuron"", ""term"": {""id"": ""CL:4023110"", ""label"": ""amygdala pyramidal neuron""}}"																											
2850	3049	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	0	Amygdala Hyperactivity	"Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.
"	biological_processes[0]	biological_processes	biological_processes			Fear Response	GO:0042596	fear response		"{""preferred_term"": ""Fear Response"", ""term"": {""id"": ""GO:0042596"", ""label"": ""fear response""}}"																											
2851	3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	GABA System Dysfunction	"Reduced GABAergic inhibition contributes to neuronal hyperexcitability and anxiety. Benzodiazepines enhance GABA function.
"	cell_types[0]	cell_types	cell_types			GABAergic Interneuron	CL:0011005	GABAergic interneuron		"{""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0011005"", ""label"": ""GABAergic interneuron""}}"																											
2852	3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	GABA System Dysfunction	"Reduced GABAergic inhibition contributes to neuronal hyperexcitability and anxiety. Benzodiazepines enhance GABA function.
"	biological_processes[0]	biological_processes	biological_processes			GABAergic Transmission	GO:0051932	synaptic transmission, GABAergic		"{""preferred_term"": ""GABAergic Transmission"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}"																											
2853	3051	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	2	Serotonin Dysregulation	"Altered serotonin signaling, particularly in raphe-prefrontal circuits, contributes to anxiety. SSRIs are first-line treatment.
"	cell_types[0]	cell_types	cell_types			Serotonergic Neuron	CL:0000850	serotonergic neuron		"{""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}"																											
2854	3051	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	2	Serotonin Dysregulation	"Altered serotonin signaling, particularly in raphe-prefrontal circuits, contributes to anxiety. SSRIs are first-line treatment.
"	biological_processes[0]	biological_processes	biological_processes			Serotonin Signaling	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Serotonin Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
2855	3052	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	3	HPA Axis Dysregulation	"Chronic activation of the stress response system with elevated cortisol contributes to sustained anxiety and physical symptoms.
"	biological_processes[0]	biological_processes	biological_processes			Stress Response	GO:0006950	response to stress		"{""preferred_term"": ""Stress Response"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}"																											
2856	3053	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	4	Noradrenergic Hyperactivity	"Elevated norepinephrine activity in locus coeruleus contributes to hyperarousal and somatic symptoms of anxiety.
"	cell_types[0]	cell_types	cell_types			Noradrenergic Neuron	CL:0008025	noradrenergic neuron		"{""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}"																											
2857	3055	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	6	Epigenetic Alterations	"DNA methylation changes in anxiety-related genes, particularly in monocytes and granulocytes. Methylation sites identified in genes involved in neurogenesis and fear memory.
"	cell_types[0]	cell_types	cell_types			Monocyte	CL:0000576	monocyte		"{""preferred_term"": ""Monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
2858	3055	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	6	Epigenetic Alterations	"DNA methylation changes in anxiety-related genes, particularly in monocytes and granulocytes. Methylation sites identified in genes involved in neurogenesis and fear memory.
"	cell_types[1]	cell_types	cell_types			Granulocyte	CL:0000094	granulocyte		"{""preferred_term"": ""Granulocyte"", ""term"": {""id"": ""CL:0000094"", ""label"": ""granulocyte""}}"																											
2866	3075	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	0	Dendritic Cell Activation in Vessel Wall	Adventitial dendritic cells become activated and produce chemokines that recruit T cells and macrophages. Vascular dendritic cells may sense pathogen-associated or damage-associated molecular patterns.	cell_types[0]	cell_types	cell_types			Dendritic Cell	CL:0000451	dendritic cell		"{""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
2867	3075	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	0	Dendritic Cell Activation in Vessel Wall	Adventitial dendritic cells become activated and produce chemokines that recruit T cells and macrophages. Vascular dendritic cells may sense pathogen-associated or damage-associated molecular patterns.	biological_processes[0]	biological_processes	biological_processes			Immune Response	GO:0006955	immune response		"{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
2868	3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	Th1 and Th17 T Cell Infiltration	CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
2869	3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	Th1 and Th17 T Cell Infiltration	CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2870	3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	Th1 and Th17 T Cell Infiltration	CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2871	3077	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	2	Giant Cell Formation and Intimal Hyperplasia	Multinucleated giant cells form at the media-intima junction. Smooth muscle cells proliferate causing intimal hyperplasia, leading to vessel stenosis and ischemic complications.	cell_types[0]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
2872	3077	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	2	Giant Cell Formation and Intimal Hyperplasia	Multinucleated giant cells form at the media-intima junction. Smooth muscle cells proliferate causing intimal hyperplasia, leading to vessel stenosis and ischemic complications.	biological_processes[0]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}"																											
2877	3101	130	Glaucoma	Glaucoma.yaml	pathophysiology	0	Elevated Intraocular Pressure	"Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.
"	biological_processes[0]	biological_processes	biological_processes			Fluid Homeostasis	GO:0030104	water homeostasis		"{""preferred_term"": ""Fluid Homeostasis"", ""term"": {""id"": ""GO:0030104"", ""label"": ""water homeostasis""}}"																											
2878	3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	Retinal Ganglion Cell Death	"Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.
"	cell_types[0]	cell_types	cell_types			Retinal Ganglion Cell	CL:0000740	retinal ganglion cell		"{""preferred_term"": ""Retinal Ganglion Cell"", ""term"": {""id"": ""CL:0000740"", ""label"": ""retinal ganglion cell""}}"																											
2879	3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	Retinal Ganglion Cell Death	"Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.
"	biological_processes[0]	biological_processes	biological_processes			Apoptosis	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
2880	3104	130	Glaucoma	Glaucoma.yaml	pathophysiology	3	Trabecular Meshwork Dysfunction	"Age-related changes, oxidative stress, and altered extracellular matrix reduce outflow facility. Increased resistance to aqueous outflow.
"	cell_types[0]	cell_types	cell_types			Trabecular Meshwork Cell	CL:0002367	trabecular meshwork cell		"{""preferred_term"": ""Trabecular Meshwork Cell"", ""term"": {""id"": ""CL:0002367"", ""label"": ""trabecular meshwork cell""}}"																											
2887	3130	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	0	TERT Promoter Activation	TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
2888	3130	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	0	TERT Promoter Activation	TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature.	biological_processes[0]	biological_processes	biological_processes			telomere maintenance via telomerase	GO:0007004	telomere maintenance via telomerase		"{""modifier"": ""INCREASED"", ""preferred_term"": ""telomere maintenance via telomerase"", ""term"": {""id"": ""GO:0007004"", ""label"": ""telomere maintenance via telomerase""}}"			INCREASED																								
2889	3130	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	0	TERT Promoter Activation	TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
2890	3131	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	1	Chromosome 7 Gain and Chromosome 10 Loss	Combined gain of chromosome 7 (+7) and loss of chromosome 10 (-10) is a defining molecular feature of IDH-wildtype glioblastoma, present in over 90% of cases. Chromosome 7 gain amplifies EGFR and MET. Chromosome 10 loss deletes PTEN and other tumor suppressors.	biological_processes[0]	biological_processes	biological_processes			chromosome organization	GO:0051276	chromosome organization		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}"			ABNORMAL																								
2891	3132	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	2	EGFR/MET Pathway Activation	EGFR is amplified in 40-50% and MET in 5% of glioblastomas. EGFR amplification is often accompanied by EGFRvIII, a constitutively active deletion variant lacking exons 2-7. These alterations drive proliferation through RAS/RAF/MAPK and PI3K/AKT pathways.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
2892	3132	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	2	EGFR/MET Pathway Activation	EGFR is amplified in 40-50% and MET in 5% of glioblastomas. EGFR amplification is often accompanied by EGFRvIII, a constitutively active deletion variant lacking exons 2-7. These alterations drive proliferation through RAS/RAF/MAPK and PI3K/AKT pathways.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
2893	3133	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	3	PTEN Tumor Suppressor Loss	PTEN loss through chromosome 10 deletion, mutation, or epigenetic silencing occurs in 40-50% of glioblastomas. Loss of PTEN phosphatase activity leads to constitutive PI3K/AKT/mTOR pathway activation, promoting survival and growth.	biological_processes[0]	biological_processes	biological_processes			negative regulation of phosphatidylinositol 3-kinase signaling	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014067"", ""label"": ""negative regulation of phosphatidylinositol 3-kinase signaling""}}"			DECREASED																								
2894	3134	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	4	PI3K/AKT/mTOR Pathway Hyperactivation	Constitutive PI3K/AKT/mTOR activation through EGFR amplification, PIK3CA mutation, or PTEN loss promotes cell survival, proliferation, metabolism, and angiogenesis. This pathway is active in nearly all glioblastomas.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2895	3134	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	4	PI3K/AKT/mTOR Pathway Hyperactivation	Constitutive PI3K/AKT/mTOR activation through EGFR amplification, PIK3CA mutation, or PTEN loss promotes cell survival, proliferation, metabolism, and angiogenesis. This pathway is active in nearly all glioblastomas.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
2896	3135	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	5	Unlimited Replicative Potential	Telomerase reactivation through TERT promoter mutations enables glioblastoma cells to bypass replicative senescence and achieve unlimited proliferative capacity, a hallmark of cancer.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2897	3136	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Multiple converging pathways (RTK signaling, PI3K/AKT/mTOR, cell cycle dysregulation) drive rapid proliferation characteristic of glioblastoma. High mitotic index and proliferation markers (Ki-67 often >20%) are typical.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
2898	3136	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Multiple converging pathways (RTK signaling, PI3K/AKT/mTOR, cell cycle dysregulation) drive rapid proliferation characteristic of glioblastoma. High mitotic index and proliferation markers (Ki-67 often >20%) are typical.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
2912	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	Decreased G6PD Enzyme Activity	Mutations in the G6PD gene lead to reduced or absent enzyme activity.	locations[0]	locations	locations			erythrocyte	UBERON:0000178	blood		"{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}"																											
2913	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	Decreased G6PD Enzyme Activity	Mutations in the G6PD gene lead to reduced or absent enzyme activity.	biological_processes[0]	biological_processes	biological_processes			pentose-phosphate shunt	GO:0006098	pentose-phosphate shunt		"{""preferred_term"": ""pentose-phosphate shunt"", ""term"": {""id"": ""GO:0006098"", ""label"": ""pentose-phosphate shunt""}}"																											
2914	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	Decreased G6PD Enzyme Activity	Mutations in the G6PD gene lead to reduced or absent enzyme activity.	cell_types[0]	cell_types	cell_types			erythrocyte	CL:0000232	erythrocyte		"{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
2915	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.	biological_processes[0]	biological_processes	biological_processes			NADPH regeneration	GO:0006739	NADPH regeneration		"{""preferred_term"": ""NADPH regeneration"", ""term"": {""id"": ""GO:0006739"", ""label"": ""NADPH regeneration""}}"																											
2916	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.	biological_processes[1]	biological_processes	biological_processes			glutathione metabolic process	GO:0006749	glutathione metabolic process		"{""preferred_term"": ""glutathione metabolic process"", ""term"": {""id"": ""GO:0006749"", ""label"": ""glutathione metabolic process""}}"																											
2917	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.	cell_types[0]	cell_types	cell_types			erythrocyte	CL:0000232	erythrocyte		"{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
2918	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.	chemical_entities[0]	chemical_entities	chemical_entities			NADPH	CHEBI:16474	NADPH		"{""preferred_term"": ""NADPH"", ""term"": {""id"": ""CHEBI:16474"", ""label"": ""NADPH""}}"																											
2919	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.	chemical_entities[1]	chemical_entities	chemical_entities			glutathione	CHEBI:16856	glutathione		"{""preferred_term"": ""glutathione"", ""term"": {""id"": ""CHEBI:16856"", ""label"": ""glutathione""}}"																											
2920	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
2921	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	cell_types[0]	cell_types	cell_types			erythrocyte	CL:0000232	erythrocyte		"{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
2922	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	locations[0]	locations	locations			blood	UBERON:0000178	blood		"{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}"																											
2923	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	locations[1]	locations	locations			spleen	UBERON:0002106	spleen		"{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}"																											
2924	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	chemical_entities[0]	chemical_entities	chemical_entities			hydrogen peroxide	CHEBI:16240	hydrogen peroxide		"{""preferred_term"": ""hydrogen peroxide"", ""term"": {""id"": ""CHEBI:16240"", ""label"": ""hydrogen peroxide""}}"																											
2925	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	Acute Hemolytic Anemia	Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis.	biological_processes[0]	biological_processes	biological_processes			hemolysis in other organism	GO:0002937	hemolysis in other organism		"{""preferred_term"": ""hemolysis in other organism"", ""term"": {""id"": ""GO:0002937"", ""label"": ""hemolysis in other organism""}}"																											
2926	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	Acute Hemolytic Anemia	Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis.	cell_types[0]	cell_types	cell_types			erythrocyte	CL:0000232	erythrocyte		"{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
2927	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	Acute Hemolytic Anemia	Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis.	locations[0]	locations	locations			blood	UBERON:0000178	blood		"{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}"																											
2928	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	Acute Hemolytic Anemia	Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis.	locations[1]	locations	locations			spleen	UBERON:0002106	spleen		"{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}"																											
2938	3181	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	0	PTCH1 Germline Mutations	PTCH1 encodes Patched 1, a 12-pass transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Germline heterozygous loss-of-function mutations in PTCH1 predispose to tumors following Knudson's two-hit model. Loss of the remaining wild-type allele in somatic cells leads to constitutive Hedgehog pathway activation and tumor development.	cell_types[0]	cell_types	cell_types			basal cell of epidermis	CL:0002187	basal cell of epidermis		"{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}"																											
2939	3181	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	0	PTCH1 Germline Mutations	PTCH1 encodes Patched 1, a 12-pass transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Germline heterozygous loss-of-function mutations in PTCH1 predispose to tumors following Knudson's two-hit model. Loss of the remaining wild-type allele in somatic cells leads to constitutive Hedgehog pathway activation and tumor development.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
2940	3182	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	1	SUFU Germline Mutations	A minority of Gorlin syndrome cases (approximately 5%) are caused by germline mutations in SUFU (Suppressor of Fused), which encodes a negative regulator of GLI transcription factors. SUFU mutations are associated with markedly higher risk of medulloblastoma (up to 20-fold higher) compared to PTCH1 mutations, with tumors typically occurring before age 3 years.	biological_processes[0]	biological_processes	biological_processes			negative regulation of smoothened signaling pathway	GO:0045879	negative regulation of smoothened signaling pathway		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of smoothened signaling pathway"", ""term"": {""id"": ""GO:0045879"", ""label"": ""negative regulation of smoothened signaling pathway""}}"			DECREASED																								
2941	3183	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	2	Constitutive Hedgehog Pathway Activation	Loss of PTCH1 function or SUFU mutations result in constitutive activation of the Hedgehog signaling cascade. Without functional PTCH1, Smoothened is no longer suppressed and activates GLI transcription factors, driving expression of target genes involved in proliferation, survival, and developmental patterning.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
2961	3214	134	Gout	Gout.yaml	pathophysiology	0	Hyperuricemia	"Elevated serum uric acid from increased purine metabolism or decreased renal excretion leads to supersaturation and crystal formation. Urate is the end product of purine catabolism in humans.
"	biological_processes[0]	biological_processes	biological_processes			Purine Metabolism	GO:0006144	purine nucleobase metabolic process		"{""preferred_term"": ""Purine Metabolism"", ""term"": {""id"": ""GO:0006144"", ""label"": ""purine nucleobase metabolic process""}}"																											
2962	3216	134	Gout	Gout.yaml	pathophysiology	2	Inflammasome Activation	"MSU crystals are phagocytosed by macrophages, activating NLRP3 inflammasome and triggering IL-1beta release, driving acute inflammatory flare.
"	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2963	3216	134	Gout	Gout.yaml	pathophysiology	2	Inflammasome Activation	"MSU crystals are phagocytosed by macrophages, activating NLRP3 inflammasome and triggering IL-1beta release, driving acute inflammatory flare.
"	biological_processes[0]	biological_processes	biological_processes			Inflammasome Activation	GO:0072559	NLRP3 inflammasome complex assembly		"{""preferred_term"": ""Inflammasome Activation"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}"																											
2964	3217	134	Gout	Gout.yaml	pathophysiology	3	Neutrophil Recruitment	"IL-1beta and other cytokines recruit neutrophils to the joint, amplifying inflammation and causing the intense pain and swelling of acute gout attacks.
"	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2965	3219	134	Gout	Gout.yaml	pathophysiology	5	Neutrophil Extracellular Trap Formation	"Neutrophils form extracellular traps (NETs) in response to MSU crystals. NETs initially amplify inflammation but aggregated NETs (aggNETs) promote resolution by encapsulating crystals, degrading cytokines, and blocking further neutrophil recruitment. NETs also contribute to tophi formation.
"	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2970	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption	Biallelic loss-of-function mutations in YY1AP1 disrupt the INO80 ATP-dependent chromatin-remodeling complex, impairing transcriptional programs essential for vascular smooth muscle cell (VSMC) differentiation and homeostasis.	biological_processes[0]	biological_processes	biological_processes			chromatin remodeling	GO:0006338	chromatin remodeling		"{""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}"																											
2971	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption	Biallelic loss-of-function mutations in YY1AP1 disrupt the INO80 ATP-dependent chromatin-remodeling complex, impairing transcriptional programs essential for vascular smooth muscle cell (VSMC) differentiation and homeostasis.	biological_processes[1]	biological_processes	biological_processes			transcriptional regulation	GO:0006355	regulation of transcription, DNA-templated		"{""preferred_term"": ""transcriptional regulation"", ""term"": {""id"": ""GO:0006355"", ""label"": ""regulation of transcription, DNA-templated""}}"																											
2972	3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis	Loss of YY1AP1 in vascular smooth muscle cells leads to increased p21/CDKN1A levels, G1/G2 cell-cycle arrest, reduced VSMC proliferation, and impaired TGF--driven upregulation of contractile markers (SM -actin, SM22, calponin), resulting in focal stenoses and occlusions in multiple arterial beds. Progressive vascular disease can lead to ischemic and hemorrhagic stroke, myocardial infarction, and other thrombovascular complications.	biological_processes[0]	biological_processes	biological_processes			smooth muscle cell differentiation	GO:0051145	smooth muscle cell differentiation		"{""preferred_term"": ""smooth muscle cell differentiation"", ""term"": {""id"": ""GO:0051145"", ""label"": ""smooth muscle cell differentiation""}}"																											
2973	3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis	Loss of YY1AP1 in vascular smooth muscle cells leads to increased p21/CDKN1A levels, G1/G2 cell-cycle arrest, reduced VSMC proliferation, and impaired TGF--driven upregulation of contractile markers (SM -actin, SM22, calponin), resulting in focal stenoses and occlusions in multiple arterial beds. Progressive vascular disease can lead to ischemic and hemorrhagic stroke, myocardial infarction, and other thrombovascular complications.	biological_processes[1]	biological_processes	biological_processes			cell cycle arrest	GO:0007050	cell cycle arrest		"{""preferred_term"": ""cell cycle arrest"", ""term"": {""id"": ""GO:0007050"", ""label"": ""cell cycle arrest""}}"																											
2984	3252	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	0	ANCA-Mediated Neutrophil Activation	Anti-proteinase 3 (PR3) antibodies bind to primed neutrophils, causing activation, degranulation, and release of reactive oxygen species and lytic enzymes. This causes direct endothelial damage and vessel wall necrosis.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
2985	3252	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	0	ANCA-Mediated Neutrophil Activation	Anti-proteinase 3 (PR3) antibodies bind to primed neutrophils, causing activation, degranulation, and release of reactive oxygen species and lytic enzymes. This causes direct endothelial damage and vessel wall necrosis.	biological_processes[0]	biological_processes	biological_processes			Neutrophil Activation	GO:0042119	neutrophil activation		"{""preferred_term"": ""Neutrophil Activation"", ""term"": {""id"": ""GO:0042119"", ""label"": ""neutrophil activation""}}"																											
2986	3253	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	1	Granuloma Formation	Granulomatous inflammation with multinucleated giant cells, epithelioid macrophages, and necrosis affects the respiratory tract. T cells and macrophages organize into granulomas that destroy tissue.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
2987	3253	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	1	Granuloma Formation	Granulomatous inflammation with multinucleated giant cells, epithelioid macrophages, and necrosis affects the respiratory tract. T cells and macrophages organize into granulomas that destroy tissue.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
2988	3254	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	2	Complement Alternative Pathway Activation	The alternative complement pathway amplifies inflammation in GPA. C5a recruits and activates neutrophils, creating a positive feedback loop of vascular damage.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
2995	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	Autoantibody Production	The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
2996	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	Autoantibody Production	The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
2997	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	Autoantibody Production	The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.	biological_processes[0]	biological_processes	biological_processes			cAMP-mediated signaling	GO:0019933	cAMP-mediated signaling		"{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}"																											
2998	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	Autoantibody Production	The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
2999	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	Thyroid Overactivity	Excessive stimulation of the thyroid gland results in increased production of thyroid hormones (thyroxine, T4, and triiodothyronine, T3).	biological_processes[0]	biological_processes	biological_processes			thyroid hormone biosynthetic process	GO:0006590	thyroid hormone generation		"{""preferred_term"": ""thyroid hormone biosynthetic process"", ""term"": {""id"": ""GO:0006590"", ""label"": ""thyroid hormone generation""}}"																											
3000	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	Thyroid Overactivity	Excessive stimulation of the thyroid gland results in increased production of thyroid hormones (thyroxine, T4, and triiodothyronine, T3).	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
3001	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
3002	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
3003	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	cell_types[2]	cell_types	cell_types			T follicular helper cell	CL:0002038	T follicular helper cell		"{""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}"																											
3004	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	cell_types[3]	cell_types	cell_types			CD4-positive, alpha-beta T cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
3005	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	cell_types[4]	cell_types	cell_types			regulatory T cell	CL:0000815	regulatory T cell		"{""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}"																											
3006	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"																											
3007	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	cell_types[0]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
3008	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[0]	biological_processes	biological_processes			cAMP-mediated signaling	GO:0019933	cAMP-mediated signaling		"{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}"																											
3009	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[1]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
3010	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[2]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"																											
3011	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[3]	biological_processes	biological_processes			adipocyte differentiation	GO:0045444	adipocyte differentiation		"{""preferred_term"": ""adipocyte differentiation"", ""term"": {""id"": ""GO:0045444"", ""label"": ""adipocyte differentiation""}}"																											
3012	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[4]	biological_processes	biological_processes			hyaluronan biosynthetic process	GO:0030213	hyaluronan biosynthetic process		"{""preferred_term"": ""hyaluronan biosynthetic process"", ""term"": {""id"": ""GO:0030213"", ""label"": ""hyaluronan biosynthetic process""}}"																											
3013	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	biological_processes[5]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
3014	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	locations[0]	locations	locations			orbit	UBERON:0001697	orbit		"{""preferred_term"": ""orbit"", ""term"": {""id"": ""UBERON:0001697"", ""label"": ""orbit""}}"																											
3015	3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.	locations[1]	locations	locations			extraocular muscle	UBERON:0001576	extraocular muscle		"{""preferred_term"": ""extraocular muscle"", ""term"": {""id"": ""UBERON:0001576"", ""label"": ""extraocular muscle""}}"																											
3016	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
3017	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	cell_types[1]	cell_types	cell_types			T follicular helper cell	CL:0002038	T follicular helper cell		"{""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}"																											
3018	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"																											
3019	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	biological_processes[1]	biological_processes	biological_processes			adaptive immune response	GO:0002250	adaptive immune response		"{""preferred_term"": ""adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
3020	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	biological_processes[2]	biological_processes	biological_processes			germinal center formation	GO:0002467	germinal center formation		"{""preferred_term"": ""germinal center formation"", ""term"": {""id"": ""GO:0002467"", ""label"": ""germinal center formation""}}"																											
3021	3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
3040	3309	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	0	Molecular Mimicry and Antiganglioside Antibodies	Antibodies against bacterial lipooligosaccharides (especially from Campylobacter jejuni) cross-react with gangliosides on peripheral nerves. Anti-GM1, anti-GD1a, and anti-GQ1b antibodies are associated with specific clinical subtypes.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
3041	3310	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	1	Complement-Mediated Nerve Damage	Antibody binding activates complement cascade, leading to membrane attack complex deposition on Schwann cells and nodes of Ranvier. This causes demyelination in AIDP or axonal damage in AMAN/AMSAN variants.	cell_types[0]	cell_types	cell_types			Schwann Cell	CL:0002573	Schwann cell		"{""preferred_term"": ""Schwann Cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}"																											
3042	3310	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	1	Complement-Mediated Nerve Damage	Antibody binding activates complement cascade, leading to membrane attack complex deposition on Schwann cells and nodes of Ranvier. This causes demyelination in AIDP or axonal damage in AMAN/AMSAN variants.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
3043	3311	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	2	Macrophage-Mediated Demyelination	In AIDP, macrophages infiltrate peripheral nerves and strip myelin from axons. T cells may also contribute to the inflammatory milieu and tissue damage.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
3044	3311	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	2	Macrophage-Mediated Demyelination	In AIDP, macrophages infiltrate peripheral nerves and strip myelin from axons. T cells may also contribute to the inflammatory milieu and tissue damage.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3050	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3051	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.	biological_processes[0]	biological_processes	biological_processes			histone H3-K27 methylation	GO:0098532	histone H3-K27 methylation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""histone H3-K27 methylation"", ""term"": {""id"": ""GO:0098532"", ""label"": ""histone H3-K27 methylation""}}"			DECREASED																								
3052	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.	locations[0]	locations	locations			pons	UBERON:0000988	pons		"{""preferred_term"": ""pons"", ""term"": {""id"": ""UBERON:0000988"", ""label"": ""pons""}}"																											
3053	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.	locations[1]	locations	locations			dorsal plus ventral thalamus	UBERON:0001897	dorsal plus ventral thalamus		"{""preferred_term"": ""dorsal plus ventral thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}"																											
3054	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.	locations[2]	locations	locations			spinal cord	UBERON:0002240	spinal cord		"{""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}"																											
3055	3332	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	1	PRC2 Complex Inhibition and H3K27me3 Loss	The H3 K27M mutant histone binds to and inhibits EZH2, the catalytic subunit of PRC2, which normally trimethylates H3K27. This results in global loss of H3K27me3, a repressive epigenetic mark, leading to aberrant gene activation and loss of cell identity.	biological_processes[0]	biological_processes	biological_processes			negative regulation of gene expression, epigenetic	GO:0045814	negative regulation of gene expression, epigenetic		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0045814"", ""label"": ""negative regulation of gene expression, epigenetic""}}"			DECREASED																								
3056	3333	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	2	Epigenetic Derepression and Aberrant Gene Activation	Global loss of H3K27me3 causes derepression of genes normally silenced during development, including proliferative and stemness genes. Paradoxically, some loci show retained or increased H3K27me3, suggesting complex redistribution rather than simple loss.	biological_processes[0]	biological_processes	biological_processes			gene expression	GO:0010467	gene expression		"{""modifier"": ""INCREASED"", ""preferred_term"": ""gene expression"", ""term"": {""id"": ""GO:0010467"", ""label"": ""gene expression""}}"			INCREASED																								
3057	3333	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	2	Epigenetic Derepression and Aberrant Gene Activation	Global loss of H3K27me3 causes derepression of genes normally silenced during development, including proliferative and stemness genes. Paradoxically, some loci show retained or increased H3K27me3, suggesting complex redistribution rather than simple loss.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3058	3334	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	3	Loss of Glial Differentiation	Epigenetic dysregulation prevents normal glial differentiation, maintaining cells in a proliferative, undifferentiated state. This contributes to the aggressive behavior and treatment resistance of these tumors.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3059	3334	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	3	Loss of Glial Differentiation	Epigenetic dysregulation prevents normal glial differentiation, maintaining cells in a proliferative, undifferentiated state. This contributes to the aggressive behavior and treatment resistance of these tumors.	biological_processes[0]	biological_processes	biological_processes			glial cell differentiation	GO:0010001	glial cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""glial cell differentiation"", ""term"": {""id"": ""GO:0010001"", ""label"": ""glial cell differentiation""}}"			DECREASED																								
3069	3347	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	0	ERBB2 Gene Amplification	HER2-positive breast cancer is driven by amplification of the ERBB2 gene on chromosome 17q12, resulting in overexpression of the HER2 receptor tyrosine kinase. Gene amplification typically results in 25-50 copies per cell, leading to massive receptor overexpression on the cell surface.	cell_types[0]	cell_types	cell_types			luminal epithelial cell of mammary gland	CL:0002326	luminal epithelial cell of mammary gland		"{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}"																											
3070	3347	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	0	ERBB2 Gene Amplification	HER2-positive breast cancer is driven by amplification of the ERBB2 gene on chromosome 17q12, resulting in overexpression of the HER2 receptor tyrosine kinase. Gene amplification typically results in 25-50 copies per cell, leading to massive receptor overexpression on the cell surface.	biological_processes[0]	biological_processes	biological_processes			ERBB2 signaling pathway	GO:0038128	ERBB2 signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}"			INCREASED																								
3071	3348	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	1	Constitutive Receptor Activation	Massive HER2 overexpression promotes spontaneous receptor homodimerization and heterodimerization with other ERBB family members (EGFR, HER3, HER4) without ligand binding. This constitutive activation drives downstream signaling cascades promoting proliferation, survival, and invasion.	biological_processes[0]	biological_processes	biological_processes			transmembrane receptor protein tyrosine kinase signaling pathway	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}"			INCREASED																								
3072	3349	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	2	Downstream Oncogenic Signaling	Activated HER2 signals through PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways, promoting cell proliferation, survival, and resistance to apoptosis. HER2-HER3 heterodimers are particularly potent activators of the PI3K pathway.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
3073	3349	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	2	Downstream Oncogenic Signaling	Activated HER2 signals through PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways, promoting cell proliferation, survival, and resistance to apoptosis. HER2-HER3 heterodimers are particularly potent activators of the PI3K pathway.	biological_processes[1]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
3074	3350	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	3	Uncontrolled Proliferation	Constitutive HER2 signaling drives continuous cell cycle progression and resistance to apoptotic signals. HER2+ tumors are typically high grade with high proliferation indices (high Ki-67).	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3084	3366	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase on the cell surface. Amplified HER2 forms homodimers and heterodimers with other ERBB family members (particularly HER3), leading to ligand-independent receptor activation and downstream signaling.	cell_types[0]	cell_types	cell_types			colon epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
3085	3366	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase on the cell surface. Amplified HER2 forms homodimers and heterodimers with other ERBB family members (particularly HER3), leading to ligand-independent receptor activation and downstream signaling.	biological_processes[0]	biological_processes	biological_processes			ERBB2 signaling pathway	GO:0038128	ERBB2 signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}"			INCREASED																								
3086	3367	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	1	MAPK Pathway Activation	HER2 receptor activation leads to recruitment of adaptor proteins (GRB2/SOS) that activate RAS, initiating the MAPK signaling cascade. This drives cell proliferation and survival. The MAPK pathway is a major effector of HER2 oncogenic signaling in colorectal cancer.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
3087	3368	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	HER2 heterodimerization with HER3 is particularly potent at activating PI3K signaling because HER3 contains multiple PI3K binding sites. This leads to AKT activation, promoting cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to HER2-targeted therapy.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
3088	3369	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	3	Enhanced Cell Proliferation	Combined MAPK and PI3K pathway activation drives enhanced cell proliferation through cyclin D1 induction and cell cycle progression. This leads to uncontrolled tumor growth dependent on HER2 signaling.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
3089	3369	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	3	Enhanced Cell Proliferation	Combined MAPK and PI3K pathway activation drives enhanced cell proliferation through cyclin D1 induction and cell cycle progression. This leads to uncontrolled tumor growth dependent on HER2 signaling.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3104	3386	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis.	cell_types[0]	cell_types	cell_types			epithelial cell of stomach	CL:0002178	epithelial cell of stomach		"{""preferred_term"": ""epithelial cell of stomach"", ""term"": {""id"": ""CL:0002178"", ""label"": ""epithelial cell of stomach""}}"																											
3105	3386	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis.	biological_processes[0]	biological_processes	biological_processes			ERBB2 signaling pathway	GO:0038128	ERBB2 signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}"			INCREASED																								
3106	3386	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis.	locations[0]	locations	locations			stomach	UBERON:0000945	stomach		"{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}"																											
3107	3387	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	1	MAPK Pathway Activation	HER2 receptor activation recruits GRB2/SOS adaptor proteins, activating RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation, including cyclin D1 and MYC.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
3108	3388	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	HER2/HER3 heterodimerization is particularly effective at activating PI3K because HER3 contains six PI3K binding motifs. PI3K activation leads to AKT phosphorylation, promoting cell survival, protein synthesis through mTOR, and resistance to apoptosis. PI3K pathway alterations may confer resistance to HER2-targeted therapy.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
3109	3389	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	3	Enhanced Proliferation and Tumor Growth	Combined MAPK and PI3K/AKT pathway activation drives uncontrolled cell proliferation and tumor growth. HER2-positive tumors are dependent on HER2 signaling, making them vulnerable to HER2-targeted therapies.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3124	3403	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	0	P4HTM Gene Loss-of-Function	Biallelic loss-of-function variants in P4HTM result in loss of ER-resident transmembrane prolyl 4-hydroxylase activity. The enzyme contains an EF-hand domain that allows calcium-dependent regulation of its catalytic activity, linking the genetic defect to both HIF signaling and calcium homeostasis pathways.	genes[0]	genes	genes			P4HTM				"{""preferred_term"": ""P4HTM""}"																											
3125	3404	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	1	Dysregulated Astrocyte Calcium Signaling	P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission.	cell_types[0]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3126	3404	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	1	Dysregulated Astrocyte Calcium Signaling	P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission.	biological_processes[0]	biological_processes	biological_processes			Calcium ion transmembrane transport	GO:0070588	calcium ion transmembrane transport		"{""preferred_term"": ""Calcium ion transmembrane transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}"																											
3127	3404	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	1	Dysregulated Astrocyte Calcium Signaling	P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission.	biological_processes[1]	biological_processes	biological_processes			Gliotransmitter secretion	GO:0099177	gliotransmitter secretion		"{""preferred_term"": ""Gliotransmitter secretion"", ""term"": {""id"": ""GO:0099177"", ""label"": ""gliotransmitter secretion""}}"																											
3128	3405	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	2	Central Respiratory Control Dysfunction	Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections.	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
3129	3405	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	2	Central Respiratory Control Dysfunction	Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections.	biological_processes[0]	biological_processes	biological_processes			Regulation of respiratory system process	GO:0044065	regulation of respiratory system process		"{""preferred_term"": ""Regulation of respiratory system process"", ""term"": {""id"": ""GO:0044065"", ""label"": ""regulation of respiratory system process""}}"																											
3130	3405	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	2	Central Respiratory Control Dysfunction	Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections.	biological_processes[1]	biological_processes	biological_processes			Response to hypoxia	GO:0001666	response to hypoxia		"{""preferred_term"": ""Response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"																											
3131	3406	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	3	Mitochondrial Dysfunction	A subset of HIDEA patients show mitochondrial respiratory chain complex deficiency in muscle biopsies, suggesting that P4H-TM loss can affect mitochondrial function.	biological_processes[0]	biological_processes	biological_processes			Oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""Oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
3152	3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	TP53 Mutation and Inactivation	TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair.	cell_types[0]	cell_types	cell_types			squamous epithelial cell	CL:0000076	squamous epithelial cell		"{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}"																											
3153	3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	TP53 Mutation and Inactivation	TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
3154	3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	TP53 Mutation and Inactivation	TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3155	3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	TP53 Mutation and Inactivation	TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair.	genes[0]	genes	genes			TP53				"{""preferred_term"": ""TP53""}"																											
3156	3440	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	1	CDKN2A/p16 Inactivation	CDKN2A is inactivated by deletion, mutation, or promoter hypermethylation in approximately 60-70% of HPV-negative HNSCC. Loss of p16INK4a removes inhibition of CDK4/6, promoting cell cycle progression through the restriction point.	genes[0]	genes	genes			CDKN2A				"{""preferred_term"": ""CDKN2A""}"																											
3157	3440	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	1	CDKN2A/p16 Inactivation	CDKN2A is inactivated by deletion, mutation, or promoter hypermethylation in approximately 60-70% of HPV-negative HNSCC. Loss of p16INK4a removes inhibition of CDK4/6, promoting cell cycle progression through the restriction point.	biological_processes[0]	biological_processes	biological_processes			negative regulation of G1/S transition	GO:0045786	negative regulation of G1/S transition of mitotic cell cycle		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of G1/S transition"", ""term"": {""id"": ""GO:0045786"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}"			DECREASED																								
3158	3441	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	2	EGFR Overexpression and Signaling	EGFR is overexpressed in 80-90% of HNSCC and amplified in a subset. EGFR signaling activates RAS-MAPK and PI3K-AKT pathways, promoting proliferation, survival, and invasion. EGFR is a validated therapeutic target in HNSCC.	biological_processes[0]	biological_processes	biological_processes			epidermal growth factor receptor signaling pathway	GO:0007173	epidermal growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}"			INCREASED																								
3159	3442	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	3	NOTCH1 Inactivation	NOTCH1 loss-of-function mutations occur in approximately 15-20% of HPV-negative HNSCC. NOTCH signaling normally promotes squamous differentiation and growth arrest, functioning as a tumor suppressor in squamous epithelia.	genes[0]	genes	genes			NOTCH1				"{""preferred_term"": ""NOTCH1""}"																											
3160	3442	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	3	NOTCH1 Inactivation	NOTCH1 loss-of-function mutations occur in approximately 15-20% of HPV-negative HNSCC. NOTCH signaling normally promotes squamous differentiation and growth arrest, functioning as a tumor suppressor in squamous epithelia.	biological_processes[0]	biological_processes	biological_processes			Notch signaling pathway	GO:0007219	Notch signaling pathway		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Notch signaling pathway"", ""term"": {""id"": ""GO:0007219"", ""label"": ""Notch signaling pathway""}}"			DECREASED																								
3175	3463	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	0	E6-Mediated p53 Degradation	HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors.	cell_types[0]	cell_types	cell_types			squamous epithelial cell	CL:0000076	squamous epithelial cell		"{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}"																											
3176	3463	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	0	E6-Mediated p53 Degradation	HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors.	biological_processes[0]	biological_processes	biological_processes			proteasome-mediated ubiquitin-dependent protein catabolic process	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process		"{""modifier"": ""INCREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}"			INCREASED																								
3177	3463	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	0	E6-Mediated p53 Degradation	HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3178	3463	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	0	E6-Mediated p53 Degradation	HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors.	locations[0]	locations	locations			oropharynx	UBERON:0001729	oropharynx		"{""preferred_term"": ""oropharynx"", ""term"": {""id"": ""UBERON:0001729"", ""label"": ""oropharynx""}}"																											
3179	3464	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	1	E7-Mediated pRB Inactivation	HPV E7 oncoprotein binds and degrades the retinoblastoma protein (pRB), releasing E2F transcription factors to drive S-phase entry. This causes compensatory overexpression of p16INK4a, which serves as a clinical biomarker for HPV-associated tumors.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			ABNORMAL																								
3180	3464	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	1	E7-Mediated pRB Inactivation	HPV E7 oncoprotein binds and degrades the retinoblastoma protein (pRB), releasing E2F transcription factors to drive S-phase entry. This causes compensatory overexpression of p16INK4a, which serves as a clinical biomarker for HPV-associated tumors.	biological_processes[1]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
3181	3465	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	2	Viral Oncogene Integration	HPV genome integration into the host chromosome disrupts the E2 viral repressor, leading to constitutive E6/E7 expression. However, episomal HPV may also drive carcinogenesis in some HPV-positive oropharyngeal cancers.	biological_processes[0]	biological_processes	biological_processes			viral DNA integration into host DNA	GO:0044826	viral DNA integration into host DNA		"{""preferred_term"": ""viral DNA integration into host DNA"", ""term"": {""id"": ""GO:0044826"", ""label"": ""viral DNA integration into host DNA""}}"																											
3182	3466	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	3	Immune Evasion	HPV-positive HNSCC evades immune surveillance through downregulation of antigen presentation and PD-L1 expression. However, these tumors are generally more immunogenic than HPV-negative HNSCC, contributing to better prognosis and response to immunotherapy.	biological_processes[0]	biological_processes	biological_processes			negative regulation of T cell mediated immunity	GO:0002710	negative regulation of T cell mediated immunity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of T cell mediated immunity"", ""term"": {""id"": ""GO:0002710"", ""label"": ""negative regulation of T cell mediated immunity""}}"			INCREASED																								
3194	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	Autoimmune Thyroid Destruction	"T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.
"	cell_types[0]	cell_types	cell_types			Thyroid Epithelial Cell	CL:0002257	epithelial cell of thyroid gland		"{""preferred_term"": ""Thyroid Epithelial Cell"", ""term"": {""id"": ""CL:0002257"", ""label"": ""epithelial cell of thyroid gland""}}"																											
3195	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	Autoimmune Thyroid Destruction	"T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.
"	cell_types[1]	cell_types	cell_types			T Helper Cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
3196	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	Autoimmune Thyroid Destruction	"T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.
"	biological_processes[0]	biological_processes	biological_processes			Autoimmune Response	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains		"{""preferred_term"": ""Autoimmune Response"", ""term"": {""id"": ""GO:0002460"", ""label"": ""adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains""}}"																											
3197	3489	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	1	Lymphocytic Infiltration	"Dense lymphocytic infiltration of the thyroid gland with germinal center formation. CD4+ T cells, CD8+ T cells, and B cells accumulate in the thyroid parenchyma.
"	cell_types[0]	cell_types	cell_types			B Cell	CL:0000236	B cell		"{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
3198	3490	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	2	Thyroid Hormone Deficiency	"Progressive destruction of thyroid tissue leads to decreased production of T3 and T4, resulting in hypothyroidism with elevated TSH through negative feedback.
"	biological_processes[0]	biological_processes	biological_processes			Thyroid Hormone Synthesis	GO:0006590	thyroid hormone generation		"{""preferred_term"": ""Thyroid Hormone Synthesis"", ""term"": {""id"": ""GO:0006590"", ""label"": ""thyroid hormone generation""}}"																											
3205	3512	147	Heart Failure	Heart_Failure.yaml	pathophysiology	0	Myocardial Contractile Dysfunction	"Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.
"	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3206	3512	147	Heart Failure	Heart_Failure.yaml	pathophysiology	0	Myocardial Contractile Dysfunction	"Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.
"	biological_processes[0]	biological_processes	biological_processes			Cardiac Contraction	GO:0060047	heart contraction		"{""preferred_term"": ""Cardiac Contraction"", ""term"": {""id"": ""GO:0060047"", ""label"": ""heart contraction""}}"																											
3207	3513	147	Heart Failure	Heart_Failure.yaml	pathophysiology	1	Neurohormonal Activation	"Compensatory activation of RAAS and sympathetic nervous system initially maintains cardiac output but leads to maladaptive remodeling, sodium retention, and progressive dysfunction.
"	biological_processes[0]	biological_processes	biological_processes			RAAS Activation	GO:0002018	renin-angiotensin regulation of aldosterone production		"{""preferred_term"": ""RAAS Activation"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}"																											
3208	3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	Ventricular Remodeling	"Structural changes including ventricular dilation, hypertrophy, and fibrosis that initially compensate but eventually worsen heart function.
"	cell_types[0]	cell_types	cell_types			Cardiac Fibroblast	CL:0002548	fibroblast of cardiac tissue		"{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}"																											
3209	3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	Ventricular Remodeling	"Structural changes including ventricular dilation, hypertrophy, and fibrosis that initially compensate but eventually worsen heart function.
"	biological_processes[0]	biological_processes	biological_processes			Cardiac Remodeling	GO:0060420	regulation of heart growth		"{""preferred_term"": ""Cardiac Remodeling"", ""term"": {""id"": ""GO:0060420"", ""label"": ""regulation of heart growth""}}"																											
3216	3533	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	0	HFE Loss Lowers Hepcidin	"Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction, leaving circulating hepcidin inappropriately low relative to body iron stores.
"	biological_processes[0]	biological_processes	biological_processes			iron ion homeostasis	GO:0055072	iron ion homeostasis		"{""preferred_term"": ""iron ion homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}"																											
3217	3534	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	1	Low Hepcidin Leads to Ferroportin Hyperabsorption	"Suppressed hepcidin fails to internalize and degrade ferroportin on enterocytes, so dietary iron efflux into plasma is unchecked, driving systemic iron overload.
"	biological_processes[0]	biological_processes	biological_processes			iron ion transport	GO:0006826	iron ion transport		"{""preferred_term"": ""iron ion transport"", ""term"": {""id"": ""GO:0006826"", ""label"": ""iron ion transport""}}"																											
3218	3535	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	2	Hepatic Iron Toxicity	"Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation, and hepatocellular damage. Progressive iron accumulation causes fibrosis and can lead to cirrhosis and hepatocellular carcinoma.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3219	3535	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	2	Hepatic Iron Toxicity	"Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation, and hepatocellular damage. Progressive iron accumulation causes fibrosis and can lead to cirrhosis and hepatocellular carcinoma.
"	biological_processes[0]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress		"{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
3220	3536	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	3	Cardiac Iron Deposition	"Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility, leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.
"	cell_types[0]	cell_types	cell_types			cardiac muscle cell	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3221	3536	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	3	Cardiac Iron Deposition	"Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility, leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.
"	biological_processes[0]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress		"{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
3222	3537	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	4	Pancreatic Iron Toxicity	"Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin secretion, leading to diabetes mellitus (""bronze diabetes"").
"	cell_types[0]	cell_types	cell_types			type B pancreatic cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
3223	3537	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	4	Pancreatic Iron Toxicity	"Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin secretion, leading to diabetes mellitus (""bronze diabetes"").
"	biological_processes[0]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress		"{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
3234	3556	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	0	Factor VIII Deficiency	"Mutations in the F8 gene cause deficient or dysfunctional factor VIII protein. Factor VIII is a cofactor for factor IXa in the intrinsic coagulation pathway, essential for thrombin generation and fibrin clot formation.
"	biological_processes[0]	biological_processes	biological_processes			Blood Coagulation	GO:0007596	blood coagulation		"{""preferred_term"": ""Blood Coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
3235	3557	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	1	Impaired Thrombin Generation	"Without functional factor VIII, the intrinsic tenase complex cannot form efficiently. This results in inadequate thrombin generation and unstable fibrin clot formation, leading to prolonged bleeding.
"	biological_processes[0]	biological_processes	biological_processes			Fibrin Clot Formation	GO:0072378	blood coagulation, fibrin clot formation		"{""preferred_term"": ""Fibrin Clot Formation"", ""term"": {""id"": ""GO:0072378"", ""label"": ""blood coagulation, fibrin clot formation""}}"																											
3245	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	Hepatocyte Infection and cccDNA Formation	HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection.	cell_types[0]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3246	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	Hepatocyte Infection and cccDNA Formation	HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
3247	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	Hepatocyte Infection and cccDNA Formation	HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection.	biological_processes[0]	biological_processes	biological_processes			viral entry into host cell	GO:0046718	viral entry into host cell		"{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}"																											
3248	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	Hepatocyte Infection and cccDNA Formation	HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection.	biological_processes[1]	biological_processes	biological_processes			epigenetic regulation of gene expression	GO:0040029	epigenetic regulation of gene expression		"{""preferred_term"": ""epigenetic regulation of gene expression"", ""term"": {""id"": ""GO:0040029"", ""label"": ""epigenetic regulation of gene expression""}}"																											
3249	3589	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	1	HBV DNA Integration	Integration of viral dslDNA into host genome occurs at sites of DNA damage, driving insertional mutagenesis, structural rearrangements, and activation of proto-oncogenes.	biological_processes[0]	biological_processes	biological_processes			DNA integration	GO:0015074	DNA integration		"{""preferred_term"": ""DNA integration"", ""term"": {""id"": ""GO:0015074"", ""label"": ""DNA integration""}}"																											
3250	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	Chronic Inflammation	Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3251	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	Chronic Inflammation	Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells.	cell_types[1]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell		"{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
3252	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	Chronic Inflammation	Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells.	cell_types[2]	cell_types	cell_types			inflammatory macrophage	CL:0000863	inflammatory macrophage	Liver-resident macrophages (Kupffer cells)	"{""description"": ""Liver-resident macrophages (Kupffer cells)"", ""preferred_term"": ""inflammatory macrophage"", ""term"": {""id"": ""CL:0000863"", ""label"": ""inflammatory macrophage""}}"																											
3253	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	Immune Evasion and T Cell Exhaustion	HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3254	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	Immune Evasion and T Cell Exhaustion	HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors.	cell_types[1]	cell_types	cell_types			regulatory T cell	CL:0000815	regulatory T cell		"{""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}"																											
3255	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	Immune Evasion and T Cell Exhaustion	HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors.	biological_processes[0]	biological_processes	biological_processes			negative regulation of T cell activation	GO:0050868	negative regulation of T cell activation		"{""preferred_term"": ""negative regulation of T cell activation"", ""term"": {""id"": ""GO:0050868"", ""label"": ""negative regulation of T cell activation""}}"																											
3256	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	Immune Evasion and T Cell Exhaustion	HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors.	biological_processes[1]	biological_processes	biological_processes			cGAS-STING signaling pathway	GO:0061761	cGAS-STING signaling pathway		"{""preferred_term"": ""cGAS-STING signaling pathway"", ""term"": {""id"": ""GO:0061761"", ""label"": ""cGAS-STING signaling pathway""}}"																											
3271	3629	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	0	Viral Replication and Hepatocyte Injury	"HCV is a positive-sense single-stranded RNA virus that replicates primarily in hepatocytes. Viral replication causes direct cytopathic effects and triggers immune-mediated hepatocyte destruction. The virus evades immune clearance through high mutation rates and quasispecies diversity.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3272	3629	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	0	Viral Replication and Hepatocyte Injury	"HCV is a positive-sense single-stranded RNA virus that replicates primarily in hepatocytes. Viral replication causes direct cytopathic effects and triggers immune-mediated hepatocyte destruction. The virus evades immune clearance through high mutation rates and quasispecies diversity.
"	biological_processes[0]	biological_processes	biological_processes			viral life cycle	GO:0019058	viral life cycle		"{""preferred_term"": ""viral life cycle"", ""term"": {""id"": ""GO:0019058"", ""label"": ""viral life cycle""}}"																											
3273	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"	cell_types[0]	cell_types	cell_types			hepatic stellate cell	CL:0000632	hepatic stellate cell		"{""preferred_term"": ""hepatic stellate cell"", ""term"": {""id"": ""CL:0000632"", ""label"": ""hepatic stellate cell""}}"																											
3274	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
3275	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"	biological_processes[0]	biological_processes	biological_processes			chronic inflammatory response	GO:0002544	chronic inflammatory response		"{""preferred_term"": ""chronic inflammatory response"", ""term"": {""id"": ""GO:0002544"", ""label"": ""chronic inflammatory response""}}"																											
3276	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"	biological_processes[1]	biological_processes	biological_processes			hepatic stellate cell activation	GO:0035733	hepatic stellate cell activation		"{""preferred_term"": ""hepatic stellate cell activation"", ""term"": {""id"": ""GO:0035733"", ""label"": ""hepatic stellate cell activation""}}"																											
3277	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"	biological_processes[2]	biological_processes	biological_processes			collagen biosynthetic process	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
3278	3631	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	2	Immune Evasion	"HCV employs multiple strategies to evade host immune responses, including interference with interferon signaling, rapid viral mutation generating escape variants, and exhaustion of HCV-specific T cells.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3279	3631	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	2	Immune Evasion	"HCV employs multiple strategies to evade host immune responses, including interference with interferon signaling, rapid viral mutation generating escape variants, and exhaustion of HCV-specific T cells.
"	biological_processes[0]	biological_processes	biological_processes			symbiont-mediated suppression of host type I interferon-mediated signaling pathway	GO:0039502	symbiont-mediated suppression of host type I interferon-mediated signaling pathway		"{""preferred_term"": ""symbiont-mediated suppression of host type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0039502"", ""label"": ""symbiont-mediated suppression of host type I interferon-mediated signaling pathway""}}"																											
3280	3632	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	3	Hepatocellular Carcinoma Development	"Chronic inflammation, oxidative stress, and direct viral effects on cell signaling pathways contribute to hepatocarcinogenesis. Cirrhosis is the major risk factor, but HCC can occur in non-cirrhotic livers.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3291	3655	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	0	Chronic Liver Injury and Cirrhosis	Most HCC arises in the context of chronic liver disease and cirrhosis. Persistent hepatocyte death and regeneration in an inflammatory environment promotes accumulation of genetic alterations. Cirrhosis itself is a premalignant condition with ongoing oxidative stress and genomic instability.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3292	3655	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	0	Chronic Liver Injury and Cirrhosis	Most HCC arises in the context of chronic liver disease and cirrhosis. Persistent hepatocyte death and regeneration in an inflammatory environment promotes accumulation of genetic alterations. Cirrhosis itself is a premalignant condition with ongoing oxidative stress and genomic instability.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
3293	3656	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	1	Telomere Dysfunction and Genomic Instability	Chronic hepatocyte proliferation leads to telomere shortening, causing genomic instability. TERT promoter mutations, which are the most common HCC mutations, reactivate telomerase to enable unlimited replication. This creates a checkpoint bypass allowing survival of genetically unstable cells.	biological_processes[0]	biological_processes	biological_processes			telomere maintenance	GO:0000723	telomere maintenance		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""telomere maintenance"", ""term"": {""id"": ""GO:0000723"", ""label"": ""telomere maintenance""}}"			ABNORMAL																								
3294	3657	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	2	Accumulation of Driver Mutations	Multiple driver genes are recurrently mutated in HCC, including TERT promoter (60%), TP53 (30%), CTNNB1 (30%), AXIN1 (10%), and ARID1A (10%). These mutations affect telomere maintenance, cell cycle control, WNT signaling, and chromatin remodeling.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
3295	3658	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	3	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) or inactivating mutations in AXIN1 lead to constitutive WNT pathway activation. This drives cell proliferation and is associated with a distinct molecular subclass of HCC with specific clinical features including cholestasis and immune exclusion.	biological_processes[0]	biological_processes	biological_processes			Wnt signaling pathway	GO:0016055	Wnt signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"			INCREASED																								
3296	3659	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	4	TP53 Pathway Inactivation	TP53 mutations are common in HCC, particularly in HBV-associated and aflatoxin-associated tumors. Loss of p53 function removes a critical checkpoint, allowing survival of cells with DNA damage and promoting genomic instability.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3297	3660	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	5	Enhanced Hepatocyte Proliferation	Combined effects of telomerase reactivation, cell cycle checkpoint loss, and mitogenic signaling drive uncontrolled hepatocyte proliferation and tumor growth.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3298	3661	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	6	Angiogenesis and VEGF Signaling	HCC is a highly vascular tumor dependent on angiogenesis. VEGF signaling promotes new blood vessel formation supplying the tumor. VEGF also has immunosuppressive effects, contributing to the immune-excluded microenvironment. This provides the rationale for anti-VEGF therapy in combination with immunotherapy.	biological_processes[0]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
3314	3683	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	0	BRCA1/2 Tumor Suppressor Loss	Germline heterozygous BRCA1 or BRCA2 mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates BRCA function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
3315	3684	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	1	Homologous Recombination Deficiency	BRCA1 and BRCA2 are essential components of the homologous recombination (HR) pathway for error-free repair of DNA double-strand breaks. Loss of BRCA function forces cells to rely on error-prone repair pathways such as non-homologous end joining, leading to genomic instability.	biological_processes[0]	biological_processes	biological_processes			homologous recombination	GO:0035825	homologous recombination		"{""modifier"": ""DECREASED"", ""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}"			DECREASED																								
3316	3685	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	2	Genomic Instability	Loss of HR-mediated repair leads to accumulation of chromosomal aberrations, large-scale genomic rearrangements, and copy number alterations. This pattern of genomic instability, termed 'BRCAness' or homologous recombination deficiency (HRD), is characteristic of BRCA-deficient tumors and creates therapeutic vulnerability to PARP inhibitors.	biological_processes[0]	biological_processes	biological_processes			regulation of DNA damage checkpoint	GO:0010618	regulation of DNA damage checkpoint		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of DNA damage checkpoint"", ""term"": {""id"": ""GO:0010618"", ""label"": ""regulation of DNA damage checkpoint""}}"			ABNORMAL																								
3317	3686	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	3	Tumor Development	Progressive accumulation of genomic alterations in BRCA-deficient cells leads to transformation and tumor development. The tissue specificity (breast, ovary) may relate to estrogen exposure and proliferative demands on these tissues, though the precise mechanisms remain incompletely understood.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3334	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.	cell_types[0]	cell_types	cell_types			enteric neuron	CL:0007011	enteric neuron		"{""modifier"": ""ABSENT"", ""preferred_term"": ""enteric neuron"", ""term"": {""id"": ""CL:0007011"", ""label"": ""enteric neuron""}}"			ABSENT																								
3335	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.	biological_processes[0]	biological_processes	biological_processes			neural crest cell migration	GO:0001755	neural crest cell migration		"{""modifier"": ""DECREASED"", ""preferred_term"": ""neural crest cell migration"", ""term"": {""id"": ""GO:0001755"", ""label"": ""neural crest cell migration""}}"			DECREASED																								
3336	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			DECREASED																								
3337	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.	locations[0]	locations	locations			myenteric nerve plexus	UBERON:0002439	myenteric nerve plexus		"{""preferred_term"": ""myenteric nerve plexus"", ""term"": {""id"": ""UBERON:0002439"", ""label"": ""myenteric nerve plexus""}}"																											
3338	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.	locations[1]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
3339	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.	cell_types[0]	cell_types	cell_types			enteric neuron	CL:0007011	enteric neuron		"{""modifier"": ""ABSENT"", ""preferred_term"": ""enteric neuron"", ""term"": {""id"": ""CL:0007011"", ""label"": ""enteric neuron""}}"			ABSENT																								
3340	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.	biological_processes[0]	biological_processes	biological_processes			neuron differentiation	GO:0030182	neuron differentiation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""neuron differentiation"", ""term"": {""id"": ""GO:0030182"", ""label"": ""neuron differentiation""}}"			ABNORMAL																								
3341	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.	biological_processes[1]	biological_processes	biological_processes			peristalsis	GO:0030432	peristalsis		"{""modifier"": ""DECREASED"", ""preferred_term"": ""peristalsis"", ""term"": {""id"": ""GO:0030432"", ""label"": ""peristalsis""}}"			DECREASED																								
3342	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.	locations[0]	locations	locations			enteric nervous system	UBERON:0002005	enteric nervous system		"{""preferred_term"": ""enteric nervous system"", ""term"": {""id"": ""UBERON:0002005"", ""label"": ""enteric nervous system""}}"																											
3343	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.	locations[1]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
3355	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	gene	gene	$	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	TBX5	hgnc:11610	TBX5		"{""preferred_term"": ""TBX5"", ""term"": {""id"": ""hgnc:11610"", ""label"": ""TBX5""}}"																											
3356	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	cell_types[0]	cell_types	cell_types			Cardiac muscle cell	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3357	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	locations[0]	locations	locations			Heart atrium	UBERON:0002373	heart atrium		"{""preferred_term"": ""Heart atrium"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""heart atrium""}}"																											
3358	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	locations[1]	locations	locations			Forelimb bud	UBERON:0004385	forelimb bud		"{""preferred_term"": ""Forelimb bud"", ""term"": {""id"": ""UBERON:0004385"", ""label"": ""forelimb bud""}}"																											
3359	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	locations[2]	locations	locations			Atrial conduction system	UBERON:0004535	atrial conduction system		"{""preferred_term"": ""Atrial conduction system"", ""term"": {""id"": ""UBERON:0004535"", ""label"": ""atrial conduction system""}}"																											
3360	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	biological_processes[0]	biological_processes	biological_processes			Heart development	GO:0007507	heart development		"{""preferred_term"": ""Heart development"", ""term"": {""id"": ""GO:0007507"", ""label"": ""heart development""}}"																											
3361	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	biological_processes[1]	biological_processes	biological_processes			Atrial septum morphogenesis	GO:0003181	atrial septum morphogenesis		"{""preferred_term"": ""Atrial septum morphogenesis"", ""term"": {""id"": ""GO:0003181"", ""label"": ""atrial septum morphogenesis""}}"																											
3362	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	biological_processes[2]	biological_processes	biological_processes			Cardiac conduction	GO:0061337	cardiac conduction		"{""preferred_term"": ""Cardiac conduction"", ""term"": {""id"": ""GO:0061337"", ""label"": ""cardiac conduction""}}"																											
3363	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	biological_processes[3]	biological_processes	biological_processes			Limb bud formation	GO:0030326	limb bud formation		"{""preferred_term"": ""Limb bud formation"", ""term"": {""id"": ""GO:0030326"", ""label"": ""limb bud formation""}}"																											
3364	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	biological_processes[4]	biological_processes	biological_processes			Regulation of gene expression, epigenetic	GO:0040029	regulation of gene expression, epigenetic		"{""preferred_term"": ""Regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0040029"", ""label"": ""regulation of gene expression, epigenetic""}}"																											
3365	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	cellular_components[0]	cellular_components	cellular_components			Chromatin	GO:0000785	chromatin		"{""preferred_term"": ""Chromatin"", ""term"": {""id"": ""GO:0000785"", ""label"": ""chromatin""}}"																											
3366	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	cellular_components[1]	cellular_components	cellular_components			Enhancer	GO:0035326	enhancer		"{""preferred_term"": ""Enhancer"", ""term"": {""id"": ""GO:0035326"", ""label"": ""enhancer""}}"																											
3367	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"	cellular_components[2]	cellular_components	cellular_components			Nucleosome	GO:0000786	nucleosome		"{""preferred_term"": ""Nucleosome"", ""term"": {""id"": ""GO:0000786"", ""label"": ""nucleosome""}}"																											
3368	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	genes[0]	genes	genes			GATA4	hgnc:4172	GATA4		"{""preferred_term"": ""GATA4"", ""term"": {""id"": ""hgnc:4172"", ""label"": ""GATA4""}}"																											
3369	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	genes[1]	genes	genes			ZFPM2	hgnc:12855	ZFPM2		"{""preferred_term"": ""ZFPM2"", ""term"": {""id"": ""hgnc:12855"", ""label"": ""ZFPM2""}}"																											
3370	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	genes[2]	genes	genes			CHD4	hgnc:1914	CHD4		"{""preferred_term"": ""CHD4"", ""term"": {""id"": ""hgnc:1914"", ""label"": ""CHD4""}}"																											
3371	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	genes[3]	genes	genes			SMARCA4	hgnc:11100	SMARCA4		"{""preferred_term"": ""SMARCA4"", ""term"": {""id"": ""hgnc:11100"", ""label"": ""SMARCA4""}}"																											
3372	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	genes[4]	genes	genes			NKX2-5	hgnc:7781	NKX2-5		"{""preferred_term"": ""NKX2-5"", ""term"": {""id"": ""hgnc:7781"", ""label"": ""NKX2-5""}}"																											
3373	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	cell_types[0]	cell_types	cell_types			Cardiac muscle cell	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3374	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	biological_processes[0]	biological_processes	biological_processes			Regulation of gene expression, epigenetic	GO:0040029	regulation of gene expression, epigenetic		"{""preferred_term"": ""Regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0040029"", ""label"": ""regulation of gene expression, epigenetic""}}"																											
3375	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"	biological_processes[1]	biological_processes	biological_processes			Cardiac conduction	GO:0061337	cardiac conduction		"{""preferred_term"": ""Cardiac conduction"", ""term"": {""id"": ""GO:0061337"", ""label"": ""cardiac conduction""}}"																											
3390	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	CAG Repeat Expansion in the HTT Gene	Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3391	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	CAG Repeat Expansion in the HTT Gene	Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein.	locations[1]	locations	locations			cerebral cortex	UBERON:0000955	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}"																											
3392	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	CAG Repeat Expansion in the HTT Gene	Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein.	biological_processes[0]	biological_processes	biological_processes			DNA mismatch repair	GO:0006298	mismatch repair		"{""preferred_term"": ""DNA mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}"																											
3393	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3394	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.	locations[1]	locations	locations			cerebral cortex	UBERON:0000955	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}"																											
3395	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.	cell_types[0]	cell_types	cell_types			medium spiny neuron	CL:1001474	medium spiny neuron		"{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}"																											
3396	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.	biological_processes[0]	biological_processes	biological_processes			protein aggregation	GO:0070841	inclusion body assembly		"{""preferred_term"": ""protein aggregation"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}"																											
3397	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.	biological_processes[1]	biological_processes	biological_processes			autophagy	GO:0006914	autophagy		"{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
3398	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3399	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	cell_types[0]	cell_types	cell_types			medium spiny neuron	CL:1001474	medium spiny neuron		"{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}"																											
3400	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3401	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	biological_processes[0]	biological_processes	biological_processes			chemical synaptic transmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
3402	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	biological_processes[1]	biological_processes	biological_processes			excitatory postsynaptic potential	GO:0060079	excitatory postsynaptic potential		"{""preferred_term"": ""excitatory postsynaptic potential"", ""term"": {""id"": ""GO:0060079"", ""label"": ""excitatory postsynaptic potential""}}"																											
3403	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.	biological_processes[2]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
3404	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3405	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	locations[1]	locations	locations			cerebral cortex	UBERON:0000955	cerebral cortex		"{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}"																											
3406	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	cell_types[0]	cell_types	cell_types			medium spiny neuron	CL:1001474	medium spiny neuron		"{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}"																											
3407	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3408	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	biological_processes[0]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
3409	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	biological_processes[1]	biological_processes	biological_processes			mitochondrion organization	GO:0007005	mitochondrion organization		"{""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}"																											
3410	3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.	biological_processes[2]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
3411	3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3412	3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
3413	3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3414	3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3415	3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.	biological_processes[1]	biological_processes	biological_processes			microglial cell activation	GO:0001774	microglial cell activation		"{""preferred_term"": ""microglial cell activation"", ""term"": {""id"": ""GO:0001774"", ""label"": ""microglial cell activation""}}"																											
3416	3787	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	5	D2 Receptor Medium Spiny Neuron Selective Vulnerability	D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons.	locations[0]	locations	locations			striatum	UBERON:0001880	striatum		"{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}"																											
3417	3787	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	5	D2 Receptor Medium Spiny Neuron Selective Vulnerability	D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons.	cell_types[0]	cell_types	cell_types			medium spiny neuron	CL:1001474	medium spiny neuron		"{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}"																											
3418	3787	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	5	D2 Receptor Medium Spiny Neuron Selective Vulnerability	D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons.	biological_processes[0]	biological_processes	biological_processes			protein aggregation	GO:0070841	inclusion body assembly		"{""preferred_term"": ""protein aggregation"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}"																											
3419	3787	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	5	D2 Receptor Medium Spiny Neuron Selective Vulnerability	D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons.	biological_processes[1]	biological_processes	biological_processes			synaptic transmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
3434	3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	Left Ventricular Hypertrophy	The heart muscle thickens to cope with increased workload, but this can lead to stiffness and impaired filling.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3435	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.	cell_types[0]	cell_types	cell_types			Cardiac Fibroblast	CL:0002548	fibroblast of cardiac tissue		"{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}"																											
3436	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
3437	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.	biological_processes[1]	biological_processes	biological_processes			collagen fibril organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
3438	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.	locations[0]	locations	locations			myocardial interstitium				"{""preferred_term"": ""myocardial interstitium""}"																											
3439	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.	locations[1]	locations	locations			perivascular space				"{""preferred_term"": ""perivascular space""}"																											
3440	3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
3441	3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.	cell_types[1]	cell_types	cell_types			pericyte	CL:0000669	pericyte		"{""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}"																											
3442	3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.	biological_processes[0]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"																											
3443	3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.	biological_processes[1]	biological_processes	biological_processes			regulation of nitric oxide biosynthetic process	GO:0045428	regulation of nitric oxide biosynthetic process		"{""preferred_term"": ""regulation of nitric oxide biosynthetic process"", ""term"": {""id"": ""GO:0045428"", ""label"": ""regulation of nitric oxide biosynthetic process""}}"																											
3444	3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.	locations[0]	locations	locations			coronary microvasculature				"{""preferred_term"": ""coronary microvasculature""}"																											
3445	3816	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	5	Oxidative Stress and Mitochondrial Dysfunction	NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B.	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
3446	3816	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	5	Oxidative Stress and Mitochondrial Dysfunction	NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B.	biological_processes[1]	biological_processes	biological_processes			superoxide metabolic process	GO:0006801	superoxide metabolic process		"{""preferred_term"": ""superoxide metabolic process"", ""term"": {""id"": ""GO:0006801"", ""label"": ""superoxide metabolic process""}}"																											
3447	3816	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	5	Oxidative Stress and Mitochondrial Dysfunction	NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B.	biological_processes[2]	biological_processes	biological_processes			mitochondrial electron transport	GO:0006123	mitochondrial electron transport, NADH to ubiquinone		"{""preferred_term"": ""mitochondrial electron transport"", ""term"": {""id"": ""GO:0006123"", ""label"": ""mitochondrial electron transport, NADH to ubiquinone""}}"																											
3448	3816	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	5	Oxidative Stress and Mitochondrial Dysfunction	NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B.	cellular_components[0]	cellular_components	cellular_components			mitochondrion	GO:0005739	mitochondrion		"{""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}"																											
3449	3817	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	6	Inflammasome Activation	Pressure overload and oxidative stress activate the NLRP3 inflammasome, leading to caspase-1 activation and release of IL-1 and IL-18. This inflammatory signaling amplifies cardiac fibrosis, hypertrophy, and adverse remodeling.	biological_processes[0]	biological_processes	biological_processes			inflammasome complex assembly	GO:0061702	inflammasome complex assembly		"{""preferred_term"": ""inflammasome complex assembly"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex assembly""}}"																											
3450	3817	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	6	Inflammasome Activation	Pressure overload and oxidative stress activate the NLRP3 inflammasome, leading to caspase-1 activation and release of IL-1 and IL-18. This inflammatory signaling amplifies cardiac fibrosis, hypertrophy, and adverse remodeling.	biological_processes[1]	biological_processes	biological_processes			interleukin-1 beta production	GO:0032611	interleukin-1 beta production		"{""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
3474	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3475	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	locations[0]	locations	locations			left ventricle	UBERON:0002084	heart left ventricle		"{""preferred_term"": ""left ventricle"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}"																											
3476	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	locations[1]	locations	locations			interventricular septum	UBERON:0002094	interventricular septum		"{""preferred_term"": ""interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}"																											
3477	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	cellular_components[0]	cellular_components	cellular_components			sarcomere	GO:0030017	sarcomere		"{""preferred_term"": ""sarcomere"", ""term"": {""id"": ""GO:0030017"", ""label"": ""sarcomere""}}"																											
3478	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	cellular_components[1]	cellular_components	cellular_components			thick filament	GO:0005863	myosin filament		"{""preferred_term"": ""thick filament"", ""term"": {""id"": ""GO:0005863"", ""label"": ""myosin filament""}}"																											
3479	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	cellular_components[2]	cellular_components	cellular_components			thin filament	GO:0005865	striated muscle thin filament		"{""preferred_term"": ""thin filament"", ""term"": {""id"": ""GO:0005865"", ""label"": ""striated muscle thin filament""}}"																											
3480	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	biological_processes[0]	biological_processes	biological_processes			muscle contraction	GO:0006936	muscle contraction		"{""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}"																											
3481	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	biological_processes[1]	biological_processes	biological_processes			regulation of heart contraction	GO:0008016	regulation of heart contraction		"{""preferred_term"": ""regulation of heart contraction"", ""term"": {""id"": ""GO:0008016"", ""label"": ""regulation of heart contraction""}}"																											
3482	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.	biological_processes[2]	biological_processes	biological_processes			ATP hydrolysis activity	GO:0016887	ATP hydrolysis activity		"{""preferred_term"": ""ATP hydrolysis activity"", ""term"": {""id"": ""GO:0016887"", ""label"": ""ATP hydrolysis activity""}}"																											
3483	3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	Myocyte Disarray	Disorganization of heart muscle cells contributes to the stiffness and dysfunction of the myocardium. Loss of physiological fiber alignment and orientation creates structural abnormalities that impair contractile efficiency and promote arrhythmogenic substrate.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3484	3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	Myocyte Disarray	Disorganization of heart muscle cells contributes to the stiffness and dysfunction of the myocardium. Loss of physiological fiber alignment and orientation creates structural abnormalities that impair contractile efficiency and promote arrhythmogenic substrate.	locations[0]	locations	locations			ventricular myocardium	UBERON:0002084	heart left ventricle		"{""preferred_term"": ""ventricular myocardium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}"																											
3485	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	cell_types[0]	cell_types	cell_types			Interstitial Cells	CL:4030031	interstitial cell		"{""preferred_term"": ""Interstitial Cells"", ""term"": {""id"": ""CL:4030031"", ""label"": ""interstitial cell""}}"																											
3486	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	cell_types[1]	cell_types	cell_types			cardiac fibroblast	CL:0002548	fibroblast of cardiac tissue		"{""preferred_term"": ""cardiac fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}"																											
3487	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	locations[0]	locations	locations			myocardial interstitium	UBERON:0002084	heart left ventricle		"{""preferred_term"": ""myocardial interstitium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}"																											
3488	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
3489	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	biological_processes[1]	biological_processes	biological_processes			response to TGF-beta	GO:0071559	response to transforming growth factor beta		"{""preferred_term"": ""response to TGF-beta"", ""term"": {""id"": ""GO:0071559"", ""label"": ""response to transforming growth factor beta""}}"																											
3490	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.	cellular_components[0]	cellular_components	cellular_components			extracellular matrix	GO:0031012	extracellular matrix		"{""preferred_term"": ""extracellular matrix"", ""term"": {""id"": ""GO:0031012"", ""label"": ""extracellular matrix""}}"																											
3491	3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3492	3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.	biological_processes[0]	biological_processes	biological_processes			calcium ion transport	GO:0006816	calcium ion transport		"{""preferred_term"": ""calcium ion transport"", ""term"": {""id"": ""GO:0006816"", ""label"": ""calcium ion transport""}}"																											
3493	3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.	biological_processes[1]	biological_processes	biological_processes			regulation of cardiac muscle contraction	GO:0055117	regulation of cardiac muscle contraction		"{""preferred_term"": ""regulation of cardiac muscle contraction"", ""term"": {""id"": ""GO:0055117"", ""label"": ""regulation of cardiac muscle contraction""}}"																											
3494	3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.	cellular_components[0]	cellular_components	cellular_components			sarcoplasmic reticulum	GO:0016529	sarcoplasmic reticulum		"{""preferred_term"": ""sarcoplasmic reticulum"", ""term"": {""id"": ""GO:0016529"", ""label"": ""sarcoplasmic reticulum""}}"																											
3495	3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.	locations[0]	locations	locations			left ventricle	UBERON:0002084	heart left ventricle		"{""preferred_term"": ""left ventricle"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}"																											
3496	3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3497	3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.	biological_processes[0]	biological_processes	biological_processes			ATP metabolic process	GO:0046034	ATP metabolic process		"{""preferred_term"": ""ATP metabolic process"", ""term"": {""id"": ""GO:0046034"", ""label"": ""ATP metabolic process""}}"																											
3498	3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.	biological_processes[1]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
3499	3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.	cellular_components[0]	cellular_components	cellular_components			mitochondrion	GO:0005739	mitochondrion		"{""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}"																											
3500	3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.	locations[0]	locations	locations			myocardium	UBERON:0002084	heart left ventricle		"{""preferred_term"": ""myocardium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}"																											
3501	3863	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	5	Left Ventricular Outflow Tract Obstruction	Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling.	cell_types[0]	cell_types	cell_types			Cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
3502	3863	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	5	Left Ventricular Outflow Tract Obstruction	Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling.	locations[0]	locations	locations			interventricular septum	UBERON:0002094	interventricular septum		"{""preferred_term"": ""interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}"																											
3503	3863	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	5	Left Ventricular Outflow Tract Obstruction	Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling.	locations[1]	locations	locations			mitral valve	UBERON:0002135	mitral valve		"{""preferred_term"": ""mitral valve"", ""term"": {""id"": ""UBERON:0002135"", ""label"": ""mitral valve""}}"																											
3504	3863	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	5	Left Ventricular Outflow Tract Obstruction	Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling.	locations[2]	locations	locations			left ventricular outflow tract	UBERON:0016480	cardiac outflow tract		"{""preferred_term"": ""left ventricular outflow tract"", ""term"": {""id"": ""UBERON:0016480"", ""label"": ""cardiac outflow tract""}}"																											
3520	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	Type II Collagen Structural Defect	"COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
3521	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	Type II Collagen Structural Defect	"COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.
"	cell_types[1]	cell_types	cell_types			Growth Plate Chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
3522	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	Type II Collagen Structural Defect	"COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
3523	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	Type II Collagen Structural Defect	"COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.
"	biological_processes[1]	biological_processes	biological_processes			Cartilage Development	GO:0051216	cartilage development		"{""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}"																											
3524	3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	Endoplasmic Reticulum Stress and Chondrocyte Apoptosis	"Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
3525	3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	Endoplasmic Reticulum Stress and Chondrocyte Apoptosis	"Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.
"	biological_processes[0]	biological_processes	biological_processes			ER Stress Response	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
3526	3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	Endoplasmic Reticulum Stress and Chondrocyte Apoptosis	"Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.
"	biological_processes[1]	biological_processes	biological_processes			Apoptosis	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
3533	3896	163	Hypochondroplasia	Hypochondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"	gene	gene	$	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"	FGFR3	hgnc:3690	FGFR3	Fibroblast growth factor receptor 3 with activating mutation causing mild gain-of-function.	"{""description"": ""Fibroblast growth factor receptor 3 with activating mutation causing mild gain-of-function."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"			INCREASED																								
3534	3896	163	Hypochondroplasia	Hypochondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"	cell_types[0]	cell_types	cell_types			Growth plate chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
3535	3896	163	Hypochondroplasia	Hypochondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"	biological_processes[0]	biological_processes	biological_processes			FGFR signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
3536	3896	163	Hypochondroplasia	Hypochondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"	biological_processes[1]	biological_processes	biological_processes			Endochondral ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
3545	3911	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	0	IDH Neomorphic Enzyme Activity	Wild-type IDH1 and IDH2 convert isocitrate to alpha-ketoglutarate in the cytoplasm and mitochondria respectively. Mutant IDH enzymes gain neomorphic activity, reducing alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate (2-HG), which accumulates to millimolar concentrations in leukemic cells.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
3546	3912	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	1	2-HG Accumulation and Dioxygenase Inhibition	2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits alpha-ketoglutarate-dependent dioxygenases. Key targets include TET2 DNA demethylases, Jumonji-domain histone demethylases, and prolyl hydroxylases. This disrupts normal epigenetic regulation and hypoxia responses.	biological_processes[0]	biological_processes	biological_processes			DNA demethylation	GO:0080111	DNA demethylation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA demethylation"", ""term"": {""id"": ""GO:0080111"", ""label"": ""DNA demethylation""}}"			DECREASED																								
3547	3913	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	2	DNA Hypermethylation	Inhibition of TET2 by 2-HG impairs the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, disrupting active DNA demethylation. This causes hypermethylation at gene promoters, silencing differentiation genes and contributing to the leukemic phenotype.	biological_processes[0]	biological_processes	biological_processes			myeloid cell differentiation	GO:0030099	myeloid cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}"			DECREASED																								
3548	3914	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	3	Histone Methylation Dysregulation	2-HG inhibits Jumonji-domain histone demethylases that remove methyl groups from lysine residues on histones. This causes accumulation of repressive histone marks and altered gene expression patterns contributing to leukemogenesis.	biological_processes[0]	biological_processes	biological_processes			histone demethylation	GO:0016577	histone demethylation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""histone demethylation"", ""term"": {""id"": ""GO:0016577"", ""label"": ""histone demethylation""}}"			DECREASED																								
3549	3915	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	The combined epigenetic effects of 2-HG on DNA methylation and histone modifications block normal myeloid differentiation, maintaining leukemic cells in an immature blast state. IDH inhibitors can overcome this block, inducing differentiation of leukemic blasts.	cell_types[0]	cell_types	cell_types			myeloid cell	CL:0000763	myeloid cell		"{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}"																											
3550	3915	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	The combined epigenetic effects of 2-HG on DNA methylation and histone modifications block normal myeloid differentiation, maintaining leukemic cells in an immature blast state. IDH inhibitors can overcome this block, inducing differentiation of leukemic blasts.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
3565	3936	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3566	3936	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis.	biological_processes[0]	biological_processes	biological_processes			tricarboxylic acid cycle	GO:0006099	tricarboxylic acid cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""tricarboxylic acid cycle"", ""term"": {""id"": ""GO:0006099"", ""label"": ""tricarboxylic acid cycle""}}"			ABNORMAL																								
3567	3936	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
3568	3937	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	1	2-HG Accumulation and Epigenetic Dysregulation	D-2-hydroxyglutarate competitively inhibits alpha-ketoglutarate-dependent dioxygenases including TET2 (DNA demethylation) and Jumonji-domain histone demethylases. This results in global DNA hypermethylation (G-CIMP phenotype) and histone hypermethylation, blocking cellular differentiation.	biological_processes[0]	biological_processes	biological_processes			DNA methylation	GO:0006306	DNA methylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}"			INCREASED																								
3569	3937	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	1	2-HG Accumulation and Epigenetic Dysregulation	D-2-hydroxyglutarate competitively inhibits alpha-ketoglutarate-dependent dioxygenases including TET2 (DNA demethylation) and Jumonji-domain histone demethylases. This results in global DNA hypermethylation (G-CIMP phenotype) and histone hypermethylation, blocking cellular differentiation.	biological_processes[1]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
3570	3938	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	2	Blocked Glial Differentiation	Epigenetic dysregulation caused by 2-HG prevents normal glial differentiation programs, maintaining cells in a proliferative progenitor-like state. This contributes to tumor formation but also underlies the better prognosis compared to IDH-wildtype tumors due to retained differentiation potential.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
3571	3938	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	2	Blocked Glial Differentiation	Epigenetic dysregulation caused by 2-HG prevents normal glial differentiation programs, maintaining cells in a proliferative progenitor-like state. This contributes to tumor formation but also underlies the better prognosis compared to IDH-wildtype tumors due to retained differentiation potential.	biological_processes[0]	biological_processes	biological_processes			glial cell differentiation	GO:0010001	glial cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""glial cell differentiation"", ""term"": {""id"": ""GO:0010001"", ""label"": ""glial cell differentiation""}}"			DECREASED																								
3581	3955	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells.	cell_types[0]	cell_types	cell_types			cholangiocyte	CL:1000488	cholangiocyte		"{""preferred_term"": ""cholangiocyte"", ""term"": {""id"": ""CL:1000488"", ""label"": ""cholangiocyte""}}"																											
3582	3955	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells.	biological_processes[0]	biological_processes	biological_processes			isocitrate dehydrogenase (NADP+) activity	GO:0004450	isocitrate dehydrogenase (NADP+) activity		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""isocitrate dehydrogenase (NADP+) activity"", ""term"": {""id"": ""GO:0004450"", ""label"": ""isocitrate dehydrogenase (NADP+) activity""}}"			ABNORMAL																								
3583	3955	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells.	locations[0]	locations	locations			intrahepatic bile duct	UBERON:0003704	intrahepatic bile duct		"{""preferred_term"": ""intrahepatic bile duct"", ""term"": {""id"": ""UBERON:0003704"", ""label"": ""intrahepatic bile duct""}}"																											
3584	3957	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	2	Epigenetic Dysregulation and DNA Hypermethylation	2-HG inhibition of TET2 blocks conversion of 5-methylcytosine to 5-hydroxymethylcytosine, causing DNA hypermethylation. This CpG island methylator phenotype (CIMP) silences tumor suppressor genes and differentiation programs, contributing to the block in cellular differentiation characteristic of IDH-mutant tumors.	biological_processes[0]	biological_processes	biological_processes			DNA methylation	GO:0006306	DNA methylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}"			INCREASED																								
3585	3959	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	4	Differentiation Block and Tumor Growth	Combined epigenetic alterations block normal cholangiocyte differentiation, maintaining cells in a progenitor-like state with proliferative capacity. This promotes tumor growth while the cells retain sensitivity to IDH inhibition, which can restore differentiation programs.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3597	3980	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas.	cell_types[0]	cell_types	cell_types			oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
3598	3980	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas.	biological_processes[0]	biological_processes	biological_processes			tricarboxylic acid cycle	GO:0006099	tricarboxylic acid cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""tricarboxylic acid cycle"", ""term"": {""id"": ""GO:0006099"", ""label"": ""tricarboxylic acid cycle""}}"			ABNORMAL																								
3599	3980	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas.	locations[0]	locations	locations			brain	UBERON:0000955	brain		"{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
3600	3981	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	1	1p/19q Codeletion	The 1p/19q codeletion results from an unbalanced translocation t(1;19)(q10;p10) occurring early in tumorigenesis. This leads to loss of tumor suppressor genes including CIC on 19q and FUBP1 on 1p. The codeletion is associated with oligodendroglial differentiation and exceptional chemosensitivity.	biological_processes[0]	biological_processes	biological_processes			chromosome organization	GO:0051276	chromosome organization		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}"			ABNORMAL																								
3601	3982	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	2	G-CIMP Hypermethylation Phenotype	Glioma CpG island methylator phenotype (G-CIMP) results from 2-HG-mediated inhibition of TET enzymes and histone demethylases. This leads to widespread promoter hypermethylation, altered gene expression, and blocked differentiation. G-CIMP is associated with favorable prognosis.	biological_processes[0]	biological_processes	biological_processes			DNA methylation	GO:0006306	DNA methylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}"			INCREASED																								
3602	3983	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	3	CIC/FUBP1 Tumor Suppressor Loss	CIC (Capicua) on 19q13 is mutated in approximately 70% of oligodendrogliomas. FUBP1 on 1p31 is mutated in approximately 30%. These mutations cooperate with IDH mutation and 1p/19q codeletion to drive oligodendroglioma formation.	biological_processes[0]	biological_processes	biological_processes			negative regulation of cell population proliferation	GO:0008285	negative regulation of cell population proliferation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of cell population proliferation"", ""term"": {""id"": ""GO:0008285"", ""label"": ""negative regulation of cell population proliferation""}}"			DECREASED																								
3603	3984	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	4	Oligodendroglial Tumorigenesis	The combination of IDH mutation, 1p/19q codeletion, and CIC/FUBP1 mutations drives oligodendroglioma formation. These tumors retain oligodendroglial differentiation markers and maintain sensitivity to DNA-damaging agents, likely due to intact DNA damage response pathways.	cell_types[0]	cell_types	cell_types			oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
3604	3984	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	4	Oligodendroglial Tumorigenesis	The combination of IDH mutation, 1p/19q codeletion, and CIC/FUBP1 mutations drives oligodendroglioma formation. These tumors retain oligodendroglial differentiation markers and maintain sensitivity to DNA-damaging agents, likely due to intact DNA damage response pathways.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3612	3999	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	0	Galactose-Deficient IgA1 Production	Aberrantly glycosylated IgA1 with reduced galactose in the hinge region is produced by mucosal B cells. This galactose-deficient IgA1 (Gd-IgA1) is the key autoantigen in IgA nephropathy.	cell_types[0]	cell_types	cell_types			B Cell	CL:0000236	B cell		"{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
3613	3999	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	0	Galactose-Deficient IgA1 Production	Aberrantly glycosylated IgA1 with reduced galactose in the hinge region is produced by mucosal B cells. This galactose-deficient IgA1 (Gd-IgA1) is the key autoantigen in IgA nephropathy.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
3614	4000	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	1	Anti-Gd-IgA1 Autoantibody Formation	IgG and IgA autoantibodies recognize exposed GalNAc residues on Gd-IgA1. These autoantibodies form circulating immune complexes with Gd-IgA1 that deposit in the glomerular mesangium.	biological_processes[0]	biological_processes	biological_processes			Immune Complex Formation	GO:0006955	immune response		"{""preferred_term"": ""Immune Complex Formation"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
3615	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	Mesangial Cell Activation and Proliferation	IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components.	cell_types[0]	cell_types	cell_types			Mesangial Cell	CL:0000650	mesangial cell		"{""preferred_term"": ""Mesangial Cell"", ""term"": {""id"": ""CL:0000650"", ""label"": ""mesangial cell""}}"																											
3616	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	Mesangial Cell Activation and Proliferation	IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components.	biological_processes[0]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}"																											
3617	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	Mesangial Cell Activation and Proliferation	IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components.	biological_processes[1]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
3622	4014	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	0	Antiplatelet Antibody Production	Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis.	cell_types[0]	cell_types	cell_types			Platelet	CL:0000233	platelet		"{""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}"																											
3623	4014	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	0	Antiplatelet Antibody Production	Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
3624	4014	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	0	Antiplatelet Antibody Production	Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis.	biological_processes[0]	biological_processes	biological_processes			Phagocytosis	GO:0006909	phagocytosis		"{""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}"																											
3625	4015	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	1	Impaired Megakaryopoiesis	Autoantibodies also target megakaryocytes, impairing platelet production. T cell-mediated megakaryocyte damage and cytokine effects further suppress thrombopoiesis.	cell_types[0]	cell_types	cell_types			Megakaryocyte	CL:0000556	megakaryocyte		"{""preferred_term"": ""Megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}"																											
3626	4015	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	1	Impaired Megakaryopoiesis	Autoantibodies also target megakaryocytes, impairing platelet production. T cell-mediated megakaryocyte damage and cytokine effects further suppress thrombopoiesis.	biological_processes[0]	biological_processes	biological_processes			Platelet Formation	GO:0030220	platelet formation		"{""preferred_term"": ""Platelet Formation"", ""term"": {""id"": ""GO:0030220"", ""label"": ""platelet formation""}}"																											
3627	4016	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	2	T Cell Dysregulation	Th1/Th17 imbalance and reduced regulatory T cell function contribute to loss of tolerance. Cytotoxic T cells may directly kill platelets and megakaryocytes.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
3628	4016	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	2	T Cell Dysregulation	Th1/Th17 imbalance and reduced regulatory T cell function contribute to loss of tolerance. Cytotoxic T cells may directly kill platelets and megakaryocytes.	biological_processes[0]	biological_processes	biological_processes			Immune Regulation	GO:0002682	regulation of immune system process		"{""preferred_term"": ""Immune Regulation"", ""term"": {""id"": ""GO:0002682"", ""label"": ""regulation of immune system process""}}"																											
3629	4017	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	3	Complement Activation	Classical complement pathway activation occurs in many ITP patients, with C3, C4, and C9 deposition on platelets. Complement activation enhances platelet opsonization and clearance. Elevated complement activation markers correlate with disease severity and platelet count.	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
3634	4028	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	1	Host Genetic Susceptibility and Immune Response	Host genetic factors and immune response pathways influence progression from exposure to mild or severe infection and determine disease outcomes.	biological_processes[0]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"			ABNORMAL																								
3649	4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	Visceral Hypersensitivity	"Enhanced perception of normal gut sensations leads to pain and discomfort. Lowered pain thresholds in response to balloon distension. Central sensitization contributes.
"	biological_processes[0]	biological_processes	biological_processes			Pain Perception	GO:0048265	response to pain		"{""preferred_term"": ""Pain Perception"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}"																											
3650	4044	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	1	Gut Dysmotility	"Altered intestinal motility patterns with either accelerated (diarrhea-predominant) or delayed (constipation-predominant) transit. Abnormal colonic contractions.
"	biological_processes[0]	biological_processes	biological_processes			Gut Motility	GO:0030432	peristalsis		"{""preferred_term"": ""Gut Motility"", ""term"": {""id"": ""GO:0030432"", ""label"": ""peristalsis""}}"																											
3651	4045	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	2	Gut-Brain Axis Dysfunction	"Bidirectional communication between gut and brain is disrupted. Stress and psychological factors modulate gut function through autonomic and neuroendocrine pathways.
"	biological_processes[0]	biological_processes	biological_processes			Nervous System Process	GO:0050877	nervous system process		"{""preferred_term"": ""Nervous System Process"", ""term"": {""id"": ""GO:0050877"", ""label"": ""nervous system process""}}"																											
3652	4047	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	4	Immune Activation and Mast Cell Degranulation	"Low-grade mucosal immune activation with increased mast cell density and degranulation near enteric nerves. Mast cell mediators including histamine and tryptase excite visceral sensory neurons, contributing to pain and hypersensitivity.
"	biological_processes[0]	biological_processes	biological_processes			Mast Cell Activation	GO:0045576	mast cell activation		"{""preferred_term"": ""Mast Cell Activation"", ""term"": {""id"": ""GO:0045576"", ""label"": ""mast cell activation""}}"																											
3653	4048	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	5	Microbiome Dysbiosis	"Altered composition and function of gut microbiota may contribute to symptoms. Post-infectious IBS follows gastroenteritis in some patients.
"	biological_processes[0]	biological_processes	biological_processes			Host-Microbiome Interaction	GO:0044003	modification by symbiont of host morphology or physiology		"{""preferred_term"": ""Host-Microbiome Interaction"", ""term"": {""id"": ""GO:0044003"", ""label"": ""modification by symbiont of host morphology or physiology""}}"																											
3660	4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
3661	4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
3662	4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
3673	4090	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Neurons in the brain exhibit increased excitability, particularly in response to visual stimuli.	cell_types[0]	cell_types	cell_types			Excitatory Glutamatergic Neuron	CL:0000679	glutamatergic neuron	Neurons that use glutamate as their primary neurotransmitter and mediate excitatory synaptic transmission.	"{""description"": ""Neurons that use glutamate as their primary neurotransmitter and mediate excitatory synaptic transmission."", ""preferred_term"": ""Excitatory Glutamatergic Neuron"", ""term"": {""id"": ""CL:0000679"", ""label"": ""glutamatergic neuron""}}"																											
3674	4090	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Neurons in the brain exhibit increased excitability, particularly in response to visual stimuli.	biological_processes[0]	biological_processes	biological_processes			chemical synaptic transmission	GO:0007268	chemical synaptic transmission	Process of synaptic signaling involving neurotransmitter release and receptor activation.	"{""description"": ""Process of synaptic signaling involving neurotransmitter release and receptor activation."", ""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
3675	4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	Disrupted Cortical Function	Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures.	locations[0]	locations	locations			Visual Cortex	UBERON:0000411	visual cortex	Brain region in the occipital lobe responsible for processing visual information.	"{""description"": ""Brain region in the occipital lobe responsible for processing visual information."", ""preferred_term"": ""Visual Cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}"																											
3676	4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	Disrupted Cortical Function	Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures.	locations[1]	locations	locations			Thalamus	UBERON:0001897	dorsal plus ventral thalamus	Central brain structure that relays sensory and motor signals to the cerebral cortex.	"{""description"": ""Central brain structure that relays sensory and motor signals to the cerebral cortex."", ""preferred_term"": ""Thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}"																											
3677	4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	Disrupted Cortical Function	Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures.	biological_processes[0]	biological_processes	biological_processes			visual perception	GO:0007601	visual perception	Process by which visual stimuli are received and interpreted by the nervous system.	"{""description"": ""Process by which visual stimuli are received and interpreted by the nervous system."", ""preferred_term"": ""visual perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}"																											
3689	4114	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	KIT mutations, most commonly in exons 11, 13, and 17, result in constitutive receptor activation independent of stem cell factor (SCF) ligand binding. Mutations may cause ligand-independent dimerization, altered kinase domain conformation, or loss of autoinhibitory mechanisms, leading to persistent downstream signaling.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
3690	4114	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	KIT mutations, most commonly in exons 11, 13, and 17, result in constitutive receptor activation independent of stem cell factor (SCF) ligand binding. Mutations may cause ligand-independent dimerization, altered kinase domain conformation, or loss of autoinhibitory mechanisms, leading to persistent downstream signaling.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
3691	4115	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	1	MAPK Pathway Activation	Activated KIT recruits adapter proteins that engage RAS-MAPK signaling, driving melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle progression.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
3692	4116	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	KIT activates PI3K through recruitment and phosphorylation of adapter proteins. Subsequent AKT activation promotes cell survival through inhibition of pro-apoptotic proteins and activation of mTOR signaling.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
3693	4117	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	3	Uncontrolled Melanocyte Proliferation	Constitutive KIT signaling through MAPK and PI3K pathways drives abnormal melanocyte proliferation in acral and mucosal sites, leading to tumor formation.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
3694	4117	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	3	Uncontrolled Melanocyte Proliferation	Constitutive KIT signaling through MAPK and PI3K pathways drives abnormal melanocyte proliferation in acral and mucosal sites, leading to tumor formation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3695	4118	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	4	Cell Survival and Anti-Apoptosis	PI3K-AKT activation downstream of KIT promotes melanoma cell survival through phosphorylation-mediated inactivation of pro-apoptotic proteins and activation of survival pathways.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3704	4133	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	0	KRAS G12C Oncogenic Mutation	The KRAS G12C mutation substitutes cysteine for glycine at codon 12, impairing GTPase activity and trapping KRAS in the active GTP-bound state. However, unlike other KRAS mutations, G12C retains some GTPase activity, cycling between active (GTP-bound) and inactive (GDP-bound) states. This cycling creates a therapeutic window for covalent inhibitors that bind the mutant cysteine in the GDP-bound state.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
3705	4133	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	0	KRAS G12C Oncogenic Mutation	The KRAS G12C mutation substitutes cysteine for glycine at codon 12, impairing GTPase activity and trapping KRAS in the active GTP-bound state. However, unlike other KRAS mutations, G12C retains some GTPase activity, cycling between active (GTP-bound) and inactive (GDP-bound) states. This cycling creates a therapeutic window for covalent inhibitors that bind the mutant cysteine in the GDP-bound state.	biological_processes[0]	biological_processes	biological_processes			small GTPase mediated signal transduction	GO:0007264	small GTPase mediated signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""small GTPase mediated signal transduction"", ""term"": {""id"": ""GO:0007264"", ""label"": ""small GTPase mediated signal transduction""}}"			INCREASED																								
3706	4134	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive RAS Signaling	Mutant KRAS drives constitutive activation of downstream effector pathways including RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The MAPK pathway is the predominant driver of oncogenic phenotypes in KRAS-mutant NSCLC.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
3707	4134	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive RAS Signaling	Mutant KRAS drives constitutive activation of downstream effector pathways including RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The MAPK pathway is the predominant driver of oncogenic phenotypes in KRAS-mutant NSCLC.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
3708	4135	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Survival	Constitutive KRAS signaling promotes uncontrolled cell proliferation through ERK-mediated transcription of cell cycle genes and survival through AKT-mediated inhibition of apoptosis.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3709	4136	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	3	KRAS G12C Inhibitor Resistance	Resistance to KRAS G12C inhibitors develops through multiple mechanisms: secondary KRAS mutations (Y96C, R68S, H95D/Q/R), KRAS amplification, bypass pathway activation (MET, EGFR, FGFR, PI3K), and histologic transformation. Adaptive feedback through RTK reactivation (EGFR, FGFR, SHP2) is common.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
3720	4154	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	0	HHV-8 Latent Infection of Endothelial Cells	HHV-8 infects endothelial cells and establishes latent infection with expression of latency-associated nuclear antigen (LANA), vFLIP, and vCyclin. LANA maintains the viral episome and inhibits p53 and Rb tumor suppressor function. Latently infected cells undergo spindle cell transformation characteristic of KS.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
3721	4154	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	0	HHV-8 Latent Infection of Endothelial Cells	HHV-8 infects endothelial cells and establishes latent infection with expression of latency-associated nuclear antigen (LANA), vFLIP, and vCyclin. LANA maintains the viral episome and inhibits p53 and Rb tumor suppressor function. Latently infected cells undergo spindle cell transformation characteristic of KS.	biological_processes[0]	biological_processes	biological_processes			viral transcription	GO:0019083	viral transcription		"{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}"																											
3722	4155	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	1	vFLIP-Mediated NF-kappaB Activation	Viral FLICE inhibitory protein (vFLIP) constitutively activates NF-kappaB signaling by interacting with IKK complex. This promotes cell survival, inflammation, and cytokine production. vFLIP also inhibits caspase-8-mediated apoptosis, providing resistance to death receptor-induced cell death.	biological_processes[0]	biological_processes	biological_processes			positive regulation of NF-kappaB transcription factor activity	GO:0051092	positive regulation of NF-kappaB transcription factor activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of NF-kappaB transcription factor activity"", ""term"": {""id"": ""GO:0051092"", ""label"": ""positive regulation of NF-kappaB transcription factor activity""}}"			INCREASED																								
3723	4156	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	2	vCyclin-Mediated Cell Cycle Dysregulation	Viral cyclin (vCyclin) forms active complexes with CDK6 that are resistant to inhibition by p16INK4A, p21, and p27. This drives cells through G1/S checkpoint regardless of normal growth regulatory signals, contributing to uncontrolled proliferation.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			ABNORMAL																								
3724	4157	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	3	vGPCR-Mediated Angiogenic Signaling	The viral G protein-coupled receptor (vGPCR) is expressed during lytic reactivation and activates multiple signaling pathways in a ligand-independent manner, including VEGF production and MAPK activation. vGPCR is highly oncogenic and promotes the angiogenic, inflammatory microenvironment characteristic of KS lesions.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
3725	4158	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	4	Apoptosis Resistance and Cell Survival	Multiple viral genes cooperate to prevent apoptosis: vFLIP inhibits caspase-8 and activates NF-kappaB; LANA inhibits p53; vBCL-2 mimics cellular BCL-2. This multi-layered apoptosis resistance enables survival and accumulation of infected cells.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3726	4159	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	5	Uncontrolled Cell Proliferation	Combined effects of vCyclin, LANA-mediated Rb inhibition, and growth factor signaling drive spindle cell proliferation, forming the characteristic KS lesions.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3727	4160	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	6	Angiogenic Proliferation	KS lesions are highly vascular due to vGPCR-induced VEGF and inflammatory cytokine production. The aberrant angiogenesis creates the characteristic red-purple appearance and contributes to edema and hemorrhage.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
3728	4160	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	6	Angiogenic Proliferation	KS lesions are highly vascular due to vGPCR-induced VEGF and inflammatory cytokine production. The aberrant angiogenesis creates the characteristic red-purple appearance and contributes to edema and hemorrhage.	biological_processes[0]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
3740	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	cell_types[0]	cell_types	cell_types			vascular endothelial cell	CL:0000071	blood vessel endothelial cell	Primary target cells undergoing activation and dysfunction	"{""description"": ""Primary target cells undergoing activation and dysfunction"", ""preferred_term"": ""vascular endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}"																											
3741	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	cell_types[1]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil	Recruited to vessel walls during necrotizing arteritis phase	"{""description"": ""Recruited to vessel walls during necrotizing arteritis phase"", ""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
3742	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	cell_types[2]	cell_types	cell_types			monocyte	CL:0000576	monocyte	Activated by immune complexes and FcR signaling	"{""description"": ""Activated by immune complexes and FcR signaling"", ""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
3743	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	cell_types[3]	cell_types	cell_types			macrophage	CL:0000235	macrophage	Present in coronary lesions producing cytokines	"{""description"": ""Present in coronary lesions producing cytokines"", ""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
3744	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	biological_processes[0]	biological_processes	biological_processes			endothelial cell activation	GO:0042118	endothelial cell activation	Cytokine-driven upregulation of adhesion molecules and inflammatory mediators	"{""description"": ""Cytokine-driven upregulation of adhesion molecules and inflammatory mediators"", ""preferred_term"": ""endothelial cell activation"", ""term"": {""id"": ""GO:0042118"", ""label"": ""endothelial cell activation""}}"																											
3745	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	biological_processes[1]	biological_processes	biological_processes			leukocyte adhesion to vascular endothelial cell	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	ICAM-1/VCAM-1 mediated leukocyte recruitment	"{""description"": ""ICAM-1/VCAM-1 mediated leukocyte recruitment"", ""preferred_term"": ""leukocyte adhesion to vascular endothelial cell"", ""term"": {""id"": ""GO:1904996"", ""label"": ""positive regulation of leukocyte adhesion to vascular endothelial cell""}}"																											
3746	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	biological_processes[2]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response	Systemic hyperinflammatory syndrome with cytokine cascades	"{""description"": ""Systemic hyperinflammatory syndrome with cytokine cascades"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3747	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	locations[0]	locations	locations			coronary artery	UBERON:0001621	coronary artery	Primary site of arteritis and aneurysm formation	"{""description"": ""Primary site of arteritis and aneurysm formation"", ""preferred_term"": ""coronary artery"", ""term"": {""id"": ""UBERON:0001621"", ""label"": ""coronary artery""}}"																											
3748	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.	locations[1]	locations	locations			artery wall	UBERON:0035965	artery wall	All three layers (intima, media, adventitia) undergo inflammation	"{""description"": ""All three layers (intima, media, adventitia) undergo inflammation"", ""preferred_term"": ""artery wall"", ""term"": {""id"": ""UBERON:0035965"", ""label"": ""artery wall""}}"																											
3749	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta T cell	CL:0000625	CD8-positive, alpha-beta T cell	CD8+ T cells present in coronary lesions	"{""description"": ""CD8+ T cells present in coronary lesions"", ""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3750	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[1]	cell_types	cell_types			T-helper 17 cell	CL:0000899	T-helper 17 cell	Th17 expansion associated with coronary damage and IVIG resistance	"{""description"": ""Th17 expansion associated with coronary damage and IVIG resistance"", ""preferred_term"": ""T-helper 17 cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}"																											
3751	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[2]	cell_types	cell_types			regulatory T cell	CL:0000815	regulatory T cell	Treg imbalance contributes to immune dysregulation	"{""description"": ""Treg imbalance contributes to immune dysregulation"", ""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}"																											
3752	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[3]	cell_types	cell_types			plasmablast	CL:0000980	plasmablast	Convergent antigen-driven plasmablast responses in some patients	"{""description"": ""Convergent antigen-driven plasmablast responses in some patients"", ""preferred_term"": ""plasmablast"", ""term"": {""id"": ""CL:0000980"", ""label"": ""plasmablast""}}"																											
3753	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[4]	cell_types	cell_types			plasma cell	CL:0000786	plasma cell	IgA plasma cells found in coronary lesions	"{""description"": ""IgA plasma cells found in coronary lesions"", ""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}"																											
3754	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	cell_types[5]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell	Involved in antigen presentation and T-cell activation	"{""description"": ""Involved in antigen presentation and T-cell activation"", ""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
3755	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[0]	biological_processes	biological_processes			NLRP3 inflammasome complex assembly	GO:0072559	NLRP3 inflammasome complex assembly	NLRP3 inflammasome activation leading to IL-1 release	"{""description"": ""NLRP3 inflammasome activation leading to IL-1 release"", ""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}"																											
3756	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[1]	biological_processes	biological_processes			interleukin-1 beta production	GO:0032611	interleukin-1 beta production	IL-1 promotes endothelial injury and inflammation	"{""description"": ""IL-1 promotes endothelial injury and inflammation"", ""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}"																											
3757	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[2]	biological_processes	biological_processes			tumor necrosis factor production	GO:0032640	tumor necrosis factor production	TNF- induces endothelial activation and NF-B signaling	"{""description"": ""TNF- induces endothelial activation and NF-B signaling"", ""preferred_term"": ""tumor necrosis factor production"", ""term"": {""id"": ""GO:0032640"", ""label"": ""tumor necrosis factor production""}}"																											
3758	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[3]	biological_processes	biological_processes			interleukin-17 production	GO:0032620	interleukin-17 production	IL-17 from Th17 cells promotes neutrophil recruitment	"{""description"": ""IL-17 from Th17 cells promotes neutrophil recruitment"", ""preferred_term"": ""interleukin-17 production"", ""term"": {""id"": ""GO:0032620"", ""label"": ""interleukin-17 production""}}"																											
3759	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[4]	biological_processes	biological_processes			calcium ion transmembrane transport	GO:0070588	calcium ion transmembrane transport	Dysregulated Ca2+/calcineurin-NFAT signaling pathway	"{""description"": ""Dysregulated Ca2+/calcineurin-NFAT signaling pathway"", ""preferred_term"": ""calcium ion transmembrane transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}"																											
3760	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[5]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation	Enhanced T-cell activation via CD40-CD40L co-stimulation	"{""description"": ""Enhanced T-cell activation via CD40-CD40L co-stimulation"", ""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
3761	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.	biological_processes[6]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation	Complement fixation contributes to vascular injury	"{""description"": ""Complement fixation contributes to vascular injury"", ""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
3776	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	Gap Junction Dysfunction	"Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.
"	cell_types[0]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
3777	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	Gap Junction Dysfunction	"Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.
"	biological_processes[0]	biological_processes	biological_processes			Gap junction assembly	GO:0016264	gap junction assembly		"{""preferred_term"": ""Gap junction assembly"", ""term"": {""id"": ""GO:0016264"", ""label"": ""gap junction assembly""}}"																											
3778	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	Gap Junction Dysfunction	"Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.
"	biological_processes[1]	biological_processes	biological_processes			Cell-cell signaling	GO:0007267	cell-cell signaling		"{""preferred_term"": ""Cell-cell signaling"", ""term"": {""id"": ""GO:0007267"", ""label"": ""cell-cell signaling""}}"																											
3779	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	Gap Junction Dysfunction	"Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.
"	locations[0]	locations	locations			Skin of palm and sole	UBERON:0013776	skin of palmar/plantar part of autopod		"{""preferred_term"": ""Skin of palm and sole"", ""term"": {""id"": ""UBERON:0013776"", ""label"": ""skin of palmar/plantar part of autopod""}}"																											
3780	4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	Abnormal Epidermal Differentiation	"Defective gap junction signaling leads to hyperproliferation and abnormal keratinization of palmoplantar epidermis, resulting in the characteristic thickened honeycomb-patterned skin. The mutation impairs epidermal differentiation as well as inner ear function.
"	cell_types[0]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
3781	4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	Abnormal Epidermal Differentiation	"Defective gap junction signaling leads to hyperproliferation and abnormal keratinization of palmoplantar epidermis, resulting in the characteristic thickened honeycomb-patterned skin. The mutation impairs epidermal differentiation as well as inner ear function.
"	biological_processes[0]	biological_processes	biological_processes			Keratinocyte differentiation	GO:0030216	keratinocyte differentiation		"{""preferred_term"": ""Keratinocyte differentiation"", ""term"": {""id"": ""GO:0030216"", ""label"": ""keratinocyte differentiation""}}"																											
3782	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	Mutant Loricrin Nuclear Accumulation	"In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.
"	cell_types[0]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
3783	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	Mutant Loricrin Nuclear Accumulation	"In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.
"	biological_processes[0]	biological_processes	biological_processes			Cornified envelope assembly	GO:1903575	cornified envelope assembly		"{""preferred_term"": ""Cornified envelope assembly"", ""term"": {""id"": ""GO:1903575"", ""label"": ""cornified envelope assembly""}}"																											
3784	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	Mutant Loricrin Nuclear Accumulation	"In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.
"	biological_processes[1]	biological_processes	biological_processes			Keratinocyte differentiation	GO:0030216	keratinocyte differentiation		"{""preferred_term"": ""Keratinocyte differentiation"", ""term"": {""id"": ""GO:0030216"", ""label"": ""keratinocyte differentiation""}}"																											
3785	4227	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	4	Cochlear Dysfunction	"Connexin 26 is essential for potassium recycling in the cochlea. Its dysfunction disrupts the endocochlear potential required for auditory transduction, causing sensorineural hearing loss. This phenotype is specific to GJB2 mutations and is absent in the loricrin-associated variant.
"	locations[0]	locations	locations			Cochlea	UBERON:0001844	cochlea		"{""preferred_term"": ""Cochlea"", ""term"": {""id"": ""UBERON:0001844"", ""label"": ""cochlea""}}"																											
3794	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	cell_types[0]	cell_types	cell_types			Sertoli Cell	CL:0000216	Sertoli cell		"{""preferred_term"": ""Sertoli Cell"", ""term"": {""id"": ""CL:0000216"", ""label"": ""Sertoli cell""}}"																											
3795	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	cell_types[1]	cell_types	cell_types			Leydig Cell	CL:0000178	Leydig cell		"{""preferred_term"": ""Leydig Cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}"																											
3796	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	cell_types[2]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
3797	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	cell_types[3]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
3798	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	biological_processes[0]	biological_processes	biological_processes			Spermatogenesis	GO:0007283	spermatogenesis		"{""preferred_term"": ""Spermatogenesis"", ""term"": {""id"": ""GO:0007283"", ""label"": ""spermatogenesis""}}"																											
3799	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	biological_processes[1]	biological_processes	biological_processes			Angiogenesis	GO:0001525	angiogenesis		"{""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"																											
3800	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	biological_processes[2]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3801	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	biological_processes[3]	biological_processes	biological_processes			Extracellular Matrix Organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""Extracellular Matrix Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
3802	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	locations[0]	locations	locations			Testis	UBERON:0000473	testis		"{""preferred_term"": ""Testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}"																											
3803	4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.	locations[1]	locations	locations			Seminiferous Tubule	UBERON:0001343	seminiferous tubule of testis		"{""preferred_term"": ""Seminiferous Tubule"", ""term"": {""id"": ""UBERON:0001343"", ""label"": ""seminiferous tubule of testis""}}"																											
3804	4254	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	2	Progressive Germ Cell Loss	Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.	cell_types[0]	cell_types	cell_types			Spermatocyte	CL:0000017	spermatocyte		"{""preferred_term"": ""Spermatocyte"", ""term"": {""id"": ""CL:0000017"", ""label"": ""spermatocyte""}}"																											
3805	4254	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	2	Progressive Germ Cell Loss	Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.	biological_processes[0]	biological_processes	biological_processes			Apoptotic Process	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
3806	4254	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	2	Progressive Germ Cell Loss	Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.	biological_processes[1]	biological_processes	biological_processes			Spermatogenesis	GO:0007283	spermatogenesis		"{""preferred_term"": ""Spermatogenesis"", ""term"": {""id"": ""GO:0007283"", ""label"": ""spermatogenesis""}}"																											
3807	4254	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	2	Progressive Germ Cell Loss	Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.	locations[0]	locations	locations			Seminiferous Tubule	UBERON:0001343	seminiferous tubule of testis		"{""preferred_term"": ""Seminiferous Tubule"", ""term"": {""id"": ""UBERON:0001343"", ""label"": ""seminiferous tubule of testis""}}"																											
3808	4255	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	3	Hypergonadotropic Hypogonadism	Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.	cell_types[0]	cell_types	cell_types			Leydig Cell	CL:0000178	Leydig cell		"{""preferred_term"": ""Leydig Cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}"																											
3809	4255	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	3	Hypergonadotropic Hypogonadism	Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.	biological_processes[0]	biological_processes	biological_processes			Testosterone Biosynthetic Process	GO:0061370	testosterone biosynthetic process		"{""preferred_term"": ""Testosterone Biosynthetic Process"", ""term"": {""id"": ""GO:0061370"", ""label"": ""testosterone biosynthetic process""}}"																											
3810	4255	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	3	Hypergonadotropic Hypogonadism	Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.	biological_processes[1]	biological_processes	biological_processes			Hormone Secretion	GO:0046879	hormone secretion		"{""preferred_term"": ""Hormone Secretion"", ""term"": {""id"": ""GO:0046879"", ""label"": ""hormone secretion""}}"																											
3811	4255	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	3	Hypergonadotropic Hypogonadism	Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.	locations[0]	locations	locations			Testis	UBERON:0000473	testis		"{""preferred_term"": ""Testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}"																											
3828	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	Type II Collagen Structural Abnormality	"Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
3829	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	Type II Collagen Structural Abnormality	"Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
3830	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	Type II Collagen Structural Abnormality	"Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.
"	biological_processes[1]	biological_processes	biological_processes			Cartilage Development	GO:0051216	cartilage development		"{""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}"																											
3831	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	Type II Collagen Structural Abnormality	"Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.
"	biological_processes[2]	biological_processes	biological_processes			ECM Organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""ECM Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
3848	4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	Gluten-triggered intestinal autoimmunity in celiac disease	"Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.
"	cell_types[0]	cell_types	cell_types			T lymphocyte	CL:0000084	T cell		"{""preferred_term"": ""T lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
3849	4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	Gluten-triggered intestinal autoimmunity in celiac disease	"Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.
"	biological_processes[0]	biological_processes	biological_processes			antigen processing and presentation	GO:0019882	antigen processing and presentation		"{""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}"																											
3850	4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	Gluten-triggered intestinal autoimmunity in celiac disease	"Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.
"	biological_processes[1]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
3851	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"	cell_types[0]	cell_types	cell_types			capillary endothelial cell	CL:0002144	capillary endothelial cell		"{""preferred_term"": ""capillary endothelial cell"", ""term"": {""id"": ""CL:0002144"", ""label"": ""capillary endothelial cell""}}"																											
3852	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"	cell_types[1]	cell_types	cell_types			eosinophil	CL:0000041	mature eosinophil		"{""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000041"", ""label"": ""mature eosinophil""}}"																											
3853	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"	cell_types[2]	cell_types	cell_types			basophil	CL:0000767	basophil		"{""preferred_term"": ""basophil"", ""term"": {""id"": ""CL:0000767"", ""label"": ""basophil""}}"																											
3854	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"	biological_processes[0]	biological_processes	biological_processes			regulation of vascular permeability	GO:0043114	regulation of vascular permeability		"{""preferred_term"": ""regulation of vascular permeability"", ""term"": {""id"": ""GO:0043114"", ""label"": ""regulation of vascular permeability""}}"																											
3855	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3856	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	Alveolar hemorrhage and hemosiderin accumulation	"Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.
"	cell_types[0]	cell_types	cell_types			alveolar macrophage	CL:0000583	alveolar macrophage		"{""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}"																											
3857	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	Alveolar hemorrhage and hemosiderin accumulation	"Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.
"	cell_types[1]	cell_types	cell_types			pulmonary alveolar type 2 cell	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""pulmonary alveolar type 2 cell"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
3858	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	Alveolar hemorrhage and hemosiderin accumulation	"Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.
"	biological_processes[0]	biological_processes	biological_processes			heme catabolic process	GO:0006785	heme catabolic process		"{""preferred_term"": ""heme catabolic process"", ""term"": {""id"": ""GO:0006785"", ""label"": ""heme catabolic process""}}"																											
3859	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	Alveolar hemorrhage and hemosiderin accumulation	"Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.
"	biological_processes[1]	biological_processes	biological_processes			iron ion homeostasis	GO:0055072	iron ion homeostasis		"{""preferred_term"": ""iron ion homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}"																											
3860	4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	Iron and heme-driven oxidative injury and chronic remodeling	"Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.
"	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
3861	4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	Iron and heme-driven oxidative injury and chronic remodeling	"Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.
"	biological_processes[1]	biological_processes	biological_processes			epithelium regeneration	GO:0060574	epithelium regeneration		"{""preferred_term"": ""epithelium regeneration"", ""term"": {""id"": ""GO:0060574"", ""label"": ""epithelium regeneration""}}"																											
3862	4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	Iron and heme-driven oxidative injury and chronic remodeling	"Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.
"	biological_processes[2]	biological_processes	biological_processes			reactive oxygen species metabolic process	GO:0072593	reactive oxygen species metabolic process		"{""preferred_term"": ""reactive oxygen species metabolic process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}"																											
3889	4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	Failed foregut partitioning	Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus.	locations[0]	locations	locations			foregut	UBERON:0001041	foregut		"{""preferred_term"": ""foregut"", ""term"": {""id"": ""UBERON:0001041"", ""label"": ""foregut""}}"																											
3890	4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	Failed foregut partitioning	Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus.	biological_processes[0]	biological_processes	biological_processes			digestive tract development	GO:0048565	digestive tract development		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""digestive tract development"", ""term"": {""id"": ""GO:0048565"", ""label"": ""digestive tract development""}}"			DYSREGULATED																								
3891	4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	Failed foregut partitioning	Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus.	biological_processes[1]	biological_processes	biological_processes			respiratory system development	GO:0060541	respiratory system development		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""respiratory system development"", ""term"": {""id"": ""GO:0060541"", ""label"": ""respiratory system development""}}"			DYSREGULATED																								
3892	4337	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	1	Disrupted BMP4 signaling during larynx development	Disruption of BMP4 signaling perturbs laryngeal development and is associated with laryngeal cleft in a mouse model.	biological_processes[0]	biological_processes	biological_processes			BMP signaling pathway	GO:0030509	BMP signaling pathway		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}"			DYSREGULATED																								
3893	4337	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	1	Disrupted BMP4 signaling during larynx development	Disruption of BMP4 signaling perturbs laryngeal development and is associated with laryngeal cleft in a mouse model.	biological_processes[1]	biological_processes	biological_processes			larynx development	GO:0120224	larynx development		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""larynx development"", ""term"": {""id"": ""GO:0120224"", ""label"": ""larynx development""}}"			DYSREGULATED																								
3894	4338	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	2	Posterior communication between larynx/trachea and esophagus	Abnormal posterior cleft connects the larynx/trachea with the esophagus.	locations[0]	locations	locations			larynx	UBERON:0001737	larynx		"{""preferred_term"": ""larynx"", ""term"": {""id"": ""UBERON:0001737"", ""label"": ""larynx""}}"																											
3895	4338	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	2	Posterior communication between larynx/trachea and esophagus	Abnormal posterior cleft connects the larynx/trachea with the esophagus.	locations[1]	locations	locations			trachea	UBERON:0003126	trachea		"{""preferred_term"": ""trachea"", ""term"": {""id"": ""UBERON:0003126"", ""label"": ""trachea""}}"																											
3896	4338	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	2	Posterior communication between larynx/trachea and esophagus	Abnormal posterior cleft connects the larynx/trachea with the esophagus.	locations[2]	locations	locations			esophagus	UBERON:0001043	esophagus		"{""preferred_term"": ""esophagus"", ""term"": {""id"": ""UBERON:0001043"", ""label"": ""esophagus""}}"																											
3897	4339	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	3	Foregut maldevelopment during respiratory and digestive tract development	Disrupted foregut development underlies formation of the cleft.	locations[0]	locations	locations			foregut	UBERON:0001041	foregut		"{""preferred_term"": ""foregut"", ""term"": {""id"": ""UBERON:0001041"", ""label"": ""foregut""}}"																											
3898	4339	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	3	Foregut maldevelopment during respiratory and digestive tract development	Disrupted foregut development underlies formation of the cleft.	biological_processes[0]	biological_processes	biological_processes			digestive tract development	GO:0048565	digestive tract development		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""digestive tract development"", ""term"": {""id"": ""GO:0048565"", ""label"": ""digestive tract development""}}"			DYSREGULATED																								
3899	4339	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	3	Foregut maldevelopment during respiratory and digestive tract development	Disrupted foregut development underlies formation of the cleft.	biological_processes[1]	biological_processes	biological_processes			respiratory system development	GO:0060541	respiratory system development		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""respiratory system development"", ""term"": {""id"": ""GO:0060541"", ""label"": ""respiratory system development""}}"			DYSREGULATED																								
3900	4340	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	4	Enriched esophageal malformation gene expression in lateral plate mesoderm	Esophageal malformation genes show highest expression in lateral plate mesoderm during early development, implicating this tissue in maldevelopment.	locations[0]	locations	locations			lateral plate mesoderm	UBERON:0003081	lateral plate mesoderm		"{""preferred_term"": ""lateral plate mesoderm"", ""term"": {""id"": ""UBERON:0003081"", ""label"": ""lateral plate mesoderm""}}"																											
3935	4366	183	Leishmaniasis	Leishmaniasis.yaml	pathophysiology	0	Intracellular amastigote replication in macrophages	Promastigotes differentiate into amastigotes that multiply inside host macrophages.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
3942	4381	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	0	TP53 Tumor Suppressor Loss	Germline heterozygous TP53 mutations result in haploinsufficiency for p53 function. Somatic loss or inactivation of the remaining wild-type allele (second hit) eliminates p53 tumor suppressor activity, removing a critical checkpoint against malignant transformation.	biological_processes[0]	biological_processes	biological_processes			signal transduction by p53 class mediator	GO:0072331	signal transduction by p53 class mediator		"{""modifier"": ""DECREASED"", ""preferred_term"": ""signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0072331"", ""label"": ""signal transduction by p53 class mediator""}}"			DECREASED																								
3943	4382	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	1	Loss of DNA Damage Response	p53 is a master regulator of the DNA damage response. Upon detecting DNA damage, p53 activates transcription of genes involved in cell cycle arrest, DNA repair, and apoptosis. Loss of p53 function eliminates this critical surveillance mechanism.	biological_processes[0]	biological_processes	biological_processes			DNA damage response, signal transduction by p53 class mediator	GO:0030330	DNA damage response, signal transduction by p53 class mediator		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response, signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0030330"", ""label"": ""DNA damage response, signal transduction by p53 class mediator""}}"			DECREASED																								
3944	4383	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	2	Loss of Cell Cycle Checkpoint Control	p53 induces G1 arrest in response to DNA damage by activating p21 (CDKN1A) transcription, which inhibits cyclin-dependent kinases. Without p53, cells with damaged DNA continue through the cell cycle, replicating mutations.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			ABNORMAL																								
3945	4384	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	3	Impaired Apoptosis	p53 promotes apoptosis through transcriptional activation of pro-apoptotic genes (BAX, PUMA, NOXA) and repression of anti-apoptotic BCL2. Loss of p53 allows damaged and potentially transformed cells to survive and proliferate.	biological_processes[0]	biological_processes	biological_processes			intrinsic apoptotic signaling pathway by p53 class mediator	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator		"{""modifier"": ""DECREASED"", ""preferred_term"": ""intrinsic apoptotic signaling pathway by p53 class mediator"", ""term"": {""id"": ""GO:0072332"", ""label"": ""intrinsic apoptotic signaling pathway by p53 class mediator""}}"			DECREASED																								
3946	4384	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	3	Impaired Apoptosis	p53 promotes apoptosis through transcriptional activation of pro-apoptotic genes (BAX, PUMA, NOXA) and repression of anti-apoptotic BCL2. Loss of p53 allows damaged and potentially transformed cells to survive and proliferate.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
3947	4385	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	4	Genomic Instability	Loss of p53-mediated checkpoints and DNA repair coordination leads to progressive accumulation of genomic alterations including point mutations, chromosomal rearrangements, and aneuploidy. This genomic instability accelerates tumor development and drives cancer heterogeneity.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
3948	4386	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	5	Tumor Development	The combination of impaired DNA damage response, loss of cell cycle checkpoints, defective apoptosis, and genomic instability creates a permissive environment for tumor development. Different tissues vary in susceptibility, explaining the characteristic cancer spectrum of LFS.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
3960	4417	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	0	Hepatocyte Injury and Death	"Chronic liver injury from any cause leads to ongoing hepatocyte death, triggering inflammation and regenerative responses that promote fibrosis.
"	cell_types[0]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
3961	4418	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	1	Hepatic Stellate Cell Activation	"Quiescent stellate cells transform into myofibroblasts, producing excessive collagen and extracellular matrix. This is the central event in liver fibrosis.
"	cell_types[0]	cell_types	cell_types			Hepatic Stellate Cell	CL:0000632	hepatic stellate cell		"{""preferred_term"": ""Hepatic Stellate Cell"", ""term"": {""id"": ""CL:0000632"", ""label"": ""hepatic stellate cell""}}"																											
3962	4418	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	1	Hepatic Stellate Cell Activation	"Quiescent stellate cells transform into myofibroblasts, producing excessive collagen and extracellular matrix. This is the central event in liver fibrosis.
"	biological_processes[0]	biological_processes	biological_processes			Fibrosis	GO:0097186	amelogenesis		"{""preferred_term"": ""Fibrosis"", ""term"": {""id"": ""GO:0097186"", ""label"": ""amelogenesis""}}"																											
3963	4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	Portal Hypertension	"Increased resistance to portal blood flow due to architectural distortion and nodule formation. Leads to varices, ascites, and splenomegaly.
"	cell_types[0]	cell_types	cell_types			Endothelial Cell of Hepatic Sinusoid	CL:1000398	endothelial cell of hepatic sinusoid		"{""preferred_term"": ""Endothelial Cell of Hepatic Sinusoid"", ""term"": {""id"": ""CL:1000398"", ""label"": ""endothelial cell of hepatic sinusoid""}}"																											
3964	4420	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	3	Synthetic Dysfunction	"Reduced hepatocyte mass impairs production of clotting factors, albumin, and other proteins, leading to coagulopathy and hypoalbuminemia.
"	biological_processes[0]	biological_processes	biological_processes			Protein Synthesis	GO:0006412	translation		"{""preferred_term"": ""Protein Synthesis"", ""term"": {""id"": ""GO:0006412"", ""label"": ""translation""}}"																											
3978	4445	188	Long COVID	Long_COVID.yaml	pathophysiology	0	Viral Persistence	"SARS-CoV-2 viral reservoirs may persist in tissues including gut, brain, and other organs for months after acute infection. The gastrointestinal tract has emerged as a particularly significant reservoir site, with viral RNA detected in approximately 30% of intestinal specimens from Long COVID patients.
"	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
3979	4445	188	Long COVID	Long_COVID.yaml	pathophysiology	0	Viral Persistence	"SARS-CoV-2 viral reservoirs may persist in tissues including gut, brain, and other organs for months after acute infection. The gastrointestinal tract has emerged as a particularly significant reservoir site, with viral RNA detected in approximately 30% of intestinal specimens from Long COVID patients.
"	cell_types[1]	cell_types	cell_types			CD8-positive T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3980	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	Systemic Immune Activation	"Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.
"	cell_types[0]	cell_types	cell_types			CD4-positive T cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4-positive T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
3981	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	Systemic Immune Activation	"Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.
"	cell_types[1]	cell_types	cell_types			CD8-positive T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3982	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	Systemic Immune Activation	"Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
3983	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	Systemic Immune Activation	"Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.
"	biological_processes[1]	biological_processes	biological_processes			JAK-STAT signaling	GO:0007259	cell surface receptor signaling pathway via JAK-STAT		"{""preferred_term"": ""JAK-STAT signaling"", ""term"": {""id"": ""GO:0007259"", ""label"": ""cell surface receptor signaling pathway via JAK-STAT""}}"																											
3984	4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	T Cell Exhaustion and Tissue Trafficking	"SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.
"	cell_types[0]	cell_types	cell_types			CD4-positive T cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4-positive T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
3985	4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	T Cell Exhaustion and Tissue Trafficking	"SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.
"	cell_types[1]	cell_types	cell_types			CD8-positive T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
3986	4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	T Cell Exhaustion and Tissue Trafficking	"SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.
"	biological_processes[0]	biological_processes	biological_processes			T cell migration	GO:0072678	T cell migration		"{""preferred_term"": ""T cell migration"", ""term"": {""id"": ""GO:0072678"", ""label"": ""T cell migration""}}"																											
3987	4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	T Cell Exhaustion and Tissue Trafficking	"SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.
"	biological_processes[1]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
3988	4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	Endothelial Dysfunction and Microclots	"Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.
"	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
3989	4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	Endothelial Dysfunction and Microclots	"Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.
"	cell_types[1]	cell_types	cell_types			platelet	CL:0000233	platelet		"{""preferred_term"": ""platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}"																											
3990	4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	Endothelial Dysfunction and Microclots	"Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.
"	biological_processes[0]	biological_processes	biological_processes			fibrinolysis	GO:0042730	fibrinolysis		"{""preferred_term"": ""fibrinolysis"", ""term"": {""id"": ""GO:0042730"", ""label"": ""fibrinolysis""}}"																											
3991	4449	188	Long COVID	Long_COVID.yaml	pathophysiology	4	Serotonin Depletion Mechanisms	"Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.
"	biological_processes[0]	biological_processes	biological_processes			tryptophan transport	GO:0015827	tryptophan transport		"{""preferred_term"": ""tryptophan transport"", ""term"": {""id"": ""GO:0015827"", ""label"": ""tryptophan transport""}}"																											
3992	4449	188	Long COVID	Long_COVID.yaml	pathophysiology	4	Serotonin Depletion Mechanisms	"Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.
"	biological_processes[1]	biological_processes	biological_processes			platelet activation	GO:0030168	platelet activation		"{""preferred_term"": ""platelet activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}"																											
3993	4449	188	Long COVID	Long_COVID.yaml	pathophysiology	4	Serotonin Depletion Mechanisms	"Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.
"	biological_processes[2]	biological_processes	biological_processes			serotonin metabolic process	GO:0042427	serotonin metabolic process		"{""preferred_term"": ""serotonin metabolic process"", ""term"": {""id"": ""GO:0042427"", ""label"": ""serotonin metabolic process""}}"																											
3994	4450	188	Long COVID	Long_COVID.yaml	pathophysiology	5	Vagus-Hippocampal Signaling Impairment	"Peripheral serotonin depletion weakens vagus nerve activity, leading to impaired hippocampal responses and memory formation that contribute to cognitive symptoms in Long COVID.
"	biological_processes[0]	biological_processes	biological_processes			regulation of synaptic plasticity	GO:0048167	regulation of synaptic plasticity		"{""preferred_term"": ""regulation of synaptic plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"																											
3995	4450	188	Long COVID	Long_COVID.yaml	pathophysiology	5	Vagus-Hippocampal Signaling Impairment	"Peripheral serotonin depletion weakens vagus nerve activity, leading to impaired hippocampal responses and memory formation that contribute to cognitive symptoms in Long COVID.
"	biological_processes[1]	biological_processes	biological_processes			memory	GO:0007613	memory		"{""preferred_term"": ""memory"", ""term"": {""id"": ""GO:0007613"", ""label"": ""memory""}}"																											
3996	4451	188	Long COVID	Long_COVID.yaml	pathophysiology	6	Autonomic Nervous System Dysfunction	"Dysautonomia, particularly postural orthostatic tachycardia syndrome (POTS), develops in many Long COVID patients. This may be related to virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes.
"	biological_processes[0]	biological_processes	biological_processes			mast cell activation	GO:0045576	mast cell activation		"{""preferred_term"": ""mast cell activation"", ""term"": {""id"": ""GO:0045576"", ""label"": ""mast cell activation""}}"																											
3997	4452	188	Long COVID	Long_COVID.yaml	pathophysiology	7	Impaired Mitochondrial Energy Production	"Long COVID is associated with reduced mitochondrial ATP production and impaired oxidative phosphorylation, contributing to fatigue, cognitive disturbances, and exercise intolerance.
"	biological_processes[0]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
3998	4452	188	Long COVID	Long_COVID.yaml	pathophysiology	7	Impaired Mitochondrial Energy Production	"Long COVID is associated with reduced mitochondrial ATP production and impaired oxidative phosphorylation, contributing to fatigue, cognitive disturbances, and exercise intolerance.
"	biological_processes[1]	biological_processes	biological_processes			ATP biosynthetic process	GO:0006754	ATP biosynthetic process		"{""preferred_term"": ""ATP biosynthetic process"", ""term"": {""id"": ""GO:0006754"", ""label"": ""ATP biosynthetic process""}}"																											
3999	4453	188	Long COVID	Long_COVID.yaml	pathophysiology	8	Metabolic Shift and Oxidative Stress	"Mitochondrial impairment drives a shift toward glycolysis with associated oxidative stress and metabolic disturbances, further exacerbating systemic symptoms in Long COVID.
"	biological_processes[0]	biological_processes	biological_processes			glycolytic process	GO:0006096	glycolytic process		"{""preferred_term"": ""glycolytic process"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}"																											
4000	4453	188	Long COVID	Long_COVID.yaml	pathophysiology	8	Metabolic Shift and Oxidative Stress	"Mitochondrial impairment drives a shift toward glycolysis with associated oxidative stress and metabolic disturbances, further exacerbating systemic symptoms in Long COVID.
"	biological_processes[1]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
4001	4454	188	Long COVID	Long_COVID.yaml	pathophysiology	9	Mast Cell Activation	"Mast cell activation syndrome (MCAS) has been implicated in Long COVID pathophysiology. Mast cell degranulation releases pro-inflammatory mediators including histamine, contributing to fatigue, brain fog, cardiovascular symptoms, and gastrointestinal disturbances.
"	cell_types[0]	cell_types	cell_types			mast cell	CL:0000097	mast cell		"{""preferred_term"": ""mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}"																											
4002	4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	Neuroinflammation	"Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.
"	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
4003	4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	Neuroinflammation	"Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.
"	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
4004	4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	Neuroinflammation	"Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4030	4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	Odontogenic Source Infection (Mandibular Molar)	Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4031	4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	Odontogenic Source Infection (Mandibular Molar)	Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces.	biological_processes[0]	biological_processes	biological_processes			Response to bacterium	GO:0009617	response to bacterium		"{""preferred_term"": ""Response to bacterium"", ""term"": {""id"": ""GO:0009617"", ""label"": ""response to bacterium""}}"																											
4032	4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	Odontogenic Source Infection (Mandibular Molar)	Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces.	locations[0]	locations	locations			Root of tooth	UBERON:0011605	root of tooth		"{""preferred_term"": ""Root of tooth"", ""term"": {""id"": ""UBERON:0011605"", ""label"": ""root of tooth""}}"																											
4033	4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	Odontogenic Source Infection (Mandibular Molar)	Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces.	locations[1]	locations	locations			Mandibular molar tooth	UBERON:0001094	mandibular molar tooth		"{""preferred_term"": ""Mandibular molar tooth"", ""term"": {""id"": ""UBERON:0001094"", ""label"": ""mandibular molar tooth""}}"																											
4034	4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	Polymicrobial Cellulitis of Mouth Floor	Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4035	4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	Polymicrobial Cellulitis of Mouth Floor	Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4036	4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	Polymicrobial Cellulitis of Mouth Floor	Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis.	locations[0]	locations	locations			Floor of mouth	UBERON:0003688	floor of mouth		"{""preferred_term"": ""Floor of mouth"", ""term"": {""id"": ""UBERON:0003688"", ""label"": ""floor of mouth""}}"																											
4037	4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	Polymicrobial Cellulitis of Mouth Floor	Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis.	locations[1]	locations	locations			Submandibular space	UBERON:0012443	submandibular space		"{""preferred_term"": ""Submandibular space"", ""term"": {""id"": ""UBERON:0012443"", ""label"": ""submandibular space""}}"																											
4038	4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	Cervical Fascial Spread Across Submandibular-Sublingual Spaces	Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4039	4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	Cervical Fascial Spread Across Submandibular-Sublingual Spaces	Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4040	4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	Cervical Fascial Spread Across Submandibular-Sublingual Spaces	Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces.	locations[0]	locations	locations			Submandibular gland	UBERON:0002048	submandibular gland		"{""preferred_term"": ""Submandibular gland"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""submandibular gland""}}"																											
4041	4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	Cervical Fascial Spread Across Submandibular-Sublingual Spaces	Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces.	locations[1]	locations	locations			Sublingual gland	UBERON:0001839	sublingual gland		"{""preferred_term"": ""Sublingual gland"", ""term"": {""id"": ""UBERON:0001839"", ""label"": ""sublingual gland""}}"																											
4042	4497	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	3	Descending Necrotizing Mediastinitis Extension	Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4043	4497	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	3	Descending Necrotizing Mediastinitis Extension	Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4044	4497	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	3	Descending Necrotizing Mediastinitis Extension	Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis.	locations[0]	locations	locations			Mediastinum	UBERON:0002416	mediastinum		"{""preferred_term"": ""Mediastinum"", ""term"": {""id"": ""UBERON:0002416"", ""label"": ""mediastinum""}}"																											
4045	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	Tongue Elevation and Airway Narrowing from Floor Edema	Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4046	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	Tongue Elevation and Airway Narrowing from Floor Edema	Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea.	biological_processes[0]	biological_processes	biological_processes			Regulation of vascular permeability	GO:0043112	regulation of vascular permeability		"{""preferred_term"": ""Regulation of vascular permeability"", ""term"": {""id"": ""GO:0043112"", ""label"": ""regulation of vascular permeability""}}"																											
4047	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	Tongue Elevation and Airway Narrowing from Floor Edema	Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea.	locations[0]	locations	locations			Oropharynx	UBERON:0001729	oropharynx		"{""preferred_term"": ""Oropharynx"", ""term"": {""id"": ""UBERON:0001729"", ""label"": ""oropharynx""}}"																											
4048	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	Tongue Elevation and Airway Narrowing from Floor Edema	Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea.	locations[1]	locations	locations			Floor of mouth	UBERON:0003688	floor of mouth		"{""preferred_term"": ""Floor of mouth"", ""term"": {""id"": ""UBERON:0003688"", ""label"": ""floor of mouth""}}"																											
4070	4513	190	Lung Carcinoma	Lung_Carcinoma.yaml	pathophysiology	1	VEGFA-Mediated Angiogenesis	VEGFA-driven angiogenesis contributes to lung cancer progression and promotes a proangiogenic signaling network.	biological_processes[0]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
4088	4543	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	0	Spirochete Invasion and Dissemination	"Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
"	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4089	4543	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	0	Spirochete Invasion and Dissemination	"Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
"	biological_processes[0]	biological_processes	biological_processes			cell adhesion	GO:0007155	cell adhesion		"{""preferred_term"": ""cell adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}"																											
4090	4544	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	1	Autoimmune Activation after Persistent Infection	"Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.
"	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4091	4544	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	1	Autoimmune Activation after Persistent Infection	"Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.
"	biological_processes[0]	biological_processes	biological_processes			immune system process	GO:0002376	immune system process		"{""preferred_term"": ""immune system process"", ""term"": {""id"": ""GO:0002376"", ""label"": ""immune system process""}}"																											
4092	4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	Inflammatory Response and Tissue Damage	"The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4093	4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	Inflammatory Response and Tissue Damage	"The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
"	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
4094	4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	Inflammatory Response and Tissue Damage	"The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
"	cell_types[2]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4095	4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	Inflammatory Response and Tissue Damage	"The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4111	4561	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	0	Lymphatic vessel blockage and dysfunction	Adult lymphatic filariae in lymph vessels provoke blockage and host responses that impair lymphatic function and drive fibrosis.	locations[0]	locations	locations			lymphatic vessel	UBERON:0001473	lymphatic vessel		"{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}"																											
4112	4562	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	1	Lymphatic vessel remodeling and dilation	Adult parasites damage lymphatic valves and remodel lymphatic vessels, causing lymphatic dilation.	locations[0]	locations	locations			lymphatic vessel	UBERON:0001473	lymphatic vessel		"{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}"																											
4120	4572	193	Lymphoma	Lymphoma.yaml	pathophysiology	1	Hodgkin/Reed-Sternberg Cell Origin	Hodgkin lymphoma is characterized by clonal Hodgkin/Reed-Sternberg cells that derive from B cells.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4144	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	locations[0]	locations	locations			nucleus	UBERON:0000062	nucleus		"{""preferred_term"": ""nucleus"", ""term"": {""id"": ""UBERON:0000062"", ""label"": ""nucleus""}}"																											
4145	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	cell_types[0]	cell_types	cell_types			colonic epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
4146	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	cell_types[1]	cell_types	cell_types			endometrial epithelial cell	CL:0002656	glandular endometrial unciliated epithelial cell		"{""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}"																											
4147	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	cellular_components[0]	cellular_components	cellular_components			nucleoplasm	GO:0005654	nucleoplasm		"{""preferred_term"": ""nucleoplasm"", ""term"": {""id"": ""GO:0005654"", ""label"": ""nucleoplasm""}}"																											
4148	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	protein_complexes[0]	protein_complexes	protein_complexes			mismatch repair complex	GO:0032300	mismatch repair complex		"{""preferred_term"": ""mismatch repair complex"", ""term"": {""id"": ""GO:0032300"", ""label"": ""mismatch repair complex""}}"																											
4149	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	biological_processes[0]	biological_processes	biological_processes			mismatch repair	GO:0006298	mismatch repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}"			DECREASED																								
4150	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	biological_processes[1]	biological_processes	biological_processes			DNA-templated DNA replication maintenance of fidelity	GO:0045005	DNA-templated DNA replication maintenance of fidelity		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA-templated DNA replication maintenance of fidelity"", ""term"": {""id"": ""GO:0045005"", ""label"": ""DNA-templated DNA replication maintenance of fidelity""}}"			DECREASED																								
4151	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.	biological_processes[2]	biological_processes	biological_processes			DNA damage response	GO:0006974	DNA damage response		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}"			ABNORMAL																								
4152	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
4153	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.	locations[1]	locations	locations			endometrium	UBERON:0001295	endometrium		"{""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}"																											
4154	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.	cell_types[0]	cell_types	cell_types			colonic epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
4155	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.	cell_types[1]	cell_types	cell_types			endometrial epithelial cell	CL:0002656	glandular endometrial unciliated epithelial cell		"{""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}"																											
4156	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.	biological_processes[0]	biological_processes	biological_processes			DNA-templated DNA replication maintenance of fidelity	GO:0045005	DNA-templated DNA replication maintenance of fidelity		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA-templated DNA replication maintenance of fidelity"", ""term"": {""id"": ""GO:0045005"", ""label"": ""DNA-templated DNA replication maintenance of fidelity""}}"			DECREASED																								
4157	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
4158	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.	locations[1]	locations	locations			endometrium	UBERON:0001295	endometrium		"{""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}"																											
4159	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.	cell_types[0]	cell_types	cell_types			colonic epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
4160	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.	cell_types[1]	cell_types	cell_types			endometrial epithelial cell	CL:0002656	glandular endometrial unciliated epithelial cell		"{""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}"																											
4161	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4162	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
4163	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	locations[1]	locations	locations			endometrium	UBERON:0001295	endometrium		"{""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}"																											
4164	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
4165	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	biological_processes[0]	biological_processes	biological_processes			antigen processing and presentation of peptide antigen via MHC class I	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I		"{""modifier"": ""INCREASED"", ""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class I"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}"			INCREASED																								
4166	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	biological_processes[1]	biological_processes	biological_processes			type I interferon-mediated signaling pathway	GO:0060337	type I interferon-mediated signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon-mediated signaling pathway""}}"			INCREASED																								
4167	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.	biological_processes[2]	biological_processes	biological_processes			T cell mediated cytotoxicity directed against tumor cell target	GO:0002419	T cell mediated cytotoxicity directed against tumor cell target		"{""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity directed against tumor cell target"", ""term"": {""id"": ""GO:0002419"", ""label"": ""T cell mediated cytotoxicity directed against tumor cell target""}}"			INCREASED																								
4168	4601	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	4	Immune Checkpoint Blockade Sensitivity	Lynch-associated dMMR/MSI tumors with high neoantigen burden are enriched for anti-tumor T-cell activity and show strong responses to PD-1 blockade.	biological_processes[0]	biological_processes	biological_processes			T cell mediated cytotoxicity directed against tumor cell target	GO:0002419	T cell mediated cytotoxicity directed against tumor cell target		"{""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity directed against tumor cell target"", ""term"": {""id"": ""GO:0002419"", ""label"": ""T cell mediated cytotoxicity directed against tumor cell target""}}"			INCREASED																								
4179	4614	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	0	Impaired medium-chain fatty acid beta-oxidation	"MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.
"	locations[0]	locations	locations			mitochondrial matrix	GO:0005759	mitochondrial matrix		"{""preferred_term"": ""mitochondrial matrix"", ""term"": {""id"": ""GO:0005759"", ""label"": ""mitochondrial matrix""}}"																											
4180	4614	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	0	Impaired medium-chain fatty acid beta-oxidation	"MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.
"	biological_processes[0]	biological_processes	biological_processes			fatty acid beta-oxidation	GO:0006635	fatty acid beta-oxidation		"{""preferred_term"": ""fatty acid beta-oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}"																											
4181	4614	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	0	Impaired medium-chain fatty acid beta-oxidation	"MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.
"	biological_processes[1]	biological_processes	biological_processes			medium-chain fatty acyl-CoA dehydrogenase activity	GO:0070991	medium-chain fatty acyl-CoA dehydrogenase activity		"{""preferred_term"": ""medium-chain fatty acyl-CoA dehydrogenase activity"", ""term"": {""id"": ""GO:0070991"", ""label"": ""medium-chain fatty acyl-CoA dehydrogenase activity""}}"																											
4182	4616	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	2	Toxic metabolite accumulation	"Accumulation of medium-chain fatty acids and their conjugates (octanoate, octanoylcarnitine) may have direct toxic effects on brain and liver tissue. Accumulated acyl-CoA intermediates deplete free coenzyme A and may cause mitochondrial dysfunction.
"	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
4183	4616	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	2	Toxic metabolite accumulation	"Accumulation of medium-chain fatty acids and their conjugates (octanoate, octanoylcarnitine) may have direct toxic effects on brain and liver tissue. Accumulated acyl-CoA intermediates deplete free coenzyme A and may cause mitochondrial dysfunction.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
4193	4633	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	0	MET Exon 14 Splice Mutations	MET exon 14 skipping results from splice site mutations that cause exclusion of exon 14 during pre-mRNA splicing. Exon 14 encodes a juxtamembrane regulatory domain containing a CBL E3 ubiquitin ligase binding site (Y1003). Loss of this domain prevents receptor ubiquitination and degradation, leading to prolonged MET signaling after ligand stimulation.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
4194	4633	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	0	MET Exon 14 Splice Mutations	MET exon 14 skipping results from splice site mutations that cause exclusion of exon 14 during pre-mRNA splicing. Exon 14 encodes a juxtamembrane regulatory domain containing a CBL E3 ubiquitin ligase binding site (Y1003). Loss of this domain prevents receptor ubiquitination and degradation, leading to prolonged MET signaling after ligand stimulation.	biological_processes[0]	biological_processes	biological_processes			transmembrane receptor protein tyrosine kinase signaling pathway	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}"			INCREASED																								
4195	4634	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	1	Prolonged MET Signaling	METex14 skipping results in prolonged receptor activation and downstream signaling through RAS-MAPK, PI3K-AKT, and STAT3 pathways. HGF (hepatocyte growth factor) ligand binding triggers signaling, but receptor downregulation is impaired.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4196	4634	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	1	Prolonged MET Signaling	METex14 skipping results in prolonged receptor activation and downstream signaling through RAS-MAPK, PI3K-AKT, and STAT3 pathways. HGF (hepatocyte growth factor) ligand binding triggers signaling, but receptor downregulation is impaired.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
4197	4635	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Migration	MET signaling promotes cell proliferation, survival, motility, and invasion. The HGF-MET axis is particularly important for epithelial-mesenchymal transition and metastasis.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4198	4636	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	3	MET Inhibitor Resistance	Resistance to MET inhibitors can develop through secondary MET kinase mutations (D1228N/V, Y1230C/H), MET amplification increase, or bypass pathway activation (KRAS, EGFR, HER3). On-target resistance mutations affect drug binding.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
4209	4657	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Loss of MMR protein function (MLH1, MSH2, MSH6, or PMS2) impairs the recognition and repair of DNA replication errors. The MMR system normally corrects base-base mismatches and insertion/deletion loops at microsatellite sequences. Deficiency leads to accumulation of thousands of somatic mutations.	cell_types[0]	cell_types	cell_types			colon epithelial cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
4210	4657	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Loss of MMR protein function (MLH1, MSH2, MSH6, or PMS2) impairs the recognition and repair of DNA replication errors. The MMR system normally corrects base-base mismatches and insertion/deletion loops at microsatellite sequences. Deficiency leads to accumulation of thousands of somatic mutations.	biological_processes[0]	biological_processes	biological_processes			mismatch repair	GO:0006298	mismatch repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}"			DECREASED																								
4211	4658	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	1	Microsatellite Instability	Microsatellites are repetitive DNA sequences highly susceptible to replication errors. Without functional MMR, these sequences accumulate insertions and deletions, detectable as length variations (instability) compared to normal tissue. MSI-H is defined as instability at two or more of five standard markers.	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
4212	4660	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	3	Frameshift Mutations in Tumor Suppressors	Coding microsatellites in tumor suppressor genes (TGFbetaRII, BAX, ACVR2, IGF2R) accumulate frameshift mutations, inactivating their tumor suppressive functions. TGFbetaRII frameshift is particularly common, disrupting TGF-beta growth inhibition.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4213	4661	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	4	Neoantigen-Driven Immune Response	The high neoantigen burden in MSI-H tumors stimulates robust anti-tumor immunity. Tumor-infiltrating lymphocytes, particularly CD8+ cytotoxic T cells, recognize and attack tumor cells presenting neoantigens. However, tumors upregulate PD-L1 as an adaptive resistance mechanism.	cell_types[0]	cell_types	cell_types			CD8-positive, alpha-beta T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
4214	4661	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	4	Neoantigen-Driven Immune Response	The high neoantigen burden in MSI-H tumors stimulates robust anti-tumor immunity. Tumor-infiltrating lymphocytes, particularly CD8+ cytotoxic T cells, recognize and attack tumor cells presenting neoantigens. However, tumors upregulate PD-L1 as an adaptive resistance mechanism.	biological_processes[0]	biological_processes	biological_processes			T cell mediated cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"			INCREASED																								
4225	4681	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	0	Mismatch Repair Deficiency	Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions.	cell_types[0]	cell_types	cell_types			endometrial epithelial cell	CL:0002149	epithelial cell of uterus		"{""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002149"", ""label"": ""epithelial cell of uterus""}}"																											
4226	4681	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	0	Mismatch Repair Deficiency	Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions.	biological_processes[0]	biological_processes	biological_processes			mismatch repair	GO:0006298	mismatch repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}"			DECREASED																								
4227	4681	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	0	Mismatch Repair Deficiency	Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions.	locations[0]	locations	locations			endometrium	UBERON:0001295	endometrium		"{""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}"																											
4228	4682	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	1	Microsatellite Instability	Deficient mismatch repair leads to instability at microsatellite loci, short tandem repeat sequences throughout the genome. MSI-H status is defined by instability at multiple markers and serves as a biomarker for dMMR.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			DECREASED																								
4229	4683	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	2	Hypermutation and Neoantigen Generation	MMR deficiency causes a hypermutated tumor phenotype with high tumor mutational burden (TMB). Frameshift mutations at coding microsatellites generate neoantigens recognized by the immune system, explaining the high response rates to immune checkpoint inhibition.	biological_processes[0]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"			INCREASED																								
4238	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"	cell_types[0]	cell_types	cell_types			Serotonergic Neuron	CL:0000850	serotonergic neuron		"{""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}"																											
4239	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"	cell_types[1]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
4240	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"	cell_types[2]	cell_types	cell_types			Noradrenergic Neuron	CL:0008025	noradrenergic neuron		"{""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}"																											
4241	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"	biological_processes[0]	biological_processes	biological_processes			Serotonin Signaling	GO:0007210	serotonin receptor signaling pathway		"{""preferred_term"": ""Serotonin Signaling"", ""term"": {""id"": ""GO:0007210"", ""label"": ""serotonin receptor signaling pathway""}}"																											
4242	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"	biological_processes[1]	biological_processes	biological_processes			Dopamine Signaling	GO:0007212	dopamine receptor signaling pathway		"{""preferred_term"": ""Dopamine Signaling"", ""term"": {""id"": ""GO:0007212"", ""label"": ""dopamine receptor signaling pathway""}}"																											
4243	4708	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	1	HPA Axis Dysregulation	"Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.
"	cell_types[0]	cell_types	cell_types			Corticotroph	CL:0002309	corticotroph		"{""preferred_term"": ""Corticotroph"", ""term"": {""id"": ""CL:0002309"", ""label"": ""corticotroph""}}"																											
4244	4708	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	1	HPA Axis Dysregulation	"Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.
"	biological_processes[0]	biological_processes	biological_processes			Cortisol Response	GO:0071385	cellular response to glucocorticoid stimulus		"{""preferred_term"": ""Cortisol Response"", ""term"": {""id"": ""GO:0071385"", ""label"": ""cellular response to glucocorticoid stimulus""}}"																											
4245	4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	Neuroplasticity Deficits	"Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
4246	4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	Neuroplasticity Deficits	"Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Plasticity	GO:0048167	regulation of synaptic plasticity		"{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}"																											
4247	4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	Neuroinflammation	"Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in depression. Inflammation may contribute to monoamine depletion and neuroplasticity deficits.
"	cell_types[0]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
4258	4736	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	0	Asbestos-Induced Mesothelial Injury	Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation.	cell_types[0]	cell_types	cell_types			mesothelial cell	CL:0000077	mesothelial cell		"{""preferred_term"": ""mesothelial cell"", ""term"": {""id"": ""CL:0000077"", ""label"": ""mesothelial cell""}}"																											
4259	4736	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	0	Asbestos-Induced Mesothelial Injury	Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"			INCREASED																								
4260	4736	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	0	Asbestos-Induced Mesothelial Injury	Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation.	biological_processes[1]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""modifier"": ""INCREASED"", ""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"			INCREASED																								
4261	4736	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	0	Asbestos-Induced Mesothelial Injury	Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation.	locations[0]	locations	locations			pleura	UBERON:0000977	pleura		"{""preferred_term"": ""pleura"", ""term"": {""id"": ""UBERON:0000977"", ""label"": ""pleura""}}"																											
4262	4737	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	1	BAP1 Tumor Suppressor Inactivation	BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation.	genes[0]	genes	genes			BAP1				"{""preferred_term"": ""BAP1""}"																											
4263	4737	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	1	BAP1 Tumor Suppressor Inactivation	BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation.	biological_processes[0]	biological_processes	biological_processes			histone deubiquitination	GO:0016578	histone deubiquitination		"{""modifier"": ""DECREASED"", ""preferred_term"": ""histone deubiquitination"", ""term"": {""id"": ""GO:0016578"", ""label"": ""histone deubiquitination""}}"			DECREASED																								
4264	4737	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	1	BAP1 Tumor Suppressor Inactivation	BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation.	biological_processes[1]	biological_processes	biological_processes			DNA damage response	GO:0006974	DNA damage response		"{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}"			DECREASED																								
4265	4738	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	2	NF2/Merlin Inactivation	The NF2 gene encoding merlin is frequently inactivated in mesothelioma (approximately 50% of cases). Merlin loss activates YAP/TAZ signaling through the Hippo pathway, promoting cell proliferation and inhibiting contact-dependent growth arrest.	genes[0]	genes	genes			NF2				"{""preferred_term"": ""NF2""}"																											
4266	4738	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	2	NF2/Merlin Inactivation	The NF2 gene encoding merlin is frequently inactivated in mesothelioma (approximately 50% of cases). Merlin loss activates YAP/TAZ signaling through the Hippo pathway, promoting cell proliferation and inhibiting contact-dependent growth arrest.	biological_processes[0]	biological_processes	biological_processes			Hippo signaling	GO:0035329	hippo signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Hippo signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}"			DECREASED																								
4267	4739	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	3	CDKN2A/p16 Loss	Homozygous deletion of CDKN2A, encoding p16INK4a and p14ARF, occurs in approximately 70% of mesotheliomas. Loss of p16 removes CDK4/6 inhibition, promoting cell cycle progression, while p14ARF loss compromises p53 stabilization.	genes[0]	genes	genes			CDKN2A				"{""preferred_term"": ""CDKN2A""}"																											
4268	4739	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	3	CDKN2A/p16 Loss	Homozygous deletion of CDKN2A, encoding p16INK4a and p14ARF, occurs in approximately 70% of mesotheliomas. Loss of p16 removes CDK4/6 inhibition, promoting cell cycle progression, while p14ARF loss compromises p53 stabilization.	biological_processes[0]	biological_processes	biological_processes			negative regulation of G1/S transition	GO:0045786	negative regulation of G1/S transition of mitotic cell cycle		"{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of G1/S transition"", ""term"": {""id"": ""GO:0045786"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}"			DECREASED																								
4280	4749	201	Malnutrition-Related Diabetes Mellitus	Malnutrition-related_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin deficiency from beta-cell impairment in undernutrition	Undernutrition-associated diabetes involves insulin deficiency from pancreatic beta-cell impairment.	cell_types[0]	cell_types	cell_types			pancreatic beta cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""pancreatic beta cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
4281	4749	201	Malnutrition-Related Diabetes Mellitus	Malnutrition-related_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin deficiency from beta-cell impairment in undernutrition	Undernutrition-associated diabetes involves insulin deficiency from pancreatic beta-cell impairment.	biological_processes[0]	biological_processes	biological_processes			insulin secretion	GO:0030073	insulin secretion		"{""preferred_term"": ""insulin secretion"", ""term"": {""id"": ""GO:0030073"", ""label"": ""insulin secretion""}}"																											
4284	4760	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	0	CCND1 Translocation and Cyclin D1 Overexpression	The t(11;14)(q13;q32) translocation places the CCND1 gene under control of the immunoglobulin heavy chain enhancer, causing constitutive overexpression of cyclin D1. This is the hallmark genetic event in MCL, occurring in virtually all cases, and drives cell cycle progression.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4285	4760	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	0	CCND1 Translocation and Cyclin D1 Overexpression	The t(11;14)(q13;q32) translocation places the CCND1 gene under control of the immunoglobulin heavy chain enhancer, causing constitutive overexpression of cyclin D1. This is the hallmark genetic event in MCL, occurring in virtually all cases, and drives cell cycle progression.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""INCREASED"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			INCREASED																								
4286	4761	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	1	Cell Cycle Dysregulation	Cyclin D1 overexpression accelerates G1 to S phase transition by activating CDK4/6, which phosphorylates retinoblastoma protein (RB1) and releases E2F transcription factors. This overcomes normal cell cycle checkpoints and drives proliferation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4287	4762	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	2	BTK and BCR Signaling Dependence	MCL cells are dependent on B-cell receptor signaling through BTK for survival. This pathway provides proliferative and anti-apoptotic signals essential for MCL cell maintenance. BTK inhibitors exploit this dependence, particularly effective in relapsed MCL.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"			INCREASED																								
4288	4763	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	3	NF-kB Activation	Constitutive NF-kB signaling is common in MCL, driven by BCR signaling and genetic alterations affecting the NF-kB pathway. NF-kB promotes expression of anti-apoptotic genes contributing to MCL cell survival.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
4289	4764	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	4	Uncontrolled B-cell Proliferation	The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
4290	4764	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	4	Uncontrolled B-cell Proliferation	The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration.	locations[1]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
4291	4764	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	4	Uncontrolled B-cell Proliferation	The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4308	4796	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	0	Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency	"Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
4309	4796	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	0	Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency	"Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.
"	biological_processes[0]	biological_processes	biological_processes			branched-chain amino acid catabolic process	GO:0009083	branched-chain amino acid catabolic process		"{""preferred_term"": ""branched-chain amino acid catabolic process"", ""term"": {""id"": ""GO:0009083"", ""label"": ""branched-chain amino acid catabolic process""}}"																											
4310	4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	Leucine and Ketoacid Neurotoxicity	"Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.
"	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
4311	4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	Leucine and Ketoacid Neurotoxicity	"Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.
"	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
4312	4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	Leucine and Ketoacid Neurotoxicity	"Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.
"	biological_processes[0]	biological_processes	biological_processes			generation of precursor metabolites and energy	GO:0006091	generation of precursor metabolites and energy		"{""preferred_term"": ""generation of precursor metabolites and energy"", ""term"": {""id"": ""GO:0006091"", ""label"": ""generation of precursor metabolites and energy""}}"																											
4313	4798	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	2	Skeletal Muscle Dysfunction	"Skeletal muscle is a major site of BCAA metabolism and accumulates toxic ketoacids. MSUD causes muscle fiber abnormalities and atrophy, with KIC disrupting mitochondrial metabolism in myocytes and causing reduced TCA cycle flux and ATP depletion.
"	cell_types[0]	cell_types	cell_types			skeletal muscle fiber	CL:0008002	skeletal muscle fiber		"{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}"																											
4340	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	FBN1 Gene Mutation	Mutations in the FBN1 gene result in defective fibrillin-1 protein, which affects the elasticity and strength of connective tissues.	gene	gene	$	FBN1 Gene Mutation	Mutations in the FBN1 gene result in defective fibrillin-1 protein, which affects the elasticity and strength of connective tissues.	FBN1	hgnc:3603	FBN1	Gene encoding fibrillin-1, a structural glycoprotein essential for elastic fiber formation in connective tissue.	"{""description"": ""Gene encoding fibrillin-1, a structural glycoprotein essential for elastic fiber formation in connective tissue."", ""preferred_term"": ""FBN1"", ""term"": {""id"": ""hgnc:3603"", ""label"": ""FBN1""}}"																											
4341	4836	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	1	Dysregulated TGF-beta Signaling	Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling.	biological_processes[0]	biological_processes	biological_processes			transforming growth factor beta receptor signaling pathway	GO:0007179	transforming growth factor beta receptor signaling pathway		"{""preferred_term"": ""transforming growth factor beta receptor signaling pathway"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}"																											
4342	4836	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	1	Dysregulated TGF-beta Signaling	Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling.	biological_processes[1]	biological_processes	biological_processes			SMAD protein signal transduction	GO:0060395	SMAD protein signal transduction		"{""preferred_term"": ""SMAD protein signal transduction"", ""term"": {""id"": ""GO:0060395"", ""label"": ""SMAD protein signal transduction""}}"																											
4343	4836	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	1	Dysregulated TGF-beta Signaling	Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling.	cell_types[0]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
4344	4836	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	1	Dysregulated TGF-beta Signaling	Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling.	locations[0]	locations	locations			aorta	UBERON:0000947	aorta		"{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}"																											
4345	4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
4346	4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.	biological_processes[1]	biological_processes	biological_processes			proteolysis	GO:0006508	proteolysis		"{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}"																											
4347	4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.	cell_types[0]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
4348	4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.	cell_types[1]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
4349	4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.	locations[0]	locations	locations			aorta tunica media	UBERON:0005797	aorta tunica media		"{""preferred_term"": ""aorta tunica media"", ""term"": {""id"": ""UBERON:0005797"", ""label"": ""aorta tunica media""}}"																											
4350	4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.	biological_processes[0]	biological_processes	biological_processes			cellular response to mechanical stimulus	GO:0071260	cellular response to mechanical stimulus		"{""preferred_term"": ""cellular response to mechanical stimulus"", ""term"": {""id"": ""GO:0071260"", ""label"": ""cellular response to mechanical stimulus""}}"																											
4351	4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.	biological_processes[1]	biological_processes	biological_processes			integrin-mediated signaling pathway	GO:0007229	integrin-mediated signaling pathway		"{""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}"																											
4352	4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.	cell_types[0]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
4353	4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.	cell_types[1]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4354	4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.	locations[0]	locations	locations			aorta	UBERON:0000947	aorta		"{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}"																											
4355	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4356	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	biological_processes[1]	biological_processes	biological_processes			leukocyte migration	GO:0050900	leukocyte migration		"{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}"																											
4357	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
4358	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	cell_types[1]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
4359	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	locations[0]	locations	locations			aorta tunica intima	UBERON:0006878	aorta tunica intima		"{""preferred_term"": ""aorta tunica intima"", ""term"": {""id"": ""UBERON:0006878"", ""label"": ""aorta tunica intima""}}"																											
4360	4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.	locations[1]	locations	locations			aorta tunica media	UBERON:0005797	aorta tunica media		"{""preferred_term"": ""aorta tunica media"", ""term"": {""id"": ""UBERON:0005797"", ""label"": ""aorta tunica media""}}"																											
4361	4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.	biological_processes[0]	biological_processes	biological_processes			mitochondrial ATP synthesis coupled electron transport	GO:0042775	mitochondrial ATP synthesis coupled electron transport		"{""preferred_term"": ""mitochondrial ATP synthesis coupled electron transport"", ""term"": {""id"": ""GO:0042775"", ""label"": ""mitochondrial ATP synthesis coupled electron transport""}}"																											
4362	4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.	biological_processes[1]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
4363	4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.	cell_types[0]	cell_types	cell_types			vascular associated smooth muscle cell	CL:0000359	vascular associated smooth muscle cell		"{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}"																											
4364	4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.	cell_types[1]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4365	4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.	locations[0]	locations	locations			aorta	UBERON:0000947	aorta		"{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}"																											
4420	4903	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	0	Primary cilium membrane protein dysfunction (TMEM67/meckelin)	Pathogenic variants in TMEM67 disrupt primary cilium membrane components.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4421	4904	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	1	Ciliary base protein dysfunction (MKS1)	Loss of MKS1 perturbs proteins associated with the ciliary base/basal body.	cellular_components[0]	cellular_components	cellular_components			ciliary basal body	GO:0036064	ciliary basal body		"{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}"																											
4422	4904	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	1	Ciliary base protein dysfunction (MKS1)	Loss of MKS1 perturbs proteins associated with the ciliary base/basal body.	cellular_components[1]	cellular_components	cellular_components			ciliary base	GO:0097546	ciliary base		"{""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4423	4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	Basal body localization without proper ciliogenesis	Basal bodies localize apically, yet cilia fail to form in many tissues.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4424	4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	Basal body localization without proper ciliogenesis	Basal bodies localize apically, yet cilia fail to form in many tissues.	cellular_components[1]	cellular_components	cellular_components			ciliary basal body	GO:0036064	ciliary basal body		"{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}"																											
4425	4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	Basal body localization without proper ciliogenesis	Basal bodies localize apically, yet cilia fail to form in many tissues.	cellular_components[2]	cellular_components	cellular_components			ciliary base	GO:0097546	ciliary base		"{""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4426	4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	Basal body localization without proper ciliogenesis	Basal bodies localize apically, yet cilia fail to form in many tissues.	biological_processes[0]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"			DYSREGULATED																								
4427	4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	Defective cilia formation across multiple tissues	Primary cilia fail to form in many tissues in vivo.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4428	4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	Defective cilia formation across multiple tissues	Primary cilia fail to form in many tissues in vivo.	cellular_components[1]	cellular_components	cellular_components			ciliary basal body	GO:0036064	ciliary basal body		"{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}"																											
4429	4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	Defective cilia formation across multiple tissues	Primary cilia fail to form in many tissues in vivo.	cellular_components[2]	cellular_components	cellular_components			ciliary base	GO:0097546	ciliary base		"{""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4430	4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	Defective cilia formation across multiple tissues	Primary cilia fail to form in many tissues in vivo.	biological_processes[0]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"			DYSREGULATED																								
4431	4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	Loss of primary cilia (failed ciliogenesis)	Primary cilia are absent, reflecting failed ciliogenesis.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4432	4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	Loss of primary cilia (failed ciliogenesis)	Primary cilia are absent, reflecting failed ciliogenesis.	cellular_components[1]	cellular_components	cellular_components			ciliary basal body	GO:0036064	ciliary basal body		"{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}"																											
4433	4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	Loss of primary cilia (failed ciliogenesis)	Primary cilia are absent, reflecting failed ciliogenesis.	cellular_components[2]	cellular_components	cellular_components			ciliary base	GO:0097546	ciliary base		"{""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4434	4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	Loss of primary cilia (failed ciliogenesis)	Primary cilia are absent, reflecting failed ciliogenesis.	biological_processes[0]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"			DYSREGULATED																								
4435	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	Reduced axonemal microtubule posttranslational modifications	Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4436	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	Reduced axonemal microtubule posttranslational modifications	Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications.	cellular_components[1]	cellular_components	cellular_components			axoneme	GO:0005930	axoneme		"{""preferred_term"": ""axoneme"", ""term"": {""id"": ""GO:0005930"", ""label"": ""axoneme""}}"																											
4437	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	Reduced axonemal microtubule posttranslational modifications	Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications.	cellular_components[2]	cellular_components	cellular_components			ciliary basal body	GO:0036064	ciliary basal body		"{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}"																											
4438	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	Reduced axonemal microtubule posttranslational modifications	Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications.	cellular_components[3]	cellular_components	cellular_components			ciliary base	GO:0097546	ciliary base		"{""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4439	4909	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	6	Impaired initiation of ciliogenesis	B9 proteins facilitate early ciliogenesis; disruption impairs initiation.	biological_processes[0]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"			DYSREGULATED																								
4440	4910	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	7	TMEM67 cleavage uncouples ciliogenesis and Wnt signaling	Proteolytic cleavage of TMEM67 separates ciliary assembly from Wnt pathway activity.	biological_processes[0]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"			DYSREGULATED																								
4441	4910	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	7	TMEM67 cleavage uncouples ciliogenesis and Wnt signaling	Proteolytic cleavage of TMEM67 separates ciliary assembly from Wnt pathway activity.	biological_processes[1]	biological_processes	biological_processes			Wnt signaling pathway	GO:0016055	Wnt signaling pathway		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"			DYSREGULATED																								
4442	4911	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	8	TMEM17 loss disrupts Sonic Hedgehog signaling	TMEM17 dysfunction at the ciliary transition zone abrogates Sonic Hedgehog signaling.	biological_processes[0]	biological_processes	biological_processes			hedgehog signaling pathway	GO:0007224	hedgehog signaling pathway		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}"			DYSREGULATED																								
4443	4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	Altered Hedgehog signaling in neural tube patterning	Hedgehog signaling is altered during neural tube development.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4444	4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	Altered Hedgehog signaling in neural tube patterning	Hedgehog signaling is altered during neural tube development.	locations[0]	locations	locations			neural tube	UBERON:0001049	neural tube		"{""preferred_term"": ""neural tube"", ""term"": {""id"": ""UBERON:0001049"", ""label"": ""neural tube""}}"																											
4445	4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	Altered Hedgehog signaling in neural tube patterning	Hedgehog signaling is altered during neural tube development.	biological_processes[0]	biological_processes	biological_processes			hedgehog signaling pathway	GO:0007224	hedgehog signaling pathway		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}"			DYSREGULATED																								
4446	4913	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	10	Altered Hedgehog signaling in limb patterning	Hedgehog signaling is altered during limb development.	cellular_components[0]	cellular_components	cellular_components			primary cilium	GO:0005929	cilium		"{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4447	4913	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	10	Altered Hedgehog signaling in limb patterning	Hedgehog signaling is altered during limb development.	biological_processes[0]	biological_processes	biological_processes			hedgehog signaling pathway	GO:0007224	hedgehog signaling pathway		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}"			DYSREGULATED																								
4468	4931	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	0	RET Proto-Oncogene Activation	Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival.	cell_types[0]	cell_types	cell_types			parafollicular cell	CL:0000570	parafollicular cell		"{""preferred_term"": ""parafollicular cell"", ""term"": {""id"": ""CL:0000570"", ""label"": ""parafollicular cell""}}"																											
4469	4931	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	0	RET Proto-Oncogene Activation	Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			receptor signaling protein tyrosine kinase activity	GO:0004716	receptor signaling protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}"			INCREASED																								
4470	4931	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	0	RET Proto-Oncogene Activation	Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival.	gene_products[0]	gene_products	gene_products			RET receptor tyrosine kinase	NCIT:C18539	Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret		"{""preferred_term"": ""RET receptor tyrosine kinase"", ""term"": {""id"": ""NCIT:C18539"", ""label"": ""Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret""}}"																											
4471	4931	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	0	RET Proto-Oncogene Activation	Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival.	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
4472	4932	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	RET activation stimulates the RAS-RAF-MEK-ERK signaling cascade, driving uncontrolled C-cell proliferation. This pathway is a major effector of RET-mediated transformation in MTC.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4473	4933	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	RET activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting C-cell survival and resistance to apoptosis. This cooperates with MAPK signaling to drive MTC tumorigenesis.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
4484	4951	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	0	SHH Pathway Activation	The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors.	cell_types[0]	cell_types	cell_types			cerebellar granule cell	CL:0001031	cerebellar granule cell		"{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}"																											
4485	4951	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	0	SHH Pathway Activation	The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors.	biological_processes[0]	biological_processes	biological_processes			smoothened signaling pathway	GO:0007224	smoothened signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"			INCREASED																								
4486	4951	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	0	SHH Pathway Activation	The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors.	locations[0]	locations	locations			cerebellum	UBERON:0002037	cerebellum		"{""preferred_term"": ""cerebellum"", ""term"": {""id"": ""UBERON:0002037"", ""label"": ""cerebellum""}}"																											
4487	4952	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	1	GLI Transcription Factor Activation	Activated SMO leads to nuclear translocation of GLI transcription factors (GLI1, GLI2) which activate target genes including PTCH1 (feedback), GLI1, MYCN, CCND1, and BCL2. GLI2 amplification can drive pathway activation independently of upstream components.	biological_processes[0]	biological_processes	biological_processes			positive regulation of gene expression	GO:0010628	positive regulation of gene expression		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of gene expression"", ""term"": {""id"": ""GO:0010628"", ""label"": ""positive regulation of gene expression""}}"			INCREASED																								
4488	4953	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	2	Cerebellar Granule Cell Proliferation	SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation.	cell_types[0]	cell_types	cell_types			cerebellar granule cell	CL:0001031	cerebellar granule cell		"{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}"																											
4489	4953	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	2	Cerebellar Granule Cell Proliferation	SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4490	4953	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	2	Cerebellar Granule Cell Proliferation	SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation.	biological_processes[1]	biological_processes	biological_processes			cerebellum development	GO:0021549	cerebellum development		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cerebellum development"", ""term"": {""id"": ""GO:0021549"", ""label"": ""cerebellum development""}}"			ABNORMAL																								
4500	4971	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	0	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes.	cell_types[0]	cell_types	cell_types			cerebellar granule cell	CL:0001031	cerebellar granule cell		"{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}"																											
4501	4971	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	0	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes.	biological_processes[0]	biological_processes	biological_processes			Wnt signaling pathway	GO:0016055	Wnt signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"			INCREASED																								
4502	4971	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	0	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes.	locations[0]	locations	locations			cerebellum	UBERON:0002037	cerebellum		"{""preferred_term"": ""cerebellum"", ""term"": {""id"": ""UBERON:0002037"", ""label"": ""cerebellum""}}"																											
4503	4972	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	1	Nuclear Beta-Catenin Accumulation	Stabilized beta-catenin accumulates in the nucleus where it acts as a transcriptional coactivator with TCF/LEF family transcription factors. Nuclear beta-catenin immunostaining is a diagnostic hallmark of WNT-activated medulloblastoma.	biological_processes[0]	biological_processes	biological_processes			canonical Wnt signaling pathway	GO:0060070	canonical Wnt signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""canonical Wnt signaling pathway"", ""term"": {""id"": ""GO:0060070"", ""label"": ""canonical Wnt signaling pathway""}}"			INCREASED																								
4504	4973	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	2	WNT Target Gene Activation	Nuclear beta-catenin/TCF complexes drive expression of WNT target genes including MYC, CCND1 (cyclin D1), AXIN2, and DKK1. These genes promote proliferation and can serve as biomarkers of WNT pathway activation.	biological_processes[0]	biological_processes	biological_processes			positive regulation of gene expression	GO:0010628	positive regulation of gene expression		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of gene expression"", ""term"": {""id"": ""GO:0010628"", ""label"": ""positive regulation of gene expression""}}"			INCREASED																								
4505	4974	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	3	Cell Proliferation and Tumor Formation	WNT pathway activation drives proliferation of cerebellar progenitor cells, likely from the lower rhombic lip region. Despite constitutive pathway activation, these tumors have favorable biology, possibly due to their differentiation state or immunological features.	cell_types[0]	cell_types	cell_types			cerebellar granule cell	CL:0001031	cerebellar granule cell		"{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}"																											
4506	4974	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	3	Cell Proliferation and Tumor Formation	WNT pathway activation drives proliferation of cerebellar progenitor cells, likely from the lower rhombic lip region. Despite constitutive pathway activation, these tumors have favorable biology, possibly due to their differentiation state or immunological features.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4516	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	genes[0]	genes	genes			BRAF	hgnc:1097	BRAF		"{""preferred_term"": ""BRAF"", ""term"": {""id"": ""hgnc:1097"", ""label"": ""BRAF""}}"																											
4517	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	genes[1]	genes	genes			NRAS	hgnc:7989	NRAS		"{""preferred_term"": ""NRAS"", ""term"": {""id"": ""hgnc:7989"", ""label"": ""NRAS""}}"																											
4518	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
4519	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	cell_types[1]	cell_types	cell_types			neural crest cell	CL:0011012	neural crest cell		"{""preferred_term"": ""neural crest cell"", ""term"": {""id"": ""CL:0011012"", ""label"": ""neural crest cell""}}"																											
4520	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
4521	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	biological_processes[1]	biological_processes	biological_processes			cellular senescence	GO:0090398	cellular senescence		"{""preferred_term"": ""cellular senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}"																											
4522	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	biological_processes[2]	biological_processes	biological_processes			telomere maintenance	GO:0000723	telomere maintenance		"{""preferred_term"": ""telomere maintenance"", ""term"": {""id"": ""GO:0000723"", ""label"": ""telomere maintenance""}}"																											
4523	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	locations[0]	locations	locations			skin	UBERON:0002097	skin		"{""preferred_term"": ""skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin""}}"																											
4524	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.	locations[1]	locations	locations			leptomeninx	UBERON:0000391	leptomeninx		"{""preferred_term"": ""leptomeninx"", ""term"": {""id"": ""UBERON:0000391"", ""label"": ""leptomeninx""}}"																											
4525	4997	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	2	PI3K-AKT-mTOR Pathway Activation	Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy.	genes[0]	genes	genes			PTEN	hgnc:9588	PTEN		"{""preferred_term"": ""PTEN"", ""term"": {""id"": ""hgnc:9588"", ""label"": ""PTEN""}}"																											
4526	4997	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	2	PI3K-AKT-mTOR Pathway Activation	Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol-mediated signaling	GO:0048015	phosphatidylinositol-mediated signaling		"{""preferred_term"": ""phosphatidylinositol-mediated signaling"", ""term"": {""id"": ""GO:0048015"", ""label"": ""phosphatidylinositol-mediated signaling""}}"																											
4527	4997	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	2	PI3K-AKT-mTOR Pathway Activation	Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy.	biological_processes[1]	biological_processes	biological_processes			TOR signaling	GO:0031929	TOR signaling		"{""preferred_term"": ""TOR signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}"																											
4540	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	cell_types[0]	cell_types	cell_types			epithelioid macrophage	CL:0002150	epithelioid macrophage		"{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}"																											
4541	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	cell_types[1]	cell_types	cell_types			T lymphocyte	CL:0000084	T cell		"{""preferred_term"": ""T lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4542	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	biological_processes[0]	biological_processes	biological_processes			granuloma formation	GO:0034612	response to tumor necrosis factor		"{""preferred_term"": ""granuloma formation"", ""term"": {""id"": ""GO:0034612"", ""label"": ""response to tumor necrosis factor""}}"																											
4543	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	biological_processes[1]	biological_processes	biological_processes			leukocyte migration	GO:0050900	leukocyte migration		"{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}"																											
4544	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	locations[0]	locations	locations			lip	UBERON:0000953	lip		"{""preferred_term"": ""lip"", ""term"": {""id"": ""UBERON:0000953"", ""label"": ""lip""}}"																											
4545	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	locations[1]	locations	locations			oral mucosa	UBERON:0001830	oral mucosa		"{""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0001830"", ""label"": ""oral mucosa""}}"																											
4546	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"	locations[2]	locations	locations			tongue	UBERON:0001723	tongue		"{""preferred_term"": ""tongue"", ""term"": {""id"": ""UBERON:0001723"", ""label"": ""tongue""}}"																											
4547	5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement	"The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
"	cell_types[0]	cell_types	cell_types			epithelioid macrophage	CL:0002150	epithelioid macrophage		"{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}"																											
4548	5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement	"The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
"	biological_processes[0]	biological_processes	biological_processes			response to tumor necrosis factor	GO:0034612	response to tumor necrosis factor		"{""preferred_term"": ""response to tumor necrosis factor"", ""term"": {""id"": ""GO:0034612"", ""label"": ""response to tumor necrosis factor""}}"																											
4549	5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement	"The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
"	biological_processes[1]	biological_processes	biological_processes			interferon-gamma-mediated signaling pathway	GO:0060333	interferon-gamma-mediated signaling pathway		"{""preferred_term"": ""interferon-gamma-mediated signaling pathway"", ""term"": {""id"": ""GO:0060333"", ""label"": ""interferon-gamma-mediated signaling pathway""}}"																											
4550	5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement	"The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
"	locations[0]	locations	locations			oral mucosa	UBERON:0001830	oral mucosa		"{""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0001830"", ""label"": ""oral mucosa""}}"																											
4551	5031	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	2	Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema	"Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.
"	cell_types[0]	cell_types	cell_types			endothelial cell of lymphatic vessel	CL:0002138	endothelial cell of lymphatic vessel		"{""preferred_term"": ""endothelial cell of lymphatic vessel"", ""term"": {""id"": ""CL:0002138"", ""label"": ""endothelial cell of lymphatic vessel""}}"																											
4552	5031	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	2	Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema	"Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.
"	biological_processes[0]	biological_processes	biological_processes			lymphatic vessel development	GO:0001945	lymphatic vessel development		"{""preferred_term"": ""lymphatic vessel development"", ""term"": {""id"": ""GO:0001945"", ""label"": ""lymphatic vessel development""}}"																											
4553	5031	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	2	Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema	"Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.
"	locations[0]	locations	locations			lymphatic vessel	UBERON:0001473	lymphatic vessel		"{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}"																											
4568	5042	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	1	Ion Transport Dysfunction	"Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
"	biological_processes[0]	biological_processes	biological_processes			potassium ion transport	GO:0006813	potassium ion transport		"{""preferred_term"": ""potassium ion transport"", ""term"": {""id"": ""GO:0006813"", ""label"": ""potassium ion transport""}}"																											
4569	5042	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	1	Ion Transport Dysfunction	"Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
"	biological_processes[1]	biological_processes	biological_processes			sodium ion transport	GO:0006814	sodium ion transport		"{""preferred_term"": ""sodium ion transport"", ""term"": {""id"": ""GO:0006814"", ""label"": ""sodium ion transport""}}"																											
4570	5042	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	1	Ion Transport Dysfunction	"Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
"	biological_processes[2]	biological_processes	biological_processes			water homeostasis	GO:0030104	water homeostasis		"{""preferred_term"": ""water homeostasis"", ""term"": {""id"": ""GO:0030104"", ""label"": ""water homeostasis""}}"																											
4571	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	Autoimmune and Inflammatory Mechanisms	"Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4572	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	Autoimmune and Inflammatory Mechanisms	"Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.
"	biological_processes[1]	biological_processes	biological_processes			NF-kB signaling	GO:0038123	nuclear factor-kappa B signaling		"{""preferred_term"": ""NF-kB signaling"", ""term"": {""id"": ""GO:0038123"", ""label"": ""nuclear factor-kappa B signaling""}}"																											
4573	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	Autoimmune and Inflammatory Mechanisms	"Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.
"	biological_processes[2]	biological_processes	biological_processes			response to cytokine	GO:0071345	cellular response to cytokine stimulus		"{""preferred_term"": ""response to cytokine"", ""term"": {""id"": ""GO:0071345"", ""label"": ""cellular response to cytokine stimulus""}}"																											
4574	5044	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	3	Blood-Labyrinth Barrier Dysfunction and Oxidative Stress	"The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine levels indicate oxidative stress-mediated cascading cellular injury.
"	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
4588	5065	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	0	Viral T Antigen Oncogenesis	In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation.	cell_types[0]	cell_types	cell_types			Merkel cell	CL:0000242	Merkel cell		"{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}"																											
4589	5065	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	0	Viral T Antigen Oncogenesis	In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4590	5065	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	0	Viral T Antigen Oncogenesis	In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
4591	5066	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	1	RB1 Pathway Inactivation	In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein. In virus-negative MCC, RB1 is frequently inactivated by somatic mutations. In both cases, loss of RB1 function releases E2F transcription factors to drive cell cycle progression and proliferation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4592	5067	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	2	UV-Induced Mutagenesis	In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors.	cell_types[0]	cell_types	cell_types			Merkel cell	CL:0000242	Merkel cell		"{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}"																											
4593	5067	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	2	UV-Induced Mutagenesis	In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4594	5067	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	2	UV-Induced Mutagenesis	In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
4595	5068	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	3	Uncontrolled Merkel Cell Proliferation	Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin.	cell_types[0]	cell_types	cell_types			Merkel cell	CL:0000242	Merkel cell		"{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}"																											
4596	5068	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	3	Uncontrolled Merkel Cell Proliferation	Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4610	5096	214	Migraine	Migraine.yaml	pathophysiology	0	Cortical Spreading Depression	"Wave of neuronal depolarization spreading across cortex underlies aura. Triggers activation of trigeminal pathways and may initiate headache phase.
"	biological_processes[0]	biological_processes	biological_processes			Neural Signaling	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Neural Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
4611	5097	214	Migraine	Migraine.yaml	pathophysiology	1	Trigeminovascular Activation	"Activation of trigeminal nerve fibers innervating meningeal blood vessels releases CGRP and other neuropeptides, causing neurogenic inflammation and pain.
"	biological_processes[0]	biological_processes	biological_processes			Pain Signaling	GO:0048265	response to pain		"{""preferred_term"": ""Pain Signaling"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}"																											
4618	5118	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	0	Anti-U1 RNP Autoimmunity	High-titer antibodies against U1 small nuclear ribonucleoprotein (U1 RNP) are the serological hallmark. These antibodies may directly contribute to disease through immune complex formation and cellular dysfunction.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
4619	5119	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	1	T Cell-Mediated Inflammation	CD4+ T cells recognizing U1 RNP antigens drive the autoimmune response. Th1 and Th17 cytokines contribute to tissue inflammation and damage across multiple organ systems.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
4620	5119	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	1	T Cell-Mediated Inflammation	CD4+ T cells recognizing U1 RNP antigens drive the autoimmune response. Th1 and Th17 cytokines contribute to tissue inflammation and damage across multiple organ systems.	biological_processes[0]	biological_processes	biological_processes			Adaptive Immune Response	GO:0002250	adaptive immune response		"{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
4621	5120	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	2	Vascular Dysfunction	Endothelial injury and proliferative vasculopathy similar to systemic sclerosis contribute to Raynaud's phenomenon and may lead to pulmonary arterial hypertension in some patients.	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4622	5120	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	2	Vascular Dysfunction	Endothelial injury and proliferative vasculopathy similar to systemic sclerosis contribute to Raynaud's phenomenon and may lead to pulmonary arterial hypertension in some patients.	biological_processes[0]	biological_processes	biological_processes			Blood Vessel Development	GO:0001568	blood vessel development		"{""preferred_term"": ""Blood Vessel Development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}"																											
4623	5121	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	3	Muscle Inflammation	Inflammatory myopathy with lymphocytic infiltration of skeletal muscle leads to proximal muscle weakness, similar to polymyositis.	cell_types[0]	cell_types	cell_types			Skeletal Muscle Cell	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
4624	5121	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	3	Muscle Inflammation	Inflammatory myopathy with lymphocytic infiltration of skeletal muscle leads to proximal muscle weakness, similar to polymyositis.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4625	5122	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	4	Type I Interferon Signature	Pervasive DNA hypomethylation at interferon-inducible genes drives constitutive type I interferon pathway activation. This epigenetic signature is shared with SLE and Sjogren syndrome but is particularly pronounced in MCTD, contributing to immune dysregulation and disease heterogeneity.	biological_processes[0]	biological_processes	biological_processes			Type I Interferon Signaling Pathway	GO:0060337	type I interferon signaling pathway		"{""preferred_term"": ""Type I Interferon Signaling Pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}"																											
4637	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
4638	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	cell_types[1]	cell_types	cell_types			Langerhans cell	CL:0000453	Langerhans cell		"{""preferred_term"": ""Langerhans cell"", ""term"": {""id"": ""CL:0000453"", ""label"": ""Langerhans cell""}}"																											
4639	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	cell_types[2]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
4640	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	locations[0]	locations	locations			skin epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
4641	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	locations[1]	locations	locations			mucosa	UBERON:0000344	mucosa		"{""preferred_term"": ""mucosa"", ""term"": {""id"": ""UBERON:0000344"", ""label"": ""mucosa""}}"																											
4642	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	biological_processes[0]	biological_processes	biological_processes			viral entry into host cell	GO:0046718	viral entry into host cell		"{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}"																											
4643	5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.	biological_processes[1]	biological_processes	biological_processes			viral genome replication	GO:0019079	viral genome replication		"{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}"																											
4644	5148	216	Monkeypox	Monkeypox.yaml	pathophysiology	1	Lymphatic Dissemination	Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy.	cell_types[0]	cell_types	cell_types			Langerhans cell	CL:0000453	Langerhans cell		"{""preferred_term"": ""Langerhans cell"", ""term"": {""id"": ""CL:0000453"", ""label"": ""Langerhans cell""}}"																											
4645	5148	216	Monkeypox	Monkeypox.yaml	pathophysiology	1	Lymphatic Dissemination	Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy.	cell_types[1]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
4646	5148	216	Monkeypox	Monkeypox.yaml	pathophysiology	1	Lymphatic Dissemination	Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy.	locations[0]	locations	locations			lymph node	UBERON:0000029	lymph node		"{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}"																											
4647	5148	216	Monkeypox	Monkeypox.yaml	pathophysiology	1	Lymphatic Dissemination	Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy.	biological_processes[0]	biological_processes	biological_processes			leukocyte migration	GO:0050900	leukocyte migration		"{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}"																											
4648	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
4649	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.	locations[0]	locations	locations			blood	UBERON:0000178	blood		"{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}"																											
4650	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.	locations[1]	locations	locations			spleen	UBERON:0002106	spleen		"{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}"																											
4651	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.	locations[2]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
4652	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.	biological_processes[0]	biological_processes	biological_processes			virion attachment to host cell	GO:0019062	virion attachment to host cell		"{""preferred_term"": ""virion attachment to host cell"", ""term"": {""id"": ""GO:0019062"", ""label"": ""virion attachment to host cell""}}"																											
4653	5150	216	Monkeypox	Monkeypox.yaml	pathophysiology	3	Viral Factory Formation	MPXV replicates entirely in the host cytoplasm, forming ER-associated viral factories (Guarnieri bodies) where genome replication and virion assembly occur.	biological_processes[0]	biological_processes	biological_processes			viral genome replication	GO:0019079	viral genome replication		"{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}"																											
4654	5150	216	Monkeypox	Monkeypox.yaml	pathophysiology	3	Viral Factory Formation	MPXV replicates entirely in the host cytoplasm, forming ER-associated viral factories (Guarnieri bodies) where genome replication and virion assembly occur.	biological_processes[1]	biological_processes	biological_processes			virion assembly	GO:0019068	virion assembly		"{""preferred_term"": ""virion assembly"", ""term"": {""id"": ""GO:0019068"", ""label"": ""virion assembly""}}"																											
4655	5151	216	Monkeypox	Monkeypox.yaml	pathophysiology	4	Extracellular Enveloped Virion Formation	The virus produces two infectious forms - intracellular mature virions (IMV) released by cell lysis, and extracellular enveloped virions (EEV) that acquire additional membrane for efficient cell-to-cell spread. Viral proteins F13L, B5R, A34R, and A36R orchestrate EEV formation and actin-based motility.	biological_processes[0]	biological_processes	biological_processes			viral budding via host ESCRT complex	GO:0039702	viral budding via host ESCRT complex		"{""preferred_term"": ""viral budding via host ESCRT complex"", ""term"": {""id"": ""GO:0039702"", ""label"": ""viral budding via host ESCRT complex""}}"																											
4656	5151	216	Monkeypox	Monkeypox.yaml	pathophysiology	4	Extracellular Enveloped Virion Formation	The virus produces two infectious forms - intracellular mature virions (IMV) released by cell lysis, and extracellular enveloped virions (EEV) that acquire additional membrane for efficient cell-to-cell spread. Viral proteins F13L, B5R, A34R, and A36R orchestrate EEV formation and actin-based motility.	biological_processes[1]	biological_processes	biological_processes			viral release from host cell	GO:0019076	viral release from host cell		"{""preferred_term"": ""viral release from host cell"", ""term"": {""id"": ""GO:0019076"", ""label"": ""viral release from host cell""}}"																											
4657	5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.	cell_types[0]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell		"{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4658	5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.	cell_types[1]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
4659	5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.	biological_processes[0]	biological_processes	biological_processes			type I interferon signaling pathway	GO:0060337	type I interferon signaling pathway		"{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}"																											
4660	5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.	biological_processes[1]	biological_processes	biological_processes			innate immune response	GO:0045087	innate immune response		"{""preferred_term"": ""innate immune response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}"																											
4661	5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.	biological_processes[2]	biological_processes	biological_processes			I-kappaB kinase/NF-kappaB signaling	GO:0007249	I-kappaB kinase/NF-kappaB signaling		"{""preferred_term"": ""I-kappaB kinase/NF-kappaB signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""I-kappaB kinase/NF-kappaB signaling""}}"																											
4662	5153	216	Monkeypox	Monkeypox.yaml	pathophysiology	6	Skin Lesion Pathogenesis	Epidermal keratinocytes undergo ballooning degeneration with cytoplasmic viral inclusions. Lesions evolve through characteristic stages - macule, papule, vesicle, pustule, and crust formation over approximately 3 weeks.	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
4663	5153	216	Monkeypox	Monkeypox.yaml	pathophysiology	6	Skin Lesion Pathogenesis	Epidermal keratinocytes undergo ballooning degeneration with cytoplasmic viral inclusions. Lesions evolve through characteristic stages - macule, papule, vesicle, pustule, and crust formation over approximately 3 weeks.	locations[0]	locations	locations			skin epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
4683	5183	217	Muenke Syndrome	Muenke_Syndrome.yaml	pathophysiology	0	FGFR3 Gain-of-Function in Cranial Sutures	"The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
4684	5183	217	Muenke Syndrome	Muenke_Syndrome.yaml	pathophysiology	0	FGFR3 Gain-of-Function in Cranial Sutures	"The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
4685	5183	217	Muenke Syndrome	Muenke_Syndrome.yaml	pathophysiology	0	FGFR3 Gain-of-Function in Cranial Sutures	"The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
4694	5199	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	0	RET Oncogene Activation	Germline activating mutations in RET cause ligand-independent receptor dimerization and constitutive tyrosine kinase activation. Unlike tumor suppressor syndromes, only one mutant allele is required (no second hit). This represents a gain-of-function oncogene mechanism.	biological_processes[0]	biological_processes	biological_processes			transmembrane receptor protein tyrosine kinase signaling pathway	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}"			INCREASED																								
4695	5199	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	0	RET Oncogene Activation	Germline activating mutations in RET cause ligand-independent receptor dimerization and constitutive tyrosine kinase activation. Unlike tumor suppressor syndromes, only one mutant allele is required (no second hit). This represents a gain-of-function oncogene mechanism.	gene_products[0]	gene_products	gene_products			RET receptor	NCIT:C18539	Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret		"{""preferred_term"": ""RET receptor"", ""term"": {""id"": ""NCIT:C18539"", ""label"": ""Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret""}}"																											
4696	5200	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	1	Downstream Signaling Cascade Activation	Constitutively active RET phosphorylates intracellular substrates and activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways. These promote cell proliferation, survival, and transformation of neuroendocrine cell populations.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4697	5200	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	1	Downstream Signaling Cascade Activation	Constitutively active RET phosphorylates intracellular substrates and activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways. These promote cell proliferation, survival, and transformation of neuroendocrine cell populations.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
4698	5201	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	2	Neuroendocrine Cell Transformation	Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma.	cell_types[0]	cell_types	cell_types			parafollicular cell	CL:0000570	parafollicular cell		"{""preferred_term"": ""parafollicular cell"", ""term"": {""id"": ""CL:0000570"", ""label"": ""parafollicular cell""}}"																											
4699	5201	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	2	Neuroendocrine Cell Transformation	Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma.	cell_types[1]	cell_types	cell_types			chromaffin cell	CL:0000166	chromaffin cell		"{""preferred_term"": ""chromaffin cell"", ""term"": {""id"": ""CL:0000166"", ""label"": ""chromaffin cell""}}"																											
4700	5201	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	2	Neuroendocrine Cell Transformation	Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4714	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[0]	cell_types	cell_types			Oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
4715	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4716	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[2]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4717	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[3]	cell_types	cell_types			Microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""Microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
4718	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[4]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
4719	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	cell_types[5]	cell_types	cell_types			CD4-positive, alpha-beta T cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
4720	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	biological_processes[0]	biological_processes	biological_processes			Antigen processing and presentation of peptide antigen via MHC class II	GO:0002495	antigen processing and presentation of peptide antigen via MHC class II		"{""preferred_term"": ""Antigen processing and presentation of peptide antigen via MHC class II"", ""term"": {""id"": ""GO:0002495"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class II""}}"																											
4721	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	biological_processes[1]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
4722	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	biological_processes[2]	biological_processes	biological_processes			Cytokine-mediated signaling pathway	GO:0019221	cytokine-mediated signaling pathway		"{""preferred_term"": ""Cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"																											
4723	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	biological_processes[3]	biological_processes	biological_processes			Complement activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
4724	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	biological_processes[4]	biological_processes	biological_processes			Myelination	GO:0042552	myelination		"{""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
4725	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[0]	locations	locations			Central nervous system	UBERON:0001017	central nervous system		"{""preferred_term"": ""Central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}"																											
4726	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[1]	locations	locations			Meninges	UBERON:0002303	meninges		"{""preferred_term"": ""Meninges"", ""term"": {""id"": ""UBERON:0002303"", ""label"": ""meninges""}}"																											
4727	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[2]	locations	locations			White matter	UBERON:0002316	white matter		"{""preferred_term"": ""White matter"", ""term"": {""id"": ""UBERON:0002316"", ""label"": ""white matter""}}"																											
4728	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[3]	locations	locations			Gray matter	UBERON:0002020	gray matter		"{""preferred_term"": ""Gray matter"", ""term"": {""id"": ""UBERON:0002020"", ""label"": ""gray matter""}}"																											
4729	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[4]	locations	locations			Brain	UBERON:0000955	brain		"{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
4730	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.	locations[5]	locations	locations			Spinal cord	UBERON:0002240	spinal cord		"{""preferred_term"": ""Spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}"																											
4743	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[0]	genes	genes			IL6	hgnc:6018	IL6		"{""preferred_term"": ""IL6"", ""term"": {""id"": ""hgnc:6018"", ""label"": ""IL6""}}"																											
4744	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[1]	genes	genes			IL10	hgnc:5962	IL10		"{""preferred_term"": ""IL10"", ""term"": {""id"": ""hgnc:5962"", ""label"": ""IL10""}}"																											
4745	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[2]	genes	genes			TNF	hgnc:11892	TNF		"{""preferred_term"": ""TNF"", ""term"": {""id"": ""hgnc:11892"", ""label"": ""TNF""}}"																											
4746	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[3]	genes	genes			IL18	hgnc:5973	IL18		"{""preferred_term"": ""IL18"", ""term"": {""id"": ""hgnc:5973"", ""label"": ""IL18""}}"																											
4747	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[4]	genes	genes			IL1B	hgnc:5992	IL1B		"{""preferred_term"": ""IL1B"", ""term"": {""id"": ""hgnc:5992"", ""label"": ""IL1B""}}"																											
4748	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[5]	genes	genes			IL17A	hgnc:5981	IL17A		"{""preferred_term"": ""IL17A"", ""term"": {""id"": ""hgnc:5981"", ""label"": ""IL17A""}}"																											
4749	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[6]	genes	genes			IFNG	hgnc:5438	IFNG		"{""preferred_term"": ""IFNG"", ""term"": {""id"": ""hgnc:5438"", ""label"": ""IFNG""}}"																											
4750	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[7]	genes	genes			CXCL9	hgnc:10563	CXCL9		"{""preferred_term"": ""CXCL9"", ""term"": {""id"": ""hgnc:10563"", ""label"": ""CXCL9""}}"																											
4751	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	genes[8]	genes	genes			CXCL10	hgnc:10637	CXCL10		"{""preferred_term"": ""CXCL10"", ""term"": {""id"": ""hgnc:10637"", ""label"": ""CXCL10""}}"																											
4752	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	cell_types[0]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
4753	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4754	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	cell_types[2]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell		"{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4755	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	cell_types[3]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
4756	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4757	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	biological_processes[1]	biological_processes	biological_processes			cytokine-mediated signaling pathway	GO:0019221	cytokine-mediated signaling pathway		"{""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"																											
4758	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.	locations[0]	locations	locations			blood	UBERON:0000178	blood		"{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}"																											
4759	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	genes[0]	genes	genes			TRBV11-2	hgnc:12262	TRBV11-2		"{""preferred_term"": ""TRBV11-2"", ""term"": {""id"": ""hgnc:12262"", ""label"": ""TRBV11-2""}}"																											
4760	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	genes[1]	genes	genes			IL18	hgnc:5973	IL18		"{""preferred_term"": ""IL18"", ""term"": {""id"": ""hgnc:5973"", ""label"": ""IL18""}}"																											
4761	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	genes[2]	genes	genes			FAS	hgnc:11920	FAS		"{""preferred_term"": ""FAS"", ""term"": {""id"": ""hgnc:11920"", ""label"": ""FAS""}}"																											
4762	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4763	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	cell_types[1]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell		"{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4764	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	cell_types[2]	cell_types	cell_types			monocyte	CL:0000576	monocyte		"{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
4765	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	biological_processes[0]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
4766	5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.	biological_processes[1]	biological_processes	biological_processes			immune response-activating signal transduction	GO:0002757	immune response-activating signal transduction		"{""preferred_term"": ""immune response-activating signal transduction"", ""term"": {""id"": ""GO:0002757"", ""label"": ""immune response-activating signal transduction""}}"																											
4767	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	genes[0]	genes	genes			SNX8	hgnc:14972	SNX8		"{""preferred_term"": ""SNX8"", ""term"": {""id"": ""hgnc:14972"", ""label"": ""SNX8""}}"																											
4768	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	genes[1]	genes	genes			MAVS	hgnc:29233	MAVS		"{""preferred_term"": ""MAVS"", ""term"": {""id"": ""hgnc:29233"", ""label"": ""MAVS""}}"																											
4769	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4770	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	cell_types[1]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4771	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	biological_processes[0]	biological_processes	biological_processes			response to virus	GO:0009615	response to virus		"{""preferred_term"": ""response to virus"", ""term"": {""id"": ""GO:0009615"", ""label"": ""response to virus""}}"																											
4772	5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.	biological_processes[1]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4773	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	genes[0]	genes	genes			CFH	hgnc:4883	CFH		"{""preferred_term"": ""CFH"", ""term"": {""id"": ""hgnc:4883"", ""label"": ""CFH""}}"																											
4774	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	genes[1]	genes	genes			C5	hgnc:1331	C5		"{""preferred_term"": ""C5"", ""term"": {""id"": ""hgnc:1331"", ""label"": ""C5""}}"																											
4775	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	genes[2]	genes	genes			PLA2G2A	hgnc:9031	PLA2G2A		"{""preferred_term"": ""PLA2G2A"", ""term"": {""id"": ""hgnc:9031"", ""label"": ""PLA2G2A""}}"																											
4776	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4777	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
4778	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	biological_processes[1]	biological_processes	biological_processes			blood coagulation	GO:0007596	blood coagulation		"{""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
4779	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	locations[0]	locations	locations			blood vessel	UBERON:0001981	blood vessel		"{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}"																											
4780	5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.	locations[1]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
4781	5275	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	5	Intestinal Barrier Dysfunction and Antigen Persistence	Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses.	cell_types[0]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
4782	5275	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	5	Intestinal Barrier Dysfunction and Antigen Persistence	Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses.	cell_types[1]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
4783	5275	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	5	Intestinal Barrier Dysfunction and Antigen Persistence	Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4784	5275	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	5	Intestinal Barrier Dysfunction and Antigen Persistence	Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
4785	5276	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	6	Cardiac Involvement and Myocardial Dysfunction	Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers.	cell_types[0]	cell_types	cell_types			cardiac muscle cell	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
4786	5276	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	6	Cardiac Involvement and Myocardial Dysfunction	Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
4787	5276	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	6	Cardiac Involvement and Myocardial Dysfunction	Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
4788	5276	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	6	Cardiac Involvement and Myocardial Dysfunction	Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers.	locations[0]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
4805	5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	Innate Immune Hyperreactivity	Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.	cell_types[0]	cell_types	cell_types			Natural Killer Cell	CL:0000623	natural killer cell		"{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4806	5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	Innate Immune Hyperreactivity	Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.	cell_types[1]	cell_types	cell_types			Monocyte	CL:0000576	monocyte		"{""preferred_term"": ""Monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}"																											
4807	5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	Innate Immune Hyperreactivity	Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.	biological_processes[0]	biological_processes	biological_processes			Innate Immune Response	GO:0045087	innate immune response		"{""preferred_term"": ""Innate Immune Response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}"																											
4808	5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	Innate Immune Hyperreactivity	Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.	biological_processes[1]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
4809	5302	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	1	Natural Killer Cell Dysfunction	Reproducible deficits in natural killer cell cytotoxicity and phenotype abnormalities, representing one of the most consistent biological findings in ME/CFS.	cell_types[0]	cell_types	cell_types			Natural Killer Cell	CL:0000623	natural killer cell		"{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4810	5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	T-Cell Immunometabolic Dysfunction	CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.	cell_types[0]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
4811	5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	T-Cell Immunometabolic Dysfunction	CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.	cell_types[1]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
4812	5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	T-Cell Immunometabolic Dysfunction	CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.	biological_processes[0]	biological_processes	biological_processes			T Cell Activation	GO:0042110	T cell activation		"{""preferred_term"": ""T Cell Activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
4813	5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	T-Cell Immunometabolic Dysfunction	CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.	biological_processes[1]	biological_processes	biological_processes			Glycolysis	GO:0006096	glycolytic process		"{""preferred_term"": ""Glycolysis"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}"																											
4814	5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	Endothelial Dysfunction and Coagulopathy	Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
4815	5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	Endothelial Dysfunction and Coagulopathy	Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.	cell_types[1]	cell_types	cell_types			Platelet	CL:0000233	platelet		"{""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}"																											
4816	5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	Endothelial Dysfunction and Coagulopathy	Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.	biological_processes[0]	biological_processes	biological_processes			Blood Coagulation	GO:0007596	blood coagulation		"{""preferred_term"": ""Blood Coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
4817	5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	Endothelial Dysfunction and Coagulopathy	Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.	biological_processes[1]	biological_processes	biological_processes			Platelet Activation	GO:0030168	platelet activation		"{""preferred_term"": ""Platelet Activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}"																											
4818	5305	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	4	TRPM3 Ion Channel Dysfunction	Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways.	cell_types[0]	cell_types	cell_types			Natural Killer Cell	CL:0000623	natural killer cell		"{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
4819	5305	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	4	TRPM3 Ion Channel Dysfunction	Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways.	biological_processes[0]	biological_processes	biological_processes			Calcium Ion Transmembrane Transport	GO:0070588	calcium ion transmembrane transport		"{""preferred_term"": ""Calcium Ion Transmembrane Transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}"																											
4820	5306	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	5	Neuroinflammation and Cerebral Hypoperfusion	Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia.	locations[0]	locations	locations			Brain	UBERON:0000955	brain		"{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
4821	5306	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	5	Neuroinflammation and Cerebral Hypoperfusion	Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia.	locations[1]	locations	locations			Brainstem	UBERON:0002298	brainstem		"{""preferred_term"": ""Brainstem"", ""term"": {""id"": ""UBERON:0002298"", ""label"": ""brainstem""}}"																											
4822	5307	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	6	Mitochondrial Dysfunction	Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise.	cellular_components[0]	cellular_components	cellular_components			Mitochondrion	GO:0005739	mitochondrion		"{""preferred_term"": ""Mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}"																											
4823	5307	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	6	Mitochondrial Dysfunction	Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise.	biological_processes[0]	biological_processes	biological_processes			Fatty Acid Beta-Oxidation	GO:0006635	fatty acid beta-oxidation		"{""preferred_term"": ""Fatty Acid Beta-Oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}"																											
4824	5307	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	6	Mitochondrial Dysfunction	Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise.	biological_processes[1]	biological_processes	biological_processes			Response to Oxidative Stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
4835	5336	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	0	Autoantibody-Mediated NMJ Dysfunction	"Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.
"	cell_types[0]	cell_types	cell_types			Skeletal Muscle Cell	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
4836	5336	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	0	Autoantibody-Mediated NMJ Dysfunction	"Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.
"	biological_processes[0]	biological_processes	biological_processes			Neuromuscular Transmission	GO:0007274	neuromuscular synaptic transmission		"{""preferred_term"": ""Neuromuscular Transmission"", ""term"": {""id"": ""GO:0007274"", ""label"": ""neuromuscular synaptic transmission""}}"																											
4837	5337	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	1	Complement Activation	"Anti-AChR antibodies activate the classical complement pathway, leading to membrane attack complex formation and destruction of the postsynaptic membrane architecture.
"	biological_processes[0]	biological_processes	biological_processes			Complement Activation	GO:0006956	complement activation		"{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
4838	5338	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	2	Thymic Abnormalities	"Thymic hyperplasia (65-75% of patients) or thymoma (10-15%) is common. The thymus may serve as the site of autoimmunization, containing myoid cells expressing AChR that activate autoreactive T cells.
"	cell_types[0]	cell_types	cell_types			Thymic Epithelial Cell	CL:0002293	epithelial cell of thymus		"{""preferred_term"": ""Thymic Epithelial Cell"", ""term"": {""id"": ""CL:0002293"", ""label"": ""epithelial cell of thymus""}}"																											
4855	5361	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	0	NPM1 Cytoplasmic Mislocalization	NPM1 is a nucleolar phosphoprotein that shuttles between the nucleolus, nucleoplasm, and cytoplasm. Wild-type NPM1 localizes predominantly to nucleoli due to a C-terminal nucleolar localization signal. Mutations in exon 12 disrupt this signal and create a nuclear export signal, causing aberrant cytoplasmic accumulation (NPMc+). This depletes nucleolar NPM1, disrupting its normal functions.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
4856	5362	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	1	ARF-p53 Pathway Disruption	Wild-type NPM1 stabilizes the ARF tumor suppressor in the nucleolus. Cytoplasmic NPM1 delocalizes ARF, reducing its ability to inhibit MDM2 and stabilize p53. This impairs the p53-mediated response to oncogenic stress and DNA damage.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
4857	5363	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	2	HOX Gene Dysregulation	NPM1-mutated AML consistently shows upregulation of HOXA and HOXB cluster genes, including HOXA9 and MEIS1. These transcription factors promote self-renewal of leukemic cells and block normal myeloid differentiation. This HOX signature is a defining feature of NPM1-mutated AML.	cell_types[0]	cell_types	cell_types			myeloblast	CL:0000835	myeloblast		"{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}"																											
4858	5363	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	2	HOX Gene Dysregulation	NPM1-mutated AML consistently shows upregulation of HOXA and HOXB cluster genes, including HOXA9 and MEIS1. These transcription factors promote self-renewal of leukemic cells and block normal myeloid differentiation. This HOX signature is a defining feature of NPM1-mutated AML.	biological_processes[0]	biological_processes	biological_processes			myeloid cell differentiation	GO:0030099	myeloid cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}"			DECREASED																								
4859	5364	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	3	Impaired Tumor Suppression	The combined effects of ARF-p53 pathway disruption and loss of NPM1 nucleolar functions impair the cell's ability to respond to oncogenic signals with appropriate growth arrest or apoptosis.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
4860	5365	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	NPM1-mutated AML blasts show a characteristic partial differentiation with monocytic features. The HOX gene signature and NPM1 cytoplasmic localization maintain the cells in a progenitor state while allowing some differentiation along the myelomonocytic lineage.	cell_types[0]	cell_types	cell_types			myeloid cell	CL:0000763	myeloid cell		"{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}"																											
4861	5365	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	NPM1-mutated AML blasts show a characteristic partial differentiation with monocytic features. The HOX gene signature and NPM1 cytoplasmic localization maintain the cells in a progenitor state while allowing some differentiation along the myelomonocytic lineage.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
4873	5379	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	0	NRAS Q61 Oncogenic Mutation	NRAS mutations at codon 61 (Q61R, Q61K, Q61L) impair intrinsic GTPase activity and reduce sensitivity to GTPase-activating proteins (GAPs), resulting in constitutively GTP-bound active NRAS. This locks the protein in its active conformation, continuously stimulating downstream effector pathways.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
4874	5379	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	0	NRAS Q61 Oncogenic Mutation	NRAS mutations at codon 61 (Q61R, Q61K, Q61L) impair intrinsic GTPase activity and reduce sensitivity to GTPase-activating proteins (GAPs), resulting in constitutively GTP-bound active NRAS. This locks the protein in its active conformation, continuously stimulating downstream effector pathways.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
4875	5380	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	1	Dual MAPK and PI3K Pathway Activation	Unlike BRAF mutations that primarily activate MAPK signaling, oncogenic NRAS simultaneously activates both the RAF-MEK-ERK (MAPK) pathway and the PI3K-AKT pathway. This dual pathway activation contributes to the aggressive biology and relative treatment resistance of NRAS-mutant melanoma.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4876	5381	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
4877	5381	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression.	locations[0]	locations	locations			skin of body	UBERON:0002097	skin of body		"{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
4878	5381	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4879	5382	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	3	Enhanced Cell Survival	PI3K-AKT pathway activation downstream of NRAS promotes melanoma cell survival through phosphorylation and inactivation of pro-apoptotic proteins, activation of mTOR signaling, and metabolic reprogramming. This contributes to therapy resistance and the need for combination treatment strategies.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
4886	5396	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	0	NTRK Gene Fusion and Constitutive TRK Activation	Chromosomal rearrangements fuse the kinase domain of NTRK genes with various upstream partners that provide dimerization domains. This creates constitutively active chimeric TRK proteins that signal independently of neurotrophin ligands.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
4887	5397	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	Constitutive TRK activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled cell proliferation. This is a major effector pathway of TRK-mediated oncogenesis.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4888	5398	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	TRK activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives aggressive tumor growth.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
4895	5413	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	0	Orexin/Hypocretin Deficiency	"Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.
"	cell_types[0]	cell_types	cell_types			Orexin Neuron	CL:0011109	hypocretin-secreting neuron		"{""preferred_term"": ""Orexin Neuron"", ""term"": {""id"": ""CL:0011109"", ""label"": ""hypocretin-secreting neuron""}}"																											
4896	5413	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	0	Orexin/Hypocretin Deficiency	"Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.
"	biological_processes[0]	biological_processes	biological_processes			Sleep-Wake Regulation	GO:0042745	circadian sleep/wake cycle		"{""preferred_term"": ""Sleep-Wake Regulation"", ""term"": {""id"": ""GO:0042745"", ""label"": ""circadian sleep/wake cycle""}}"																											
4897	5414	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	1	Autoimmune Destruction	"Strong HLA-DQB1*06:02 association suggests autoimmune etiology. T-cell mediated destruction of hypocretin neurons is the leading hypothesis. Environmental triggers (infections, H1N1 vaccination) may initiate the autoimmune response in genetically susceptible individuals.
"	biological_processes[0]	biological_processes	biological_processes			Autoimmune Response	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains		"{""preferred_term"": ""Autoimmune Response"", ""term"": {""id"": ""GO:0002460"", ""label"": ""adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains""}}"																											
4912	5437	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	0	EBV Latent Membrane Protein 1 (LMP1) Signaling	LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition.	cell_types[0]	cell_types	cell_types			squamous epithelial cell	CL:0000076	squamous epithelial cell		"{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}"																											
4913	5437	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	0	EBV Latent Membrane Protein 1 (LMP1) Signaling	LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition.	biological_processes[0]	biological_processes	biological_processes			NF-kappaB signaling	GO:0038061	NIK/NF-kappaB signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""NF-kappaB signaling"", ""term"": {""id"": ""GO:0038061"", ""label"": ""NIK/NF-kappaB signaling""}}"			INCREASED																								
4914	5437	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	0	EBV Latent Membrane Protein 1 (LMP1) Signaling	LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4915	5437	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	0	EBV Latent Membrane Protein 1 (LMP1) Signaling	LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition.	locations[0]	locations	locations			nasopharynx	UBERON:0001728	nasopharynx		"{""preferred_term"": ""nasopharynx"", ""term"": {""id"": ""UBERON:0001728"", ""label"": ""nasopharynx""}}"																											
4916	5438	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	1	LMP2A-Mediated B Cell Receptor Mimicry	LMP2A is a viral protein that mimics an activated B cell receptor, providing survival signals that prevent viral lytic reactivation and maintain latency. In epithelial cells, LMP2A activates PI3K/AKT and promotes cell motility.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
4917	5439	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	2	EBNA1-Mediated Viral Maintenance	EBNA1 is essential for EBV genome replication and maintenance during latency. It tethers viral episomes to host chromosomes and contributes to genomic instability by inducing oxidative stress and interfering with DNA damage responses.	biological_processes[0]	biological_processes	biological_processes			viral genome replication	GO:0019079	viral genome replication		"{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}"																											
4918	5440	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	3	Host Genetic Susceptibility	Specific HLA haplotypes, particularly HLA-A2, are associated with increased NPC risk in endemic populations. Additional susceptibility loci have been identified in GWAS studies, including genes involved in immune function and DNA repair.	genes[0]	genes	genes			HLA-A				"{""preferred_term"": ""HLA-A""}"																											
4919	5441	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	4	Immune Evasion	EBV-infected NPC cells evade immune surveillance through multiple mechanisms including PD-L1 upregulation, suppression of antigen presentation, and recruitment of regulatory T cells. This provides rationale for immune checkpoint inhibition.	biological_processes[0]	biological_processes	biological_processes			negative regulation of T cell mediated immunity	GO:0002710	negative regulation of T cell mediated immunity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of T cell mediated immunity"", ""term"": {""id"": ""GO:0002710"", ""label"": ""negative regulation of T cell mediated immunity""}}"			INCREASED																								
4933	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	Ciliary Dysfunction	Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.	genes[0]	genes	genes			NPHP1	hgnc:7905	NPHP1		"{""preferred_term"": ""NPHP1"", ""term"": {""id"": ""hgnc:7905"", ""label"": ""NPHP1""}}"																											
4934	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	Ciliary Dysfunction	Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.	cellular_components[0]	cellular_components	cellular_components			Primary Cilium	GO:0005929	cilium		"{""preferred_term"": ""Primary Cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
4935	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	Ciliary Dysfunction	Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.	cell_types[0]	cell_types	cell_types			Renal Tubular Epithelial Cell	CL:1000494	nephron tubule epithelial cell		"{""preferred_term"": ""Renal Tubular Epithelial Cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}"																											
4936	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	Impaired Cell Signaling	Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.	pathways[0]	pathways	pathways			Wnt Pathway	GO:0016055	Wnt signaling pathway		"{""preferred_term"": ""Wnt Pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"																											
4937	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	Impaired Cell Signaling	Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.	pathways[1]	pathways	pathways			Hedgehog Pathway	GO:0007224	smoothened signaling pathway		"{""preferred_term"": ""Hedgehog Pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}"																											
4938	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	Impaired Cell Signaling	Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.	pathways[2]	pathways	pathways			EGFR Signaling	GO:0038127	ERBB signaling pathway		"{""preferred_term"": ""EGFR Signaling"", ""term"": {""id"": ""GO:0038127"", ""label"": ""ERBB signaling pathway""}}"																											
4939	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	Impaired Cell Signaling	Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.	pathways[3]	pathways	pathways			Hippo Signaling	GO:0035329	hippo signaling		"{""preferred_term"": ""Hippo Signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}"																											
4940	5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	Renal Tubular Dysfunction	Ciliary dysfunction in renal tubular epithelial cells impairs fluid and electrolyte balance, leading to polyuria and polydipsia.	locations[0]	locations	locations			Renal Tubule	UBERON:0009773	renal tubule		"{""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}"																											
4941	5468	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	3	Interstitial Fibrosis	Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis.	locations[0]	locations	locations			Kidney Interstitium	UBERON:0005215	kidney interstitium		"{""preferred_term"": ""Kidney Interstitium"", ""term"": {""id"": ""UBERON:0005215"", ""label"": ""kidney interstitium""}}"																											
4942	5468	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	3	Interstitial Fibrosis	Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis.	cell_types[0]	cell_types	cell_types			Renal Interstitial Fibroblast	CL:1000692	kidney interstitial fibroblast		"{""preferred_term"": ""Renal Interstitial Fibroblast"", ""term"": {""id"": ""CL:1000692"", ""label"": ""kidney interstitial fibroblast""}}"																											
4943	5469	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	4	Renal Cyst Formation	Abnormal cell proliferation and differentiation result in the formation of cysts in the kidney tubules, contributing to the loss of renal function.	locations[0]	locations	locations			Renal Tubule	UBERON:0009773	renal tubule		"{""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}"																											
4944	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	Extrarenal Manifestations	Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues.	locations[0]	locations	locations			Liver	UBERON:0002107	liver		"{""preferred_term"": ""Liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
4945	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	Extrarenal Manifestations	Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues.	locations[1]	locations	locations			Retina	UBERON:0000966	retina		"{""preferred_term"": ""Retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}"																											
4946	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	Extrarenal Manifestations	Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues.	locations[2]	locations	locations			Brain	UBERON:0000955	brain		"{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
4947	5474	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	9	DNA Damage and Senescence	NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress.	locations[0]	locations	locations			Nucleus	GO:0005634	nucleus		"{""preferred_term"": ""Nucleus"", ""term"": {""id"": ""GO:0005634"", ""label"": ""nucleus""}}"																											
4948	5474	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	9	DNA Damage and Senescence	NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress.	locations[1]	locations	locations			Renal Tubule	UBERON:0009773	renal tubule		"{""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}"																											
4949	5474	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	9	DNA Damage and Senescence	NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress.	genes[0]	genes	genes			NPHP1	hgnc:7905	NPHP1		"{""preferred_term"": ""NPHP1"", ""term"": {""id"": ""hgnc:7905"", ""label"": ""NPHP1""}}"																											
4950	5475	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	10	Aberrant Actin Remodeling and Hippo Activation	Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.	locations[0]	locations	locations			Ciliary Base	GO:0097546	ciliary base		"{""preferred_term"": ""Ciliary Base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}"																											
4951	5475	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	10	Aberrant Actin Remodeling and Hippo Activation	Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.	locations[1]	locations	locations			Centrosome	GO:0005813	centrosome		"{""preferred_term"": ""Centrosome"", ""term"": {""id"": ""GO:0005813"", ""label"": ""centrosome""}}"																											
4952	5475	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	10	Aberrant Actin Remodeling and Hippo Activation	Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.	pathways[0]	pathways	pathways			Hippo Signaling	GO:0035329	hippo signaling		"{""preferred_term"": ""Hippo Signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}"																											
4953	5475	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	10	Aberrant Actin Remodeling and Hippo Activation	Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.	pathways[1]	pathways	pathways			Actin Cytoskeleton Organization	GO:0030036	actin cytoskeleton organization		"{""preferred_term"": ""Actin Cytoskeleton Organization"", ""term"": {""id"": ""GO:0030036"", ""label"": ""actin cytoskeleton organization""}}"																											
4969	5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	Neural Crest Developmental Arrest	Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation.	cell_types[0]	cell_types	cell_types			neural crest derived neuroblast	CL:0002676	neural crest derived neuroblast		"{""preferred_term"": ""neural crest derived neuroblast"", ""term"": {""id"": ""CL:0002676"", ""label"": ""neural crest derived neuroblast""}}"																											
4970	5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	Neural Crest Developmental Arrest	Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
4971	5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	Neural Crest Developmental Arrest	Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation.	locations[0]	locations	locations			adrenal gland	UBERON:0002369	adrenal gland		"{""preferred_term"": ""adrenal gland"", ""term"": {""id"": ""UBERON:0002369"", ""label"": ""adrenal gland""}}"																											
4972	5502	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	1	MYCN-Driven Proliferation	MYCN amplification results in massive overexpression of the MYCN transcription factor, which drives cell cycle progression, inhibits differentiation, and promotes genomic instability. MYCN-amplified tumors have a distinct aggressive phenotype with rapid growth and early metastasis.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
4973	5503	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	2	ALK Signaling Activation	ALK (anaplastic lymphoma kinase) is activated by point mutations in approximately 8-10% of neuroblastomas, and by amplification in additional cases. ALK mutations are enriched in familial neuroblastoma and represent a therapeutic target for ALK inhibitors.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4990	5519	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	0	NF1 Tumor Suppressor Loss	Germline heterozygous NF1 mutations result in haploinsufficiency for neurofibromin function. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates neurofibromin completely, resulting in loss of RAS negative regulation and driving tumorigenesis. This follows Knudson's two-hit hypothesis.	biological_processes[0]	biological_processes	biological_processes			regulation of Ras protein signal transduction	GO:0046578	regulation of Ras protein signal transduction		"{""modifier"": ""DECREASED"", ""preferred_term"": ""regulation of Ras protein signal transduction"", ""term"": {""id"": ""GO:0046578"", ""label"": ""regulation of Ras protein signal transduction""}}"			DECREASED																								
4991	5520	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	1	RAS-MAPK Pathway Hyperactivation	Neurofibromin normally accelerates GTP hydrolysis on RAS proteins, promoting the inactive GDP-bound state. Loss of neurofibromin results in prolonged RAS-GTP accumulation and constitutive activation of the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival.	biological_processes[0]	biological_processes	biological_processes			Ras protein signal transduction	GO:0007265	Ras protein signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Ras protein signal transduction"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}"			INCREASED																								
4992	5520	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	1	RAS-MAPK Pathway Hyperactivation	Neurofibromin normally accelerates GTP hydrolysis on RAS proteins, promoting the inactive GDP-bound state. Loss of neurofibromin results in prolonged RAS-GTP accumulation and constitutive activation of the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival.	biological_processes[1]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
4993	5521	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	2	Uncontrolled Neural Crest Cell Proliferation	Neural crest-derived cells (Schwann cells, melanocytes) show particular dependence on RAS-MAPK signaling. Loss of neurofibromin drives uncontrolled proliferation of these cell types, resulting in neurofibromas (Schwann cell tumors) and hyperpigmented skin lesions (cafe-au-lait macules from melanocyte hyperproliferation).	cell_types[0]	cell_types	cell_types			Schwann cell	CL:0002573	Schwann cell		"{""preferred_term"": ""Schwann cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}"																											
4994	5521	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	2	Uncontrolled Neural Crest Cell Proliferation	Neural crest-derived cells (Schwann cells, melanocytes) show particular dependence on RAS-MAPK signaling. Loss of neurofibromin drives uncontrolled proliferation of these cell types, resulting in neurofibromas (Schwann cell tumors) and hyperpigmented skin lesions (cafe-au-lait macules from melanocyte hyperproliferation).	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
5029	5536	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	0	AQP4-IgG-Mediated Astrocyte Injury	Autoantibodies against AQP4 bind astrocytic end-feet and trigger complement-dependent astrocyte damage, driving neuroinflammation.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5030	5536	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	0	AQP4-IgG-Mediated Astrocyte Injury	Autoantibodies against AQP4 bind astrocytic end-feet and trigger complement-dependent astrocyte damage, driving neuroinflammation.	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"			INCREASED																								
5031	5537	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	1	AQP4 Endocytosis and Complement-Independent Cytotoxicity	NMO-IgG can induce complement-independent astrocyte injury, with antibody- induced endocytosis of AQP4 implicated in this mechanism.	biological_processes[0]	biological_processes	biological_processes			endocytosis	GO:0006897	endocytosis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}"			INCREASED																								
5038	5548	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	0	Aquaporin-4 Autoimmunity	"Anti-AQP4 (NMO-IgG) antibodies bind to aquaporin-4 water channels predominantly expressed on astrocyte end-feet at the blood-brain barrier. This initiates complement-dependent cytotoxicity leading to astrocyte death, secondary oligodendrocyte damage, demyelination, and neuronal injury.
"	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5039	5548	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	0	Aquaporin-4 Autoimmunity	"Anti-AQP4 (NMO-IgG) antibodies bind to aquaporin-4 water channels predominantly expressed on astrocyte end-feet at the blood-brain barrier. This initiates complement-dependent cytotoxicity leading to astrocyte death, secondary oligodendrocyte damage, demyelination, and neuronal injury.
"	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
5040	5549	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	1	Complement-Mediated Astrocyte Destruction	"AQP4-IgG binding activates the classical complement cascade, leading to membrane attack complex formation and astrocyte lysis. This distinguishes NMOSD from MS where complement activation is less prominent.
"	biological_processes[0]	biological_processes	biological_processes			complement activation, classical pathway	GO:0006958	complement activation, classical pathway		"{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}"																											
5041	5550	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	2	Blood-Brain Barrier Disruption	"Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.
"	locations[0]	locations	locations			blood brain barrier	UBERON:0000120	blood brain barrier		"{""preferred_term"": ""blood brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood brain barrier""}}"																											
5042	5550	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	2	Blood-Brain Barrier Disruption	"Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
5043	5550	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	2	Blood-Brain Barrier Disruption	"Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.
"	cell_types[1]	cell_types	cell_types			eosinophil	CL:0000771	eosinophil		"{""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000771"", ""label"": ""eosinophil""}}"																											
5044	5551	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	3	Secondary Demyelination	"Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.
"	cell_types[0]	cell_types	cell_types			oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
5045	5551	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	3	Secondary Demyelination	"Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.
"	biological_processes[0]	biological_processes	biological_processes			myelination	GO:0042552	myelination		"{""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
5046	5551	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	3	Secondary Demyelination	"Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.
"	cellular_components[0]	cellular_components	cellular_components			myelin sheath	GO:0043209	myelin sheath		"{""preferred_term"": ""myelin sheath"", ""term"": {""id"": ""GO:0043209"", ""label"": ""myelin sheath""}}"																											
5065	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	Oncogenic Driver Mutations	Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival.	biological_processes[0]	biological_processes	biological_processes			transmembrane receptor protein tyrosine kinase signaling pathway	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	Dysregulated RTK signaling via EGFR, ALK, MET drives proliferation and survival	"{""description"": ""Dysregulated RTK signaling via EGFR, ALK, MET drives proliferation and survival"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}"																											
5066	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	Oncogenic Driver Mutations	Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival.	biological_processes[1]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade	Constitutive MAPK activation via KRAS, EGFR, ALK mutations	"{""description"": ""Constitutive MAPK activation via KRAS, EGFR, ALK mutations"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
5067	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	Immune Evasion	Cancer cells develop mechanisms to evade detection and destruction by the immune system.	biological_processes[0]	biological_processes	biological_processes			epithelial to mesenchymal transition	GO:0001837	epithelial to mesenchymal transition	EMT programs linked to immune suppression and therapy resistance; EGFR-mutant tumors may transform to SCLC	"{""description"": ""EMT programs linked to immune suppression and therapy resistance; EGFR-mutant tumors may transform to SCLC"", ""preferred_term"": ""epithelial to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}"																											
5068	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage	Tumor-associated macrophages (TAMs) reprogrammed to cholesterol export and iron efflux states; dominant immunosuppressive population	"{""description"": ""Tumor-associated macrophages (TAMs) reprogrammed to cholesterol export and iron efflux states; dominant immunosuppressive population"", ""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
5069	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell	Reduced T cell infiltration and cytotoxicity in immunosuppressive niches; altered checkpoint co-expression patterns	"{""description"": ""Reduced T cell infiltration and cytotoxicity in immunosuppressive niches; altered checkpoint co-expression patterns"", ""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5070	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	cell_types[2]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell	Reduced NK cell cytotoxicity; inverse relationship with anti-inflammatory macrophages	"{""description"": ""Reduced NK cell cytotoxicity; inverse relationship with anti-inflammatory macrophages"", ""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
5071	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	cell_types[3]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast	Cancer-associated fibroblasts (CAFs) contribute to immunosuppressive niches and stromal remodeling	"{""description"": ""Cancer-associated fibroblasts (CAFs) contribute to immunosuppressive niches and stromal remodeling"", ""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
5072	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	biological_processes[0]	biological_processes	biological_processes			regulation of T cell activation	GO:0050863	regulation of T cell activation	Altered T cell activation in TME; checkpoint co-expression patterns; dual ICI modulates CD4+ responses	"{""description"": ""Altered T cell activation in TME; checkpoint co-expression patterns; dual ICI modulates CD4+ responses"", ""preferred_term"": ""regulation of T cell activation"", ""term"": {""id"": ""GO:0050863"", ""label"": ""regulation of T cell activation""}}"																											
5073	5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.	locations[0]	locations	locations			parenchyma of lung	UBERON:0008946	parenchyma of lung	Primary site of TME remodeling	"{""description"": ""Primary site of TME remodeling"", ""preferred_term"": ""parenchyma of lung"", ""term"": {""id"": ""UBERON:0008946"", ""label"": ""parenchyma of lung""}}"																											
5074	5587	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	4	Metabolic Rewiring	KRAS/LKB1 co-mutant tumors depend on oxidative pentose phosphate pathway (PPP) via G6PD for NADPH production, redox balance, and lipogenesis; G6PD ablation selectively suppresses tumor growth and activates p53.	biological_processes[0]	biological_processes	biological_processes			pentose-phosphate shunt	GO:0006098	pentose-phosphate shunt	KRAS/LKB1 tumors depend on oxidative PPP via G6PD for NADPH and lipogenesis	"{""description"": ""KRAS/LKB1 tumors depend on oxidative PPP via G6PD for NADPH and lipogenesis"", ""preferred_term"": ""pentose-phosphate shunt"", ""term"": {""id"": ""GO:0006098"", ""label"": ""pentose-phosphate shunt""}}"																											
5075	5587	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	4	Metabolic Rewiring	KRAS/LKB1 co-mutant tumors depend on oxidative pentose phosphate pathway (PPP) via G6PD for NADPH production, redox balance, and lipogenesis; G6PD ablation selectively suppresses tumor growth and activates p53.	biological_processes[1]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress	G6PD impairment disrupts redox balance and activates p53	"{""description"": ""G6PD impairment disrupts redox balance and activates p53"", ""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
5097	5613	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	0	SHP2 Gain-of-Function Activation	PTPN11 mutations destabilize the autoinhibitory interaction between the N-SH2 and PTP domains, resulting in constitutively elevated phosphatase activity. SHP2 is a positive regulator of RAS-MAPK signaling and gain-of-function mutations lead to enhanced ERK activation.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine phosphatase activity	GO:0004725	protein tyrosine phosphatase activity		"{""preferred_term"": ""protein tyrosine phosphatase activity"", ""term"": {""id"": ""GO:0004725"", ""label"": ""protein tyrosine phosphatase activity""}}"																											
5098	5614	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	1	SOS1-Mediated RAS-GTP Loading	SOS1 gain-of-function mutations encode guanine nucleotide exchange factor variants with enhanced activity, increasing the rate of RAS-GDP to RAS-GTP conversion and amplifying downstream MAPK signaling.	biological_processes[0]	biological_processes	biological_processes			Ras guanyl-nucleotide exchange factor activity	GO:0005088	Ras guanyl-nucleotide exchange factor activity		"{""preferred_term"": ""Ras guanyl-nucleotide exchange factor activity"", ""term"": {""id"": ""GO:0005088"", ""label"": ""Ras guanyl-nucleotide exchange factor activity""}}"																											
5099	5615	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	2	RAF1 Kinase Hyperactivation	RAF1 mutations, particularly those altering Ser259 and flanking residues, disrupt 14-3-3 binding and autoinhibition, resulting in constitutively elevated serine-threonine kinase activity and enhanced MEK phosphorylation.	biological_processes[0]	biological_processes	biological_processes			protein serine/threonine kinase activity	GO:0004674	protein serine/threonine kinase activity		"{""preferred_term"": ""protein serine/threonine kinase activity"", ""term"": {""id"": ""GO:0004674"", ""label"": ""protein serine/threonine kinase activity""}}"																											
5100	5616	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	3	RIT1-Mediated RAF Recruitment	RIT1 gain-of-function mutations cause aberrant membrane localization and RAF recruitment, bypassing normal RAS regulation and driving excessive MAPK pathway activation.	biological_processes[0]	biological_processes	biological_processes			Ras protein signal transduction	GO:0007265	Ras protein signal transduction		"{""preferred_term"": ""Ras protein signal transduction"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}"																											
5101	5617	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	4	LZTR1-Mediated RAS Proteostasis Defect	Loss of LZTR1-mediated RAS proteostasis through CRL3 E3 ligase increases RAS-family protein levels (including MRAS, RIT1, and KRAS) and MAPK signaling. Dominant LZTR1 mutations act in a dominant-negative manner to disrupt ubiquitination and degradation of RAS proteins.	biological_processes[0]	biological_processes	biological_processes			protein ubiquitination	GO:0016567	protein ubiquitination		"{""preferred_term"": ""protein ubiquitination"", ""term"": {""id"": ""GO:0016567"", ""label"": ""protein ubiquitination""}}"																											
5102	5617	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	4	LZTR1-Mediated RAS Proteostasis Defect	Loss of LZTR1-mediated RAS proteostasis through CRL3 E3 ligase increases RAS-family protein levels (including MRAS, RIT1, and KRAS) and MAPK signaling. Dominant LZTR1 mutations act in a dominant-negative manner to disrupt ubiquitination and degradation of RAS proteins.	biological_processes[1]	biological_processes	biological_processes			regulation of proteolysis	GO:0030162	regulation of proteolysis		"{""preferred_term"": ""regulation of proteolysis"", ""term"": {""id"": ""GO:0030162"", ""label"": ""regulation of proteolysis""}}"																											
5103	5618	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	5	ERK Cascade Hyperactivation	Convergent point where all upstream RAS-MAPK pathway defects lead to sustained ERK1/2 phosphorylation and hyperactivation. This affects cell proliferation, differentiation, and survival during embryonic development and postnatal life.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"																											
5104	5618	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	5	ERK Cascade Hyperactivation	Convergent point where all upstream RAS-MAPK pathway defects lead to sustained ERK1/2 phosphorylation and hyperactivation. This affects cell proliferation, differentiation, and survival during embryonic development and postnatal life.	biological_processes[1]	biological_processes	biological_processes			regulation of ERK1 and ERK2 cascade	GO:0070372	regulation of ERK1 and ERK2 cascade		"{""preferred_term"": ""regulation of ERK1 and ERK2 cascade"", ""term"": {""id"": ""GO:0070372"", ""label"": ""regulation of ERK1 and ERK2 cascade""}}"																											
5105	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.	biological_processes[0]	biological_processes	biological_processes			endocardial cushion to mesenchymal transition	GO:0001837	epithelial to mesenchymal transition involved in endocardial cushion formation		"{""preferred_term"": ""endocardial cushion to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition involved in endocardial cushion formation""}}"																											
5106	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.	biological_processes[1]	biological_processes	biological_processes			heart valve morphogenesis	GO:0003179	heart valve morphogenesis		"{""preferred_term"": ""heart valve morphogenesis"", ""term"": {""id"": ""GO:0003179"", ""label"": ""heart valve morphogenesis""}}"																											
5107	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.	cell_types[0]	cell_types	cell_types			endocardial cell	CL:0002350	endocardial cell		"{""preferred_term"": ""endocardial cell"", ""term"": {""id"": ""CL:0002350"", ""label"": ""endocardial cell""}}"																											
5108	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.	locations[0]	locations	locations			pulmonary valve	UBERON:0002146	pulmonary valve		"{""preferred_term"": ""pulmonary valve"", ""term"": {""id"": ""UBERON:0002146"", ""label"": ""pulmonary valve""}}"																											
5109	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.	locations[1]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
5110	5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	Cardiomyocyte Hypertrophy	In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations.	biological_processes[0]	biological_processes	biological_processes			cardiac muscle hypertrophy	GO:0003300	cardiac muscle hypertrophy		"{""preferred_term"": ""cardiac muscle hypertrophy"", ""term"": {""id"": ""GO:0003300"", ""label"": ""cardiac muscle hypertrophy""}}"																											
5111	5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	Cardiomyocyte Hypertrophy	In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations.	cell_types[0]	cell_types	cell_types			cardiomyocyte	CL:0000746	cardiac muscle cell		"{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}"																											
5112	5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	Cardiomyocyte Hypertrophy	In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations.	locations[0]	locations	locations			heart	UBERON:0000948	heart		"{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
5155	5661	237	Obesity	Obesity.yaml	pathophysiology	0	Energy Imbalance	"Chronic positive energy balance from excess caloric intake relative to expenditure leads to fat accumulation. Multiple regulatory systems (leptin, ghrelin, insulin) fail to restore balance.
"	biological_processes[0]	biological_processes	biological_processes			Energy Homeostasis	GO:0097009	energy homeostasis		"{""preferred_term"": ""Energy Homeostasis"", ""term"": {""id"": ""GO:0097009"", ""label"": ""energy homeostasis""}}"																											
5156	5662	237	Obesity	Obesity.yaml	pathophysiology	1	Adipose Tissue Dysfunction	"Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.
"	cell_types[0]	cell_types	cell_types			Adipocyte	CL:0000136	adipocyte		"{""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}"																											
5157	5662	237	Obesity	Obesity.yaml	pathophysiology	1	Adipose Tissue Dysfunction	"Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.
"	cell_types[1]	cell_types	cell_types			Adipose Tissue Macrophage	CL:0000863	inflammatory macrophage		"{""preferred_term"": ""Adipose Tissue Macrophage"", ""term"": {""id"": ""CL:0000863"", ""label"": ""inflammatory macrophage""}}"																											
5158	5662	237	Obesity	Obesity.yaml	pathophysiology	1	Adipose Tissue Dysfunction	"Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.
"	biological_processes[0]	biological_processes	biological_processes			Adipokine Secretion	GO:0070163	regulation of adiponectin secretion		"{""preferred_term"": ""Adipokine Secretion"", ""term"": {""id"": ""GO:0070163"", ""label"": ""regulation of adiponectin secretion""}}"																											
5159	5663	237	Obesity	Obesity.yaml	pathophysiology	2	Chronic Low-Grade Inflammation	"Systemic inflammation from adipose tissue contributes to insulin resistance, cardiovascular disease, and other complications. Elevated CRP, IL-6, and TNF-alpha levels.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5160	5664	237	Obesity	Obesity.yaml	pathophysiology	3	Hypothalamic Dysregulation	"Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.
"	cell_types[0]	cell_types	cell_types			Hypothalamus Cell	CL:2000030	hypothalamus cell		"{""preferred_term"": ""Hypothalamus Cell"", ""term"": {""id"": ""CL:2000030"", ""label"": ""hypothalamus cell""}}"																											
5161	5664	237	Obesity	Obesity.yaml	pathophysiology	3	Hypothalamic Dysregulation	"Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.
"	cell_types[1]	cell_types	cell_types			Microglial Cell	CL:0000129	microglial cell		"{""preferred_term"": ""Microglial Cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
5162	5664	237	Obesity	Obesity.yaml	pathophysiology	3	Hypothalamic Dysregulation	"Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.
"	biological_processes[0]	biological_processes	biological_processes			Feeding Behavior	GO:0007631	feeding behavior		"{""preferred_term"": ""Feeding Behavior"", ""term"": {""id"": ""GO:0007631"", ""label"": ""feeding behavior""}}"																											
5163	5665	237	Obesity	Obesity.yaml	pathophysiology	4	Adipocyte Mitochondrial Dysfunction	"Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.
"	cell_types[0]	cell_types	cell_types			Adipocyte	CL:0000136	adipocyte		"{""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}"																											
5164	5665	237	Obesity	Obesity.yaml	pathophysiology	4	Adipocyte Mitochondrial Dysfunction	"Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.
"	biological_processes[0]	biological_processes	biological_processes			Mitochondrial Fission	GO:0000266	mitochondrial fission		"{""preferred_term"": ""Mitochondrial Fission"", ""term"": {""id"": ""GO:0000266"", ""label"": ""mitochondrial fission""}}"																											
5165	5665	237	Obesity	Obesity.yaml	pathophysiology	4	Adipocyte Mitochondrial Dysfunction	"Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.
"	biological_processes[1]	biological_processes	biological_processes			Fatty Acid Oxidation	GO:0019395	fatty acid oxidation		"{""preferred_term"": ""Fatty Acid Oxidation"", ""term"": {""id"": ""GO:0019395"", ""label"": ""fatty acid oxidation""}}"																											
5179	5689	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	0	Upper Airway Collapse	"During sleep, reduced muscle tone allows pharyngeal soft tissues to collapse, obstructing airflow. Anatomical factors (retrognathia, large tonsils, obesity) predispose to collapse.
"	biological_processes[0]	biological_processes	biological_processes			Muscle Relaxation	GO:0006939	smooth muscle contraction		"{""preferred_term"": ""Muscle Relaxation"", ""term"": {""id"": ""GO:0006939"", ""label"": ""smooth muscle contraction""}}"																											
5180	5690	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	1	Intermittent Hypoxia	"Repeated episodes of oxygen desaturation trigger oxidative stress, sympathetic activation, and systemic inflammation. Contributes to cardiovascular complications.
"	biological_processes[0]	biological_processes	biological_processes			Response to Hypoxia	GO:0001666	response to hypoxia		"{""preferred_term"": ""Response to Hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"																											
5181	5691	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	2	Sleep Fragmentation	"Frequent arousals to restore airway patency disrupt sleep architecture, reducing restorative sleep and causing daytime sleepiness.
"	biological_processes[0]	biological_processes	biological_processes			Sleep Regulation	GO:0030431	sleep		"{""preferred_term"": ""Sleep Regulation"", ""term"": {""id"": ""GO:0030431"", ""label"": ""sleep""}}"																											
5182	5693	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	4	Systemic Inflammation	"Intermittent hypoxia activates inflammatory pathways (NF-kB), elevating CRP, IL-6, and TNF-alpha. Contributes to metabolic dysfunction and atherosclerosis.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5195	5725	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	0	Cartilage Degradation	"Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
5196	5725	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	0	Cartilage Degradation	"Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.
"	biological_processes[0]	biological_processes	biological_processes			Cartilage Catabolism	GO:0071346	cellular response to interferon-gamma		"{""preferred_term"": ""Cartilage Catabolism"", ""term"": {""id"": ""GO:0071346"", ""label"": ""cellular response to interferon-gamma""}}"																											
5197	5726	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	1	Subchondral Bone Changes	"Bone remodeling with subchondral sclerosis, cyst formation, and osteophyte development at joint margins. Bone changes may precede and contribute to cartilage damage.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5198	5726	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	1	Subchondral Bone Changes	"Bone remodeling with subchondral sclerosis, cyst formation, and osteophyte development at joint margins. Bone changes may precede and contribute to cartilage damage.
"	cell_types[1]	cell_types	cell_types			Osteoclast	CL:0000092	osteoclast		"{""preferred_term"": ""Osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}"																											
5199	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	Synovial Inflammation	"Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.
"	cell_types[0]	cell_types	cell_types			Synoviocyte	CL:0000214	synovial cell		"{""preferred_term"": ""Synoviocyte"", ""term"": {""id"": ""CL:0000214"", ""label"": ""synovial cell""}}"																											
5200	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	Synovial Inflammation	"Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.
"	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
5201	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	Synovial Inflammation	"Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5207	5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	Type I Collagen Haploinsufficiency	"Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5208	5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	Type I Collagen Haploinsufficiency	"Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Fibril Organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
5209	5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	Type I Collagen Haploinsufficiency	"Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.
"	biological_processes[1]	biological_processes	biological_processes			Bone Development	GO:0060348	bone development		"{""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}"																											
5219	5754	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	0	Dominant-Negative Collagen Disruption	"Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5220	5754	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	0	Dominant-Negative Collagen Disruption	"Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Fibril Organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
5221	5754	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	0	Dominant-Negative Collagen Disruption	"Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.
"	biological_processes[1]	biological_processes	biological_processes			Ossification	GO:0001503	ossification		"{""preferred_term"": ""Ossification"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}"																											
5222	5755	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	1	ER Stress and Osteoblast Dysfunction	"Misfolded procollagen accumulates in the endoplasmic reticulum, triggering ER stress responses that impair osteoblast function and survival.
"	biological_processes[0]	biological_processes	biological_processes			ER Stress Response	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
5230	5765	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	pathophysiology	0	Dominant-Negative Collagen Defect	"Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5231	5765	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	pathophysiology	0	Dominant-Negative Collagen Defect	"Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Fibril Organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
5232	5765	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	pathophysiology	0	Dominant-Negative Collagen Defect	"Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.
"	biological_processes[1]	biological_processes	biological_processes			Bone Development	GO:0060348	bone development		"{""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}"																											
5245	5780	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	pathophysiology	0	Moderate Collagen Structural Defect	"Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5246	5780	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	pathophysiology	0	Moderate Collagen Structural Defect	"Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Fibril Organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
5247	5780	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	pathophysiology	0	Moderate Collagen Structural Defect	"Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.
"	biological_processes[1]	biological_processes	biological_processes			Bone Development	GO:0060348	bone development		"{""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}"																											
5257	5792	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	pathophysiology	0	IFITM5 Gain-of-Function	"The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5258	5792	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	pathophysiology	0	IFITM5 Gain-of-Function	"The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.
"	biological_processes[0]	biological_processes	biological_processes			Bone Mineralization	GO:0030282	bone mineralization		"{""preferred_term"": ""Bone Mineralization"", ""term"": {""id"": ""GO:0030282"", ""label"": ""bone mineralization""}}"																											
5259	5792	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	pathophysiology	0	IFITM5 Gain-of-Function	"The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.
"	biological_processes[1]	biological_processes	biological_processes			Osteoblast Differentiation	GO:0001649	osteoblast differentiation		"{""preferred_term"": ""Osteoblast Differentiation"", ""term"": {""id"": ""GO:0001649"", ""label"": ""osteoblast differentiation""}}"																											
5270	5805	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	0	Collagen 3-Hydroxylation Deficiency	"CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5271	5805	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	0	Collagen 3-Hydroxylation Deficiency	"CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.
"	biological_processes[0]	biological_processes	biological_processes			Protein Hydroxylation	GO:0018126	protein hydroxylation		"{""preferred_term"": ""Protein Hydroxylation"", ""term"": {""id"": ""GO:0018126"", ""label"": ""protein hydroxylation""}}"																											
5272	5805	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	0	Collagen 3-Hydroxylation Deficiency	"CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.
"	biological_processes[1]	biological_processes	biological_processes			Collagen Fibril Organization	GO:0030199	collagen fibril organization		"{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}"																											
5273	5806	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	1	ER Stress from Abnormal Collagen Folding	"Delayed collagen folding leads to accumulation of procollagen in the ER, triggering ER stress and contributing to osteoblast dysfunction.
"	biological_processes[0]	biological_processes	biological_processes			ER Stress Response	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
5284	5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	Bone Remodeling Imbalance	"Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.
"	cell_types[0]	cell_types	cell_types			Osteoclast	CL:0000092	osteoclast		"{""preferred_term"": ""Osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}"																											
5285	5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	Bone Remodeling Imbalance	"Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.
"	cell_types[1]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5286	5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	Bone Remodeling Imbalance	"Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.
"	biological_processes[0]	biological_processes	biological_processes			Bone Remodeling	GO:0046849	bone remodeling		"{""preferred_term"": ""Bone Remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}"																											
5287	5832	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	1	RANKL/OPG Dysregulation	"Increased RANKL and decreased osteoprotegerin (OPG) ratio promotes osteoclast differentiation and activation. Estrogen normally suppresses RANKL and increases OPG.
"	biological_processes[0]	biological_processes	biological_processes			Osteoclast Differentiation	GO:0030316	osteoclast differentiation		"{""preferred_term"": ""Osteoclast Differentiation"", ""term"": {""id"": ""GO:0030316"", ""label"": ""osteoclast differentiation""}}"																											
5303	5848	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	1	Tumor Immune Microenvironment Remodeling	Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5304	5848	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	1	Tumor Immune Microenvironment Remodeling	Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression.	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
5305	5848	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	1	Tumor Immune Microenvironment Remodeling	Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression.	biological_processes[0]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"			ABNORMAL																								
5311	5857	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	0	PIK3CA Oncogenic Mutations	Activating PIK3CA mutations occur as somatic events in breast cancer cells. Hotspot mutations cluster in the helical domain (E542K, E545K) and kinase domain (H1047R). These mutations cause constitutive PI3K activity independent of upstream receptor tyrosine kinase signaling.	cell_types[0]	cell_types	cell_types			luminal epithelial cell of mammary gland	CL:0002326	luminal epithelial cell of mammary gland		"{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}"																											
5312	5857	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	0	PIK3CA Oncogenic Mutations	Activating PIK3CA mutations occur as somatic events in breast cancer cells. Hotspot mutations cluster in the helical domain (E542K, E545K) and kinase domain (H1047R). These mutations cause constitutive PI3K activity independent of upstream receptor tyrosine kinase signaling.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
5313	5858	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	1	Constitutive PI3K-AKT Pathway Activation	Mutant PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), recruiting and activating AKT (protein kinase B). Activated AKT phosphorylates numerous substrates promoting cell survival, proliferation, metabolism, and resistance to apoptosis.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol-mediated signaling	GO:0048015	phosphatidylinositol-mediated signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol-mediated signaling"", ""term"": {""id"": ""GO:0048015"", ""label"": ""phosphatidylinositol-mediated signaling""}}"			INCREASED																								
5314	5858	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	1	Constitutive PI3K-AKT Pathway Activation	Mutant PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), recruiting and activating AKT (protein kinase B). Activated AKT phosphorylates numerous substrates promoting cell survival, proliferation, metabolism, and resistance to apoptosis.	biological_processes[1]	biological_processes	biological_processes			protein kinase B signaling	GO:0043491	protein kinase B signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase B signaling"", ""term"": {""id"": ""GO:0043491"", ""label"": ""protein kinase B signaling""}}"			INCREASED																								
5315	5859	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	2	mTOR Pathway Activation	AKT activates mTORC1 by inhibiting the TSC1/TSC2 complex, relieving suppression of the small GTPase Rheb. Active mTORC1 promotes protein synthesis, cell growth, and metabolic reprogramming through S6K1 and 4E-BP1 phosphorylation.	biological_processes[0]	biological_processes	biological_processes			TOR signaling	GO:0031929	TOR signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""TOR signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}"			INCREASED																								
5316	5860	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	3	Cell Survival and Proliferation	PI3K-AKT signaling promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins (BAD, FOXO transcription factors) and cell proliferation through multiple mechanisms including cyclin D1 stabilization.	biological_processes[0]	biological_processes	biological_processes			negative regulation of apoptotic process	GO:0043066	negative regulation of apoptotic process		"{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of apoptotic process"", ""term"": {""id"": ""GO:0043066"", ""label"": ""negative regulation of apoptotic process""}}"			INCREASED																								
5317	5860	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	3	Cell Survival and Proliferation	PI3K-AKT signaling promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins (BAD, FOXO transcription factors) and cell proliferation through multiple mechanisms including cyclin D1 stabilization.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
5318	5861	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	4	Endocrine Resistance	In ER+ breast cancer, PIK3CA mutations confer partial resistance to endocrine therapy through crosstalk between PI3K and ER signaling. PI3K pathway activation can maintain tumor growth despite estrogen deprivation.	biological_processes[0]	biological_processes	biological_processes			intracellular estrogen receptor signaling pathway	GO:0030520	intracellular estrogen receptor signaling pathway		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""intracellular estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}"			ABNORMAL																								
5338	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	Dopaminergic Neuron Loss	"Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5339	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	Dopaminergic Neuron Loss	"Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.
"	biological_processes[0]	biological_processes	biological_processes			Dopamine Biosynthesis	GO:0042416	dopamine biosynthetic process		"{""preferred_term"": ""Dopamine Biosynthesis"", ""term"": {""id"": ""GO:0042416"", ""label"": ""dopamine biosynthetic process""}}"																											
5340	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	Alpha-Synuclein Aggregation	"Misfolded alpha-synuclein protein accumulates to form Lewy bodies and Lewy neurites. These aggregates spread through the nervous system in a prion-like manner, contributing to neurodegeneration.
"	biological_processes[0]	biological_processes	biological_processes			inclusion body assembly	GO:0070841	inclusion body assembly		"{""preferred_term"": ""inclusion body assembly"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}"																											
5341	5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	Mitochondrial Dysfunction	"Impaired mitochondrial function, particularly complex I deficiency, leads to oxidative stress and neuronal death. Multiple PD genes (PINK1, Parkin, DJ-1) regulate mitochondrial quality control.
"	biological_processes[0]	biological_processes	biological_processes			mitochondrion organization	GO:0007005	mitochondrion organization		"{""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}"																											
5342	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	Neuroinflammation	"Activated microglia and astrocytes contribute to neurodegeneration through release of pro-inflammatory cytokines and oxidative stress.
"	cell_types[0]	cell_types	cell_types			Microglia	CL:0000129	microglial cell		"{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
5343	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	Neuroinflammation	"Activated microglia and astrocytes contribute to neurodegeneration through release of pro-inflammatory cytokines and oxidative stress.
"	cell_types[1]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5344	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	Autophagy-Lysosome Pathway Dysfunction	"Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5345	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	Autophagy-Lysosome Pathway Dysfunction	"Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.
"	biological_processes[0]	biological_processes	biological_processes			Autophagy	GO:0006914	autophagy		"{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
5346	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	Autophagy-Lysosome Pathway Dysfunction	"Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.
"	biological_processes[1]	biological_processes	biological_processes			Chaperone-mediated Autophagy	GO:0061684	chaperone-mediated autophagy		"{""preferred_term"": ""Chaperone-mediated Autophagy"", ""term"": {""id"": ""GO:0061684"", ""label"": ""chaperone-mediated autophagy""}}"																											
5347	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	Gut-Brain Axis Dysfunction	"Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.
"	cell_types[0]	cell_types	cell_types			Enteric Neuron	CL:0000107	autonomic neuron		"{""preferred_term"": ""Enteric Neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}"																											
5348	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	Gut-Brain Axis Dysfunction	"Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.
"	cell_types[1]	cell_types	cell_types			Enteroendocrine Cell	CL:0000164	enteroendocrine cell		"{""preferred_term"": ""Enteroendocrine Cell"", ""term"": {""id"": ""CL:0000164"", ""label"": ""enteroendocrine cell""}}"																											
5349	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	Gut-Brain Axis Dysfunction	"Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5350	5891	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	6	Oxidative Stress	"Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5351	5891	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	6	Oxidative Stress	"Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.
"	biological_processes[0]	biological_processes	biological_processes			Response to Oxidative Stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
5352	5891	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	6	Oxidative Stress	"Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.
"	biological_processes[1]	biological_processes	biological_processes			ROS Metabolic Process	GO:0072593	reactive oxygen species metabolic process		"{""preferred_term"": ""ROS Metabolic Process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}"																											
5353	5892	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	7	Calcium Dysregulation	"Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5354	5892	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	7	Calcium Dysregulation	"Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.
"	biological_processes[0]	biological_processes	biological_processes			Calcium Ion Homeostasis	GO:0055074	calcium ion homeostasis		"{""preferred_term"": ""Calcium Ion Homeostasis"", ""term"": {""id"": ""GO:0055074"", ""label"": ""calcium ion homeostasis""}}"																											
5355	5892	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	7	Calcium Dysregulation	"Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.
"	biological_processes[1]	biological_processes	biological_processes			Calcium Ion Transport	GO:0070588	calcium ion transmembrane transport		"{""preferred_term"": ""Calcium Ion Transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}"																											
5356	5893	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	8	Endoplasmic Reticulum Stress	"Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5357	5893	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	8	Endoplasmic Reticulum Stress	"Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.
"	biological_processes[0]	biological_processes	biological_processes			ER Stress Response	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
5358	5893	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	8	Endoplasmic Reticulum Stress	"Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.
"	biological_processes[1]	biological_processes	biological_processes			Unfolded Protein Response	GO:0030968	endoplasmic reticulum unfolded protein response		"{""preferred_term"": ""Unfolded Protein Response"", ""term"": {""id"": ""GO:0030968"", ""label"": ""endoplasmic reticulum unfolded protein response""}}"																											
5359	5894	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	9	Synaptic Dysfunction	"Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5360	5894	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	9	Synaptic Dysfunction	"Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Vesicle Cycle	GO:0099504	synaptic vesicle cycle		"{""preferred_term"": ""Synaptic Vesicle Cycle"", ""term"": {""id"": ""GO:0099504"", ""label"": ""synaptic vesicle cycle""}}"																											
5361	5894	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	9	Synaptic Dysfunction	"Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.
"	biological_processes[1]	biological_processes	biological_processes			Synaptic Vesicle Endocytosis	GO:0048488	synaptic vesicle endocytosis		"{""preferred_term"": ""Synaptic Vesicle Endocytosis"", ""term"": {""id"": ""GO:0048488"", ""label"": ""synaptic vesicle endocytosis""}}"																											
5362	5895	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	10	Iron Accumulation and Ferroptosis	"Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.
"	cell_types[0]	cell_types	cell_types			Dopaminergic Neuron	CL:0000700	dopaminergic neuron		"{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}"																											
5363	5895	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	10	Iron Accumulation and Ferroptosis	"Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.
"	biological_processes[0]	biological_processes	biological_processes			Iron Ion Homeostasis	GO:0055072	iron ion homeostasis		"{""preferred_term"": ""Iron Ion Homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}"																											
5364	5895	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	10	Iron Accumulation and Ferroptosis	"Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.
"	biological_processes[1]	biological_processes	biological_processes			Ferroptosis	GO:0097707	ferroptotic cell death		"{""preferred_term"": ""Ferroptosis"", ""term"": {""id"": ""GO:0097707"", ""label"": ""ferroptotic cell death""}}"																											
5365	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"	cell_types[0]	cell_types	cell_types			Brain Endothelial Cell	CL:0002618	endothelial cell of umbilical vein		"{""preferred_term"": ""Brain Endothelial Cell"", ""term"": {""id"": ""CL:0002618"", ""label"": ""endothelial cell of umbilical vein""}}"																											
5366	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"	cell_types[1]	cell_types	cell_types			Pericyte	CL:0000669	pericyte		"{""preferred_term"": ""Pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}"																											
5367	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"	cell_types[2]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5368	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"	biological_processes[0]	biological_processes	biological_processes			BBB Maintenance	GO:0035633	maintenance of blood-brain barrier		"{""preferred_term"": ""BBB Maintenance"", ""term"": {""id"": ""GO:0035633"", ""label"": ""maintenance of blood-brain barrier""}}"																											
5369	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"	biological_processes[1]	biological_processes	biological_processes			Vascular Permeability	GO:0043114	regulation of vascular permeability		"{""preferred_term"": ""Vascular Permeability"", ""term"": {""id"": ""GO:0043114"", ""label"": ""regulation of vascular permeability""}}"																											
5388	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	Autoimmune T-Cell Predominant Inflammation	Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5389	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	Autoimmune T-Cell Predominant Inflammation	Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.	biological_processes[0]	biological_processes	biological_processes			Adaptive immune response	GO:0002250	adaptive immune response		"{""preferred_term"": ""Adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
5390	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	Autoimmune T-Cell Predominant Inflammation	Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.	locations[0]	locations	locations			Vitreous humor	UBERON:0001286	vitreous humor		"{""preferred_term"": ""Vitreous humor"", ""term"": {""id"": ""UBERON:0001286"", ""label"": ""vitreous humor""}}"																											
5391	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	Autoimmune T-Cell Predominant Inflammation	Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.	locations[1]	locations	locations			Pars plana	UBERON:0004548	pars plana of ciliary body		"{""preferred_term"": ""Pars plana"", ""term"": {""id"": ""UBERON:0004548"", ""label"": ""pars plana of ciliary body""}}"																											
5392	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	Vitreous Cell Infiltration	Dense inflammatory cell infiltration and haze within the vitreous cavity.	cell_types[0]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5393	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	Vitreous Cell Infiltration	Dense inflammatory cell infiltration and haze within the vitreous cavity.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5394	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	Vitreous Cell Infiltration	Dense inflammatory cell infiltration and haze within the vitreous cavity.	locations[0]	locations	locations			Vitreous humor	UBERON:0001286	vitreous humor		"{""preferred_term"": ""Vitreous humor"", ""term"": {""id"": ""UBERON:0001286"", ""label"": ""vitreous humor""}}"																											
5395	5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	Snowbank Formation at Pars Plana	Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.	cell_types[0]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5396	5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	Snowbank Formation at Pars Plana	Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.	biological_processes[0]	biological_processes	biological_processes			Extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
5397	5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	Snowbank Formation at Pars Plana	Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.	locations[0]	locations	locations			Pars plana	UBERON:0004548	pars plana of ciliary body		"{""preferred_term"": ""Pars plana"", ""term"": {""id"": ""UBERON:0004548"", ""label"": ""pars plana of ciliary body""}}"																											
5398	5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	Snowbank Formation at Pars Plana	Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.	locations[1]	locations	locations			Peripheral retina	UBERON:0001789	retina		"{""preferred_term"": ""Peripheral retina"", ""term"": {""id"": ""UBERON:0001789"", ""label"": ""retina""}}"																											
5399	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	Peripheral Retinal Vasculitis and Sheathing	Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.	cell_types[0]	cell_types	cell_types			Endothelial cell of vascular tree	CL:0002139	endothelial cell of vascular tree		"{""preferred_term"": ""Endothelial cell of vascular tree"", ""term"": {""id"": ""CL:0002139"", ""label"": ""endothelial cell of vascular tree""}}"																											
5400	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	Peripheral Retinal Vasculitis and Sheathing	Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.	biological_processes[0]	biological_processes	biological_processes			Inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5401	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	Peripheral Retinal Vasculitis and Sheathing	Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.	locations[0]	locations	locations			Peripheral retina	UBERON:0001789	retina		"{""preferred_term"": ""Peripheral retina"", ""term"": {""id"": ""UBERON:0001789"", ""label"": ""retina""}}"																											
5402	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	Macular Thickening from Blood-Retinal Barrier Breakdown	Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema.	cell_types[0]	cell_types	cell_types			Endothelial cell of vascular tree	CL:0002139	endothelial cell of vascular tree		"{""preferred_term"": ""Endothelial cell of vascular tree"", ""term"": {""id"": ""CL:0002139"", ""label"": ""endothelial cell of vascular tree""}}"																											
5403	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	Macular Thickening from Blood-Retinal Barrier Breakdown	Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema.	biological_processes[0]	biological_processes	biological_processes			Regulation of vascular permeability	GO:0043112	regulation of vascular permeability		"{""preferred_term"": ""Regulation of vascular permeability"", ""term"": {""id"": ""GO:0043112"", ""label"": ""regulation of vascular permeability""}}"																											
5404	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	Macular Thickening from Blood-Retinal Barrier Breakdown	Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema.	locations[0]	locations	locations			Macula of retina	UBERON:0008901	macula lutea		"{""preferred_term"": ""Macula of retina"", ""term"": {""id"": ""UBERON:0008901"", ""label"": ""macula lutea""}}"																											
5433	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	Viral Replication	The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.	cell_types[0]	cell_types	cell_types			Erythroid Progenitor Cells	CL:0000038	erythroid progenitor cell		"{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}"																											
5434	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	Viral Replication	The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.	biological_processes[0]	biological_processes	biological_processes			viral genome replication	GO:0019079	viral genome replication		"{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}"																											
5435	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	Viral Replication	The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.	biological_processes[1]	biological_processes	biological_processes			DNA replication	GO:0006260	DNA replication		"{""preferred_term"": ""DNA replication"", ""term"": {""id"": ""GO:0006260"", ""label"": ""DNA replication""}}"																											
5436	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	Viral Replication	The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
5437	5952	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	2	Receptor-Mediated Entry	Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.	biological_processes[0]	biological_processes	biological_processes			viral entry into host cell	GO:0046718	viral entry into host cell		"{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}"																											
5438	5952	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	2	Receptor-Mediated Entry	Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.	biological_processes[1]	biological_processes	biological_processes			endocytosis	GO:0006897	endocytosis		"{""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}"																											
5439	5952	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	2	Receptor-Mediated Entry	Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
5440	5952	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	2	Receptor-Mediated Entry	Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.	locations[1]	locations	locations			fetal liver	UBERON:0002107	fetal liver		"{""preferred_term"": ""fetal liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""fetal liver""}}"																											
5441	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	genes[0]	genes	genes			ATR	hgnc:882	ATR		"{""preferred_term"": ""ATR"", ""term"": {""id"": ""hgnc:882"", ""label"": ""ATR""}}"																											
5442	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	genes[1]	genes	genes			PRKDC	hgnc:9413	PRKDC		"{""preferred_term"": ""PRKDC"", ""term"": {""id"": ""hgnc:9413"", ""label"": ""PRKDC""}}"																											
5443	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	biological_processes[0]	biological_processes	biological_processes			DNA damage response	GO:0006974	cellular response to DNA damage stimulus		"{""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""cellular response to DNA damage stimulus""}}"																											
5444	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	biological_processes[1]	biological_processes	biological_processes			cell cycle arrest	GO:0007050	regulation of cell cycle		"{""preferred_term"": ""cell cycle arrest"", ""term"": {""id"": ""GO:0007050"", ""label"": ""regulation of cell cycle""}}"																											
5445	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	biological_processes[2]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
5446	5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.	cell_types[0]	cell_types	cell_types			Erythroid Progenitor Cells	CL:0000038	erythroid progenitor cell		"{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}"																											
5447	5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.	genes[0]	genes	genes			EPOR	hgnc:3416	EPOR		"{""preferred_term"": ""EPOR"", ""term"": {""id"": ""hgnc:3416"", ""label"": ""EPOR""}}"																											
5448	5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.	genes[1]	genes	genes			STAT5A	hgnc:11367	STAT5A		"{""preferred_term"": ""STAT5A"", ""term"": {""id"": ""hgnc:11367"", ""label"": ""STAT5A""}}"																											
5449	5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.	genes[2]	genes	genes			STAT5B	hgnc:11368	STAT5B		"{""preferred_term"": ""STAT5B"", ""term"": {""id"": ""hgnc:11368"", ""label"": ""STAT5B""}}"																											
5450	5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT cascade	GO:0007259	receptor signaling pathway via JAK-STAT		"{""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""receptor signaling pathway via JAK-STAT""}}"																											
5451	5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.	cell_types[0]	cell_types	cell_types			Erythroid Progenitor Cells	CL:0000038	erythroid progenitor cell		"{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}"																											
5458	5971	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	0	Anti-Desmoglein Autoantibodies	IgG autoantibodies against desmoglein 3 (mucosal-dominant) and desmoglein 1 (mucocutaneous) directly cause loss of keratinocyte adhesion. Antibody binding triggers intracellular signaling leading to desmosome disassembly.	cell_types[0]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
5459	5971	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	0	Anti-Desmoglein Autoantibodies	IgG autoantibodies against desmoglein 3 (mucosal-dominant) and desmoglein 1 (mucocutaneous) directly cause loss of keratinocyte adhesion. Antibody binding triggers intracellular signaling leading to desmosome disassembly.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
5460	5972	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	1	Acantholysis and Blister Formation	Loss of desmosomal adhesion causes keratinocytes to detach from each other (acantholysis). Suprabasal clefting occurs as basal keratinocytes remain attached to the basement membrane while upper layers separate.	biological_processes[0]	biological_processes	biological_processes			Cell Adhesion	GO:0007155	cell adhesion		"{""preferred_term"": ""Cell Adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}"																											
5461	5973	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	2	Signaling-Mediated Cytoskeletal Changes	Anti-desmoglein antibodies activate p38 MAPK and other signaling pathways, causing keratin filament retraction and further weakening of cell-cell adhesion independent of direct steric hindrance.	biological_processes[0]	biological_processes	biological_processes			Signal Transduction	GO:0007165	signal transduction		"{""preferred_term"": ""Signal Transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"																											
5462	5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	Immune Dysregulation and Th2/Th17 Skewing	Pemphigus vulgaris is characterized by a shift toward Th2 and Th17 cytokine profiles with elevated IL-4, IL-6, and IL-17A, along with a marked reduction in regulatory T cells (Tregs). This imbalance promotes autoreactive B cell activation and pathogenic autoantibody production.	biological_processes[0]	biological_processes	biological_processes			T Cell Differentiation	GO:0030217	T cell differentiation		"{""preferred_term"": ""T Cell Differentiation"", ""term"": {""id"": ""GO:0030217"", ""label"": ""T cell differentiation""}}"																											
5463	5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	Immune Dysregulation and Th2/Th17 Skewing	Pemphigus vulgaris is characterized by a shift toward Th2 and Th17 cytokine profiles with elevated IL-4, IL-6, and IL-17A, along with a marked reduction in regulatory T cells (Tregs). This imbalance promotes autoreactive B cell activation and pathogenic autoantibody production.	biological_processes[1]	biological_processes	biological_processes			Cytokine Production	GO:0001816	cytokine production		"{""preferred_term"": ""Cytokine Production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"																											
5468	5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	Atherosclerosis	"Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.
"	cell_types[0]	cell_types	cell_types			Foam Cell	CL:0000891	foam cell		"{""preferred_term"": ""Foam Cell"", ""term"": {""id"": ""CL:0000891"", ""label"": ""foam cell""}}"																											
5469	5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	Atherosclerosis	"Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.
"	biological_processes[0]	biological_processes	biological_processes			Lipid Accumulation	GO:0034383	low-density lipoprotein particle clearance		"{""preferred_term"": ""Lipid Accumulation"", ""term"": {""id"": ""GO:0034383"", ""label"": ""low-density lipoprotein particle clearance""}}"																											
5470	5996	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Impaired endothelium-dependent vasodilation reduces blood flow reserve. Decreased nitric oxide production and increased endothelin contribute.
"	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
5471	5996	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Impaired endothelium-dependent vasodilation reduces blood flow reserve. Decreased nitric oxide production and increased endothelin contribute.
"	biological_processes[0]	biological_processes	biological_processes			Vasodilation	GO:0042311	vasodilation		"{""preferred_term"": ""Vasodilation"", ""term"": {""id"": ""GO:0042311"", ""label"": ""vasodilation""}}"																											
5472	5997	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	2	Thrombosis	"Plaque rupture or erosion triggers thrombosis, potentially causing acute limb ischemia. Platelet activation on disrupted plaque.
"	biological_processes[0]	biological_processes	biological_processes			Thrombosis	GO:0007596	blood coagulation		"{""preferred_term"": ""Thrombosis"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"																											
5473	5998	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	3	Inflammation	"Chronic inflammation drives plaque progression and instability. Elevated CRP and inflammatory markers predict cardiovascular events.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5478	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	Peroxisome Biogenesis Defect	Mutations in PEX genes disrupt the assembly and function of peroxisomes, leading to impaired metabolic processes.	cellular_components[0]	cellular_components	cellular_components			Peroxisome	GO:0005777	peroxisome		"{""preferred_term"": ""Peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}"																											
5479	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.	biological_processes[0]	biological_processes	biological_processes			fatty acid beta-oxidation	GO:0006635	fatty acid beta-oxidation		"{""preferred_term"": ""fatty acid beta-oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}"																											
5480	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.	biological_processes[1]	biological_processes	biological_processes			very long-chain fatty acid metabolic process	GO:0000038	very long-chain fatty acid metabolic process		"{""preferred_term"": ""very long-chain fatty acid metabolic process"", ""term"": {""id"": ""GO:0000038"", ""label"": ""very long-chain fatty acid metabolic process""}}"																											
5481	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.	chemical_entities[0]	chemical_entities	chemical_entities			VLCFAs				"{""preferred_term"": ""VLCFAs""}"																											
5482	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.	chemical_entities[1]	chemical_entities	chemical_entities			Bile Acid Intermediates				"{""preferred_term"": ""Bile Acid Intermediates""}"																											
5483	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.	chemical_entities[2]	chemical_entities	chemical_entities			Phytanic Acid	CHEBI:16285	phytanic acid		"{""preferred_term"": ""Phytanic Acid"", ""term"": {""id"": ""CHEBI:16285"", ""label"": ""phytanic acid""}}"																											
5484	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	Deficiency of Essential Compounds	Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions.	biological_processes[0]	biological_processes	biological_processes			ether lipid biosynthetic process	GO:0008611	ether lipid biosynthetic process		"{""preferred_term"": ""ether lipid biosynthetic process"", ""term"": {""id"": ""GO:0008611"", ""label"": ""ether lipid biosynthetic process""}}"																											
5485	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	Deficiency of Essential Compounds	Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions.	biological_processes[1]	biological_processes	biological_processes			bile acid biosynthetic process	GO:0006699	bile acid biosynthetic process		"{""preferred_term"": ""bile acid biosynthetic process"", ""term"": {""id"": ""GO:0006699"", ""label"": ""bile acid biosynthetic process""}}"																											
5486	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	Deficiency of Essential Compounds	Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions.	chemical_entities[0]	chemical_entities	chemical_entities			Plasmalogen				"{""preferred_term"": ""Plasmalogen""}"																											
5487	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	Deficiency of Essential Compounds	Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions.	chemical_entities[1]	chemical_entities	chemical_entities			Docosahexaenoic acid	CHEBI:28125	docosahexaenoic acid		"{""preferred_term"": ""Docosahexaenoic acid"", ""term"": {""id"": ""CHEBI:28125"", ""label"": ""docosahexaenoic acid""}}"																											
5488	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	Neurological Dysfunction	Accumulation of toxic metabolites and deficiency of essential compounds lead to demyelination, neuronal migration defects, and neurodegeneration.	locations[0]	locations	locations			central nervous system	UBERON:0001017	central nervous system		"{""preferred_term"": ""central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}"																											
5489	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	Neurological Dysfunction	Accumulation of toxic metabolites and deficiency of essential compounds lead to demyelination, neuronal migration defects, and neurodegeneration.	cell_types[0]	cell_types	cell_types			oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
5490	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	Hepatic Dysfunction	Accumulation of bile acid intermediates and VLCFAs, along with oxidative stress, cause hepatomegaly, fibrosis, and liver failure.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
5491	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	Hepatic Dysfunction	Accumulation of bile acid intermediates and VLCFAs, along with oxidative stress, cause hepatomegaly, fibrosis, and liver failure.	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
5492	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	Skeletal Abnormalities	Plasmalogen deficiency disrupts normal bone formation, leading to rhizomelic shortening of limbs and chondrodysplasia punctata.	locations[0]	locations	locations			bones	UBERON:0001474	bone element		"{""preferred_term"": ""bones"", ""term"": {""id"": ""UBERON:0001474"", ""label"": ""bone element""}}"																											
5493	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	Skeletal Abnormalities	Plasmalogen deficiency disrupts normal bone formation, leading to rhizomelic shortening of limbs and chondrodysplasia punctata.	locations[1]	locations	locations			cartilage	UBERON:0002418	cartilage tissue		"{""preferred_term"": ""cartilage"", ""term"": {""id"": ""UBERON:0002418"", ""label"": ""cartilage tissue""}}"																											
5494	6032	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	7	Microglial Dysfunction and Neuroinflammation	Peroxisomal defects in microglial cells induce a disease-associated microglial (DAM) signature with altered lipid metabolism, lipid droplet accumulation, and impaired autophagy, contributing to neurodegeneration.	locations[0]	locations	locations			central nervous system	UBERON:0001017	central nervous system		"{""preferred_term"": ""central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}"																											
5495	6032	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	7	Microglial Dysfunction and Neuroinflammation	Peroxisomal defects in microglial cells induce a disease-associated microglial (DAM) signature with altered lipid metabolism, lipid droplet accumulation, and impaired autophagy, contributing to neurodegeneration.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
5496	6033	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	8	Peroxisome-Organelle Crosstalk Disruption	Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles.	cellular_components[0]	cellular_components	cellular_components			peroxisome	GO:0005777	peroxisome		"{""preferred_term"": ""peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}"																											
5497	6033	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	8	Peroxisome-Organelle Crosstalk Disruption	Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles.	cellular_components[1]	cellular_components	cellular_components			endoplasmic reticulum	GO:0005783	endoplasmic reticulum		"{""preferred_term"": ""endoplasmic reticulum"", ""term"": {""id"": ""GO:0005783"", ""label"": ""endoplasmic reticulum""}}"																											
5498	6033	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	8	Peroxisome-Organelle Crosstalk Disruption	Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles.	cellular_components[2]	cellular_components	cellular_components			mitochondrion	GO:0005739	mitochondrion		"{""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}"																											
5499	6034	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	9	Retinal Pigment Epithelium Dysfunction	In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss.	locations[0]	locations	locations			retina	UBERON:0000966	retina		"{""preferred_term"": ""retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}"																											
5500	6034	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	9	Retinal Pigment Epithelium Dysfunction	In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss.	cell_types[0]	cell_types	cell_types			retinal pigment epithelial cell	CL:0002586	retinal pigment epithelial cell		"{""preferred_term"": ""retinal pigment epithelial cell"", ""term"": {""id"": ""CL:0002586"", ""label"": ""retinal pigment epithelial cell""}}"																											
5501	6034	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	9	Retinal Pigment Epithelium Dysfunction	In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss.	cell_types[1]	cell_types	cell_types			photoreceptor cell	CL:0000210	photoreceptor cell		"{""preferred_term"": ""photoreceptor cell"", ""term"": {""id"": ""CL:0000210"", ""label"": ""photoreceptor cell""}}"																											
5502	6035	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	10	Impaired Peroxisome Biogenesis and Import	Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes.	cellular_components[0]	cellular_components	cellular_components			peroxisome	GO:0005777	peroxisome		"{""preferred_term"": ""peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}"																											
5503	6035	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	10	Impaired Peroxisome Biogenesis and Import	Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes.	biological_processes[0]	biological_processes	biological_processes			protein import into peroxisome matrix	GO:0016558	protein import into peroxisome matrix		"{""preferred_term"": ""protein import into peroxisome matrix"", ""term"": {""id"": ""GO:0016558"", ""label"": ""protein import into peroxisome matrix""}}"																											
5504	6035	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	10	Impaired Peroxisome Biogenesis and Import	Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes.	biological_processes[1]	biological_processes	biological_processes			peroxisome organization	GO:0007031	peroxisome organization		"{""preferred_term"": ""peroxisome organization"", ""term"": {""id"": ""GO:0007031"", ""label"": ""peroxisome organization""}}"																											
5527	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	cell_types[0]	cell_types	cell_types			intestinal smooth muscle cell	CL:0002504	enteric smooth muscle cell		"{""preferred_term"": ""intestinal smooth muscle cell"", ""term"": {""id"": ""CL:0002504"", ""label"": ""enteric smooth muscle cell""}}"																											
5528	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	cell_types[1]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
5529	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"																											
5530	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	biological_processes[1]	biological_processes	biological_processes			cell proliferation	GO:0008283	cell proliferation		"{""preferred_term"": ""cell proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}"																											
5531	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	locations[0]	locations	locations			small intestine	UBERON:0002116	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}"																											
5532	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"	locations[1]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
5533	6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	mTORC1 pathway hyperactivation	"LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.
"	biological_processes[0]	biological_processes	biological_processes			mTORC1 signaling	GO:0031929	TOR signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""mTORC1 signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}"			INCREASED																								
5534	6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	mTORC1 pathway hyperactivation	"LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.
"	biological_processes[1]	biological_processes	biological_processes			cell proliferation	GO:0008283	cell proliferation		"{""preferred_term"": ""cell proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}"																											
5535	6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	mTORC1 pathway hyperactivation	"LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.
"	locations[0]	locations	locations			small intestine	UBERON:0002116	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}"																											
5536	6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	Arborizing smooth muscle core formation	"Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.
"	cell_types[0]	cell_types	cell_types			smooth muscle cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""smooth muscle cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
5537	6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	Arborizing smooth muscle core formation	"Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.
"	biological_processes[0]	biological_processes	biological_processes			smooth muscle cell differentiation	GO:0051145	smooth muscle cell differentiation		"{""preferred_term"": ""smooth muscle cell differentiation"", ""term"": {""id"": ""GO:0051145"", ""label"": ""smooth muscle cell differentiation""}}"																											
5538	6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	Arborizing smooth muscle core formation	"Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.
"	biological_processes[1]	biological_processes	biological_processes			tissue morphogenesis	GO:0048569	tissue morphogenesis		"{""preferred_term"": ""tissue morphogenesis"", ""term"": {""id"": ""GO:0048569"", ""label"": ""tissue morphogenesis""}}"																											
5539	6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	Arborizing smooth muscle core formation	"Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.
"	locations[0]	locations	locations			small intestine	UBERON:0002116	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}"																											
5549	6078	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	pathophysiology	0	FGFR Gain-of-Function Signaling	"Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.
"	cell_types[0]	cell_types	cell_types			Osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
5550	6078	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	pathophysiology	0	FGFR Gain-of-Function Signaling	"Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.
"	biological_processes[0]	biological_processes	biological_processes			FGFR Signaling	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
5551	6078	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	pathophysiology	0	FGFR Gain-of-Function Signaling	"Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.
"	biological_processes[1]	biological_processes	biological_processes			Cranial Suture Morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
5562	6093	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene in Lymphoid Progenitors	The t(9;22)(q34;q11) translocation fuses BCR on chromosome 22 with ABL1 on chromosome 9, creating the Philadelphia chromosome. In ALL, the fusion typically produces the p190 BCR-ABL1 protein (compared to p210 in CML), which has enhanced transforming activity in lymphoid cells. The fusion kinase is constitutively active, driving proliferation and survival signaling.	cell_types[0]	cell_types	cell_types			B-lymphoblast	CL:0017006	B-lymphoblast		"{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}"																											
5563	6093	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene in Lymphoid Progenitors	The t(9;22)(q34;q11) translocation fuses BCR on chromosome 22 with ABL1 on chromosome 9, creating the Philadelphia chromosome. In ALL, the fusion typically produces the p190 BCR-ABL1 protein (compared to p210 in CML), which has enhanced transforming activity in lymphoid cells. The fusion kinase is constitutively active, driving proliferation and survival signaling.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
5564	6094	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	1	Constitutive Signaling Pathway Activation	BCR-ABL1 activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways independently of normal growth factor regulation. This drives uncontrolled proliferation and confers resistance to apoptosis, enabling leukemic transformation of B-lymphoid progenitors.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
5565	6095	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	2	B-lymphoid Differentiation Block	BCR-ABL1 signaling interferes with normal B-cell development, arresting cells at an immature lymphoblast stage. The resulting cells express B-lineage markers (CD19, CD22) but lack complete B-cell maturation. IKZF1 (Ikaros) deletions, common in Ph+ ALL, further impair B-cell development.	cell_types[0]	cell_types	cell_types			B-lymphoblast	CL:0017006	B-lymphoblast		"{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}"																											
5566	6095	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	2	B-lymphoid Differentiation Block	BCR-ABL1 signaling interferes with normal B-cell development, arresting cells at an immature lymphoblast stage. The resulting cells express B-lineage markers (CD19, CD22) but lack complete B-cell maturation. IKZF1 (Ikaros) deletions, common in Ph+ ALL, further impair B-cell development.	biological_processes[0]	biological_processes	biological_processes			B cell differentiation	GO:0030183	B cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""B cell differentiation"", ""term"": {""id"": ""GO:0030183"", ""label"": ""B cell differentiation""}}"			DECREASED																								
5567	6096	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	3	Apoptosis Resistance	BCR-ABL1 activates PI3K-AKT signaling, phosphorylating and inactivating pro-apoptotic proteins including BAD. This confers resistance to normal apoptotic signals and contributes to the aggressive clinical behavior of Ph+ ALL.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
5568	6097	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	4	Lymphoblast Accumulation	The combination of enhanced proliferation, blocked differentiation, and apoptosis resistance leads to accumulation of immature B-lymphoblasts in the bone marrow, blood, and extramedullary sites.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
5569	6097	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	4	Lymphoblast Accumulation	The combination of enhanced proliferation, blocked differentiation, and apoptosis resistance leads to accumulation of immature B-lymphoblasts in the bone marrow, blood, and extramedullary sites.	cell_types[0]	cell_types	cell_types			B-lymphoblast	CL:0017006	B-lymphoblast		"{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}"																											
5587	6122	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	0	Phenylalanine Hydroxylase Deficiency	"Mutations in PAH gene cause deficient phenylalanine hydroxylase enzyme activity. Phenylalanine cannot be converted to tyrosine, leading to phenylalanine accumulation in blood and tissues.
"	biological_processes[0]	biological_processes	biological_processes			Phenylalanine Metabolism	GO:0006558	L-phenylalanine metabolic process		"{""preferred_term"": ""Phenylalanine Metabolism"", ""term"": {""id"": ""GO:0006558"", ""label"": ""L-phenylalanine metabolic process""}}"																											
5588	6123	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	1	Neurotoxicity	"Elevated phenylalanine in the brain interferes with neurotransmitter synthesis, myelin formation, and protein synthesis. Phenylalanine competes with other large neutral amino acids for transport across the blood-brain barrier.
"	biological_processes[0]	biological_processes	biological_processes			Neurodevelopment	GO:0007399	nervous system development		"{""preferred_term"": ""Neurodevelopment"", ""term"": {""id"": ""GO:0007399"", ""label"": ""nervous system development""}}"																											
5589	6124	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	2	Melanin Deficiency	"Reduced tyrosine availability impairs melanin synthesis, causing fair skin, light hair, and blue eyes characteristic of untreated PKU.
"	biological_processes[0]	biological_processes	biological_processes			Melanin Biosynthesis	GO:0042438	melanin biosynthetic process		"{""preferred_term"": ""Melanin Biosynthesis"", ""term"": {""id"": ""GO:0042438"", ""label"": ""melanin biosynthetic process""}}"																											
5603	6148	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	0	Succinate Dehydrogenase Complex Dysfunction	Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation.	cell_types[0]	cell_types	cell_types			chromaffin cell	CL:0000166	chromaffin cell		"{""preferred_term"": ""chromaffin cell"", ""term"": {""id"": ""CL:0000166"", ""label"": ""chromaffin cell""}}"																											
5604	6148	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	0	Succinate Dehydrogenase Complex Dysfunction	Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation.	biological_processes[0]	biological_processes	biological_processes			succinate dehydrogenase activity	GO:0000104	succinate dehydrogenase activity		"{""modifier"": ""DECREASED"", ""preferred_term"": ""succinate dehydrogenase activity"", ""term"": {""id"": ""GO:0000104"", ""label"": ""succinate dehydrogenase activity""}}"			DECREASED																								
5605	6148	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	0	Succinate Dehydrogenase Complex Dysfunction	Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation.	locations[0]	locations	locations			adrenal gland	UBERON:0002369	adrenal gland		"{""preferred_term"": ""adrenal gland"", ""term"": {""id"": ""UBERON:0002369"", ""label"": ""adrenal gland""}}"																											
5606	6149	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	1	Pseudohypoxia and HIF Activation	SDHx and VHL mutations cause constitutive stabilization of hypoxia-inducible factors (HIF1/2) under normoxic conditions. This pseudohypoxic state activates genes promoting angiogenesis, glycolysis, and cell survival, driving tumorigenesis.	biological_processes[0]	biological_processes	biological_processes			response to hypoxia	GO:0001666	response to hypoxia		"{""modifier"": ""INCREASED"", ""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"			INCREASED																								
5607	6150	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	2	RET Proto-Oncogene Activation	Germline RET mutations in MEN2 syndrome cause pheochromocytoma through constitutive receptor tyrosine kinase activation. RET-driven pheochromocytomas have distinct catecholamine profiles (epinephrine-predominant) compared to SDHx-related tumors.	biological_processes[0]	biological_processes	biological_processes			receptor signaling protein tyrosine kinase activity	GO:0004716	receptor signaling protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}"			INCREASED																								
5608	6151	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	3	Catecholamine Hypersecretion	Secreting PPGLs produce excess catecholamines (norepinephrine, epinephrine, dopamine), causing characteristic symptoms. The catecholamine profile provides clues to underlying genetics: norepinephrine-predominant suggests SDHx/VHL, epinephrine-predominant suggests RET/NF1.	biological_processes[0]	biological_processes	biological_processes			catecholamine biosynthetic process	GO:0042423	catecholamine biosynthetic process		"{""modifier"": ""INCREASED"", ""preferred_term"": ""catecholamine biosynthetic process"", ""term"": {""id"": ""GO:0042423"", ""label"": ""catecholamine biosynthetic process""}}"			INCREASED																								
5620	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
5621	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5622	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	cell_types[2]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
5623	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	biological_processes[0]	biological_processes	biological_processes			microtubule-based movement	GO:0007018	microtubule-based movement		"{""preferred_term"": ""microtubule-based movement"", ""term"": {""id"": ""GO:0007018"", ""label"": ""microtubule-based movement""}}"																											
5624	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	biological_processes[1]	biological_processes	biological_processes			cytoskeleton organization	GO:0007010	cytoskeleton organization		"{""preferred_term"": ""cytoskeleton organization"", ""term"": {""id"": ""GO:0007010"", ""label"": ""cytoskeleton organization""}}"																											
5625	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	locations[0]	locations	locations			frontal cortex	UBERON:0001870	frontal cortex		"{""preferred_term"": ""frontal cortex"", ""term"": {""id"": ""UBERON:0001870"", ""label"": ""frontal cortex""}}"																											
5626	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	locations[1]	locations	locations			temporal lobe	UBERON:0001871	temporal lobe		"{""preferred_term"": ""temporal lobe"", ""term"": {""id"": ""UBERON:0001871"", ""label"": ""temporal lobe""}}"																											
5627	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	locations[2]	locations	locations			hippocampus	UBERON:0001954	hippocampus		"{""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""hippocampus""}}"																											
5628	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.	locations[3]	locations	locations			dentate gyrus of hippocampal formation	UBERON:0001883	dentate gyrus of hippocampal formation		"{""preferred_term"": ""dentate gyrus of hippocampal formation"", ""term"": {""id"": ""UBERON:0001883"", ""label"": ""dentate gyrus of hippocampal formation""}}"																											
5629	6170	261	Pick Disease	Pick_Disease.yaml	pathophysiology	1	Neuroinflammation	Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease.	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
5630	6170	261	Pick Disease	Pick_Disease.yaml	pathophysiology	1	Neuroinflammation	Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease.	cell_types[1]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
5631	6170	261	Pick Disease	Pick_Disease.yaml	pathophysiology	1	Neuroinflammation	Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease.	cell_types[2]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5632	6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	Neuronal Loss	Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain.	locations[0]	locations	locations			Frontal Lobe	UBERON:0016525	frontal lobe		"{""preferred_term"": ""Frontal Lobe"", ""term"": {""id"": ""UBERON:0016525"", ""label"": ""frontal lobe""}}"																											
5633	6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	Neuronal Loss	Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain.	locations[1]	locations	locations			Temporal Lobe	UBERON:0001871	temporal lobe		"{""preferred_term"": ""Temporal Lobe"", ""term"": {""id"": ""UBERON:0001871"", ""label"": ""temporal lobe""}}"																											
5654	6200	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	0	Hepatic metacestode implantation	Oncospheres establish multilocular metacestode vesicles within the liver parenchyma, anchoring infection to hepatic tissue.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
5655	6201	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	1	Daughter cyst proliferation and matrix remodeling	Metacestodes bud daughter cysts that coalesce into a multilocular mass, expanding through hepatic parenchyma while remodeling surrounding extracellular matrix.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
5656	6201	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	1	Daughter cyst proliferation and matrix remodeling	Metacestodes bud daughter cysts that coalesce into a multilocular mass, expanding through hepatic parenchyma while remodeling surrounding extracellular matrix.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
5657	6202	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	2	Mass effect and local invasion	The enlarging multilocular cyst complex compresses adjacent hepatic tissue and can invade neighboring structures, generating space-occupying effects.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
5672	6223	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	0	Vasopressin/cAMP-Driven Cyst Expansion	"Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.
"	cell_types[0]	cell_types	cell_types			nephron tubule epithelial cell	CL:1000494	nephron tubule epithelial cell		"{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}"																											
5673	6223	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	0	Vasopressin/cAMP-Driven Cyst Expansion	"Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.
"	biological_processes[0]	biological_processes	biological_processes			cAMP/PKA signal transduction	GO:0141156	cAMP/PKA signal transduction		"{""preferred_term"": ""cAMP/PKA signal transduction"", ""term"": {""id"": ""GO:0141156"", ""label"": ""cAMP/PKA signal transduction""}}"																											
5674	6224	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	1	Epithelial Proliferation and Kidney Enlargement	"Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.
"	cell_types[0]	cell_types	cell_types			nephron tubule epithelial cell	CL:1000494	nephron tubule epithelial cell		"{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}"																											
5675	6224	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	1	Epithelial Proliferation and Kidney Enlargement	"Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.
"	biological_processes[0]	biological_processes	biological_processes			regulation of cell proliferation	GO:0042127	regulation of cell proliferation		"{""preferred_term"": ""regulation of cell proliferation"", ""term"": {""id"": ""GO:0042127"", ""label"": ""regulation of cell proliferation""}}"																											
5676	6225	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	2	Ciliary Dysfunction	"Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.
"	cell_types[0]	cell_types	cell_types			nephron tubule epithelial cell	CL:1000494	nephron tubule epithelial cell		"{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}"																											
5677	6225	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	2	Ciliary Dysfunction	"Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.
"	biological_processes[0]	biological_processes	biological_processes			cilium organization	GO:0044782	cilium organization		"{""preferred_term"": ""cilium organization"", ""term"": {""id"": ""GO:0044782"", ""label"": ""cilium organization""}}"																											
5678	6225	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	2	Ciliary Dysfunction	"Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.
"	biological_processes[1]	biological_processes	biological_processes			cAMP/PKA signal transduction	GO:0141156	cAMP/PKA signal transduction		"{""preferred_term"": ""cAMP/PKA signal transduction"", ""term"": {""id"": ""GO:0141156"", ""label"": ""cAMP/PKA signal transduction""}}"																											
5679	6226	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	3	Fibrosis and Inflammation	"Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.
"	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
5680	6226	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	3	Fibrosis and Inflammation	"Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5691	6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	Hyperandrogenism	"Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.
"	biological_processes[0]	biological_processes	biological_processes			Androgen Biosynthesis	GO:0006702	androgen biosynthetic process		"{""preferred_term"": ""Androgen Biosynthesis"", ""term"": {""id"": ""GO:0006702"", ""label"": ""androgen biosynthetic process""}}"																											
5692	6250	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	1	Insulin Resistance	"Peripheral insulin resistance leads to compensatory hyperinsulinemia, which stimulates ovarian androgen production and inhibits hepatic SHBG synthesis, increasing free androgens.
"	biological_processes[0]	biological_processes	biological_processes			Insulin Signaling	GO:0008286	insulin receptor signaling pathway		"{""preferred_term"": ""Insulin Signaling"", ""term"": {""id"": ""GO:0008286"", ""label"": ""insulin receptor signaling pathway""}}"																											
5693	6251	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	2	Ovulatory Dysfunction	"Disrupted folliculogenesis with arrest at small antral stage leads to anovulation. Multiple small follicles accumulate (polycystic morphology) without dominant follicle selection.
"	biological_processes[0]	biological_processes	biological_processes			Ovulation	GO:0030728	ovulation		"{""preferred_term"": ""Ovulation"", ""term"": {""id"": ""GO:0030728"", ""label"": ""ovulation""}}"																											
5694	6252	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	3	Chronic Low-Grade Inflammation	"Elevated inflammatory markers (CRP, IL-6) contribute to insulin resistance and cardiovascular risk in PCOS.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5702	6269	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	0	JAK2 V617F Constitutive Activation	The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production.	cell_types[0]	cell_types	cell_types			erythroid progenitor cell	CL:0000038	erythroid progenitor cell		"{""preferred_term"": ""erythroid progenitor cell"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}"																											
5703	6269	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	0	JAK2 V617F Constitutive Activation	The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production.	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
5704	6269	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	0	JAK2 V617F Constitutive Activation	The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
5705	6270	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	1	STAT5 Hyperactivation	Constitutive JAK2 activation leads to sustained STAT5 phosphorylation and transcriptional activation of genes promoting erythroid proliferation and survival, including BCL-XL and cyclin D1.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT signaling pathway	GO:0007259	JAK-STAT cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"			INCREASED																								
5706	6271	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	2	Erythropoietin-Independent Erythropoiesis	JAK2 V617F-mutant erythroid progenitors can proliferate and differentiate in the absence of erythropoietin, forming endogenous erythroid colonies (EEC) in culture. This erythropoietin independence is a diagnostic hallmark of PV.	biological_processes[0]	biological_processes	biological_processes			erythrocyte differentiation	GO:0030218	erythrocyte differentiation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""erythrocyte differentiation"", ""term"": {""id"": ""GO:0030218"", ""label"": ""erythrocyte differentiation""}}"			INCREASED																								
5707	6272	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	3	Hyperviscosity and Thrombosis Risk	Elevated red blood cell mass increases blood viscosity and promotes thrombosis. The prothrombotic state is multifactorial, including abnormal red cell interactions, platelet activation, and endothelial dysfunction.	biological_processes[0]	biological_processes	biological_processes			blood coagulation	GO:0007596	blood coagulation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}"			ABNORMAL																								
5722	6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	CD8+ T Cell-Mediated Cytotoxicity	Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis.	cell_types[0]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
5723	6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	CD8+ T Cell-Mediated Cytotoxicity	Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis.	cell_types[1]	cell_types	cell_types			Skeletal Muscle Cell	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
5724	6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	CD8+ T Cell-Mediated Cytotoxicity	Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis.	biological_processes[0]	biological_processes	biological_processes			T Cell Cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
5725	6291	267	Polymyositis	Polymyositis.yaml	pathophysiology	1	Aberrant MHC Class I Expression	Muscle fibers, which normally do not express MHC class I, show aberrant upregulation making them targets for CD8+ T cell recognition and attack.	biological_processes[0]	biological_processes	biological_processes			MHC Class I Antigen Presentation	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I		"{""preferred_term"": ""MHC Class I Antigen Presentation"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}"																											
5726	6292	267	Polymyositis	Polymyositis.yaml	pathophysiology	2	Myositis-Specific Autoantibodies	Anti-synthetase antibodies (anti-Jo-1, anti-PL-7, anti-PL-12) define antisynthetase syndrome with myositis, ILD, and arthritis. Anti-SRP antibodies associate with necrotizing myopathy.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
5727	6293	267	Polymyositis	Polymyositis.yaml	pathophysiology	3	Pro-inflammatory Cytokine Production	IL-1, TNF-alpha, and IFN-gamma produced by infiltrating immune cells perpetuate muscle inflammation and contribute to muscle weakness independent of direct fiber destruction.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5728	6294	267	Polymyositis	Polymyositis.yaml	pathophysiology	4	ER Stress and Unfolded Protein Response	Overexpression of MHC class I in muscle fibers triggers endoplasmic reticulum stress and activation of the unfolded protein response (UPR). This includes upregulation of GRP78/BiP and NF-kappaB pathway activation, contributing to muscle fiber dysfunction independent of immune-mediated damage.	biological_processes[0]	biological_processes	biological_processes			Endoplasmic Reticulum Stress Response	GO:0034976	response to endoplasmic reticulum stress		"{""preferred_term"": ""Endoplasmic Reticulum Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}"																											
5729	6295	267	Polymyositis	Polymyositis.yaml	pathophysiology	5	Necroptosis and DAMP Release	Muscle fibers undergo necroptosis, a form of regulated cell death, releasing damage-associated molecular patterns (DAMPs) including HMGB1. This amplifies inflammation and contributes to persistent muscle weakness even after initial immune attack.	biological_processes[0]	biological_processes	biological_processes			Necroptotic Process	GO:0070266	necroptotic process		"{""preferred_term"": ""Necroptotic Process"", ""term"": {""id"": ""GO:0070266"", ""label"": ""necroptotic process""}}"																											
5730	6296	267	Polymyositis	Polymyositis.yaml	pathophysiology	6	Apoptosis of Muscle Fibers	Apoptotic cell death occurs in muscle fibers surrounding those undergoing partial invasion by CD8+ T cells. Fibers with apoptotic nuclei are surrounded by CD8+ T cells, granzyme B-positive cells, and macrophages, suggesting cytotoxic T cell-mediated apoptosis occurs in parallel to direct invasion.	biological_processes[0]	biological_processes	biological_processes			Apoptotic Process	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
5735	6308	268	Pouchitis	Pouchitis.yaml	pathophysiology	0	Bacterial Dysbiosis	"Altered gut microbiome composition in the ileal pouch, with decreased microbial diversity and shifts toward pathogenic bacterial species. The pouch environment lacks normal colonic bacteria and experiences reduced butyrate-producing bacteria, leading to an imbalanced microbial ecosystem that triggers inflammation.
"	locations[0]	locations	locations			ileum	UBERON:0002116	ileum		"{""preferred_term"": ""ileum"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""ileum""}}"																											
5736	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
5737	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"	cell_types[1]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
5738	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"	cell_types[2]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5739	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5740	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"	biological_processes[1]	biological_processes	biological_processes			cytokine production	GO:0001816	cytokine production		"{""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"																											
5741	6310	268	Pouchitis	Pouchitis.yaml	pathophysiology	2	Epithelial Barrier Dysfunction	"Disruption of tight junction proteins and increased intestinal permeability in the pouch mucosa, allowing bacterial translocation and antigenic stimulation of the underlying immune system, perpetuating the inflammatory cycle.
"	cell_types[0]	cell_types	cell_types			intestinal epithelial cell	CL:0002563	intestinal epithelial cell		"{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}"																											
5742	6310	268	Pouchitis	Pouchitis.yaml	pathophysiology	2	Epithelial Barrier Dysfunction	"Disruption of tight junction proteins and increased intestinal permeability in the pouch mucosa, allowing bacterial translocation and antigenic stimulation of the underlying immune system, perpetuating the inflammatory cycle.
"	biological_processes[0]	biological_processes	biological_processes			bicellular tight junction assembly	GO:0070830	bicellular tight junction assembly		"{""preferred_term"": ""bicellular tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""bicellular tight junction assembly""}}"																											
5743	6311	268	Pouchitis	Pouchitis.yaml	pathophysiology	3	NOD2 Genetic Susceptibility	"Genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing protein 2), particularly the NOD2insC variant (rs2066847), are strongly associated with increased risk of chronic pouchitis and Crohn's disease-like pouch phenotypes. NOD2 normally functions as an intracellular bacterial sensor that regulates autophagy and antimicrobial responses; loss-of-function variants impair bacterial clearance and increase susceptibility to inflammation.
"	genes[0]	genes	genes			NOD2	hgnc:5331	NOD2		"{""preferred_term"": ""NOD2"", ""term"": {""id"": ""hgnc:5331"", ""label"": ""NOD2""}}"																											
5753	6328	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	0	Anti-Mitochondrial Antibody Response	Autoantibodies against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) are highly specific for PBC. These antibodies may directly contribute to biliary epithelial cell damage through immune complex formation and complement activation.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
5754	6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	Biliary Epithelial Cell Targeting	CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response.	cell_types[0]	cell_types	cell_types			Cholangiocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Cholangiocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
5755	6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	Biliary Epithelial Cell Targeting	CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response.	cell_types[1]	cell_types	cell_types			CD8+ T Cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
5756	6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	Biliary Epithelial Cell Targeting	CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response.	biological_processes[0]	biological_processes	biological_processes			T Cell Cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
5757	6330	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	2	Progressive Ductopenia and Cholestasis	Destruction of bile ducts leads to ductopenia, impaired bile flow, and accumulation of toxic bile acids. Retained bile acids cause further hepatocyte damage and promote fibrosis.	biological_processes[0]	biological_processes	biological_processes			Bile Acid Metabolic Process	GO:0008206	bile acid metabolic process		"{""preferred_term"": ""Bile Acid Metabolic Process"", ""term"": {""id"": ""GO:0008206"", ""label"": ""bile acid metabolic process""}}"																											
5763	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	genes[0]	genes	genes			DNAI1	hgnc:2954	DNAI1		"{""preferred_term"": ""DNAI1"", ""term"": {""id"": ""hgnc:2954"", ""label"": ""DNAI1""}}"																											
5764	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	genes[1]	genes	genes			DNAH5	hgnc:2950	DNAH5		"{""preferred_term"": ""DNAH5"", ""term"": {""id"": ""hgnc:2950"", ""label"": ""DNAH5""}}"																											
5765	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	cell_types[0]	cell_types	cell_types			respiratory ciliated cell	CL:0002368	respiratory tract epithelial cell		"{""preferred_term"": ""respiratory ciliated cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}"																											
5766	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	cell_types[1]	cell_types	cell_types			ependymal cell	CL:0000065	ependymal cell		"{""preferred_term"": ""ependymal cell"", ""term"": {""id"": ""CL:0000065"", ""label"": ""ependymal cell""}}"																											
5767	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	biological_processes[0]	biological_processes	biological_processes			cilium movement	GO:0003341	cilium movement		"{""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}"																											
5768	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	biological_processes[1]	biological_processes	biological_processes			cilium assembly	GO:0060271	cilium assembly		"{""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}"																											
5769	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	biological_processes[2]	biological_processes	biological_processes			axoneme assembly	GO:0035082	axoneme assembly		"{""preferred_term"": ""axoneme assembly"", ""term"": {""id"": ""GO:0035082"", ""label"": ""axoneme assembly""}}"																											
5770	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	locations[0]	locations	locations			respiratory tract epithelium	UBERON:0004808	respiratory tract epithelium		"{""preferred_term"": ""respiratory tract epithelium"", ""term"": {""id"": ""UBERON:0004808"", ""label"": ""respiratory tract epithelium""}}"																											
5771	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	locations[1]	locations	locations			nasal cavity epithelium	UBERON:0000398	nasal cavity epithelium		"{""preferred_term"": ""nasal cavity epithelium"", ""term"": {""id"": ""UBERON:0000398"", ""label"": ""nasal cavity epithelium""}}"																											
5772	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	locations[2]	locations	locations			trachea	UBERON:0003126	trachea		"{""preferred_term"": ""trachea"", ""term"": {""id"": ""UBERON:0003126"", ""label"": ""trachea""}}"																											
5773	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	locations[3]	locations	locations			bronchus	UBERON:0002185	bronchus		"{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}"																											
5774	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	cellular_components[0]	cellular_components	cellular_components			Cilia	GO:0005929	cilium		"{""preferred_term"": ""Cilia"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}"																											
5775	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	cellular_components[1]	cellular_components	cellular_components			axoneme	GO:0005930	axoneme		"{""preferred_term"": ""axoneme"", ""term"": {""id"": ""GO:0005930"", ""label"": ""axoneme""}}"																											
5776	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.	cellular_components[2]	cellular_components	cellular_components			outer dynein arm	GO:0036157	outer dynein arm		"{""preferred_term"": ""outer dynein arm"", ""term"": {""id"": ""GO:0036157"", ""label"": ""outer dynein arm""}}"																											
5777	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	Impaired Mucociliary Clearance	Failure to effectively remove mucus and pathogens from respiratory passages.	biological_processes[0]	biological_processes	biological_processes			mucociliary clearance	GO:0120197	mucociliary clearance		"{""preferred_term"": ""mucociliary clearance"", ""term"": {""id"": ""GO:0120197"", ""label"": ""mucociliary clearance""}}"																											
5778	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	Impaired Mucociliary Clearance	Failure to effectively remove mucus and pathogens from respiratory passages.	locations[0]	locations	locations			respiratory system	UBERON:0001004	respiratory system		"{""preferred_term"": ""respiratory system"", ""term"": {""id"": ""UBERON:0001004"", ""label"": ""respiratory system""}}"																											
5779	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	Impaired Mucociliary Clearance	Failure to effectively remove mucus and pathogens from respiratory passages.	locations[1]	locations	locations			paranasal sinus	UBERON:0001825	paranasal sinus		"{""preferred_term"": ""paranasal sinus"", ""term"": {""id"": ""UBERON:0001825"", ""label"": ""paranasal sinus""}}"																											
5780	6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	Situs Inversus	Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.	biological_processes[0]	biological_processes	biological_processes			determination of left/right symmetry	GO:0007368	determination of left/right symmetry		"{""preferred_term"": ""determination of left/right symmetry"", ""term"": {""id"": ""GO:0007368"", ""label"": ""determination of left/right symmetry""}}"																											
5781	6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	Situs Inversus	Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.	biological_processes[1]	biological_processes	biological_processes			nodal cilium assembly	GO:1904955	motile cilium assembly		"{""preferred_term"": ""nodal cilium assembly"", ""term"": {""id"": ""GO:1904955"", ""label"": ""motile cilium assembly""}}"																											
5782	6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	Situs Inversus	Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.	locations[0]	locations	locations			embryo	UBERON:0000922	embryo		"{""preferred_term"": ""embryo"", ""term"": {""id"": ""UBERON:0000922"", ""label"": ""embryo""}}"																											
5807	6392	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling.	cell_types[0]	cell_types	cell_types			megakaryocyte	CL:0000556	megakaryocyte		"{""preferred_term"": ""megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}"																											
5808	6392	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling.	cell_types[1]	cell_types	cell_types			hematopoietic stem cell	CL:0000037	hematopoietic stem cell		"{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}"																											
5809	6392	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling.	biological_processes[0]	biological_processes	biological_processes			JAK-STAT signaling pathway	GO:0007259	JAK-STAT cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"			INCREASED																								
5810	6392	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling.	locations[0]	locations	locations			bone marrow	UBERON:0002371	bone marrow		"{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}"																											
5811	6393	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	1	Abnormal Megakaryopoiesis	Driver mutations cause aberrant megakaryocyte proliferation and maturation. Megakaryocytes show characteristic atypia with clustering, abnormal lobation, and defective platelet production.	biological_processes[0]	biological_processes	biological_processes			megakaryocyte differentiation	GO:0030219	megakaryocyte differentiation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""megakaryocyte differentiation"", ""term"": {""id"": ""GO:0030219"", ""label"": ""megakaryocyte differentiation""}}"			ABNORMAL																								
5812	6394	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	2	Cytokine-Mediated Marrow Fibrosis	Atypical megakaryocytes release profibrotic cytokines including TGF-beta, PDGF, and bFGF, stimulating marrow stromal cells to deposit reticulin and collagen fibers. Progressive fibrosis replaces normal hematopoietic tissue.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""modifier"": ""INCREASED"", ""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"			INCREASED																								
5813	6395	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	3	Extramedullary Hematopoiesis	As bone marrow function declines due to fibrosis, hematopoiesis shifts to spleen, liver, and other sites. This causes massive splenomegaly and hepatomegaly with associated symptoms.	locations[0]	locations	locations			spleen	UBERON:0002106	spleen		"{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}"																											
5814	6395	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	3	Extramedullary Hematopoiesis	As bone marrow function declines due to fibrosis, hematopoiesis shifts to spleen, liver, and other sites. This causes massive splenomegaly and hepatomegaly with associated symptoms.	biological_processes[0]	biological_processes	biological_processes			hematopoiesis	GO:0030097	hemopoiesis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""hematopoiesis"", ""term"": {""id"": ""GO:0030097"", ""label"": ""hemopoiesis""}}"			ABNORMAL																								
5831	6425	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	0	Bile Duct Inflammation and Fibrosis	Periductal inflammation with concentric fibrosis (onion-skinning) leads to progressive stricture formation. Both innate and adaptive immune cells infiltrate the bile duct epithelium.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
5832	6425	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	0	Bile Duct Inflammation and Fibrosis	Periductal inflammation with concentric fibrosis (onion-skinning) leads to progressive stricture formation. Both innate and adaptive immune cells infiltrate the bile duct epithelium.	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5833	6426	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	1	Gut-Liver Axis Dysregulation	Aberrant homing of gut-primed lymphocytes to the liver through shared adhesion molecules (MAdCAM-1, CCL25). Bacterial translocation and altered bile acid metabolism contribute to hepatic inflammation.	cell_types[0]	cell_types	cell_types			T Cell	CL:0000084	T cell		"{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
5834	6426	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	1	Gut-Liver Axis Dysregulation	Aberrant homing of gut-primed lymphocytes to the liver through shared adhesion molecules (MAdCAM-1, CCL25). Bacterial translocation and altered bile acid metabolism contribute to hepatic inflammation.	biological_processes[0]	biological_processes	biological_processes			Cell Migration	GO:0016477	cell migration		"{""preferred_term"": ""Cell Migration"", ""term"": {""id"": ""GO:0016477"", ""label"": ""cell migration""}}"																											
5835	6427	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	2	Cholangiocyte Senescence	Biliary epithelial cells undergo premature senescence with SASP (senescence- associated secretory phenotype), promoting inflammation and fibrosis through release of pro-inflammatory mediators.	biological_processes[0]	biological_processes	biological_processes			Cellular Senescence	GO:0090398	cellular senescence		"{""preferred_term"": ""Cellular Senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}"																											
5841	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	cell_types[0]	cell_types	cell_types			germinal center B cell	CL:0000844	germinal center B cell		"{""preferred_term"": ""germinal center B cell"", ""term"": {""id"": ""CL:0000844"", ""label"": ""germinal center B cell""}}"																											
5842	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	genes[0]	genes	genes			BCL2			Anti-apoptotic protein, frequently mutated or translocated in GCB-type tonsillar lymphoma	"{""description"": ""Anti-apoptotic protein, frequently mutated or translocated in GCB-type tonsillar lymphoma"", ""preferred_term"": ""BCL2""}"																											
5843	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	genes[1]	genes	genes			EZH2			Histone methyltransferase component of PRC2 complex, gain-of-function mutations drive epigenetic dysregulation	"{""description"": ""Histone methyltransferase component of PRC2 complex, gain-of-function mutations drive epigenetic dysregulation"", ""preferred_term"": ""EZH2""}"																											
5844	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	genes[2]	genes	genes			BCL6			Transcriptional repressor essential for germinal center formation	"{""description"": ""Transcriptional repressor essential for germinal center formation"", ""preferred_term"": ""BCL6""}"																											
5845	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	biological_processes[0]	biological_processes	biological_processes			regulation of apoptotic process				"{""preferred_term"": ""regulation of apoptotic process""}"																											
5846	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	biological_processes[1]	biological_processes	biological_processes			histone H3-K27 methylation				"{""preferred_term"": ""histone H3-K27 methylation""}"																											
5847	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	biological_processes[2]	biological_processes	biological_processes			germinal center formation				"{""preferred_term"": ""germinal center formation""}"																											
5848	6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.	locations[0]	locations	locations			palatine tonsil	UBERON:0002373	palatine tonsil		"{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}"																											
5849	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
5850	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	genes[0]	genes	genes			CD79B			B-cell receptor component, mutations lead to chronic active BCR signaling	"{""description"": ""B-cell receptor component, mutations lead to chronic active BCR signaling"", ""preferred_term"": ""CD79B""}"																											
5851	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	genes[1]	genes	genes			MYD88			Adaptor protein in Toll-like receptor signaling, mutations activate NF-B pathway	"{""description"": ""Adaptor protein in Toll-like receptor signaling, mutations activate NF-B pathway"", ""preferred_term"": ""MYD88""}"																											
5852	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	biological_processes[0]	biological_processes	biological_processes			B cell receptor signaling pathway				"{""preferred_term"": ""B cell receptor signaling pathway""}"																											
5853	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	biological_processes[1]	biological_processes	biological_processes			NF-kappaB signaling				"{""preferred_term"": ""NF-kappaB signaling""}"																											
5854	6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.	locations[0]	locations	locations			palatine tonsil	UBERON:0002373	palatine tonsil		"{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}"																											
5855	6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.	cell_types[0]	cell_types	cell_types			germinal center B cell	CL:0000844	germinal center B cell		"{""preferred_term"": ""germinal center B cell"", ""term"": {""id"": ""CL:0000844"", ""label"": ""germinal center B cell""}}"																											
5856	6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.	cell_types[1]	cell_types	cell_types			plasmablast	CL:0000980	plasmablast		"{""preferred_term"": ""plasmablast"", ""term"": {""id"": ""CL:0000980"", ""label"": ""plasmablast""}}"																											
5857	6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.	genes[0]	genes	genes			IRF4			Interferon regulatory factor 4, rearrangement drives MUM1 expression and plasmacytic differentiation	"{""description"": ""Interferon regulatory factor 4, rearrangement drives MUM1 expression and plasmacytic differentiation"", ""preferred_term"": ""IRF4""}"																											
5858	6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.	biological_processes[0]	biological_processes	biological_processes			plasma cell differentiation				"{""preferred_term"": ""plasma cell differentiation""}"																											
5859	6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.	locations[0]	locations	locations			palatine tonsil	UBERON:0002373	palatine tonsil		"{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}"																											
5860	6444	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	3	EBV-positive Diffuse Large B-cell Lymphoma	Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
5861	6444	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	3	EBV-positive Diffuse Large B-cell Lymphoma	Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells.	biological_processes[0]	biological_processes	biological_processes			response to virus				"{""preferred_term"": ""response to virus""}"																											
5862	6444	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	3	EBV-positive Diffuse Large B-cell Lymphoma	Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells.	biological_processes[1]	biological_processes	biological_processes			immune evasion				"{""preferred_term"": ""immune evasion""}"																											
5863	6444	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	3	EBV-positive Diffuse Large B-cell Lymphoma	Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells.	locations[0]	locations	locations			palatine tonsil	UBERON:0002373	palatine tonsil		"{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}"																											
5864	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
5865	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	genes[0]	genes	genes			MYC			Transcription factor, rearrangement drives cellular proliferation	"{""description"": ""Transcription factor, rearrangement drives cellular proliferation"", ""preferred_term"": ""MYC""}"																											
5866	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	genes[1]	genes	genes			BCL2			Anti-apoptotic protein, co-rearrangement with MYC confers high-grade biology	"{""description"": ""Anti-apoptotic protein, co-rearrangement with MYC confers high-grade biology"", ""preferred_term"": ""BCL2""}"																											
5867	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	genes[2]	genes	genes			BCL6			Germinal center transcriptional repressor, co-rearrangement with MYC confers high-grade biology	"{""description"": ""Germinal center transcriptional repressor, co-rearrangement with MYC confers high-grade biology"", ""preferred_term"": ""BCL6""}"																											
5868	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	biological_processes[0]	biological_processes	biological_processes			regulation of transcription by RNA polymerase II				"{""preferred_term"": ""regulation of transcription by RNA polymerase II""}"																											
5869	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	biological_processes[1]	biological_processes	biological_processes			negative regulation of apoptotic process				"{""preferred_term"": ""negative regulation of apoptotic process""}"																											
5870	6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.	locations[0]	locations	locations			palatine tonsil	UBERON:0002373	palatine tonsil		"{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}"																											
5894	6483	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	1	Elevated PI3K/AKT signaling in AKT1-mutant cells	"AKT1 p.E17K drives increased PI3K/AKT pathway activity in mutation-positive cells, promoting downstream overgrowth signals.
"	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase/protein kinase B signal transduction	GO:0043491	phosphatidylinositol 3-kinase/protein kinase B signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase/protein kinase B signal transduction"", ""term"": {""id"": ""GO:0043491"", ""label"": ""phosphatidylinositol 3-kinase/protein kinase B signal transduction""}}"			INCREASED																								
5895	6484	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	2	Increased pAKT signaling in AKT1-mutant lesion cells	"Lesion cells harboring AKT1 p.E17K show increased pAKT signaling within hyperplastic regions.
"	biological_processes[0]	biological_processes	biological_processes			protein phosphorylation	GO:0006468	protein phosphorylation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein phosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}"			INCREASED																								
5896	6485	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	3	Non-cell-autonomous pAKT activation in adjacent cells	"AKT1-mutant clones can induce increased pAKT signaling in nearby mutation-negative cells, consistent with non-cell-autonomous lesion propagation.
"	biological_processes[0]	biological_processes	biological_processes			cell-cell signaling	GO:0007267	cell-cell signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell-cell signaling"", ""term"": {""id"": ""GO:0007267"", ""label"": ""cell-cell signaling""}}"			INCREASED																								
5897	6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	AKT overactivation induces excessive vasculogenesis	"AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.
"	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
5898	6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	AKT overactivation induces excessive vasculogenesis	"AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.
"	biological_processes[0]	biological_processes	biological_processes			vasculogenesis	GO:0001570	vasculogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""vasculogenesis"", ""term"": {""id"": ""GO:0001570"", ""label"": ""vasculogenesis""}}"			INCREASED																								
5899	6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	AKT overactivation induces excessive vasculogenesis	"AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.
"	biological_processes[1]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
5900	6487	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	5	Mural cell dysfunction destabilizes vascular connections	"AKT-driven vascular malformations include dysfunctional PDGFR+ mural cells with impaired matrix secretion, contributing to unstable vessel connections.
"	cell_types[0]	cell_types	cell_types			pericyte	CL:0000669	pericyte		"{""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}"																											
5901	6487	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	5	Mural cell dysfunction destabilizes vascular connections	"AKT-driven vascular malformations include dysfunctional PDGFR+ mural cells with impaired matrix secretion, contributing to unstable vessel connections.
"	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""modifier"": ""DECREASED"", ""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"			DECREASED																								
5930	6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	T Cell-Mediated Inflammation	"Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.
"	cell_types[0]	cell_types	cell_types			T Helper 17 Cell	CL:0000899	T-helper 17 cell		"{""preferred_term"": ""T Helper 17 Cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}"																											
5931	6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	T Cell-Mediated Inflammation	"Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.
"	cell_types[1]	cell_types	cell_types			T Helper 1 Cell	CL:0000545	T-helper 1 cell		"{""preferred_term"": ""T Helper 1 Cell"", ""term"": {""id"": ""CL:0000545"", ""label"": ""T-helper 1 cell""}}"																											
5932	6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	T Cell-Mediated Inflammation	"Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.
"	biological_processes[0]	biological_processes	biological_processes			T Cell Activation	GO:0042110	T cell activation		"{""preferred_term"": ""T Cell Activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
5933	6535	278	Psoriasis	Psoriasis.yaml	pathophysiology	1	Keratinocyte Hyperproliferation	"Inflammatory cytokines stimulate rapid keratinocyte proliferation, reducing epidermal turnover from 28 days to 3-4 days. This produces characteristic thick, scaly plaques.
"	cell_types[0]	cell_types	cell_types			Keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
5934	6535	278	Psoriasis	Psoriasis.yaml	pathophysiology	1	Keratinocyte Hyperproliferation	"Inflammatory cytokines stimulate rapid keratinocyte proliferation, reducing epidermal turnover from 28 days to 3-4 days. This produces characteristic thick, scaly plaques.
"	biological_processes[0]	biological_processes	biological_processes			Cell Proliferation	GO:0008283	cell population proliferation		"{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"																											
5935	6536	278	Psoriasis	Psoriasis.yaml	pathophysiology	2	Dendritic Cell Activation	"Plasmacytoid and myeloid dendritic cells produce inflammatory cytokines and present antigens to activate T cells, initiating and perpetuating the inflammatory cascade.
"	cell_types[0]	cell_types	cell_types			Dendritic Cell	CL:0000451	dendritic cell		"{""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
5936	6537	278	Psoriasis	Psoriasis.yaml	pathophysiology	3	IL-23/IL-17 Axis	"IL-23 produced by dendritic cells drives Th17 cell differentiation and IL-17 production. This axis is the major therapeutic target in modern psoriasis treatment.
"	biological_processes[0]	biological_processes	biological_processes			Cytokine Signaling	GO:0019221	cytokine-mediated signaling pathway		"{""preferred_term"": ""Cytokine Signaling"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"																											
5942	6553	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	1	Cytokine Pathway Activation	Dysregulated cytokine signaling, particularly IL-23/IL-17 and TNF pathways, sustains inflammatory responses in affected tissues.	biological_processes[0]	biological_processes	biological_processes			cytokine-mediated signaling pathway	GO:0019221	cytokine-mediated signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"			INCREASED																								
5954	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	cell_types[0]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
5955	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	cell_types[1]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
5956	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	cell_types[2]	cell_types	cell_types			fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
5957	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	cell_types[3]	cell_types	cell_types			pericyte	CL:0000669	pericyte		"{""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}"																											
5958	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	locations[0]	locations	locations			pulmonary artery	UBERON:0002012	pulmonary artery		"{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}"																											
5959	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	biological_processes[0]	biological_processes	biological_processes			extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
5960	6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.	biological_processes[1]	biological_processes	biological_processes			smooth muscle cell proliferation	GO:0048661	positive regulation of smooth muscle cell proliferation		"{""preferred_term"": ""smooth muscle cell proliferation"", ""term"": {""id"": ""GO:0048661"", ""label"": ""positive regulation of smooth muscle cell proliferation""}}"																											
5961	6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
5962	6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.	locations[0]	locations	locations			pulmonary artery	UBERON:0002012	pulmonary artery		"{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}"																											
5963	6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.	biological_processes[0]	biological_processes	biological_processes			endothelial to mesenchymal transition	GO:0001837	epithelial to mesenchymal transition		"{""preferred_term"": ""endothelial to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}"																											
5964	6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
5965	6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.	biological_processes[2]	biological_processes	biological_processes			BMP signaling pathway	GO:0030509	BMP signaling pathway		"{""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}"																											
5966	6577	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	2	Inflammation and Immune Activation	Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
5967	6577	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	2	Inflammation and Immune Activation	Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes.	locations[0]	locations	locations			pulmonary artery	UBERON:0002012	pulmonary artery		"{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}"																											
5968	6577	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	2	Inflammation and Immune Activation	Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
5969	6577	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	2	Inflammation and Immune Activation	Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes.	biological_processes[1]	biological_processes	biological_processes			NF-kappaB signaling	GO:0038061	NIK/NF-kappaB signaling		"{""preferred_term"": ""NF-kappaB signaling"", ""term"": {""id"": ""GO:0038061"", ""label"": ""NIK/NF-kappaB signaling""}}"																											
5970	6578	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	3	Metabolic Reprogramming	Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance.	cell_types[0]	cell_types	cell_types			Smooth Muscle Cell	CL:0000192	smooth muscle cell		"{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}"																											
5971	6578	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	3	Metabolic Reprogramming	Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance.	cell_types[1]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
5972	6578	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	3	Metabolic Reprogramming	Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance.	biological_processes[0]	biological_processes	biological_processes			glycolytic process	GO:0006096	glycolytic process		"{""preferred_term"": ""glycolytic process"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}"																											
5973	6578	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	3	Metabolic Reprogramming	Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance.	biological_processes[1]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
5974	6579	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	4	Hypoxia Signaling	Hypoxia-inducible factor (HIF) pathway activation contributing to vasoconstriction and vascular remodeling.	biological_processes[0]	biological_processes	biological_processes			response to hypoxia	GO:0001666	response to hypoxia		"{""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"																											
5975	6579	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	4	Hypoxia Signaling	Hypoxia-inducible factor (HIF) pathway activation contributing to vasoconstriction and vascular remodeling.	biological_processes[1]	biological_processes	biological_processes			HIF-1-alpha signaling pathway	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway		"{""preferred_term"": ""HIF-1-alpha signaling pathway"", ""term"": {""id"": ""GO:0097411"", ""label"": ""hypoxia-inducible factor-1alpha signaling pathway""}}"																											
5976	6580	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	5	Increased Pulmonary Vascular Resistance	Result of vascular remodeling and vasoconstriction leading to elevated pressure in the pulmonary artery.	locations[0]	locations	locations			pulmonary artery	UBERON:0002012	pulmonary artery		"{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}"																											
5977	6581	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	6	Right Ventricular Hypertrophy	The right ventricle thickens in response to increased workload from elevated pulmonary arterial pressure.	locations[0]	locations	locations			right cardiac ventricle	UBERON:0002080	right cardiac ventricle		"{""preferred_term"": ""right cardiac ventricle"", ""term"": {""id"": ""UBERON:0002080"", ""label"": ""right cardiac ventricle""}}"																											
5992	6604	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	0	RET Fusion and Constitutive Kinase Activation	Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members).	cell_types[0]	cell_types	cell_types			thyroid follicular cell	CL:0002258	thyroid follicular cell		"{""preferred_term"": ""thyroid follicular cell"", ""term"": {""id"": ""CL:0002258"", ""label"": ""thyroid follicular cell""}}"																											
5993	6604	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	0	RET Fusion and Constitutive Kinase Activation	Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members).	biological_processes[0]	biological_processes	biological_processes			receptor signaling protein tyrosine kinase activity	GO:0004716	receptor signaling protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}"			INCREASED																								
5994	6604	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	0	RET Fusion and Constitutive Kinase Activation	Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members).	locations[0]	locations	locations			thyroid gland	UBERON:0002046	thyroid gland		"{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}"																											
5995	6605	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	Constitutive RET kinase activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled thyroid follicular cell proliferation. This is a major effector of RET-mediated thyroid tumorigenesis.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
5996	6606	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	RET activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives thyroid cancer progression.	biological_processes[0]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
6007	6622	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	0	RET Gene Rearrangement	RET rearrangements result from chromosomal inversions or translocations that fuse the RET kinase domain (10q11.21) to an N-terminal partner gene. The partner gene provides a dimerization domain, causing constitutive RET kinase activation independent of ligand. RET normally signals through GDNF family ligands and GFR-alpha co-receptors.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
6008	6622	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	0	RET Gene Rearrangement	RET rearrangements result from chromosomal inversions or translocations that fuse the RET kinase domain (10q11.21) to an N-terminal partner gene. The partner gene provides a dimerization domain, causing constitutive RET kinase activation independent of ligand. RET normally signals through GDNF family ligands and GFR-alpha co-receptors.	biological_processes[0]	biological_processes	biological_processes			protein kinase activity	GO:0004672	protein kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}"			INCREASED																								
6009	6623	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive RET Signaling	RET fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and PLCgamma pathways. RET also activates SRC family kinases and JAK-STAT signaling.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
6010	6623	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive RET Signaling	RET fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and PLCgamma pathways. RET also activates SRC family kinases and JAK-STAT signaling.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
6011	6624	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	RET-rearranged tumors exhibit oncogene addiction, becoming dependent on continued RET signaling for survival. Selective RET inhibition leads to rapid and durable tumor responses.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
6012	6625	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	3	RET Inhibitor Resistance	Resistance to selective RET inhibitors can develop through secondary RET kinase mutations (G810R/S/C solvent front mutations, V804L/M gatekeeper), RET amplification, or bypass pathway activation (MET, KRAS, BRAF). Solvent front mutations are the most common resistance mechanism.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
6023	6642	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	0	ROS1 Gene Rearrangement	ROS1 rearrangements result from chromosomal translocations that fuse the ROS1 kinase domain (6q22) to an N-terminal partner gene. The partner provides a dimerization domain, causing constitutive ROS1 kinase activation independent of ligand. ROS1 shares ~49% amino acid identity with ALK in the kinase domain, explaining cross-sensitivity to ALK inhibitors.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
6024	6642	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	0	ROS1 Gene Rearrangement	ROS1 rearrangements result from chromosomal translocations that fuse the ROS1 kinase domain (6q22) to an N-terminal partner gene. The partner provides a dimerization domain, causing constitutive ROS1 kinase activation independent of ligand. ROS1 shares ~49% amino acid identity with ALK in the kinase domain, explaining cross-sensitivity to ALK inhibitors.	biological_processes[0]	biological_processes	biological_processes			protein kinase activity	GO:0004672	protein kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}"			INCREASED																								
6025	6643	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ROS1 Signaling	ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
6026	6643	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ROS1 Signaling	ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
6027	6643	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ROS1 Signaling	ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK.	biological_processes[2]	biological_processes	biological_processes			JAK-STAT cascade	GO:0007259	JAK-STAT cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}"			INCREASED																								
6028	6644	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	ROS1-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ROS1 signaling for survival. ROS1 inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
6029	6645	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	3	ROS1 Inhibitor Resistance	Resistance to ROS1 inhibitors develops through ROS1-dependent mechanisms (secondary mutations like G2032R, D2033N, L2026M) or ROS1-independent bypass pathways (MET amplification, KRAS mutations, EGFR activation). The G2032R solvent front mutation is the most common and confers resistance to crizotinib.	biological_processes[0]	biological_processes	biological_processes			response to drug	GO:0042493	response to drug		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}"			ABNORMAL																								
6069	6716	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	0	RB1 Tumor Suppressor Inactivation	The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell.	cell_types[0]	cell_types	cell_types			retinal progenitor cell	CL:0002672	retinal progenitor cell		"{""preferred_term"": ""retinal progenitor cell"", ""term"": {""id"": ""CL:0002672"", ""label"": ""retinal progenitor cell""}}"																											
6070	6716	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	0	RB1 Tumor Suppressor Inactivation	The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell.	biological_processes[0]	biological_processes	biological_processes			G1/S transition of mitotic cell cycle	GO:0000082	G1/S transition of mitotic cell cycle		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}"			ABNORMAL																								
6071	6716	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	0	RB1 Tumor Suppressor Inactivation	The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell.	locations[0]	locations	locations			retina	UBERON:0000966	retina		"{""preferred_term"": ""retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}"																											
6072	6717	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	1	Loss of Cell Cycle Checkpoint Control	pRB normally binds and inhibits E2F transcription factors during G1 phase. When pRB is phosphorylated by cyclin-dependent kinases or functionally lost, E2F is released to activate genes required for S-phase entry, including cyclins, DNA replication factors, and proliferative genes.	biological_processes[0]	biological_processes	biological_processes			cell cycle checkpoint signaling	GO:0000075	cell cycle checkpoint signaling		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}"			DECREASED																								
6073	6717	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	1	Loss of Cell Cycle Checkpoint Control	pRB normally binds and inhibits E2F transcription factors during G1 phase. When pRB is phosphorylated by cyclin-dependent kinases or functionally lost, E2F is released to activate genes required for S-phase entry, including cyclins, DNA replication factors, and proliferative genes.	biological_processes[1]	biological_processes	biological_processes			positive regulation of transcription by RNA polymerase II	GO:0045944	positive regulation of transcription by RNA polymerase II		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}"			INCREASED																								
6074	6718	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	2	Uncontrolled Retinal Cell Proliferation	Loss of pRB-mediated cell cycle control results in constitutive E2F activity, driving retinal progenitor cells through repeated rounds of DNA replication and cell division. This uncontrolled proliferation leads to tumor formation.	cell_types[0]	cell_types	cell_types			retinal progenitor cell	CL:0002672	retinal progenitor cell		"{""preferred_term"": ""retinal progenitor cell"", ""term"": {""id"": ""CL:0002672"", ""label"": ""retinal progenitor cell""}}"																											
6075	6718	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	2	Uncontrolled Retinal Cell Proliferation	Loss of pRB-mediated cell cycle control results in constitutive E2F activity, driving retinal progenitor cells through repeated rounds of DNA replication and cell division. This uncontrolled proliferation leads to tumor formation.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
6089	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	cell_types[0]	cell_types	cell_types			muscle cell	CL:0000187	muscle cell		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""muscle cell"", ""term"": {""id"": ""CL:0000187"", ""label"": ""muscle cell""}}"			ABNORMAL																								
6090	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	cell_types[1]	cell_types	cell_types			sensory neuron	CL:0000101	sensory neuron		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""sensory neuron"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}"			ABNORMAL																								
6091	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	biological_processes[0]	biological_processes	biological_processes			regulation of muscle contraction	GO:0006937	regulation of muscle contraction		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of muscle contraction"", ""term"": {""id"": ""GO:0006937"", ""label"": ""regulation of muscle contraction""}}"			ABNORMAL																								
6092	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	biological_processes[1]	biological_processes	biological_processes			skeletal muscle contraction	GO:0003009	skeletal muscle contraction		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""skeletal muscle contraction"", ""term"": {""id"": ""GO:0003009"", ""label"": ""skeletal muscle contraction""}}"			ABNORMAL																								
6093	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	locations[0]	locations	locations			upper esophageal sphincter	UBERON:0007268	upper esophageal sphincter		"{""preferred_term"": ""upper esophageal sphincter"", ""term"": {""id"": ""UBERON:0007268"", ""label"": ""upper esophageal sphincter""}}"																											
6094	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.	locations[1]	locations	locations			cricopharyngeus muscle	UBERON:0010928	cricopharyngeus muscle		"{""preferred_term"": ""cricopharyngeus muscle"", ""term"": {""id"": ""UBERON:0010928"", ""label"": ""cricopharyngeus muscle""}}"																											
6095	6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	Elevated Upper Esophageal Sphincter Basal Pressure	Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas.	cell_types[0]	cell_types	cell_types			muscle cell	CL:0000187	muscle cell		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""muscle cell"", ""term"": {""id"": ""CL:0000187"", ""label"": ""muscle cell""}}"			ABNORMAL																								
6096	6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	Elevated Upper Esophageal Sphincter Basal Pressure	Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas.	biological_processes[0]	biological_processes	biological_processes			muscle contraction	GO:0006936	muscle contraction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}"			INCREASED																								
6097	6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	Elevated Upper Esophageal Sphincter Basal Pressure	Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas.	locations[0]	locations	locations			upper esophageal sphincter	UBERON:0007268	upper esophageal sphincter		"{""preferred_term"": ""upper esophageal sphincter"", ""term"": {""id"": ""UBERON:0007268"", ""label"": ""upper esophageal sphincter""}}"																											
6104	6742	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	0	MECP2 Dysfunction	"Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6105	6742	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	0	MECP2 Dysfunction	"Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.
"	biological_processes[0]	biological_processes	biological_processes			Gene Expression Regulation	GO:0010468	regulation of gene expression		"{""preferred_term"": ""Gene Expression Regulation"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"																											
6106	6743	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	1	Abnormal Neuronal Development	"Loss of MECP2 leads to reduced dendritic arborization, decreased synapse formation, and impaired synaptic plasticity. Neurons have smaller cell bodies and reduced connectivity, particularly affecting inhibitory circuits.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6107	6743	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	1	Abnormal Neuronal Development	"Loss of MECP2 leads to reduced dendritic arborization, decreased synapse formation, and impaired synaptic plasticity. Neurons have smaller cell bodies and reduced connectivity, particularly affecting inhibitory circuits.
"	biological_processes[0]	biological_processes	biological_processes			Synaptic Transmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""Synaptic Transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
6123	6775	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	0	Autoimmune Response	The immune system mistakenly attacks the body's own tissues, particularly the synovial membrane lining the joints.	cell_types[0]	cell_types	cell_types			Th17 Cell	CL:0000899	T-helper 17 cell		"{""preferred_term"": ""Th17 Cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}"																											
6124	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	Inflammatory Cytokine Production	Overproduction of inflammatory cytokines like TNF-, IL-1, and IL-6 leads to joint inflammation and damage.	biological_processes[0]	biological_processes	biological_processes			cytokine production	GO:0001816	cytokine production		"{""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"																											
6125	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	Inflammatory Cytokine Production	Overproduction of inflammatory cytokines like TNF-, IL-1, and IL-6 leads to joint inflammation and damage.	locations[0]	locations	locations			synovial membrane	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
6126	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	Synovial Hyperplasia	The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone.	cell_types[0]	cell_types	cell_types			Synoviocyte	CL:0000214	synovial cell		"{""preferred_term"": ""Synoviocyte"", ""term"": {""id"": ""CL:0000214"", ""label"": ""synovial cell""}}"																											
6127	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	Synovial Hyperplasia	The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6128	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	Synovial Hyperplasia	The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone.	locations[0]	locations	locations			synovial membrane	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
6129	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	Cartilage and Bone Destruction	Chronic inflammation and pannus formation lead to the erosion of articular cartilage and underlying bone.	locations[0]	locations	locations			synovial joint	UBERON:0002217	synovial joint		"{""preferred_term"": ""synovial joint"", ""term"": {""id"": ""UBERON:0002217"", ""label"": ""synovial joint""}}"																											
6130	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	Cartilage and Bone Destruction	Chronic inflammation and pannus formation lead to the erosion of articular cartilage and underlying bone.	locations[1]	locations	locations			articular cartilage	UBERON:0003676	articular cartilage tissue		"{""preferred_term"": ""articular cartilage"", ""term"": {""id"": ""UBERON:0003676"", ""label"": ""articular cartilage tissue""}}"																											
6131	6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	JAK/STAT Signaling	The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium.	biological_processes[0]	biological_processes	biological_processes			cytokine-mediated signaling pathway	GO:0019221	cytokine-mediated signaling pathway		"{""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"																											
6132	6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	JAK/STAT Signaling	The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
6133	6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	JAK/STAT Signaling	The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6134	6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	JAK/STAT Signaling	The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium.	locations[0]	locations	locations			synovial membrane	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
6135	6780	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	5	NF-B Activation	NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells.	biological_processes[0]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
6136	6780	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	5	NF-B Activation	NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells.	biological_processes[1]	biological_processes	biological_processes			cytokine production	GO:0001816	cytokine production		"{""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}"																											
6137	6780	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	5	NF-B Activation	NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
6138	6780	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	5	NF-B Activation	NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6139	6781	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	6	Neutrophil Extracellular Trap Formation	Neutrophils release extracellular traps containing citrullinated histones and autoantigens via PAD4-mediated citrullination, amplifying autoimmunity.	cell_types[0]	cell_types	cell_types			Neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6140	6781	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	6	Neutrophil Extracellular Trap Formation	Neutrophils release extracellular traps containing citrullinated histones and autoantigens via PAD4-mediated citrullination, amplifying autoimmunity.	biological_processes[0]	biological_processes	biological_processes			immune response	GO:0006955	immune response		"{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}"																											
6141	6782	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	7	B Cell and Plasma Cell Responses	B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6142	6782	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	7	B Cell and Plasma Cell Responses	B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures.	cell_types[1]	cell_types	cell_types			Plasma cell	CL:0000786	plasma cell		"{""preferred_term"": ""Plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}"																											
6143	6782	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	7	B Cell and Plasma Cell Responses	B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures.	locations[0]	locations	locations			synovial membrane	UBERON:0002018	synovial membrane of synovial joint		"{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}"																											
6144	6783	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	8	Mucosal Origins and Dysbiosis	Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination.	locations[0]	locations	locations			respiratory system mucosa	UBERON:0004785	respiratory system mucosa		"{""preferred_term"": ""respiratory system mucosa"", ""term"": {""id"": ""UBERON:0004785"", ""label"": ""respiratory system mucosa""}}"																											
6145	6783	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	8	Mucosal Origins and Dysbiosis	Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination.	locations[1]	locations	locations			oral mucosa	UBERON:0003343	oral mucosa		"{""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0003343"", ""label"": ""oral mucosa""}}"																											
6146	6783	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	8	Mucosal Origins and Dysbiosis	Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination.	locations[2]	locations	locations			intestinal mucosa	UBERON:0001277	intestinal mucosa		"{""preferred_term"": ""intestinal mucosa"", ""term"": {""id"": ""UBERON:0001277"", ""label"": ""intestinal mucosa""}}"																											
6161	6812	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	1	Decreased NK Cell Function		cell_types[0]	cell_types	cell_types			NK Cell	CL:0000623	natural killer cell		"{""preferred_term"": ""NK Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
6162	6813	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	2	Decreased total and memory B cells		cell_types[0]	cell_types	cell_types			Memory B cell	CL:0000787	memory B cell		"{""preferred_term"": ""Memory B cell"", ""term"": {""id"": ""CL:0000787"", ""label"": ""memory B cell""}}"																											
6173	6829	292	SADDAN	SADDAN.yaml	pathophysiology	0	FGFR3 p.Lys650Met mutation	"A single missense mutation at codon 650 (p.Lys650Met) in FGFR3 causes SADDAN.
"	gene	gene	$	FGFR3 p.Lys650Met mutation	"A single missense mutation at codon 650 (p.Lys650Met) in FGFR3 causes SADDAN.
"	FGFR3	hgnc:3690	FGFR3		"{""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"																											
6174	6830	292	SADDAN	SADDAN.yaml	pathophysiology	1	Constitutive FGFR3 kinase activity	"The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.
"	gene	gene	$	Constitutive FGFR3 kinase activity	"The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.
"	FGFR3	hgnc:3690	FGFR3		"{""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"																											
6175	6830	292	SADDAN	SADDAN.yaml	pathophysiology	1	Constitutive FGFR3 kinase activity	"The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.
"	biological_processes[0]	biological_processes	biological_processes			protein tyrosine kinase activity	GO:0004713	protein tyrosine kinase activity		"{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}"			INCREASED																								
6176	6830	292	SADDAN	SADDAN.yaml	pathophysiology	1	Constitutive FGFR3 kinase activity	"The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.
"	biological_processes[1]	biological_processes	biological_processes			fibroblast growth factor receptor signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"			INCREASED																								
6177	6831	292	SADDAN	SADDAN.yaml	pathophysiology	2	Severe disturbances in endochondral bone growth	"The Lys650Met mutation results in severe disturbances in endochondral bone growth.
"	cell_types[0]	cell_types	cell_types			Growth plate chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
6200	6851	293	Salla Disease	Salla_Disease.yaml	pathophysiology	0	SLC17A5 Gene Mutation	Biallelic pathogenic variants in SLC17A5 disrupt the coding or regulatory regions necessary for sialin protein function. The c.115C>T (p.Arg39Cys) Finnish founder mutation is the most common variant in Salla disease.	gene	gene	$	SLC17A5 Gene Mutation	Biallelic pathogenic variants in SLC17A5 disrupt the coding or regulatory regions necessary for sialin protein function. The c.115C>T (p.Arg39Cys) Finnish founder mutation is the most common variant in Salla disease.	SLC17A5	hgnc:10933	SLC17A5		"{""preferred_term"": ""SLC17A5"", ""term"": {""id"": ""hgnc:10933"", ""label"": ""SLC17A5""}}"																											
6201	6852	293	Salla Disease	Salla_Disease.yaml	pathophysiology	1	Loss of Sialin Protein Function	SLC17A5 mutations result in loss or substantial reduction of sialin protein expression or function. Sialin is a 12-transmembrane transporter required for proton-coupled export of free sialic acid (Neu5Ac) from lysosomes to cytosol. Mutations can occur as de novo, inherited biallelic variants, or in mosaic patterns affecting specific tissues.	biological_processes[0]	biological_processes	biological_processes			Sialic acid transport	GO:0015739	sialic acid transport		"{""modifier"": ""DECREASED"", ""preferred_term"": ""Sialic acid transport"", ""term"": {""id"": ""GO:0015739"", ""label"": ""sialic acid transport""}}"			DECREASED																								
6202	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.	cell_types[0]	cell_types	cell_types			Oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
6203	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.	cell_types[1]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6204	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.	cell_types[2]	cell_types	cell_types			Astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
6205	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.	biological_processes[0]	biological_processes	biological_processes			Glycosphingolipid metabolic process	GO:0006687	glycosphingolipid metabolic process		"{""preferred_term"": ""Glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006687"", ""label"": ""glycosphingolipid metabolic process""}}"																											
6206	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.	biological_processes[1]	biological_processes	biological_processes			Myelination	GO:0042552	myelination		"{""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
6207	6855	293	Salla Disease	Salla_Disease.yaml	pathophysiology	4	Oligodendroglial Dysfunction and Hypomyelination	Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI.	cell_types[0]	cell_types	cell_types			Oligodendrocyte	CL:0000128	oligodendrocyte		"{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
6208	6855	293	Salla Disease	Salla_Disease.yaml	pathophysiology	4	Oligodendroglial Dysfunction and Hypomyelination	Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI.	biological_processes[0]	biological_processes	biological_processes			Myelination	GO:0042552	myelination		"{""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
6209	6855	293	Salla Disease	Salla_Disease.yaml	pathophysiology	4	Oligodendroglial Dysfunction and Hypomyelination	Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI.	biological_processes[1]	biological_processes	biological_processes			CNS myelination	GO:0022010	central nervous system myelination		"{""preferred_term"": ""CNS myelination"", ""term"": {""id"": ""GO:0022010"", ""label"": ""central nervous system myelination""}}"																											
6210	6856	293	Salla Disease	Salla_Disease.yaml	pathophysiology	5	Neuronal Dysfunction and Neurodegeneration	Neurons accumulate free sialic acid and display altered GSL composition. Biochemical changes contribute to progressive neurodegeneration, manifesting as developmental delay, cognitive impairment, and progressive neurological regression.	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6211	6856	293	Salla Disease	Salla_Disease.yaml	pathophysiology	5	Neuronal Dysfunction and Neurodegeneration	Neurons accumulate free sialic acid and display altered GSL composition. Biochemical changes contribute to progressive neurodegeneration, manifesting as developmental delay, cognitive impairment, and progressive neurological regression.	biological_processes[0]	biological_processes	biological_processes			Glycosphingolipid metabolic process	GO:0006687	glycosphingolipid metabolic process		"{""preferred_term"": ""Glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006687"", ""label"": ""glycosphingolipid metabolic process""}}"																											
6225	6885	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	0	Granuloma Formation	"Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.
"	cell_types[0]	cell_types	cell_types			epithelioid macrophage	CL:0002150	epithelioid macrophage		"{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}"																											
6226	6885	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	0	Granuloma Formation	"Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.
"	cell_types[1]	cell_types	cell_types			CD4-positive helper T cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""CD4-positive helper T cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
6227	6885	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	0	Granuloma Formation	"Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.
"	biological_processes[0]	biological_processes	biological_processes			granuloma formation	GO:0002432	granuloma formation		"{""preferred_term"": ""granuloma formation"", ""term"": {""id"": ""GO:0002432"", ""label"": ""granuloma formation""}}"																											
6228	6886	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	1	Dysregulated Immune Response	"Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.
"	cell_types[0]	cell_types	cell_types			CD4-positive helper T cell	CL:0000492	CD4-positive helper T cell		"{""preferred_term"": ""CD4-positive helper T cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}"																											
6229	6886	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	1	Dysregulated Immune Response	"Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
6244	6905	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	1	Egg trapping triggers granulomatous inflammation	Eggs lodged in tissues such as the liver or bladder provoke granulomatous inflammatory responses.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
6245	6905	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	1	Egg trapping triggers granulomatous inflammation	Eggs lodged in tissues such as the liver or bladder provoke granulomatous inflammatory responses.	locations[1]	locations	locations			urinary bladder	UBERON:0001255	urinary bladder		"{""preferred_term"": ""urinary bladder"", ""term"": {""id"": ""UBERON:0001255"", ""label"": ""urinary bladder""}}"																											
6246	6906	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	2	Periportal fibrosis with portal hypertension	Chronic egg-driven inflammation promotes periportal fibrosis and portal hypertension.	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
6252	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	Dysregulation of Dopamine Neurotransmission	Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways.	biological_processes[0]	biological_processes	biological_processes			dopamine secretion	GO:0014046	dopamine secretion		"{""preferred_term"": ""dopamine secretion"", ""term"": {""id"": ""GO:0014046"", ""label"": ""dopamine secretion""}}"																											
6253	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	Dysregulation of Dopamine Neurotransmission	Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways.	locations[0]	locations	locations			striatum				"{""preferred_term"": ""striatum""}"																											
6254	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	Abnormality of Glutamergic Signaling	Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function.	cell_types[0]	cell_types	cell_types			parvalbumin-positive interneuron	CL:0000099	interneuron	NMDA hypofunction on parvalbumin interneurons leads to cortical disinhibition.	"{""description"": ""NMDA hypofunction on parvalbumin interneurons leads to cortical disinhibition."", ""preferred_term"": ""parvalbumin-positive interneuron"", ""term"": {""id"": ""CL:0000099"", ""label"": ""interneuron""}}"																											
6255	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	Abnormality of Glutamergic Signaling	Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function.	biological_processes[0]	biological_processes	biological_processes			synaptic transmission, glutamatergic	GO:0035249	synaptic transmission, glutamatergic		"{""preferred_term"": ""synaptic transmission, glutamatergic"", ""term"": {""id"": ""GO:0035249"", ""label"": ""synaptic transmission, glutamatergic""}}"																											
6256	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	Abnormality of Glutamergic Signaling	Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function.	locations[0]	locations	locations			prefrontal cortex	UBERON:0000451	prefrontal cortex		"{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}"																											
6257	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	Abnormality of Glutamergic Signaling	Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function.	locations[1]	locations	locations			hippocampus	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
6258	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	Abnormality of GABAergic Signaling	Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits.	cell_types[0]	cell_types	cell_types			parvalbumin-positive interneuron	CL:0000099	interneuron	Parvalbumin-positive GABAergic interneurons show reduced function, leading to cortical disinhibition.	"{""description"": ""Parvalbumin-positive GABAergic interneurons show reduced function, leading to cortical disinhibition."", ""preferred_term"": ""parvalbumin-positive interneuron"", ""term"": {""id"": ""CL:0000099"", ""label"": ""interneuron""}}"																											
6259	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	Abnormality of GABAergic Signaling	Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits.	biological_processes[0]	biological_processes	biological_processes			synaptic transmission, GABAergic	GO:0051932	synaptic transmission, GABAergic		"{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}"																											
6260	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	Abnormality of GABAergic Signaling	Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits.	locations[0]	locations	locations			prefrontal cortex	UBERON:0000451	prefrontal cortex		"{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}"																											
6261	6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.	cell_types[0]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell	Microglia eliminate synapses tagged by complement components during critical developmental periods.	"{""description"": ""Microglia eliminate synapses tagged by complement components during critical developmental periods."", ""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
6262	6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
6263	6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.	biological_processes[1]	biological_processes	biological_processes			synapse pruning	GO:0098883	synapse pruning		"{""preferred_term"": ""synapse pruning"", ""term"": {""id"": ""GO:0098883"", ""label"": ""synapse pruning""}}"																											
6264	6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.	locations[0]	locations	locations			prefrontal cortex	UBERON:0000451	prefrontal cortex		"{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}"																											
6265	6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.	locations[1]	locations	locations			hippocampus	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
6266	6931	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	4	Oligodendrocyte and Myelin Dysfunction	Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions.	cell_types[0]	cell_types	cell_types			oligodendrocyte	CL:0000128	oligodendrocyte	Oligodendrocyte dysfunction contributes to impaired myelination and dysconnectivity.	"{""description"": ""Oligodendrocyte dysfunction contributes to impaired myelination and dysconnectivity."", ""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}"																											
6267	6931	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	4	Oligodendrocyte and Myelin Dysfunction	Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions.	biological_processes[0]	biological_processes	biological_processes			myelination	GO:0042552	myelination		"{""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}"																											
6268	6931	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	4	Oligodendrocyte and Myelin Dysfunction	Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions.	locations[0]	locations	locations			prefrontal cortex	UBERON:0000451	prefrontal cortex		"{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}"																											
6269	6931	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	4	Oligodendrocyte and Myelin Dysfunction	Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions.	locations[1]	locations	locations			hippocampus	UBERON:0001954	Ammon's horn		"{""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}"																											
6270	6932	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	5	Mitochondrial Dysfunction and Oxidative Stress	Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation.	biological_processes[0]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"																											
6271	6932	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	5	Mitochondrial Dysfunction and Oxidative Stress	Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation.	biological_processes[1]	biological_processes	biological_processes			cellular response to oxidative stress	GO:0034599	cellular response to oxidative stress		"{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}"																											
6272	6932	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	5	Mitochondrial Dysfunction and Oxidative Stress	Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation.	locations[0]	locations	locations			prefrontal cortex	UBERON:0000451	prefrontal cortex		"{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}"																											
6273	6933	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	6	Blood-Brain Barrier Dysfunction	Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit.	cell_types[0]	cell_types	cell_types			endothelial cell	CL:0000115	endothelial cell		"{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
6274	6933	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	6	Blood-Brain Barrier Dysfunction	Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit.	cell_types[1]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
6275	6933	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	6	Blood-Brain Barrier Dysfunction	Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit.	locations[0]	locations	locations			blood-brain barrier				"{""preferred_term"": ""blood-brain barrier""}"																											
6294	6962	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	0	Embryologic developmental disruption	"The anomalies in scimitar syndrome arise from disrupted cardiopulmonary embryogenesis during the fourth to fifth week of gestation. Faulty incorporation of the common pulmonary vein into the left atrium results in the anomalous venous drainage, while abnormal branching morphogenesis of the right lung bud produces ipsilateral pulmonary hypoplasia. Aberrant systemic arterial connections and bronchopulmonary sequestration reflect concurrent errors in vascular patterning. The exact triggers are unknown, and no consistent environmental teratogenic exposure has been identified. The condition is typically sporadic.
"	biological_processes[0]	biological_processes	biological_processes			Lung development	GO:0030324	lung development		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Lung development"", ""term"": {""id"": ""GO:0030324"", ""label"": ""lung development""}}"			ABNORMAL																								
6295	6962	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	0	Embryologic developmental disruption	"The anomalies in scimitar syndrome arise from disrupted cardiopulmonary embryogenesis during the fourth to fifth week of gestation. Faulty incorporation of the common pulmonary vein into the left atrium results in the anomalous venous drainage, while abnormal branching morphogenesis of the right lung bud produces ipsilateral pulmonary hypoplasia. Aberrant systemic arterial connections and bronchopulmonary sequestration reflect concurrent errors in vascular patterning. The exact triggers are unknown, and no consistent environmental teratogenic exposure has been identified. The condition is typically sporadic.
"	biological_processes[1]	biological_processes	biological_processes			Pulmonary vein morphogenesis	GO:0060577	pulmonary vein morphogenesis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Pulmonary vein morphogenesis"", ""term"": {""id"": ""GO:0060577"", ""label"": ""pulmonary vein morphogenesis""}}"			ABNORMAL																								
6296	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	Anomalous pulmonary venous drainage	"The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.
"	locations[0]	locations	locations			Pulmonary vein	UBERON:0002016	pulmonary vein		"{""preferred_term"": ""Pulmonary vein"", ""term"": {""id"": ""UBERON:0002016"", ""label"": ""pulmonary vein""}}"																											
6297	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	Anomalous pulmonary venous drainage	"The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.
"	locations[1]	locations	locations			Inferior vena cava	UBERON:0001072	inferior vena cava		"{""preferred_term"": ""Inferior vena cava"", ""term"": {""id"": ""UBERON:0001072"", ""label"": ""inferior vena cava""}}"																											
6298	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	Anomalous pulmonary venous drainage	"The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.
"	biological_processes[0]	biological_processes	biological_processes			Pulmonary vein morphogenesis	GO:0060577	pulmonary vein morphogenesis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Pulmonary vein morphogenesis"", ""term"": {""id"": ""GO:0060577"", ""label"": ""pulmonary vein morphogenesis""}}"			ABNORMAL																								
6299	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	Anomalous pulmonary venous drainage	"The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.
"	cell_types[0]	cell_types	cell_types			Blood vessel endothelial cell	CL:0000071	blood vessel endothelial cell		"{""preferred_term"": ""Blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}"																											
6300	6964	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	2	Right lung hypoplasia	"The right lung is hypoplastic in most cases, ranging from mild volume reduction to severe underdevelopment with only one or two lobes. Right lung hypoplasia reduces the volume of blood flow through the anomalous circuit, which may paradoxically limit the hemodynamic impact of the left-to-right shunt. The hypoplasia results in dextroposition of the heart (shifting of the mediastinum to the right) rather than true dextrocardia. Right pulmonary artery hypoplasia frequently accompanies lung hypoplasia, further reducing the pulmonary vascular bed.
"	locations[0]	locations	locations			Right lung	UBERON:0002167	right lung		"{""preferred_term"": ""Right lung"", ""term"": {""id"": ""UBERON:0002167"", ""label"": ""right lung""}}"																											
6301	6964	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	2	Right lung hypoplasia	"The right lung is hypoplastic in most cases, ranging from mild volume reduction to severe underdevelopment with only one or two lobes. Right lung hypoplasia reduces the volume of blood flow through the anomalous circuit, which may paradoxically limit the hemodynamic impact of the left-to-right shunt. The hypoplasia results in dextroposition of the heart (shifting of the mediastinum to the right) rather than true dextrocardia. Right pulmonary artery hypoplasia frequently accompanies lung hypoplasia, further reducing the pulmonary vascular bed.
"	biological_processes[0]	biological_processes	biological_processes			Right lung morphogenesis	GO:0060461	right lung morphogenesis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Right lung morphogenesis"", ""term"": {""id"": ""GO:0060461"", ""label"": ""right lung morphogenesis""}}"			ABNORMAL																								
6302	6965	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	3	Anomalous systemic arterial supply	"An anomalous systemic artery arising from the thoracic or abdominal aorta supplies part of the right lower lobe in many cases. This arterial supply creates an additional left-to-right shunt by delivering systemic-pressure blood to the pulmonary vascular bed, contributing to pulmonary overcirculation and pulmonary hypertension. Bronchopulmonary sequestration frequently coexists, and aortopulmonary collateral arteries may also be present.
"	biological_processes[0]	biological_processes	biological_processes			Blood vessel development	GO:0001568	blood vessel development		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Blood vessel development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}"			ABNORMAL																								
6303	6966	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	4	Pulmonary hypertension pathogenesis	"Pulmonary hypertension in scimitar syndrome arises from multiple converging factors. The left-to-right shunt from anomalous venous drainage produces pulmonary overcirculation; right lung hypoplasia reduces the pulmonary vascular bed; anomalous systemic arterial supply adds high-pressure systemic inflow; and stenosis or obstruction of the scimitar vein elevates post-capillary pressure. These factors drive vascular remodeling including endothelial dysfunction and smooth muscle cell hypertrophy in small pulmonary arteries. Pulmonary hypertension is the major determinant of prognosis, especially in infants.
"	cell_types[0]	cell_types	cell_types			Blood vessel endothelial cell	CL:0000071	blood vessel endothelial cell		"{""preferred_term"": ""Blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}"																											
6304	6966	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	4	Pulmonary hypertension pathogenesis	"Pulmonary hypertension in scimitar syndrome arises from multiple converging factors. The left-to-right shunt from anomalous venous drainage produces pulmonary overcirculation; right lung hypoplasia reduces the pulmonary vascular bed; anomalous systemic arterial supply adds high-pressure systemic inflow; and stenosis or obstruction of the scimitar vein elevates post-capillary pressure. These factors drive vascular remodeling including endothelial dysfunction and smooth muscle cell hypertrophy in small pulmonary arteries. Pulmonary hypertension is the major determinant of prognosis, especially in infants.
"	cell_types[1]	cell_types	cell_types			Blood vessel smooth muscle cell	CL:0019018	blood vessel smooth muscle cell		"{""preferred_term"": ""Blood vessel smooth muscle cell"", ""term"": {""id"": ""CL:0019018"", ""label"": ""blood vessel smooth muscle cell""}}"																											
6305	6967	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	5	Associated atrial septal defect	"Atrial septal defect (ASD) is one of the most common cardiac malformations associated with scimitar syndrome, reported in approximately 18-43% of cases. ASD compounds the left-to-right shunt already present from the anomalous pulmonary venous drainage, increasing right heart volume overload. ASD may mask the diagnosis of scimitar syndrome by providing an apparent explanation for the shunt on echocardiography.
"	locations[0]	locations	locations			Interatrial septum	UBERON:0002085	interatrial septum		"{""preferred_term"": ""Interatrial septum"", ""term"": {""id"": ""UBERON:0002085"", ""label"": ""interatrial septum""}}"																											
6306	6968	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	6	Associated ventricular septal defect	"Ventricular septal defect (VSD) is reported in approximately 27% of scimitar syndrome cases, creating an additional left-to-right shunt at the ventricular level. Combined with the anomalous pulmonary venous drainage, VSD further increases pulmonary blood flow and the risk of pulmonary hypertension.
"	locations[0]	locations	locations			Interventricular septum	UBERON:0002094	interventricular septum		"{""preferred_term"": ""Interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}"																											
6307	6969	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	7	Patent ductus arteriosus and aortic arch anomalies	"Patent ductus arteriosus (PDA) and coarctation of the aorta are reported in a subset of scimitar syndrome cases. PDA provides an additional left-to-right shunt at the great vessel level, while coarctation may increase afterload and complicate surgical management. These great vessel anomalies are more common in the infantile form.
"	locations[0]	locations	locations			Ductus arteriosus	UBERON:0005440	ductus arteriosus		"{""preferred_term"": ""Ductus arteriosus"", ""term"": {""id"": ""UBERON:0005440"", ""label"": ""ductus arteriosus""}}"																											
6308	6969	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	7	Patent ductus arteriosus and aortic arch anomalies	"Patent ductus arteriosus (PDA) and coarctation of the aorta are reported in a subset of scimitar syndrome cases. PDA provides an additional left-to-right shunt at the great vessel level, while coarctation may increase afterload and complicate surgical management. These great vessel anomalies are more common in the infantile form.
"	locations[1]	locations	locations			Arch of aorta	UBERON:0001508	arch of aorta		"{""preferred_term"": ""Arch of aorta"", ""term"": {""id"": ""UBERON:0001508"", ""label"": ""arch of aorta""}}"																											
6309	6970	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	8	Complex congenital heart disease	"A subset of scimitar syndrome patients, particularly those presenting in infancy, have complex congenital heart disease including tetralogy of Fallot, single ventricle physiology, double outlet right ventricle, or heterotaxy. Single ventricle physiology carries particularly poor prognosis. Complex CHD is significantly more common in the infantile form and is an independent predictor of mortality.
"	locations[0]	locations	locations			Heart	UBERON:0000948	heart		"{""preferred_term"": ""Heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}"																											
6336	7006	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	0	Bony Dehiscence of Semicircular Canal	An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger.	locations[0]	locations	locations			superior semicircular canal	UBERON:0001841	anterior semicircular canal		"{""preferred_term"": ""superior semicircular canal"", ""term"": {""id"": ""UBERON:0001841"", ""label"": ""anterior semicircular canal""}}"																											
6337	7006	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	0	Bony Dehiscence of Semicircular Canal	An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger.	locations[1]	locations	locations			otic capsule	UBERON:0005411	bony otic capsule		"{""preferred_term"": ""otic capsule"", ""term"": {""id"": ""UBERON:0005411"", ""label"": ""bony otic capsule""}}"																											
6338	7007	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	1	Third Window Effect	The dehiscence acts as a third mobile window that shunts acoustic energy away from the cochlea and toward the vestibular system. A third window introduces a low mechanical impedance, shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window.	biological_processes[0]	biological_processes	biological_processes			mechanotransduction	GO:0050957	sensory perception of sound		"{""preferred_term"": ""mechanotransduction"", ""term"": {""id"": ""GO:0050957"", ""label"": ""sensory perception of sound""}}"																											
6339	7007	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	1	Third Window Effect	The dehiscence acts as a third mobile window that shunts acoustic energy away from the cochlea and toward the vestibular system. A third window introduces a low mechanical impedance, shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window.	biological_processes[1]	biological_processes	biological_processes			vestibular receptor stimulus detection	GO:0050911	vestibular receptor cell stimulus detection		"{""preferred_term"": ""vestibular receptor stimulus detection"", ""term"": {""id"": ""GO:0050911"", ""label"": ""vestibular receptor cell stimulus detection""}}"																											
6340	7008	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	2	Abnormal Sound and Pressure Transmission	Sounds and pressure changes that normally would not affect the vestibular system can now stimulate the superior semicircular canal, leading to vestibular symptoms triggered by loud sounds (Tullio phenomenon) or pressure changes (Hennebert sign). Sound energy diverted toward the dehiscence generates pressure differences across the membranous vestibular labyrinth that excite traveling waves.	cell_types[0]	cell_types	cell_types			vestibular hair cell	CL:0000609	vestibular hair cell		"{""preferred_term"": ""vestibular hair cell"", ""term"": {""id"": ""CL:0000609"", ""label"": ""vestibular hair cell""}}"																											
6341	7009	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	3	Otic Capsule Bone Biology	The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption.	cell_types[0]	cell_types	cell_types			osteoclast	CL:0000092	osteoclast		"{""preferred_term"": ""osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}"																											
6342	7009	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	3	Otic Capsule Bone Biology	The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption.	cell_types[1]	cell_types	cell_types			osteoblast	CL:0000062	osteoblast		"{""preferred_term"": ""osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}"																											
6343	7009	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	3	Otic Capsule Bone Biology	The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption.	biological_processes[0]	biological_processes	biological_processes			bone remodeling	GO:0046849	bone remodeling		"{""preferred_term"": ""bone remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}"																											
6358	7030	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	0	AGK loss of function disrupts lipid signaling	"Loss of functional AGK impairs lipid signaling activity attributed to mitochondrial acylglycerol kinase.
"	biological_processes[0]	biological_processes	biological_processes			phosphatidic acid metabolic process	GO:0046473	phosphatidic acid metabolic process		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""phosphatidic acid metabolic process"", ""term"": {""id"": ""GO:0046473"", ""label"": ""phosphatidic acid metabolic process""}}"			DYSREGULATED																								
6359	7031	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	1	TIM22 complex assembly defect	"Disrupted TIM22 complex assembly at the mitochondrial inner membrane impairs the carrier protein import machinery.
"	cellular_components[0]	cellular_components	cellular_components			mitochondrial inner membrane	GO:0005743	mitochondrial inner membrane		"{""preferred_term"": ""mitochondrial inner membrane"", ""term"": {""id"": ""GO:0005743"", ""label"": ""mitochondrial inner membrane""}}"																											
6360	7032	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	2	Reduced TIM22-mediated import of inner-membrane carrier proteins	"Disruption of the TIM22 complex reduces import of multi-pass carrier proteins and sideroflexins into the inner mitochondrial membrane.
"	biological_processes[0]	biological_processes	biological_processes			protein insertion into mitochondrial inner membrane	GO:0045039	protein insertion into mitochondrial inner membrane		"{""modifier"": ""DECREASED"", ""preferred_term"": ""protein insertion into mitochondrial inner membrane"", ""term"": {""id"": ""GO:0045039"", ""label"": ""protein insertion into mitochondrial inner membrane""}}"			DECREASED																								
6361	7033	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	3	Impaired mitochondrial one-carbon metabolism	"Reduced abundance of sideroflexins and one-carbon enzymes disrupts mitochondrial one-carbon metabolism.
"	biological_processes[0]	biological_processes	biological_processes			one-carbon metabolic process	GO:0006730	one-carbon metabolic process		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""one-carbon metabolic process"", ""term"": {""id"": ""GO:0006730"", ""label"": ""one-carbon metabolic process""}}"			DYSREGULATED																								
6362	7034	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	4	Disrupted mitochondrial phospholipid metabolism	"AGK loss alters phospholipid metabolism in mitochondrial membranes, contributing to disease pathogenesis.
"	biological_processes[0]	biological_processes	biological_processes			phospholipid metabolic process	GO:0006644	phospholipid metabolic process		"{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""phospholipid metabolic process"", ""term"": {""id"": ""GO:0006644"", ""label"": ""phospholipid metabolic process""}}"			DYSREGULATED																								
6363	7035	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	5	Oxidative phosphorylation deficiency	"Impaired respiratory chain function with reduced complex I and V activity and decreased oxygen consumption in patient cells.
"	biological_processes[0]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"			DECREASED																								
6405	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	cell_types[0]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
6406	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	cell_types[1]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6407	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	biological_processes[0]	biological_processes	biological_processes			type III protein secretion system	GO:0030257	type III protein secretion system		"{""preferred_term"": ""type III protein secretion system"", ""term"": {""id"": ""GO:0030257"", ""label"": ""type III protein secretion system""}}"																											
6408	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	biological_processes[1]	biological_processes	biological_processes			pyroptosis	GO:0070269	pyroptosis		"{""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}"																											
6409	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	biological_processes[2]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
6410	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
6411	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"	locations[1]	locations	locations			small intestine	UBERON:0002116	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}"																											
6412	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"	cell_types[0]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
6413	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"	cell_types[1]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6414	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"	biological_processes[0]	biological_processes	biological_processes			actin filament polymerization	GO:0030041	actin filament polymerization		"{""preferred_term"": ""actin filament polymerization"", ""term"": {""id"": ""GO:0030041"", ""label"": ""actin filament polymerization""}}"																											
6415	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"	biological_processes[1]	biological_processes	biological_processes			regulation of cell shape	GO:0008360	regulation of cell shape		"{""preferred_term"": ""regulation of cell shape"", ""term"": {""id"": ""GO:0008360"", ""label"": ""regulation of cell shape""}}"																											
6416	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
6417	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6418	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	cell_types[1]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
6419	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	biological_processes[0]	biological_processes	biological_processes			inflammasome complex	GO:0061702	inflammasome complex		"{""preferred_term"": ""inflammasome complex"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex""}}"																											
6420	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	biological_processes[1]	biological_processes	biological_processes			pyroptosis	GO:0070269	pyroptosis		"{""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}"																											
6421	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	biological_processes[2]	biological_processes	biological_processes			inflammatory response to bacterium	GO:0009626	inflammatory response to bacterium		"{""preferred_term"": ""inflammatory response to bacterium"", ""term"": {""id"": ""GO:0009626"", ""label"": ""inflammatory response to bacterium""}}"																											
6422	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"	locations[0]	locations	locations			colon	UBERON:0001155	colon		"{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}"																											
6423	7072	304	Shigellosis	Shigellosis.yaml	pathophysiology	3	Bacterial toxin production and endothelial damage	"Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.
"	biological_processes[0]	biological_processes	biological_processes			translation	GO:0006412	translation		"{""preferred_term"": ""translation"", ""term"": {""id"": ""GO:0006412"", ""label"": ""translation""}}"																											
6424	7072	304	Shigellosis	Shigellosis.yaml	pathophysiology	3	Bacterial toxin production and endothelial damage	"Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.
"	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
6425	7072	304	Shigellosis	Shigellosis.yaml	pathophysiology	3	Bacterial toxin production and endothelial damage	"Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.
"	cell_types[0]	cell_types	cell_types			blood vessel endothelial cell	CL:0000071	blood vessel endothelial cell		"{""preferred_term"": ""blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}"																											
6426	7073	304	Shigellosis	Shigellosis.yaml	pathophysiology	4	Intestinal barrier dysfunction and increased permeability	"Invasion and destruction of intestinal epithelium compromises the intestinal barrier function. Loss of epithelial cell integrity increases paracellular transport and bacterial translocation. This leads to increased fluid secretion, electrolyte loss, and systemic bacterial dissemination.
"	biological_processes[0]	biological_processes	biological_processes			tight junction assembly	GO:0070830	bicellular tight junction assembly		"{""preferred_term"": ""tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""bicellular tight junction assembly""}}"																											
6427	7073	304	Shigellosis	Shigellosis.yaml	pathophysiology	4	Intestinal barrier dysfunction and increased permeability	"Invasion and destruction of intestinal epithelium compromises the intestinal barrier function. Loss of epithelial cell integrity increases paracellular transport and bacterial translocation. This leads to increased fluid secretion, electrolyte loss, and systemic bacterial dissemination.
"	biological_processes[1]	biological_processes	biological_processes			ion transport	GO:0006811	ion transport		"{""preferred_term"": ""ion transport"", ""term"": {""id"": ""GO:0006811"", ""label"": ""ion transport""}}"																											
6436	7095	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	0	Hemoglobin Polymerization	"Deoxygenated HbS polymerizes into rigid fibers, deforming red blood cells into sickle shape. HbS has glutamic acid to valine substitution at position 6 of beta-globin.
"	biological_processes[0]	biological_processes	biological_processes			Protein Polymerization	GO:0051258	protein polymerization		"{""preferred_term"": ""Protein Polymerization"", ""term"": {""id"": ""GO:0051258"", ""label"": ""protein polymerization""}}"																											
6437	7096	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	1	Red Blood Cell Sickling	"Sickled RBCs are rigid and fragile, leading to hemolytic anemia and shortened RBC lifespan (10-20 days vs normal 120 days).
"	cell_types[0]	cell_types	cell_types			Red Blood Cell	CL:0000232	erythrocyte		"{""preferred_term"": ""Red Blood Cell"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}"																											
6438	7096	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	1	Red Blood Cell Sickling	"Sickled RBCs are rigid and fragile, leading to hemolytic anemia and shortened RBC lifespan (10-20 days vs normal 120 days).
"	biological_processes[0]	biological_processes	biological_processes			Hemolysis	GO:0030218	erythrocyte differentiation		"{""preferred_term"": ""Hemolysis"", ""term"": {""id"": ""GO:0030218"", ""label"": ""erythrocyte differentiation""}}"																											
6439	7097	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	2	Vaso-Occlusion	"Sickled cells adhere to vascular endothelium and obstruct microcirculation, causing tissue ischemia and pain crises. Inflammation amplifies adhesion.
"	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
6440	7097	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	2	Vaso-Occlusion	"Sickled cells adhere to vascular endothelium and obstruct microcirculation, causing tissue ischemia and pain crises. Inflammation amplifies adhesion.
"	biological_processes[0]	biological_processes	biological_processes			Cell Adhesion	GO:0007155	cell adhesion		"{""preferred_term"": ""Cell Adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}"																											
6441	7099	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	4	Chronic Organ Damage	"Repeated vaso-occlusion and ischemia-reperfusion injury cause progressive damage to spleen, kidneys, lungs, and brain.
"	biological_processes[0]	biological_processes	biological_processes			Tissue Damage	GO:0006954	inflammatory response		"{""preferred_term"": ""Tissue Damage"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
6451	7120	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	1	Maxillary Sinus Atelectasis	Progressive collapse and inward retraction of the maxillary sinus walls due to chronic negative pressure within the sinus cavity. The gas resorption causes negative pressure, which leads to osteopenia, bone remodeling, and sinus wall retraction.	locations[0]	locations	locations			maxillary sinus	UBERON:0001764	maxillary sinus		"{""preferred_term"": ""maxillary sinus"", ""term"": {""id"": ""UBERON:0001764"", ""label"": ""maxillary sinus""}}"																											
6457	7138	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	0	Exocrine Gland Lymphocytic Infiltration	CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
6458	7138	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	0	Exocrine Gland Lymphocytic Infiltration	CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction.	cell_types[1]	cell_types	cell_types			B Cell	CL:0000236	B cell		"{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6459	7138	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	0	Exocrine Gland Lymphocytic Infiltration	CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction.	biological_processes[0]	biological_processes	biological_processes			Adaptive Immune Response	GO:0002250	adaptive immune response		"{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}"																											
6460	7139	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	1	Autoantibody Production	Characteristic autoantibodies include anti-Ro/SSA and anti-La/SSB, which target ribonucleoprotein complexes. These antibodies serve as diagnostic markers and may contribute to tissue damage through immune complex formation.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
6461	7140	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	2	Type I Interferon Signature	Elevated type I interferon activity drives disease pathogenesis through activation of plasmacytoid dendritic cells and upregulation of interferon-stimulated genes in affected tissues.	biological_processes[0]	biological_processes	biological_processes			Type I Interferon Response	GO:0034340	response to type I interferon		"{""preferred_term"": ""Type I Interferon Response"", ""term"": {""id"": ""GO:0034340"", ""label"": ""response to type I interferon""}}"																											
6462	7141	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	3	Epithelial Cell Dysfunction	Salivary and lacrimal gland epithelial cells exhibit intrinsic abnormalities including aberrant apoptosis, antigen presentation via MHC class II, and production of pro-inflammatory cytokines including BAFF.	cell_types[0]	cell_types	cell_types			Epithelial Cell	CL:0000066	epithelial cell		"{""preferred_term"": ""Epithelial Cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}"																											
6463	7141	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	3	Epithelial Cell Dysfunction	Salivary and lacrimal gland epithelial cells exhibit intrinsic abnormalities including aberrant apoptosis, antigen presentation via MHC class II, and production of pro-inflammatory cytokines including BAFF.	biological_processes[0]	biological_processes	biological_processes			Apoptotic Process	GO:0006915	apoptotic process		"{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
6470	7163	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	0	TP53 Inactivation	TP53 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of p53 function eliminates the G1/S checkpoint and apoptotic response to DNA damage, enabling survival despite genomic instability.	cell_types[0]	cell_types	cell_types			type II pneumocyte	CL:0002063	pulmonary alveolar type 2 cell		"{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}"																											
6471	7163	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	0	TP53 Inactivation	TP53 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of p53 function eliminates the G1/S checkpoint and apoptotic response to DNA damage, enabling survival despite genomic instability.	biological_processes[0]	biological_processes	biological_processes			DNA damage response, signal transduction by p53 class mediator	GO:0030330	DNA damage response, signal transduction by p53 class mediator		"{""modifier"": ""ABSENT"", ""preferred_term"": ""DNA damage response, signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0030330"", ""label"": ""DNA damage response, signal transduction by p53 class mediator""}}"			ABSENT																								
6472	7164	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	1	RB1 Inactivation	RB1 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of Rb function eliminates the G1/S checkpoint by releasing E2F transcription factors, enabling uncontrolled S-phase entry.	biological_processes[0]	biological_processes	biological_processes			negative regulation of G1/S transition of mitotic cell cycle	GO:0045736	negative regulation of G1/S transition of mitotic cell cycle		"{""modifier"": ""ABSENT"", ""preferred_term"": ""negative regulation of G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0045736"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}"			ABSENT																								
6473	7165	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	2	Loss of Cell Cycle Checkpoints	Combined TP53 and RB1 loss eliminates major cell cycle checkpoints. Cells proliferate rapidly without the normal restraints on replication. This explains the rapid doubling time and initial chemosensitivity (dividing cells are vulnerable to chemotherapy).	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
6474	7166	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Genomic Instability	Loss of TP53 and RB1 leads to widespread genomic instability with frequent chromosomal gains and losses. Amplification of MYC family genes (MYC, MYCL, MYCN) occurs in ~20% of SCLC and is associated with worse prognosis.	biological_processes[0]	biological_processes	biological_processes			DNA repair	GO:0006281	DNA repair		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}"			ABNORMAL																								
6475	7167	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	4	Neuroendocrine Differentiation	SCLC cells exhibit neuroendocrine differentiation, expressing markers such as synaptophysin, chromogranin A, and CD56 (NCAM). Neuroendocrine phenotype is regulated by lineage transcription factors (ASCL1, NEUROD1). Some SCLC produces paraneoplastic hormones (ACTH, ADH).	biological_processes[0]	biological_processes	biological_processes			neuron differentiation	GO:0030182	neuron differentiation		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""neuron differentiation"", ""term"": {""id"": ""GO:0030182"", ""label"": ""neuron differentiation""}}"			ABNORMAL																								
6476	7168	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	5	Functional Neuron-SCLC Synapses	SCLC cells can form functional synapses with neurons and receive synaptic transmission.	biological_processes[0]	biological_processes	biological_processes			synapse assembly	GO:0007416	synapse assembly		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""synapse assembly"", ""term"": {""id"": ""GO:0007416"", ""label"": ""synapse assembly""}}"			ABNORMAL																								
6477	7168	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	5	Functional Neuron-SCLC Synapses	SCLC cells can form functional synapses with neurons and receive synaptic transmission.	biological_processes[1]	biological_processes	biological_processes			chemical synaptic transmission	GO:0007268	chemical synaptic transmission		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"			ABNORMAL																								
6478	7169	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	6	Neuron-Driven Proliferation	SCLC cells gain a proliferation advantage when co-cultured with neurons.	biological_processes[0]	biological_processes	biological_processes			positive regulation of cell population proliferation	GO:0008284	positive regulation of cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of cell population proliferation"", ""term"": {""id"": ""GO:0008284"", ""label"": ""positive regulation of cell population proliferation""}}"			INCREASED																								
6479	7170	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	7	Glutamate Signaling Dependency	Inhibition of glutamate signaling has therapeutic efficacy in SCLC models, implicating glutamatergic signaling in tumor growth.	biological_processes[0]	biological_processes	biological_processes			glutamate receptor signaling pathway	GO:0007215	glutamate receptor signaling pathway		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""glutamate receptor signaling pathway"", ""term"": {""id"": ""GO:0007215"", ""label"": ""glutamate receptor signaling pathway""}}"			ABNORMAL																								
6480	7170	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	7	Glutamate Signaling Dependency	Inhibition of glutamate signaling has therapeutic efficacy in SCLC models, implicating glutamatergic signaling in tumor growth.	biological_processes[1]	biological_processes	biological_processes			synaptic transmission, glutamatergic	GO:0035249	synaptic transmission, glutamatergic		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""synaptic transmission, glutamatergic"", ""term"": {""id"": ""GO:0035249"", ""label"": ""synaptic transmission, glutamatergic""}}"			ABNORMAL																								
6492	7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	Bacterial overgrowth in small intestine	"Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.
"	biological_processes[0]	biological_processes	biological_processes			response to bile acid	GO:0033993	response to bile acid		"{""preferred_term"": ""response to bile acid"", ""term"": {""id"": ""GO:0033993"", ""label"": ""response to bile acid""}}"																											
6493	7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	Bacterial overgrowth in small intestine	"Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.
"	biological_processes[1]	biological_processes	biological_processes			tight junction assembly	GO:0070830	tight junction assembly		"{""preferred_term"": ""tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""tight junction assembly""}}"																											
6494	7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	Bacterial overgrowth in small intestine	"Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.
"	cell_types[0]	cell_types	cell_types			enterocyte	CL:0000584	enterocyte		"{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}"																											
6495	7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	Bacterial overgrowth in small intestine	"Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.
"	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
6519	7215	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	0	SMN Protein Deficiency	"Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.
"	cell_types[0]	cell_types	cell_types			Motor Neuron	CL:0000100	motor neuron		"{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}"																											
6520	7215	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	0	SMN Protein Deficiency	"Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.
"	biological_processes[0]	biological_processes	biological_processes			Motor Neuron Development	GO:0048666	neuron development		"{""preferred_term"": ""Motor Neuron Development"", ""term"": {""id"": ""GO:0048666"", ""label"": ""neuron development""}}"																											
6521	7216	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	1	Motor Neuron Degeneration	"Loss of alpha motor neurons in the anterior horn of the spinal cord leads to progressive denervation of skeletal muscles. Proximal muscles are more severely affected than distal muscles.
"	cell_types[0]	cell_types	cell_types			Motor Neuron	CL:0000100	motor neuron		"{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}"																											
6522	7216	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	1	Motor Neuron Degeneration	"Loss of alpha motor neurons in the anterior horn of the spinal cord leads to progressive denervation of skeletal muscles. Proximal muscles are more severely affected than distal muscles.
"	biological_processes[0]	biological_processes	biological_processes			Neurodegeneration	GO:0070997	neuron death		"{""preferred_term"": ""Neurodegeneration"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}"																											
6529	7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6530	7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.
"	cell_types[1]	cell_types	cell_types			Growth Plate Chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
6531	7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
6532	7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.
"	biological_processes[1]	biological_processes	biological_processes			Endochondral Ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral Ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
6545	7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6546	7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"	cell_types[1]	cell_types	cell_types			Growth Plate Chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
6547	7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
6548	7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"	biological_processes[1]	biological_processes	biological_processes			Cartilage Development	GO:0051216	cartilage development		"{""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}"																											
6549	7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"	biological_processes[2]	biological_processes	biological_processes			Endochondral Ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral Ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
6550	7247	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	1	Vitreous Collagen Abnormality	"Type II collagen is a major component of the vitreous humor. Abnormal collagen leads to vitreous liquefaction, posterior vitreous detachment, and increased risk of retinal detachment.
"	biological_processes[0]	biological_processes	biological_processes			Eye Development	GO:0001654	eye development		"{""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}"																											
6563	7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	Type II Collagen Haploinsufficiency	"Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6564	7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	Type II Collagen Haploinsufficiency	"Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.
"	biological_processes[0]	biological_processes	biological_processes			Collagen Biosynthesis	GO:0032964	collagen biosynthetic process		"{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}"																											
6565	7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	Type II Collagen Haploinsufficiency	"Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.
"	biological_processes[1]	biological_processes	biological_processes			Eye Development	GO:0001654	eye development		"{""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}"																											
6566	7265	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	1	Vitreous Collagen Abnormality	"Type II collagen is essential for vitreous structure. Reduced collagen leads to vitreous liquefaction with characteristic membranous remnants visible on slit-lamp examination, posterior vitreous detachment, and increased retinal detachment risk.
"	biological_processes[0]	biological_processes	biological_processes			Eye Development	GO:0001654	eye development		"{""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}"																											
6578	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	GABAergic Inhibition Impairment	Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing.	cell_types[0]	cell_types	cell_types			GABAergic Interneuron	CL:0011005	GABAergic interneuron		"{""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0011005"", ""label"": ""GABAergic interneuron""}}"																											
6579	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	GABAergic Inhibition Impairment	Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing.	cell_types[1]	cell_types	cell_types			Purkinje cell	CL:0000121	Purkinje cell		"{""preferred_term"": ""Purkinje cell"", ""term"": {""id"": ""CL:0000121"", ""label"": ""Purkinje cell""}}"																											
6580	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	GABAergic Inhibition Impairment	Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing.	biological_processes[0]	biological_processes	biological_processes			GABAergic synaptic transmission	GO:0051932	synaptic transmission, GABAergic		"{""preferred_term"": ""GABAergic synaptic transmission"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}"																											
6581	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	GABAergic Inhibition Impairment	Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing.	biological_processes[1]	biological_processes	biological_processes			Inhibitory chemical synaptic transmission	GO:0098977	inhibitory chemical synaptic transmission		"{""preferred_term"": ""Inhibitory chemical synaptic transmission"", ""term"": {""id"": ""GO:0098977"", ""label"": ""inhibitory chemical synaptic transmission""}}"																											
6582	7287	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	1	Loss of Reciprocal Inhibition	Failure of GABAergic interneurons to inhibit antagonist motor neurons during voluntary movement, resulting in co-contraction of opposing muscle groups and the characteristic rigid posture.	cell_types[0]	cell_types	cell_types			Motor Neuron	CL:0000100	motor neuron		"{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}"																											
6583	7288	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	2	Intrathecal B-cell Autoimmunity	B-cell-mediated autoimmune inflammation with clonal B-cell activation specifically within the central nervous system. Approximately 67% of patients demonstrate oligoclonal IgG bands in the CSF, and 85% exhibit increased GAD65-specific IgG index values, indicating intrathecal antibody synthesis.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6596	7307	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	0	SS18-SSX Fusion Oncogene	The t(X;18)(p11;q11) translocation fuses the SS18 gene on chromosome 18 to one of three SSX genes (SSX1, SSX2, or rarely SSX4) on the X chromosome. The SS18-SSX fusion protein disrupts the BAF (SWI/SNF) chromatin remodeling complex, leading to aberrant transcriptional regulation and epigenetic reprogramming.	biological_processes[0]	biological_processes	biological_processes			chromatin remodeling	GO:0006338	chromatin remodeling		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}"			ABNORMAL																								
6597	7308	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	1	BAF Complex Disruption	The SS18-SSX fusion protein incorporates into the BAF chromatin remodeling complex, displacing wild-type SS18. This alters BAF complex targeting and function, particularly affecting polycomb-mediated gene repression. The fusion protein causes eviction of BAF47 (SMARCB1) from the complex at certain genomic loci.	biological_processes[0]	biological_processes	biological_processes			regulation of gene expression	GO:0010468	regulation of gene expression		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}"			ABNORMAL																								
6598	7309	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	2	Epigenetic Reprogramming	SS18-SSX-containing BAF complexes fail to properly oppose polycomb repressive complexes, leading to abnormal silencing of tumor suppressors and activation of oncogenic programs. Key target genes include BCL2 (antiapoptotic) and multiple receptor tyrosine kinases.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"			DECREASED																								
6612	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	Formation of Immune Complexes		cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6613	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	Formation of Immune Complexes		cell_types[1]	cell_types	cell_types			plasma cell	CL:0000786	plasma cell		"{""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}"																											
6614	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	Formation of Immune Complexes		cell_types[2]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6615	7341	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	1	Glomerular Immune Complex Deposition	"Circulating immune complexes containing anti-dsDNA and anti-Sm antibodies lodge in kidney glomeruli, activating complement and recruiting inflammatory cells.
"	locations[0]	locations	locations			Kidney	UBERON:0002113	kidney		"{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
6616	7341	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	1	Glomerular Immune Complex Deposition	"Circulating immune complexes containing anti-dsDNA and anti-Sm antibodies lodge in kidney glomeruli, activating complement and recruiting inflammatory cells.
"	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
6617	7342	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	2	Cutaneous Immune Complex Deposition	"Immune complexes deposit at the dermal-epidermal junction and in vessel walls of the skin, leading to cutaneous manifestations of lupus.
"	locations[0]	locations	locations			Skin	UBERON:0002097	skin of body		"{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
6618	7342	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	2	Cutaneous Immune Complex Deposition	"Immune complexes deposit at the dermal-epidermal junction and in vessel walls of the skin, leading to cutaneous manifestations of lupus.
"	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
6619	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	Synovial Immune Complex Deposition	"Immune complexes accumulate in synovial fluid and tissue of joints, activating complement and triggering inflammatory arthritis.
"	locations[0]	locations	locations			Skeletal Joint	UBERON:0000982	skeletal joint		"{""preferred_term"": ""Skeletal Joint"", ""term"": {""id"": ""UBERON:0000982"", ""label"": ""skeletal joint""}}"																											
6620	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	Synovial Immune Complex Deposition	"Immune complexes accumulate in synovial fluid and tissue of joints, activating complement and triggering inflammatory arthritis.
"	biological_processes[0]	biological_processes	biological_processes			complement activation	GO:0006956	complement activation		"{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}"																											
6621	7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	Type I Interferon Pathway Activation	Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response.	cell_types[0]	cell_types	cell_types			plasmacytoid dendritic cell	CL:0000784	plasmacytoid dendritic cell		"{""preferred_term"": ""plasmacytoid dendritic cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}"																											
6622	7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	Type I Interferon Pathway Activation	Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response.	cell_types[1]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6623	7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	Type I Interferon Pathway Activation	Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response.	cell_types[2]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
6624	7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	Type I Interferon Pathway Activation	Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response.	biological_processes[0]	biological_processes	biological_processes			type I interferon signaling pathway	GO:0060337	type I interferon signaling pathway		"{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}"																											
6625	7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6626	7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.	cell_types[1]	cell_types	cell_types			plasmacytoid dendritic cell	CL:0000784	plasmacytoid dendritic cell		"{""preferred_term"": ""plasmacytoid dendritic cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}"																											
6627	7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.	biological_processes[0]	biological_processes	biological_processes			toll-like receptor signaling pathway	GO:0002224	toll-like receptor signaling pathway		"{""preferred_term"": ""toll-like receptor signaling pathway"", ""term"": {""id"": ""GO:0002224"", ""label"": ""toll-like receptor signaling pathway""}}"																											
6628	7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.	biological_processes[1]	biological_processes	biological_processes			toll-like receptor 7 signaling pathway	GO:0034154	toll-like receptor 7 signaling pathway		"{""preferred_term"": ""toll-like receptor 7 signaling pathway"", ""term"": {""id"": ""GO:0034154"", ""label"": ""toll-like receptor 7 signaling pathway""}}"																											
6629	7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.	biological_processes[2]	biological_processes	biological_processes			toll-like receptor 9 signaling pathway	GO:0034162	toll-like receptor 9 signaling pathway		"{""preferred_term"": ""toll-like receptor 9 signaling pathway"", ""term"": {""id"": ""GO:0034162"", ""label"": ""toll-like receptor 9 signaling pathway""}}"																											
6630	7349	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	9	NETosis and Neutrophil Extracellular Trap Formation	Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis.	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6631	7349	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	9	NETosis and Neutrophil Extracellular Trap Formation	Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis.	biological_processes[0]	biological_processes	biological_processes			neutrophil degranulation	GO:0043312	neutrophil degranulation		"{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}"																											
6632	7349	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	9	NETosis and Neutrophil Extracellular Trap Formation	Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis.	biological_processes[1]	biological_processes	biological_processes			neutrophil extracellular trap formation	GO:0036230	neutrophil extracellular trap formation		"{""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0036230"", ""label"": ""neutrophil extracellular trap formation""}}"																											
6633	7350	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	10	Age-Associated B Cell Expansion	Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production.	cell_types[0]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6634	7350	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	10	Age-Associated B Cell Expansion	Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production.	biological_processes[0]	biological_processes	biological_processes			B cell activation	GO:0042113	B cell activation		"{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}"																											
6635	7350	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	10	Age-Associated B Cell Expansion	Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production.	biological_processes[1]	biological_processes	biological_processes			B cell differentiation	GO:0030183	B cell differentiation		"{""preferred_term"": ""B cell differentiation"", ""term"": {""id"": ""GO:0030183"", ""label"": ""B cell differentiation""}}"																											
6636	7351	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	11	T Follicular Helper Cell Dysregulation	T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways.	cell_types[0]	cell_types	cell_types			T follicular helper cell	CL:0002038	T follicular helper cell		"{""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}"																											
6637	7351	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	11	T Follicular Helper Cell Dysregulation	T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways.	cell_types[1]	cell_types	cell_types			T cell	CL:0000084	T cell		"{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
6638	7351	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	11	T Follicular Helper Cell Dysregulation	T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways.	biological_processes[0]	biological_processes	biological_processes			T cell activation	GO:0042110	T cell activation		"{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}"																											
6639	7351	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	11	T Follicular Helper Cell Dysregulation	T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways.	biological_processes[1]	biological_processes	biological_processes			germinal center formation	GO:0002467	germinal center formation		"{""preferred_term"": ""germinal center formation"", ""term"": {""id"": ""GO:0002467"", ""label"": ""germinal center formation""}}"																											
6640	7352	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	12	Impaired Apoptotic Cell Clearance	Defective clearance of apoptotic cells and impaired efferocytosis lead to increased exposure to nuclear antigens, propagating immune complex formation and autoantibody production.	biological_processes[0]	biological_processes	biological_processes			apoptotic cell clearance	GO:0043277	apoptotic cell clearance		"{""preferred_term"": ""apoptotic cell clearance"", ""term"": {""id"": ""GO:0043277"", ""label"": ""apoptotic cell clearance""}}"																											
6641	7352	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	12	Impaired Apoptotic Cell Clearance	Defective clearance of apoptotic cells and impaired efferocytosis lead to increased exposure to nuclear antigens, propagating immune complex formation and autoantibody production.	biological_processes[1]	biological_processes	biological_processes			efferocytosis	GO:0043277	apoptotic cell clearance		"{""preferred_term"": ""efferocytosis"", ""term"": {""id"": ""GO:0043277"", ""label"": ""apoptotic cell clearance""}}"																											
6642	7353	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	13	Complement Pathway Dysregulation	Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis.	biological_processes[0]	biological_processes	biological_processes			complement activation, classical pathway	GO:0006958	complement activation, classical pathway		"{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}"																											
6643	7353	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	13	Complement Pathway Dysregulation	Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis.	locations[0]	locations	locations			Kidney	UBERON:0002113	kidney		"{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
6644	7353	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	13	Complement Pathway Dysregulation	Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis.	locations[1]	locations	locations			Glomerulus	UBERON:0000074	renal glomerulus		"{""preferred_term"": ""Glomerulus"", ""term"": {""id"": ""UBERON:0000074"", ""label"": ""renal glomerulus""}}"																											
6661	7378	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	0	Vascular Injury and Endothelial Dysfunction	Early endothelial cell injury leads to vascular damage, intimal proliferation, and obliterative vasculopathy. Raynaud's phenomenon reflects vasospasm and structural vascular changes.	cell_types[0]	cell_types	cell_types			Endothelial Cell	CL:0000115	endothelial cell		"{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}"																											
6662	7378	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	0	Vascular Injury and Endothelial Dysfunction	Early endothelial cell injury leads to vascular damage, intimal proliferation, and obliterative vasculopathy. Raynaud's phenomenon reflects vasospasm and structural vascular changes.	biological_processes[0]	biological_processes	biological_processes			Blood Vessel Development	GO:0001568	blood vessel development		"{""preferred_term"": ""Blood Vessel Development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}"																											
6663	7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	Immune Activation and Autoantibody Production	Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines.	cell_types[0]	cell_types	cell_types			CD4+ T Cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
6664	7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	Immune Activation and Autoantibody Production	Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines.	cell_types[1]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6665	7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	Immune Activation and Autoantibody Production	Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines.	biological_processes[0]	biological_processes	biological_processes			Immunoglobulin Production	GO:0002377	immunoglobulin production		"{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}"																											
6666	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	Fibroblast Activation and Fibrosis	TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs.	cell_types[0]	cell_types	cell_types			Fibroblast	CL:0000057	fibroblast		"{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}"																											
6667	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	Fibroblast Activation and Fibrosis	TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs.	cell_types[1]	cell_types	cell_types			Myofibroblast	CL:0000186	myofibroblast cell		"{""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}"																											
6668	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	Fibroblast Activation and Fibrosis	TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs.	biological_processes[0]	biological_processes	biological_processes			Extracellular Matrix Organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""Extracellular Matrix Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
6669	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	Fibroblast Activation and Fibrosis	TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs.	biological_processes[1]	biological_processes	biological_processes			TGF-beta Signaling	GO:0007179	transforming growth factor beta receptor signaling pathway		"{""preferred_term"": ""TGF-beta Signaling"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}"																											
6674	7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	RBM10-mediated alternative splicing dysregulation	Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.	biological_processes[0]	biological_processes	biological_processes			Regulation of alternative mRNA splicing via spliceosome	GO:0000381	regulation of alternative mRNA splicing, via spliceosome		"{""preferred_term"": ""Regulation of alternative mRNA splicing via spliceosome"", ""term"": {""id"": ""GO:0000381"", ""label"": ""regulation of alternative mRNA splicing, via spliceosome""}}"																											
6675	7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	RBM10-mediated alternative splicing dysregulation	Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.	biological_processes[1]	biological_processes	biological_processes			Notch signaling pathway	GO:0007219	Notch signaling pathway		"{""preferred_term"": ""Notch signaling pathway"", ""term"": {""id"": ""GO:0007219"", ""label"": ""Notch signaling pathway""}}"																											
6676	7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	RBM10-mediated alternative splicing dysregulation	Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.	biological_processes[2]	biological_processes	biological_processes			Extracellular matrix organization	GO:0030198	extracellular matrix organization		"{""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}"																											
6677	7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	RBM10-mediated alternative splicing dysregulation	Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.	biological_processes[3]	biological_processes	biological_processes			Cytoskeleton organization	GO:0007010	cytoskeleton organization		"{""preferred_term"": ""Cytoskeleton organization"", ""term"": {""id"": ""GO:0007010"", ""label"": ""cytoskeleton organization""}}"																											
6678	7396	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	1	RBM10 splicing-independent replication fork dysfunction	RBM10 also functions in a splicing-independent manner at DNA replication forks, where it recruits HDAC1 to promote H4K16 deacetylation and maintains fork stability. Loss of RBM10 induces replication stress and creates synthetic-lethal interactions with WEE1 inhibition. This dual role provides additional pathological mechanisms affecting developmental processes through both transcriptional and chromosomal instability pathways.	biological_processes[0]	biological_processes	biological_processes			DNA replication	GO:0006268	DNA replication		"{""preferred_term"": ""DNA replication"", ""term"": {""id"": ""GO:0006268"", ""label"": ""DNA replication""}}"																											
6679	7396	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	1	RBM10 splicing-independent replication fork dysfunction	RBM10 also functions in a splicing-independent manner at DNA replication forks, where it recruits HDAC1 to promote H4K16 deacetylation and maintains fork stability. Loss of RBM10 induces replication stress and creates synthetic-lethal interactions with WEE1 inhibition. This dual role provides additional pathological mechanisms affecting developmental processes through both transcriptional and chromosomal instability pathways.	biological_processes[1]	biological_processes	biological_processes			H4-K16 deacetylation	GO:0043111	H4-K16 deacetylation		"{""preferred_term"": ""H4-K16 deacetylation"", ""term"": {""id"": ""GO:0043111"", ""label"": ""H4-K16 deacetylation""}}"																											
6701	7425	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	0	HEXA mutations	"Pathogenic variants in HEXA disrupt hexosaminidase A activity.
"	genes[0]	genes	genes			HEXA	hgnc:4878	HEXA		"{""preferred_term"": ""HEXA"", ""term"": {""id"": ""hgnc:4878"", ""label"": ""HEXA""}}"																											
6702	7426	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	1	Hexosaminidase A deficiency	"Lysosomal beta-hexosaminidase A enzyme activity is deficient in Tay-Sachs disease.
"	biological_processes[0]	biological_processes	biological_processes			ganglioside catabolic process	GO:0006689	ganglioside catabolic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""ganglioside catabolic process"", ""term"": {""id"": ""GO:0006689"", ""label"": ""ganglioside catabolic process""}}"			DECREASED																								
6703	7427	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	2	GM2 ganglioside accumulation in neurons	"GM2 ganglioside accumulates in neuronal lysosomes, particularly in the brain.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6704	7428	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	3	Neuron death	"Progressive neuronal loss occurs in the nervous system.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6705	7428	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	3	Neuron death	"Progressive neuronal loss occurs in the nervous system.
"	biological_processes[0]	biological_processes	biological_processes			neuron death	GO:0070997	neuron death		"{""preferred_term"": ""neuron death"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}"																											
6725	7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	Tetanus Toxin (Tetanospasmin) Action	"Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.
"	cell_types[0]	cell_types	cell_types			motor neuron	CL:0000100	motor neuron		"{""preferred_term"": ""motor neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}"																											
6726	7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	Tetanus Toxin (Tetanospasmin) Action	"Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.
"	biological_processes[0]	biological_processes	biological_processes			synaptic transmission, GABAergic	GO:0051932	synaptic transmission, GABAergic		"{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}"																											
6727	7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	Tetanus Toxin (Tetanospasmin) Action	"Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.
"	biological_processes[1]	biological_processes	biological_processes			synaptic transmission, glycinergic	GO:0060012	synaptic transmission, glycinergic		"{""preferred_term"": ""synaptic transmission, glycinergic"", ""term"": {""id"": ""GO:0060012"", ""label"": ""synaptic transmission, glycinergic""}}"																											
6728	7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	Tetanus Toxin (Tetanospasmin) Action	"Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.
"	biological_processes[2]	biological_processes	biological_processes			negative regulation of neurotransmitter secretion	GO:0046929	negative regulation of neurotransmitter secretion		"{""preferred_term"": ""negative regulation of neurotransmitter secretion"", ""term"": {""id"": ""GO:0046929"", ""label"": ""negative regulation of neurotransmitter secretion""}}"																											
6729	7446	323	Tetanus	Tetanus.yaml	pathophysiology	1	Autonomic Nervous System Dysfunction	"Tetanus toxin affects the autonomic nervous system, causing sympathetic overactivity that manifests as tachycardia, hypertension, arrhythmias, and hyperthermia. This autonomic instability is a major cause of morbidity and mortality in severe tetanus.
"	cell_types[0]	cell_types	cell_types			noradrenergic neuron	CL:0008025	noradrenergic neuron		"{""preferred_term"": ""noradrenergic neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}"																											
6730	7446	323	Tetanus	Tetanus.yaml	pathophysiology	1	Autonomic Nervous System Dysfunction	"Tetanus toxin affects the autonomic nervous system, causing sympathetic overactivity that manifests as tachycardia, hypertension, arrhythmias, and hyperthermia. This autonomic instability is a major cause of morbidity and mortality in severe tetanus.
"	biological_processes[0]	biological_processes	biological_processes			synaptic transmission, noradrenergic	GO:0099155	synaptic transmission, noradrenergic		"{""preferred_term"": ""synaptic transmission, noradrenergic"", ""term"": {""id"": ""GO:0099155"", ""label"": ""synaptic transmission, noradrenergic""}}"																											
6743	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	gene	gene	$	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	FGFR3	hgnc:3690	FGFR3	Fibroblast growth factor receptor 3 with severe gain-of-function mutations.	"{""description"": ""Fibroblast growth factor receptor 3 with severe gain-of-function mutations."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"			INCREASED																								
6744	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	cell_types[0]	cell_types	cell_types			Growth plate chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
6745	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	cell_types[1]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6746	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	biological_processes[0]	biological_processes	biological_processes			FGFR signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
6747	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	biological_processes[1]	biological_processes	biological_processes			Negative regulation of chondrocyte differentiation	GO:0032331	negative regulation of chondrocyte differentiation		"{""preferred_term"": ""Negative regulation of chondrocyte differentiation"", ""term"": {""id"": ""GO:0032331"", ""label"": ""negative regulation of chondrocyte differentiation""}}"																											
6748	7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"	biological_processes[2]	biological_processes	biological_processes			Endochondral ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
6749	7463	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	1	Pulmonary hypoplasia	"The severely narrow thorax restricts lung development in utero, resulting in pulmonary hypoplasia that is the primary cause of perinatal death due to respiratory insufficiency.
"	cell_types[0]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6750	7463	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	1	Pulmonary hypoplasia	"The severely narrow thorax restricts lung development in utero, resulting in pulmonary hypoplasia that is the primary cause of perinatal death due to respiratory insufficiency.
"	biological_processes[0]	biological_processes	biological_processes			Lung development	GO:0030324	lung development		"{""preferred_term"": ""Lung development"", ""term"": {""id"": ""GO:0030324"", ""label"": ""lung development""}}"																											
6760	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	gene	gene	$	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	FGFR3	hgnc:3690	FGFR3	Fibroblast growth factor receptor 3 with severe gain-of-function mutation in the kinase domain.	"{""description"": ""Fibroblast growth factor receptor 3 with severe gain-of-function mutation in the kinase domain."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}"			INCREASED																								
6761	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	cell_types[0]	cell_types	cell_types			Growth plate chondrocyte	CL:1000217	growth plate cartilage chondrocyte		"{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}"																											
6762	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	cell_types[1]	cell_types	cell_types			Chondrocyte	CL:0000138	chondrocyte		"{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}"																											
6763	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	biological_processes[0]	biological_processes	biological_processes			FGFR signaling pathway	GO:0008543	fibroblast growth factor receptor signaling pathway		"{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}"																											
6764	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	biological_processes[1]	biological_processes	biological_processes			Negative regulation of chondrocyte differentiation	GO:0032331	negative regulation of chondrocyte differentiation		"{""preferred_term"": ""Negative regulation of chondrocyte differentiation"", ""term"": {""id"": ""GO:0032331"", ""label"": ""negative regulation of chondrocyte differentiation""}}"																											
6765	7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"	biological_processes[2]	biological_processes	biological_processes			Endochondral ossification	GO:0001958	endochondral ossification		"{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}"																											
6766	7476	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	1	Premature craniosynostosis	"The FGFR3 K650E mutation affects cranial suture development, leading to the cloverleaf skull deformity (kleeblattschadel) seen in many TD2 cases. This involves premature fusion of multiple cranial sutures with compensatory bulging at patent sutures.
"	biological_processes[0]	biological_processes	biological_processes			Cranial suture morphogenesis	GO:0060363	cranial suture morphogenesis		"{""preferred_term"": ""Cranial suture morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}"																											
6779	7494	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	0	Melanocyte Activation	An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.	cell_types[0]	cell_types	cell_types			Melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""Melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
6780	7494	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	0	Melanocyte Activation	An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.	biological_processes[0]	biological_processes	biological_processes			pigmentation	GO:0043473	pigmentation		"{""preferred_term"": ""pigmentation"", ""term"": {""id"": ""GO:0043473"", ""label"": ""pigmentation""}}"																											
6781	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	Melanin Accumulation	Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin.	locations[0]	locations	locations			Epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""Epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
6782	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	locations[0]	locations	locations			Epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""Epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
6783	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6784	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	cell_types[1]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
6785	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	biological_processes[0]	biological_processes	biological_processes			neutrophil chemotaxis	GO:0030593	neutrophil chemotaxis		"{""preferred_term"": ""neutrophil chemotaxis"", ""term"": {""id"": ""GO:0030593"", ""label"": ""neutrophil chemotaxis""}}"																											
6786	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	biological_processes[1]	biological_processes	biological_processes			epidermis development	GO:0008544	epidermis development		"{""preferred_term"": ""epidermis development"", ""term"": {""id"": ""GO:0008544"", ""label"": ""epidermis development""}}"																											
6787	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.	biological_processes[2]	biological_processes	biological_processes			keratinization	GO:0031424	keratinization		"{""preferred_term"": ""keratinization"", ""term"": {""id"": ""GO:0031424"", ""label"": ""keratinization""}}"																											
6788	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	Hyper pigmentation	As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.	locations[0]	locations	locations			Skin	UBERON:0002097	skin of body		"{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
6789	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	Hyper pigmentation	As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.	locations[1]	locations	locations			skin of face	UBERON:0001456	skin of face		"{""preferred_term"": ""skin of face"", ""term"": {""id"": ""UBERON:0001456"", ""label"": ""skin of face""}}"																											
6790	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	Hyper pigmentation	As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.	locations[2]	locations	locations			neck	UBERON:0000974	neck		"{""preferred_term"": ""neck"", ""term"": {""id"": ""UBERON:0000974"", ""label"": ""neck""}}"																											
6791	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	Hyper pigmentation	As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.	locations[3]	locations	locations			back	UBERON:0002410	back		"{""preferred_term"": ""back"", ""term"": {""id"": ""UBERON:0002410"", ""label"": ""back""}}"																											
6792	7498	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	4	Desquamation	In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation.	locations[0]	locations	locations			Skin	UBERON:0002097	skin of body		"{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}"																											
6801	7514	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	0	Spinal Cord Inflammation	Focal inflammatory injury within the spinal cord disrupts motor and sensory pathways, leading to neurologic deficits.	locations[0]	locations	locations			spinal cord	UBERON:0002240	spinal cord		"{""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}"																											
6802	7514	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	0	Spinal Cord Inflammation	Focal inflammatory injury within the spinal cord disrupts motor and sensory pathways, leading to neurologic deficits.	biological_processes[0]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"			INCREASED																								
6803	7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	Immune-Mediated Neural Injury	In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury.	locations[0]	locations	locations			spinal cord	UBERON:0002240	spinal cord		"{""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}"																											
6804	7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	Immune-Mediated Neural Injury	In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury.	locations[1]	locations	locations			blood brain barrier	UBERON:0000120	blood brain barrier		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood brain barrier""}}"			ABNORMAL																								
6805	7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	Immune-Mediated Neural Injury	In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury.	cell_types[0]	cell_types	cell_types			neuron	CL:0000540	neuron		"{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
6806	7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	Immune-Mediated Neural Injury	In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury.	cellular_components[0]	cellular_components	cellular_components			myelin sheath	GO:0043209	myelin sheath		"{""modifier"": ""DECREASED"", ""preferred_term"": ""myelin sheath"", ""term"": {""id"": ""GO:0043209"", ""label"": ""myelin sheath""}}"			DECREASED																								
6817	7528	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	0	Ingestion of contaminated food or water during travel	Travelers ingest enteric pathogens through unsafe food and water, initiating diarrheal illness.	locations[0]	locations	locations			gastrointestinal tract	UBERON:0005409	gastrointestinal tract		"{""preferred_term"": ""gastrointestinal tract"", ""term"": {""id"": ""UBERON:0005409"", ""label"": ""gastrointestinal tract""}}"																											
6818	7529	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	1	ETEC adherence via colonization factors	Enterotoxigenic E. coli use colonization factors to adhere to intestinal epithelium and establish infection.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
6819	7530	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	2	Enterotoxin-driven secretory diarrhea	ETEC heat-labile and heat-stable enterotoxins bind epithelial receptors, driving chloride and water secretion and watery diarrhea.	locations[0]	locations	locations			small intestine	UBERON:0002108	small intestine		"{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}"																											
6842	7552	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	0	Loss of Hormone Receptor Signaling	TNBC lacks expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR), eliminating the growth-promoting effects of estrogen signaling that drive most breast cancers. This absence removes a key therapeutic target but also indicates fundamentally different tumor biology.	biological_processes[0]	biological_processes	biological_processes			estrogen receptor signaling pathway	GO:0030520	intracellular estrogen receptor signaling pathway		"{""modifier"": ""ABSENT"", ""preferred_term"": ""estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}"			ABSENT																								
6843	7553	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	1	Alternative Oncogenic Pathways	In the absence of hormone receptor signaling, TNBC is driven by alternative oncogenic pathways including EGFR signaling, PI3K-AKT-mTOR activation, and Wnt/beta-catenin signaling. Many TNBCs have TP53 mutations eliminating this tumor suppressor checkpoint.	biological_processes[0]	biological_processes	biological_processes			epidermal growth factor receptor signaling pathway	GO:0007173	epidermal growth factor receptor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}"			INCREASED																								
6844	7553	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	1	Alternative Oncogenic Pathways	In the absence of hormone receptor signaling, TNBC is driven by alternative oncogenic pathways including EGFR signaling, PI3K-AKT-mTOR activation, and Wnt/beta-catenin signaling. Many TNBCs have TP53 mutations eliminating this tumor suppressor checkpoint.	biological_processes[1]	biological_processes	biological_processes			phosphatidylinositol 3-kinase signaling	GO:0014065	phosphatidylinositol 3-kinase signaling		"{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}"			INCREASED																								
6845	7554	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	2	DNA Repair Deficiency	A significant subset of TNBC (~20%) harbors germline or somatic BRCA1/2 mutations resulting in homologous recombination deficiency. This creates sensitivity to platinum chemotherapy and PARP inhibitors through synthetic lethality.	biological_processes[0]	biological_processes	biological_processes			homologous recombination	GO:0035825	homologous recombination		"{""modifier"": ""DECREASED"", ""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}"			DECREASED																								
6846	7555	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	3	Aggressive Tumor Behavior	TNBC is characterized by high proliferation rates, early metastasis (especially to viscera and brain), and shorter time to recurrence compared to other breast cancer subtypes. The aggressive biology reflects activation of multiple oncogenic pathways and loss of tumor suppressors.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
6856	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6857	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	cell_types[1]	cell_types	cell_types			T Cell	CL:0000084	T cell		"{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
6858	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	cell_types[2]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6859	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	cell_types[3]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
6860	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	biological_processes[0]	biological_processes	biological_processes			type I interferon signaling pathway	GO:0034138	type I interferon signaling pathway		"{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0034138"", ""label"": ""type I interferon signaling pathway""}}"																											
6861	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	biological_processes[1]	biological_processes	biological_processes			autophagy	GO:0006914	autophagy		"{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}"																											
6862	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.	biological_processes[2]	biological_processes	biological_processes			phagosome maturation	GO:0090382	phagosome maturation		"{""preferred_term"": ""phagosome maturation"", ""term"": {""id"": ""GO:0090382"", ""label"": ""phagosome maturation""}}"																											
6863	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	cell_types[0]	cell_types	cell_types			Macrophage	CL:0000235	macrophage		"{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6864	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	cell_types[1]	cell_types	cell_types			T Cell	CL:0000084	T cell		"{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}"																											
6865	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	biological_processes[0]	biological_processes	biological_processes			lipid metabolic process	GO:0006629	lipid metabolic process		"{""preferred_term"": ""lipid metabolic process"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}"																											
6866	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	biological_processes[1]	biological_processes	biological_processes			cholesterol transport	GO:0030301	cholesterol transport		"{""preferred_term"": ""cholesterol transport"", ""term"": {""id"": ""GO:0030301"", ""label"": ""cholesterol transport""}}"																											
6867	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	biological_processes[2]	biological_processes	biological_processes			inflammatory response	GO:0006954	inflammatory response		"{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
6868	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.	locations[0]	locations	locations			Lung	UBERON:0002048	lung		"{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
6869	7580	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	2	Neutrophil Activation and NETosis	Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB.	cell_types[0]	cell_types	cell_types			neutrophil	CL:0000775	neutrophil		"{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}"																											
6870	7580	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	2	Neutrophil Activation and NETosis	Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB.	biological_processes[0]	biological_processes	biological_processes			neutrophil degranulation	GO:0043312	neutrophil degranulation		"{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}"																											
6871	7580	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	2	Neutrophil Activation and NETosis	Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB.	biological_processes[1]	biological_processes	biological_processes			neutrophil extracellular trap formation	GO:0062025	neutrophil extracellular trap formation		"{""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0062025"", ""label"": ""neutrophil extracellular trap formation""}}"																											
6872	7580	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	2	Neutrophil Activation and NETosis	Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB.	locations[0]	locations	locations			Lung	UBERON:0002048	lung		"{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
6873	7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	Tissue Damage	Active TB can cause cavitation and destruction of lung tissue.	locations[0]	locations	locations			Lung	UBERON:0002048	lung		"{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}"																											
6902	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin Resistance	"Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.
"	cell_types[0]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
6903	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin Resistance	"Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.
"	cell_types[1]	cell_types	cell_types			Skeletal Muscle Cell	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
6904	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin Resistance	"Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.
"	cell_types[2]	cell_types	cell_types			Adipocyte	CL:0000136	adipocyte		"{""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}"																											
6905	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin Resistance	"Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.
"	biological_processes[0]	biological_processes	biological_processes			Insulin Signaling	GO:0008286	insulin receptor signaling pathway		"{""preferred_term"": ""Insulin Signaling"", ""term"": {""id"": ""GO:0008286"", ""label"": ""insulin receptor signaling pathway""}}"																											
6906	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	Beta Cell Dysfunction	"Progressive loss of pancreatic beta cell function and mass leads to inadequate insulin secretion relative to insulin demand. Beta cell failure is the key determinant of disease progression.
"	cell_types[0]	cell_types	cell_types			Pancreatic Beta Cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6907	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	Beta Cell Dysfunction	"Progressive loss of pancreatic beta cell function and mass leads to inadequate insulin secretion relative to insulin demand. Beta cell failure is the key determinant of disease progression.
"	biological_processes[0]	biological_processes	biological_processes			Insulin Secretion	GO:0030073	insulin secretion		"{""preferred_term"": ""Insulin Secretion"", ""term"": {""id"": ""GO:0030073"", ""label"": ""insulin secretion""}}"																											
6908	7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	Hepatic Glucose Overproduction	"Impaired suppression of hepatic gluconeogenesis leads to elevated fasting glucose levels. The liver fails to respond appropriately to insulin signals.
"	cell_types[0]	cell_types	cell_types			Hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
6909	7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	Hepatic Glucose Overproduction	"Impaired suppression of hepatic gluconeogenesis leads to elevated fasting glucose levels. The liver fails to respond appropriately to insulin signals.
"	biological_processes[0]	biological_processes	biological_processes			Gluconeogenesis	GO:0006094	gluconeogenesis		"{""preferred_term"": ""Gluconeogenesis"", ""term"": {""id"": ""GO:0006094"", ""label"": ""gluconeogenesis""}}"																											
6910	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	Mitochondrial Dysfunction and Oxidative Stress	"Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.
"	cell_types[0]	cell_types	cell_types			Pancreatic Beta Cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6911	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	Mitochondrial Dysfunction and Oxidative Stress	"Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.
"	cell_types[1]	cell_types	cell_types			Skeletal Muscle Cell	CL:0000188	cell of skeletal muscle		"{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}"																											
6912	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	Mitochondrial Dysfunction and Oxidative Stress	"Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.
"	biological_processes[0]	biological_processes	biological_processes			Oxidative Stress Response	GO:0006979	response to oxidative stress		"{""preferred_term"": ""Oxidative Stress Response"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
6913	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	Mitochondrial Dysfunction and Oxidative Stress	"Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.
"	biological_processes[1]	biological_processes	biological_processes			Mitophagy	GO:0000422	autophagy of mitochondrion		"{""preferred_term"": ""Mitophagy"", ""term"": {""id"": ""GO:0000422"", ""label"": ""autophagy of mitochondrion""}}"																											
6914	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	Incretin Axis Dysfunction	"Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.
"	cell_types[0]	cell_types	cell_types			Pancreatic Beta Cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6915	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	Incretin Axis Dysfunction	"Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.
"	cell_types[1]	cell_types	cell_types			Enteroendocrine Cell	CL:0000164	enteroendocrine cell		"{""preferred_term"": ""Enteroendocrine Cell"", ""term"": {""id"": ""CL:0000164"", ""label"": ""enteroendocrine cell""}}"																											
6916	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	Incretin Axis Dysfunction	"Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.
"	biological_processes[0]	biological_processes	biological_processes			cAMP Signaling	GO:0019933	cAMP-mediated signaling		"{""preferred_term"": ""cAMP Signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}"																											
6917	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	Incretin Axis Dysfunction	"Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.
"	biological_processes[1]	biological_processes	biological_processes			Insulin Secretion Regulation	GO:0050796	regulation of insulin secretion		"{""preferred_term"": ""Insulin Secretion Regulation"", ""term"": {""id"": ""GO:0050796"", ""label"": ""regulation of insulin secretion""}}"																											
6936	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	Genetic Susceptibility	Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.	genes[0]	genes	genes			HLA-DQ2				"{""preferred_term"": ""HLA-DQ2""}"																											
6937	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	Genetic Susceptibility	Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.	genes[1]	genes	genes			HLA-DQ8				"{""preferred_term"": ""HLA-DQ8""}"																											
6938	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	Genetic Susceptibility	Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.	genes[2]	genes	genes			INS	hgnc:6081	INS		"{""preferred_term"": ""INS"", ""term"": {""id"": ""hgnc:6081"", ""label"": ""INS""}}"																											
6939	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	Environmental Triggers	Viral infections or early dietary factors (cow's milk, gluten) may trigger the autoimmune response in genetically susceptible individuals.	triggers[0]	triggers	triggers			Viral Infections				"{""preferred_term"": ""Viral Infections""}"																											
6940	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	Environmental Triggers	Viral infections or early dietary factors (cow's milk, gluten) may trigger the autoimmune response in genetically susceptible individuals.	triggers[1]	triggers	triggers			Early Dietary Factors				"{""preferred_term"": ""Early Dietary Factors""}"																											
6941	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	cell_types[0]	cell_types	cell_types			type B pancreatic cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6942	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	biological_processes[0]	biological_processes	biological_processes			type I interferon signaling pathway	GO:0060337	type I interferon signaling pathway		"{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}"																											
6943	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	biological_processes[1]	biological_processes	biological_processes			antigen processing and presentation of peptide antigen via MHC class I	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I		"{""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class I"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}"																											
6944	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	biological_processes[2]	biological_processes	biological_processes			chemokine production	GO:0032602	chemokine production		"{""preferred_term"": ""chemokine production"", ""term"": {""id"": ""GO:0032602"", ""label"": ""chemokine production""}}"																											
6945	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	biological_processes[3]	biological_processes	biological_processes			oxidative phosphorylation	GO:0006119	oxidative phosphorylation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}"			DECREASED																								
6946	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	chemical_entities[0]	chemical_entities	chemical_entities			interferon-alpha			Type I interferon that drives antiviral and antigen-presentation programs	"{""description"": ""Type I interferon that drives antiviral and antigen-presentation programs"", ""preferred_term"": ""interferon-alpha""}"																											
6947	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	chemical_entities[1]	chemical_entities	chemical_entities			interferon-gamma			Type II interferon that induces HLA class I upregulation and chemokine production	"{""description"": ""Type II interferon that induces HLA class I upregulation and chemokine production"", ""preferred_term"": ""interferon-gamma""}"																											
6948	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.	chemical_entities[2]	chemical_entities	chemical_entities			C-X-C motif chemokine 10			Chemokine (CXCL10) that recruits autoreactive T cells to islets	"{""description"": ""Chemokine (CXCL10) that recruits autoreactive T cells to islets"", ""preferred_term"": ""C-X-C motif chemokine 10""}"																											
6949	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[0]	cell_types	cell_types			type B pancreatic cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6950	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[1]	cell_types	cell_types			CD8-positive, alpha-beta cytotoxic T cell	CL:0000794	CD8-positive, alpha-beta cytotoxic T cell		"{""preferred_term"": ""CD8-positive, alpha-beta cytotoxic T cell"", ""term"": {""id"": ""CL:0000794"", ""label"": ""CD8-positive, alpha-beta cytotoxic T cell""}}"																											
6951	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[2]	cell_types	cell_types			CD4-positive, alpha-beta T cell	CL:0000624	CD4-positive, alpha-beta T cell		"{""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}"																											
6952	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[3]	cell_types	cell_types			regulatory T cell	CL:0000815	regulatory T cell		"{""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}"																											
6953	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[4]	cell_types	cell_types			B cell	CL:0000236	B cell		"{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}"																											
6954	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[5]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
6955	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	cell_types[6]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
6956	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	biological_processes[0]	biological_processes	biological_processes			T cell mediated cytotoxicity	GO:0001913	T cell mediated cytotoxicity		"{""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}"																											
6957	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	biological_processes[1]	biological_processes	biological_processes			autoantibody production				"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""autoantibody production""}"			ABNORMAL																								
6958	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	biological_processes[2]	biological_processes	biological_processes			cytokine-mediated signaling pathway	GO:0019221	cytokine-mediated signaling pathway		"{""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}"																											
6959	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.	locations[0]	locations	locations			pancreatic islet	UBERON:0000006	islet of Langerhans		"{""preferred_term"": ""pancreatic islet"", ""term"": {""id"": ""UBERON:0000006"", ""label"": ""islet of Langerhans""}}"																											
6960	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	Hyperglycemia	Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells.	assays[0]	assays	assays			Elevated Blood Glucose				"{""preferred_term"": ""Elevated Blood Glucose""}"																											
6961	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	Hyperglycemia	Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells.	assays[1]	assays	assays			Elevated Hemoglobin A1c (HbA1c)				"{""preferred_term"": ""Elevated Hemoglobin A1c (HbA1c)""}"																											
6962	7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	ER Stress and Unfolded Protein Response	Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.	cell_types[0]	cell_types	cell_types			type B pancreatic cell	CL:0000169	type B pancreatic cell		"{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}"																											
6963	7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	ER Stress and Unfolded Protein Response	Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.	biological_processes[0]	biological_processes	biological_processes			endoplasmic reticulum unfolded protein response	GO:0030968	endoplasmic reticulum unfolded protein response		"{""preferred_term"": ""endoplasmic reticulum unfolded protein response"", ""term"": {""id"": ""GO:0030968"", ""label"": ""endoplasmic reticulum unfolded protein response""}}"																											
6964	7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	ER Stress and Unfolded Protein Response	Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.	biological_processes[1]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
6965	7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	ER Stress and Unfolded Protein Response	Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.	chemical_entities[0]	chemical_entities	chemical_entities			interleukin-1beta			Proinflammatory cytokine that contributes to beta-cell stress and ER dysfunction	"{""description"": ""Proinflammatory cytokine that contributes to beta-cell stress and ER dysfunction"", ""preferred_term"": ""interleukin-1beta""}"																											
6983	7703	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	0	Mucosal Inflammation	"Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.
"	cell_types[0]	cell_types	cell_types			Colonic Epithelial Cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
6984	7703	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	0	Mucosal Inflammation	"Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.
"	biological_processes[0]	biological_processes	biological_processes			Inflammatory Response	GO:0006954	inflammatory response		"{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}"																											
6985	7704	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	1	Dysregulated Immune Response	"Aberrant immune response to commensal gut bacteria in genetically susceptible individuals. Th2-skewed response with IL-13 driving epithelial dysfunction.
"	cell_types[0]	cell_types	cell_types			T Helper 2 Cell	CL:0000546	T-helper 2 cell		"{""preferred_term"": ""T Helper 2 Cell"", ""term"": {""id"": ""CL:0000546"", ""label"": ""T-helper 2 cell""}}"																											
6986	7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	Epithelial Barrier Dysfunction	"Disrupted tight junctions and mucus layer allow bacterial translocation, perpetuating inflammation. Goblet cell depletion reduces protective mucus.
"	biological_processes[0]	biological_processes	biological_processes			Epithelial Barrier Function	GO:0090557	establishment of endothelial intestinal barrier		"{""preferred_term"": ""Epithelial Barrier Function"", ""term"": {""id"": ""GO:0090557"", ""label"": ""establishment of endothelial intestinal barrier""}}"																											
6987	7706	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	3	Loss of Microbial Diversity	"Reduced alpha diversity (species richness and evenness) in the colonic microbiome. Shannon and Chao1 indices are decreased compared to healthy controls, representing ecological collapse of the microbial community.
"	biological_processes[0]	biological_processes	biological_processes			Microbiome Community Dynamics	GO:0044003	modification by symbiont of host morphology or physiology		"{""preferred_term"": ""Microbiome Community Dynamics"", ""term"": {""id"": ""GO:0044003"", ""label"": ""modification by symbiont of host morphology or physiology""}}"																											
6988	7709	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	6	Decreased Butyrate Production	"Reduced fecal short-chain fatty acid (SCFA) concentrations, particularly butyrate. Butyrate is the primary energy source for colonocytes (providing ~70% of energy needs) and exerts anti-inflammatory effects via HDAC inhibition and GPR109A signaling.
"	biological_processes[0]	biological_processes	biological_processes			Short-chain Fatty Acid Metabolism	GO:0046459	short-chain fatty acid metabolic process		"{""preferred_term"": ""Short-chain Fatty Acid Metabolism"", ""term"": {""id"": ""GO:0046459"", ""label"": ""short-chain fatty acid metabolic process""}}"																											
6989	7710	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	7	Impaired Colonocyte Energy Metabolism	"Colonocytes deprived of butyrate shift from beta-oxidation to glycolysis, causing energy deficit. This impairs tight junction maintenance, mucus production by goblet cells, and epithelial renewal from crypt stem cells.
"	cell_types[0]	cell_types	cell_types			Colonic Epithelial Cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
6990	7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	NLRP3 Inflammasome-Mediated Pyroptosis	"Epithelial cell pyroptosis driven by NLRP3 inflammasome activation contributes to barrier disruption and inflammation. SLC6A14 promotes pyroptosis by upregulating NLRP3.
"	cell_types[0]	cell_types	cell_types			Colonic Epithelial Cell	CL:0011108	colon epithelial cell		"{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}"																											
6991	7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	NLRP3 Inflammasome-Mediated Pyroptosis	"Epithelial cell pyroptosis driven by NLRP3 inflammasome activation contributes to barrier disruption and inflammation. SLC6A14 promotes pyroptosis by upregulating NLRP3.
"	biological_processes[0]	biological_processes	biological_processes			Pyroptosis	GO:0070269	pyroptosis		"{""preferred_term"": ""Pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}"																											
6999	7728	335	Urticaria	Urticaria.yaml	pathophysiology	0	Mast cell-driven inflammation	Mast cells are central to chronic spontaneous urticaria, with multiple mediators contributing to disease.	cell_types[0]	cell_types	cell_types			mast cell	CL:0000097	mast cell		"{""preferred_term"": ""mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}"																											
7000	7728	335	Urticaria	Urticaria.yaml	pathophysiology	0	Mast cell-driven inflammation	Mast cells are central to chronic spontaneous urticaria, with multiple mediators contributing to disease.	biological_processes[0]	biological_processes	biological_processes			mast cell degranulation	GO:0043303	mast cell degranulation		"{""preferred_term"": ""mast cell degranulation"", ""term"": {""id"": ""GO:0043303"", ""label"": ""mast cell degranulation""}}"																											
7003	7739	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	0	GNAQ/GNA11 Oncogenic Mutations	GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
7004	7739	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	0	GNAQ/GNA11 Oncogenic Mutations	GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events.	biological_processes[0]	biological_processes	biological_processes			signal transduction	GO:0007165	signal transduction		"{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}"			INCREASED																								
7005	7739	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	0	GNAQ/GNA11 Oncogenic Mutations	GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events.	locations[0]	locations	locations			uvea	UBERON:0001768	uvea		"{""preferred_term"": ""uvea"", ""term"": {""id"": ""UBERON:0001768"", ""label"": ""uvea""}}"																											
7006	7740	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	1	PKC-MAPK Pathway Activation	Constitutively active GNAQ/GNA11 signaling activates phospholipase C-beta, generating diacylglycerol (DAG) that activates protein kinase C (PKC). PKC in turn activates the RAF-MEK-ERK cascade, driving melanocyte proliferation. This pathway represents a therapeutic target with MEK and PKC inhibitors.	biological_processes[0]	biological_processes	biological_processes			MAPK cascade	GO:0000165	MAPK cascade		"{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}"			INCREASED																								
7007	7741	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	2	Uncontrolled Uveal Melanocyte Proliferation	Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations.	cell_types[0]	cell_types	cell_types			melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
7008	7741	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	2	Uncontrolled Uveal Melanocyte Proliferation	Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations.	locations[0]	locations	locations			uvea	UBERON:0001768	uvea		"{""preferred_term"": ""uvea"", ""term"": {""id"": ""UBERON:0001768"", ""label"": ""uvea""}}"																											
7009	7741	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	2	Uncontrolled Uveal Melanocyte Proliferation	Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
7010	7742	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	3	BAP1 Loss and Metastatic Progression	BAP1 (BRCA1-associated protein 1) is a tumor suppressor encoding a deubiquitinase involved in chromatin remodeling and DNA damage response. BAP1 loss occurs in approximately 40% of uveal melanomas and is strongly associated with metastatic disease and poor prognosis. BAP1-deficient tumors exhibit altered gene expression patterns consistent with a more aggressive, less differentiated phenotype.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
7018	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	Visual Cortex Hyperexcitability	"Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.
"	cell_types[0]	cell_types	cell_types			cortical interneuron	CL:0008031	cortical interneuron		"{""preferred_term"": ""cortical interneuron"", ""term"": {""id"": ""CL:0008031"", ""label"": ""cortical interneuron""}}"																											
7019	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	Visual Cortex Hyperexcitability	"Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.
"	biological_processes[0]	biological_processes	biological_processes			visual perception	GO:0007601	visual perception		"{""preferred_term"": ""visual perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}"																											
7020	7753	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	1	Thalamocortical Network Dysfunction	"Visual snow syndrome appears to be a network disorder involving dysfunction in the thalamocortical pathway. The thalamus normally filters sensory information, and its dysfunction may lead to failure to suppress unnecessary visual noise.
"	biological_processes[0]	biological_processes	biological_processes			synaptic transmission	GO:0007268	chemical synaptic transmission		"{""preferred_term"": ""synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}"																											
7033	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	Melanocyte Destruction	Autoimmune-mediated destruction where the immune system targets melanocytes, leading to loss of skin pigment.	cell_types[0]	cell_types	cell_types			Melanocyte	CL:0000148	melanocyte		"{""preferred_term"": ""Melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}"																											
7034	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	Melanocyte Destruction	Autoimmune-mediated destruction where the immune system targets melanocytes, leading to loss of skin pigment.	cell_types[1]	cell_types	cell_types			CD8+ T Lymphocyte	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T Lymphocyte"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
7035	7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.	cell_types[0]	cell_types	cell_types			keratinocyte	CL:0000312	keratinocyte		"{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}"																											
7036	7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.	cell_types[1]	cell_types	cell_types			CD8+ T cell	CL:0000625	CD8-positive, alpha-beta T cell		"{""preferred_term"": ""CD8+ T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
7037	7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.	biological_processes[0]	biological_processes	biological_processes			response to type II interferon	GO:0034341	response to type II interferon		"{""preferred_term"": ""response to type II interferon"", ""term"": {""id"": ""GO:0034341"", ""label"": ""response to type II interferon""}}"																											
7038	7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.	biological_processes[1]	biological_processes	biological_processes			leukocyte chemotaxis	GO:0030595	leukocyte chemotaxis		"{""preferred_term"": ""leukocyte chemotaxis"", ""term"": {""id"": ""GO:0030595"", ""label"": ""leukocyte chemotaxis""}}"																											
7039	7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.	locations[0]	locations	locations			skin epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
7040	7790	338	Vitiligo	Vitiligo.yaml	pathophysiology	5	IL-15 and Tissue-Resident Memory T Cells	IL-15 promotes survival and cytotoxic function of CD8+ tissue-resident memory T cells (TRM) in skin, maintaining local immune surveillance and contributing to disease persistence and relapse. Serum IL-15 is elevated and correlates with disease extent.	cell_types[0]	cell_types	cell_types			CD8+ tissue-resident memory T cell	CL:0000625	CD8-positive, alpha-beta T cell	Specifically tissue-resident memory (TRM) phenotype with CD69+CD103+ markers	"{""description"": ""Specifically tissue-resident memory (TRM) phenotype with CD69+CD103+ markers"", ""preferred_term"": ""CD8+ tissue-resident memory T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}"																											
7041	7790	338	Vitiligo	Vitiligo.yaml	pathophysiology	5	IL-15 and Tissue-Resident Memory T Cells	IL-15 promotes survival and cytotoxic function of CD8+ tissue-resident memory T cells (TRM) in skin, maintaining local immune surveillance and contributing to disease persistence and relapse. Serum IL-15 is elevated and correlates with disease extent.	locations[0]	locations	locations			skin epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
7042	7791	338	Vitiligo	Vitiligo.yaml	pathophysiology	6	Innate Immune Activation	DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses.	cell_types[0]	cell_types	cell_types			dendritic cell	CL:0000451	dendritic cell		"{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}"																											
7043	7791	338	Vitiligo	Vitiligo.yaml	pathophysiology	6	Innate Immune Activation	DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses.	cell_types[1]	cell_types	cell_types			natural killer cell	CL:0000623	natural killer cell		"{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}"																											
7044	7791	338	Vitiligo	Vitiligo.yaml	pathophysiology	6	Innate Immune Activation	DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses.	locations[0]	locations	locations			skin epidermis	UBERON:0001003	skin epidermis		"{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}"																											
7053	7811	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	0	VHL Tumor Suppressor Loss	Germline heterozygous VHL mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates VHL function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.	biological_processes[0]	biological_processes	biological_processes			cellular response to hypoxia	GO:0071456	cellular response to hypoxia		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cellular response to hypoxia"", ""term"": {""id"": ""GO:0071456"", ""label"": ""cellular response to hypoxia""}}"			ABNORMAL																								
7054	7812	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	1	Loss of HIF Degradation	VHL protein (pVHL) functions as the substrate recognition component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha subunits for proteasomal degradation under normoxic conditions. Loss of VHL function prevents HIF-alpha degradation, allowing HIF accumulation even in the presence of oxygen.	biological_processes[0]	biological_processes	biological_processes			proteasome-mediated ubiquitin-dependent protein catabolic process	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process		"{""modifier"": ""DECREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}"			DECREASED																								
7055	7813	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	2	Constitutive HIF Activation	Stabilized HIF-alpha (primarily HIF-2alpha in RCC) dimerizes with HIF-1beta (ARNT) and translocates to the nucleus where it activates transcription of hypoxia-responsive genes. This occurs constitutively regardless of oxygen levels, creating a pseudo-hypoxic state.	biological_processes[0]	biological_processes	biological_processes			response to hypoxia	GO:0001666	response to hypoxia		"{""modifier"": ""INCREASED"", ""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}"			INCREASED																								
7056	7814	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	3	VEGF Overexpression and Angiogenesis	VEGF (vascular endothelial growth factor) is a direct HIF target gene. Constitutive HIF activation leads to chronic VEGF overexpression, driving extensive tumor angiogenesis. This explains the highly vascular nature of VHL-associated tumors, particularly hemangioblastomas and clear cell RCC.	biological_processes[0]	biological_processes	biological_processes			vascular endothelial growth factor signaling pathway	GO:0038084	vascular endothelial growth factor signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""vascular endothelial growth factor signaling pathway"", ""term"": {""id"": ""GO:0038084"", ""label"": ""vascular endothelial growth factor signaling pathway""}}"			INCREASED																								
7057	7814	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	3	VEGF Overexpression and Angiogenesis	VEGF (vascular endothelial growth factor) is a direct HIF target gene. Constitutive HIF activation leads to chronic VEGF overexpression, driving extensive tumor angiogenesis. This explains the highly vascular nature of VHL-associated tumors, particularly hemangioblastomas and clear cell RCC.	biological_processes[1]	biological_processes	biological_processes			angiogenesis	GO:0001525	angiogenesis		"{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}"			INCREASED																								
7058	7815	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	4	Growth Factor and Metabolic Reprogramming	HIF activates transcription of genes including PDGF, TGF-alpha, EGFR, GLUT1, and glycolytic enzymes. This promotes cell proliferation, survival, and a shift toward glycolytic metabolism (Warburg effect) that supports tumor growth.	biological_processes[0]	biological_processes	biological_processes			cellular glucose homeostasis	GO:0001678	cellular glucose homeostasis		"{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cellular glucose homeostasis"", ""term"": {""id"": ""GO:0001678"", ""label"": ""cellular glucose homeostasis""}}"			ABNORMAL																								
7059	7815	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	4	Growth Factor and Metabolic Reprogramming	HIF activates transcription of genes including PDGF, TGF-alpha, EGFR, GLUT1, and glycolytic enzymes. This promotes cell proliferation, survival, and a shift toward glycolytic metabolism (Warburg effect) that supports tumor growth.	biological_processes[1]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
7078	7835	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	0	Macrophage dysfunction and malabsorption	Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
7079	7835	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	0	Macrophage dysfunction and malabsorption	Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction.	biological_processes[0]	biological_processes	biological_processes			macrophage activation	GO:0042116	macrophage activation		"{""preferred_term"": ""macrophage activation"", ""term"": {""id"": ""GO:0042116"", ""label"": ""macrophage activation""}}"																											
7080	7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	Host susceptibility and immune dysregulation	Only a small fraction of exposed individuals develop Whipple disease, implicating rare inborn or acquired immune defects and risk from anti-TNF therapy.	biological_processes[0]	biological_processes	biological_processes			immune system process	GO:0002376	immune system process		"{""preferred_term"": ""immune system process"", ""term"": {""id"": ""GO:0002376"", ""label"": ""immune system process""}}"																											
7081	7837	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	2	TNF-inhibitordriven macrophage apoptosis	Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease.	cell_types[0]	cell_types	cell_types			macrophage	CL:0000235	macrophage		"{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}"																											
7082	7837	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	2	TNF-inhibitordriven macrophage apoptosis	Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease.	biological_processes[0]	biological_processes	biological_processes			apoptotic process	GO:0006915	apoptotic process		"{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}"																											
7096	7859	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	0	WT1 Inactivation	WT1 is a transcription factor essential for normal kidney and gonad development. Biallelic WT1 inactivation occurs in 10-20% of Wilms tumors. Germline WT1 mutations cause WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, intellectual disability) and Denys-Drash syndrome.	biological_processes[0]	biological_processes	biological_processes			cell differentiation	GO:0030154	cell differentiation		"{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}"			DECREASED																								
7097	7859	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	0	WT1 Inactivation	WT1 is a transcription factor essential for normal kidney and gonad development. Biallelic WT1 inactivation occurs in 10-20% of Wilms tumors. Germline WT1 mutations cause WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, intellectual disability) and Denys-Drash syndrome.	locations[0]	locations	locations			kidney	UBERON:0002113	kidney		"{""preferred_term"": ""kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}"																											
7098	7860	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	1	WTX/CTNNB1 Wnt Pathway Activation	WTX (AMER1) is a negative regulator of Wnt signaling mutated in approximately 15-20% of Wilms tumors. CTNNB1 (beta-catenin) activating mutations occur in approximately 15% of cases. Both result in constitutive Wnt pathway activation, promoting proliferation and blocking differentiation.	biological_processes[0]	biological_processes	biological_processes			Wnt signaling pathway	GO:0016055	Wnt signaling pathway		"{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}"			INCREASED																								
7099	7861	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	2	Blocked Nephron Differentiation	Wilms tumor arises from nephrogenic rests - foci of embryonic blastemal cells that persist beyond the normal period of nephrogenesis. These cells retain proliferative capacity but fail to undergo terminal differentiation into mature nephrons.	biological_processes[0]	biological_processes	biological_processes			cell population proliferation	GO:0008283	cell population proliferation		"{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}"			INCREASED																								
7115	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	Copper Accumulation	"ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.
"	biological_processes[0]	biological_processes	biological_processes			copper ion transport	GO:0006825	copper ion transport		"{""preferred_term"": ""copper ion transport"", ""term"": {""id"": ""GO:0006825"", ""label"": ""copper ion transport""}}"																											
7116	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	Copper Accumulation	"ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.
"	biological_processes[1]	biological_processes	biological_processes			copper ion homeostasis	GO:0055070	copper ion homeostasis		"{""preferred_term"": ""copper ion homeostasis"", ""term"": {""id"": ""GO:0055070"", ""label"": ""copper ion homeostasis""}}"																											
7117	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	Copper Accumulation	"ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.
"	cellular_components[0]	cellular_components	cellular_components			Golgi apparatus	GO:0005794	Golgi apparatus		"{""preferred_term"": ""Golgi apparatus"", ""term"": {""id"": ""GO:0005794"", ""label"": ""Golgi apparatus""}}"																											
7118	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	Hepatocyte Injury	"Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.
"	cell_types[0]	cell_types	cell_types			hepatocyte	CL:0000182	hepatocyte		"{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}"																											
7119	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	Hepatocyte Injury	"Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.
"	locations[0]	locations	locations			liver	UBERON:0002107	liver		"{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}"																											
7120	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	Hepatocyte Injury	"Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.
"	biological_processes[0]	biological_processes	biological_processes			response to oxidative stress	GO:0006979	response to oxidative stress		"{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}"																											
7121	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	Hepatocyte Injury	"Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.
"	biological_processes[1]	biological_processes	biological_processes			mitophagy	GO:0000423	mitophagy		"{""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000423"", ""label"": ""mitophagy""}}"																											
7122	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"	cell_types[0]	cell_types	cell_types			astrocyte	CL:0000127	astrocyte		"{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}"																											
7123	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"	cell_types[1]	cell_types	cell_types			microglial cell	CL:0000129	microglial cell		"{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}"																											
7124	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"	locations[0]	locations	locations			collection of basal ganglia	UBERON:0010011	collection of basal ganglia		"{""preferred_term"": ""collection of basal ganglia"", ""term"": {""id"": ""UBERON:0010011"", ""label"": ""collection of basal ganglia""}}"																											
7125	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"	locations[1]	locations	locations			putamen	UBERON:0001874	putamen		"{""preferred_term"": ""putamen"", ""term"": {""id"": ""UBERON:0001874"", ""label"": ""putamen""}}"																											
7126	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"	biological_processes[0]	biological_processes	biological_processes			neuron death	GO:0070997	neuron death		"{""preferred_term"": ""neuron death"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}"																											
7127	7882	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	3	Cuproptosis	"Copper-dependent cell death involving binding of copper to lipoylated enzymes in the tricarboxylic acid (TCA) cycle, leading to proteotoxic stress and mitochondrial dysfunction.
"	biological_processes[0]	biological_processes	biological_processes			cuproptosis	GO:0160119	cuproptosis		"{""preferred_term"": ""cuproptosis"", ""term"": {""id"": ""GO:0160119"", ""label"": ""cuproptosis""}}"																											
7128	7883	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	4	Ferroptosis	"Iron-related cell death pathway involving phospholipid peroxidation. Increased iron deposits in Wilson disease liver may contribute to ferroptosis alongside copper-mediated injury.
"	biological_processes[0]	biological_processes	biological_processes			ferroptosis	GO:0097707	ferroptosis		"{""preferred_term"": ""ferroptosis"", ""term"": {""id"": ""GO:0097707"", ""label"": ""ferroptosis""}}"																											
7198	7956	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	pathophysiology	0	TTT complex dysfunction	"Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.
"	cell_types[0]	cell_types	cell_types			Neuron	CL:0000540	neuron		"{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}"																											
7199	7956	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	pathophysiology	0	TTT complex dysfunction	"Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.
"	biological_processes[0]	biological_processes	biological_processes			Nonsense-mediated decay	GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay		"{""preferred_term"": ""Nonsense-mediated decay"", ""term"": {""id"": ""GO:0000184"", ""label"": ""nuclear-transcribed mRNA catabolic process, nonsense-mediated decay""}}"																											
7200	7956	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	pathophysiology	0	TTT complex dysfunction	"Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.
"	locations[0]	locations	locations			Brain	UBERON:0000955	brain		"{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}"																											
